assays_description,assays_assay_id,assays_assay_category,assays_chembl_id,assays_tid,assays_bao_format,assays_assay_cell_type,assays_cell_id,assays_assay_test_type,assays_src_id,assays_assay_strain,assays_tissue_id,assays_assay_organism,assays_variant_id,assays_assay_tax_id,assays_confidence_score,assays_curated_by,assays_relationship_type,assays_assay_type,assays_assay_tissue,assays_doc_id,assays_assay_subcellular_fraction,assays_src_assay_id
Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7524,,CHEMBL618647,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,7525,,CHEMBL618648,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,7526,,CHEMBL618649,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7527,,CHEMBL618650,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,7528,,CHEMBL618651,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,7529,,CHEMBL876497,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7530,,CHEMBL618652,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,9866,,
Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,7531,,CHEMBL618653,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,9866,,
Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,7532,,CHEMBL618654,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,9866,,
Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,7533,,CHEMBL618655,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6351,,
Compound was tested for solubility in water,7534,,CHEMBL618656,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1465,,
Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),7535,,CHEMBL618657,22229,BAO_0000100,,,,1,,,,,,0,Intermediate,U,P,,5182,,
Solubility was determined,7536,,CHEMBL618658,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17847,,
solubility in water (ug/mL) at 37 degree C.,7537,,CHEMBL618659,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15339,,
First pass metabolism and metabolic bioavailability using rat hepatic microsomes,7538,,CHEMBL618660,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5202,,
In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,7539,,CHEMBL618661,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1088,,
Half life in rats,7540,,CHEMBL873807,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3169,,
Half life in Dawley rat,7541,,CHEMBL618662,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5353,,
Half life period after 3 mg/kg iv administration,7542,,CHEMBL618663,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2864,,
Half life period after 3 mg/kg iv administration in rat,7543,,CHEMBL618664,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2864,,
Half life period after 3 mg/kg iv administration in the rat,7544,,CHEMBL618665,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2864,,
Half life period in female Sprague-Dawley rats,7545,,CHEMBL876498,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6362,,
Half life period in rat,7546,,CHEMBL618666,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6249,,
Half-life in rats was determined,7547,,CHEMBL620440,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3169,,
Half-life in rats with metabolic oxidation,7548,,CHEMBL620441,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3169,,
Half-life in rats,7549,,CHEMBL620442,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3169,,
T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7550,,CHEMBL620443,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17260,,
T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,7551,,CHEMBL620444,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17260,,
T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7552,,CHEMBL620445,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17260,,
T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,7553,,CHEMBL620446,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17260,,
Biological half-life measured in plasma of rat,7554,,CHEMBL620447,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2879,,
Biological half-life measured in plasma of rat; 22-25,7555,,CHEMBL621129,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2879,,
Biological half-life measured in plasma of rat; 9-16,7556,,CHEMBL621130,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2879,,
Compound was evaluated for its half life when administered intravenously in rat,7557,,CHEMBL873808,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3184,,
Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,7558,,CHEMBL876598,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4891,,
Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,7559,,CHEMBL621131,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,429,,
Half life (T1/2) after oral administration in rat,7560,,CHEMBL621132,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5656,,
Half life of compound after iv administration of 20 mg/kg dose in rat,7561,,CHEMBL621133,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4413,,
Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,7562,,CHEMBL621312,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Expert,N,A,,3598,,
Half life of compound was determined in rat,7563,,CHEMBL621313,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17267,,
Half life of compound was determined in rat blood,7564,,CHEMBL621314,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,4727,,
Half life at 1 mg/kg was determined in rat,7565,,CHEMBL621315,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17651,,
Half life at 10 mg/kg was determined in rat,7566,,CHEMBL621316,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17651,,
Half life in rats,7567,,CHEMBL621317,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,401,,
Half life in rats in hours,7568,,CHEMBL621318,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4942,,
Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,7569,,CHEMBL621319,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17735,,
Half life was calculated at a single intravenous administration of 20 mg/kg in rat,7570,,CHEMBL621377,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6056,,
Half life was determined,7571,,CHEMBL621378,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5213,,
Half life after i.v. administration,7572,,CHEMBL876599,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6616,,
Half life in rat after intravenous administration at a concentration 0.5 mg/kg,7573,,CHEMBL621379,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5937,,
Half life in rat plasma,7574,,CHEMBL621380,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5819,,
Half life in rat plasma; Not detected,7575,,CHEMBL621381,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5819,,
Half life in rats,7576,,CHEMBL618515,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6803,,
Half life period of compound was determined after peroral administration,7577,,CHEMBL618516,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17804,,
Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,7578,,CHEMBL618517,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17804,,
Half life period in rat,7579,,CHEMBL618518,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5948,,
Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,7580,,CHEMBL618519,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1916,,
Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,7581,,CHEMBL618698,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1916,,
Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,7582,,CHEMBL618862,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1916,,
Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,7583,,CHEMBL618863,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4890,,
Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,7584,,CHEMBL618864,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17764,,
Half life time in rat the dose of 2 mg/kg,7585,,CHEMBL618865,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4727,,
Half-life 24 hr after 10 mg/kg iv administration in rats,7586,,CHEMBL618866,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17509,,
Half-life 24 hr after 2 mg/kg iv administration in rats,7587,,CHEMBL618867,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17509,,
Half-life consistent with the observed metabolic steady state in rats,7588,,CHEMBL875828,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6597,,
Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,7589,,CHEMBL618868,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17735,,
Half-life for oxidative metabolic stability was determined using male human,7590,,CHEMBL618869,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6597,,
"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",7591,,CHEMBL618870,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17670,,
Half-life in rat plasma,7592,,CHEMBL618871,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1696,,
Half-life in rat plasma was determined,7593,,CHEMBL618872,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1742,,
Half-life in rats was determined,7594,,CHEMBL873816,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17800,,
Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,7595,,CHEMBL618873,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,12923,,
Area under curve after oral dose of 0.1 mg//kg,7596,,CHEMBL621602,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11954,,
Area under curve after oral dose of 0.3 mg/kg,7597,,CHEMBL621603,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,11954,,
Area under curve after oral dose of 1 mg/kg,7598,,CHEMBL621604,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,11954,,
Area under curve after oral dose of 10 mg/kg,7599,,CHEMBL621605,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,11954,,
Area under curve after oral dose of 23.4 mg/kg,7600,,CHEMBL621606,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,11954,,
Area under curve after oral dose of 3 mg/kg,7601,,CHEMBL621607,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,11954,,
Area under curve after oral dose of 3.87 mg/kg,7602,,CHEMBL621608,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,11954,,
Area under curve was determined,7603,,CHEMBL621609,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,5237,,
Area under curve at a dose of 10 mg/kg,7604,,CHEMBL621610,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,4026,,
Area under curve was determined; ND=No data,7605,,CHEMBL621611,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5237,,
Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,7606,,CHEMBL621612,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,7607,,CHEMBL622308,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,7608,,CHEMBL622309,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,7609,,CHEMBL622310,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,7610,,CHEMBL622311,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,7611,,CHEMBL622312,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,7612,,CHEMBL622931,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,7613,,CHEMBL622932,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,7614,,CHEMBL622736,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,7615,,CHEMBL622737,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,7616,,CHEMBL622738,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,7617,,CHEMBL622739,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,7618,,CHEMBL622740,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,7619,,CHEMBL622741,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,7620,,CHEMBL622742,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,7621,,CHEMBL622743,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
AUC in mice,7622,,CHEMBL622744,50594,BAO_0000218,,,,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,11637,,
Area under curve was measured from the graph obtained from concentration Vs time,7623,,CHEMBL624134,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11149,,
Area under curve value of compound per hour after oral administration,7624,,CHEMBL624135,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10016,,
Area under curve was determined after oral administration in rats,7625,,CHEMBL624136,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17796,,
Area under curve was determined after oral administration in rats; No data,7626,,CHEMBL624137,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17796,,
Area under curve was determined after oral administration in rats;No data,7627,,CHEMBL624320,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17796,,
Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,7628,,CHEMBL624321,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12923,,
Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,7629,,CHEMBL624322,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Area under curve was determined for the compound after iv dose of 5.06 in rats,7630,,CHEMBL624323,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,7631,,CHEMBL624324,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,7632,,CHEMBL624325,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,7633,,CHEMBL624326,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,7634,,CHEMBL624327,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,7635,,CHEMBL624328,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Area under curve was determined in Dogs after peroral administration,7636,,CHEMBL627848,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14169,,
Area under curve was determined in Rats after peroral administration,7637,,CHEMBL627849,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14169,,
Area under curve was determined in carotid blood of rat when administered intradermally,7638,,CHEMBL627850,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14258,,
Area under curve was determined in portal blood of rat when administered intradermally,7639,,CHEMBL627851,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14258,,
Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,7640,,CHEMBL627852,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,7641,,CHEMBL627853,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),7642,,CHEMBL627854,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,7643,,CHEMBL627855,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),7644,,CHEMBL627856,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,7645,,CHEMBL875339,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),7646,,CHEMBL627857,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,7647,,CHEMBL627858,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,11195,,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,7648,,CHEMBL627859,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,10130,,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,7649,,CHEMBL627860,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,10130,,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,7650,,CHEMBL627019,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,10130,,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,7651,,CHEMBL627020,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,10130,,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,7652,,CHEMBL627021,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,10130,,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,7653,,CHEMBL627022,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10130,,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,7654,,CHEMBL627023,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10130,,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,7655,,CHEMBL627024,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,10130,,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,7656,,CHEMBL627025,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,10130,,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,7657,,CHEMBL627026,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,10130,,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,7658,,CHEMBL627027,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,10130,,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,7659,,CHEMBL627028,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,10130,,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,7660,,CHEMBL627029,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,10130,,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,7661,,CHEMBL627030,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,10130,,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,7662,,CHEMBL627031,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,10130,,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,7663,,CHEMBL627032,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,10130,,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,7664,,CHEMBL627033,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10130,,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,7665,,CHEMBL627034,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10130,,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,7666,,CHEMBL627035,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,10130,,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,7667,,CHEMBL627036,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,10130,,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,7668,,CHEMBL875340,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,10130,,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,7669,,CHEMBL627037,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,10130,,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,7670,,CHEMBL627038,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,10130,,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,7671,,CHEMBL627039,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,10130,,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,7672,,CHEMBL627040,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10130,,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,7673,,CHEMBL624663,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,10130,,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,7674,,CHEMBL625963,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,10130,,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,7675,,CHEMBL876799,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,10130,,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,7676,,CHEMBL626133,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,10130,,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,7677,,CHEMBL626134,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10130,,
In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,7678,,CHEMBL626135,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6295,,
In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,7679,,CHEMBL626136,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6296,,
In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,7680,,CHEMBL626137,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6296,,
In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,7681,,CHEMBL626138,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6295,,
In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,7682,,CHEMBL626139,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6296,,
C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7683,,CHEMBL626140,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17260,,
C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,7684,,CHEMBL626141,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17260,,
C24h in rat p.o. at 20 mg/kg concentration,7685,,CHEMBL626142,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17686,,
Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7686,,CHEMBL627930,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,7687,,CHEMBL627931,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,7688,,CHEMBL627932,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7689,,CHEMBL627933,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,7690,,CHEMBL627934,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,7691,,CHEMBL627935,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,7692,,CHEMBL627936,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,7693,,CHEMBL627937,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,7694,,CHEMBL627938,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,7695,,CHEMBL627939,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,7696,,CHEMBL627940,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,7697,,CHEMBL627941,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7698,,CHEMBL876800,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,7699,,CHEMBL627942,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,7700,,CHEMBL627943,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,7701,,CHEMBL627944,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,7702,,CHEMBL627945,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,7703,,CHEMBL628584,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA at 15 min,7704,,CHEMBL628585,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA at 1 hr,7705,,CHEMBL628586,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA at 30 min,7706,,CHEMBL628587,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA at 4 hr,7707,,CHEMBL628588,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,7708,,CHEMBL628589,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,7709,,CHEMBL625304,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,7710,,CHEMBL625305,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,7711,,CHEMBL625306,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,7712,,CHEMBL625307,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,7713,,CHEMBL625308,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,7714,,CHEMBL627740,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,7715,,CHEMBL627741,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7716,,CHEMBL627742,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,7717,,CHEMBL627743,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,7718,,CHEMBL627744,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9866,,
Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,7719,,CHEMBL627745,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,7720,,CHEMBL627746,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,7721,,CHEMBL627747,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,7722,,CHEMBL876810,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,7723,,CHEMBL627748,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,7724,,CHEMBL627749,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7725,,CHEMBL627750,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,7726,,CHEMBL618728,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,7727,,CHEMBL618729,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA at 15 min,7728,,CHEMBL618730,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA at 1 hr,7729,,CHEMBL618731,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA at 30 min,7730,,CHEMBL618732,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA at 4 hr,7731,,CHEMBL618733,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,7732,,CHEMBL618734,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,7733,,CHEMBL618735,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,7734,,CHEMBL876602,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,7735,,CHEMBL618736,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,7736,,CHEMBL618737,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,7737,,CHEMBL618738,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,7738,,CHEMBL618739,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,7739,,CHEMBL618740,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7740,,CHEMBL618741,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,7741,,CHEMBL618742,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,7742,,CHEMBL618743,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,9866,,
Half-life from rat plasma at a single oral dose of 25 mg/kg,7743,,CHEMBL618744,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17752,,
Half-life in male rat,7744,,CHEMBL618745,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5610,,
Half-life in rat after peroral administration at 10 mg/kg concentration,7745,,CHEMBL620479,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Half-life in rat after peroral administration at 5 mg/kg concentration,7746,,CHEMBL620480,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Half-life in rat at a dose of 3 mg/kg,7747,,CHEMBL620481,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17771,,
Half-life was evaluated in rats,7748,,CHEMBL620482,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1974,,
Half-life was measured in rat,7749,,CHEMBL876603,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4239,,
Half-life period for the compound was determined in rats at 50 mg/kg dose,7750,,CHEMBL620483,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6681,,
Half-life period in rats after intravenous administration at 5 mg/kg,7751,,CHEMBL620484,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17752,,
Half-life period in rat at 10 mg/kg,7752,,CHEMBL620485,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6046,,
"Half-life period was determined in rats at 10 mg/kg, p.o. dose",7753,,CHEMBL620486,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
"Half-life period was determined in rats at 20 mg/kg, i.p. dose",7754,,CHEMBL620487,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
"Half-life period was determined in rats at 2 mg/kg, i.v. dose",7755,,CHEMBL620488,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
Half-life time in rat the dose of 2 mg/kg,7756,,CHEMBL620489,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4727,,
Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,7757,,CHEMBL620490,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1088,,
In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,7758,,CHEMBL620491,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5610,,
"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",7759,,CHEMBL876604,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,3032,,
Oral half life was determined,7760,,CHEMBL620492,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5199,,
"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",7761,,CHEMBL620493,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14941,,
Pharmacokinetic property (t1/2) in rat,7762,,CHEMBL620494,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4408,,
Plasma elimination half-life was determined,7763,,CHEMBL620495,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2552,,
Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,7764,,CHEMBL620496,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5199,,
Plasma half life was observed after intravenous administration in rat,7765,,CHEMBL620497,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15662,,
Plasma half-life was determined,7766,,CHEMBL620498,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1465,,
Plasma half-life following oral administration in Fisher rats,7767,,CHEMBL620499,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1446,,
Plasma half-life in rat,7768,,CHEMBL620500,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6824,,
Plasmatic Half-life after intravenous administration to rat,7769,,CHEMBL873809,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17533,,
T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,7770,,CHEMBL620501,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5979,,
Terminal half life after intravenous administration (1 mg/kg) in rat,7771,,CHEMBL620502,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4689,,
Terminal half life in Rat at a oral dose of 5 mg/kg,7772,,CHEMBL620503,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4689,,
Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,7773,,CHEMBL620504,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2463,,
Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,7774,,CHEMBL876605,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4883,,
Tested for half life value after oral administration at dosage of 4 mg/kg in rat,7775,,CHEMBL620505,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4883,,
plasma half life was observed after intravenous administration in rat,7776,,CHEMBL873811,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15662,,
Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,7777,,CHEMBL624016,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Expert,N,A,,3598,,
Half life of compound determined in rat,7778,,CHEMBL624017,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4576,,
Mean residence time determined in rat,7779,,CHEMBL624018,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4576,,
Plasma half life determined in rat,7780,,CHEMBL624019,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4576,,
Compound was evaluated for Tmax in brain after intravenous administration in male rats,7781,,CHEMBL624020,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,4910,,
Compound was evaluated for pharmacokinetic parameter maximum time period,7782,,CHEMBL624201,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4891,,
Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,7783,,CHEMBL872528,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,429,,
In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,7784,,CHEMBL624202,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,7785,,CHEMBL624203,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,7786,,CHEMBL624350,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,7787,,CHEMBL621320,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,7788,,CHEMBL621321,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17582,,
Maximum time (Tmax) required to reach Cmax in rats,7789,,CHEMBL621322,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4026,,
Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,7790,,CHEMBL621323,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4890,,
Maximum time of clearance of compound in rats after peroral administration,7791,,CHEMBL621324,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6571,,
Maximum time at the dose of 2 mg/kg in rat,7792,,CHEMBL621325,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4727,,
Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,7793,,CHEMBL875837,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17651,,
Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,7794,,CHEMBL621326,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17651,,
Tmax in Guinea pig (PO dose),7795,,CHEMBL621327,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14465,,
"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",7796,,CHEMBL621328,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14941,,
Pharmacokinetic parameter (Tmax) in rat,7797,,CHEMBL621329,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5960,,
Pharmacokinetic parameter (Tmax) was estimated,7798,,CHEMBL621330,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5022,,
Pharmacokinetic property (Tmax) in rat,7799,,CHEMBL621331,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4408,,
Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,7800,,CHEMBL621332,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5983,,
T max in Rat at a oral dose of 5 mg/kg,7801,,CHEMBL621333,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4689,,
T max was determined at 10 mg/kg po dose in rats,7802,,CHEMBL621334,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),7803,,CHEMBL621335,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,7804,,CHEMBL621336,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14180,,
Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,7805,,CHEMBL621337,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14180,,
Area under curve was measured after i.v. administration into Beagle dog.,7806,,CHEMBL621338,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14599,,
Area under curve was measured after iv administration into Beagle dog,7807,,CHEMBL875838,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14599,,
Area under curve was measured after po administration into Beagle dog,7808,,CHEMBL621339,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14599,,
Area under curve was measured after po administration into Beagle dog.,7809,,CHEMBL621340,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14599,,
Area under curve was measured at peroral dose of 3 mg/kg,7810,,CHEMBL621341,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,15675,,
Area under curve was measured by using concentration Vs time,7811,,CHEMBL621342,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12706,,
Area under curve was measured by using concentration Vs time; not tested,7812,,CHEMBL621343,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12706,,
Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),7813,,CHEMBL621344,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,9750,,
Area under curve(AUC) was measured in mice after oral administration.,7814,,CHEMBL621345,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,9750,,
Area under curve(AUC) value of the compound,7815,,CHEMBL621346,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14691,,
Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,7816,,CHEMBL621347,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14691,,
Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,7817,,CHEMBL621348,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14691,,
Area under curve(carotid artery) was determined by the availability in blood,7818,,CHEMBL621349,22224,BAO_0000019,,,,1,,178.0,,,,0,Autocuration,U,A,Blood,2939,,
Area under curve(carotid artery) was determined by the availability in blood; ND means no data,7819,,CHEMBL621350,22224,BAO_0000019,,,,1,,178.0,,,,0,Autocuration,U,A,Blood,2939,,
Area under curve(carotid artery) was determined by the availability in blood; No data,7820,,CHEMBL875839,22224,BAO_0000019,,,,1,,178.0,,,,0,Autocuration,U,A,Blood,2939,,
Area under curve(portal vein) was determined by the availability in blood,7821,,CHEMBL620211,22224,BAO_0000019,,,,1,,178.0,,,,0,Autocuration,U,A,Blood,2939,,
Area under curve(portal vein) was determined by the availability in blood; ND means no data,7822,,CHEMBL620212,22224,BAO_0000019,,,,1,,178.0,,,,0,Autocuration,U,A,Blood,2939,,
Area under curve(portal vein) was determined by the availability in blood; No data,7823,,CHEMBL620213,22224,BAO_0000019,,,,1,,178.0,,,,0,Autocuration,U,A,Blood,2939,,
"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",7824,,CHEMBL620214,50797,BAO_0000218,,,,1,,1969.0,Macaca mulatta,,9544.0,1,Intermediate,N,A,Plasma,9552,,
"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",7825,,CHEMBL620215,50797,BAO_0000218,,,,1,,1969.0,Macaca mulatta,,9544.0,1,Intermediate,N,A,Plasma,9552,,
Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,7826,,CHEMBL620216,50797,BAO_0000218,,,,1,,1969.0,Macaca mulatta,,9544.0,1,Intermediate,N,A,Plasma,9552,,
"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",7827,,CHEMBL620888,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,9552,,
"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",7828,,CHEMBL620889,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,9552,,
Area under plasma concentration vs time curve observed in rats for 0-3 h,7829,,CHEMBL620890,22224,BAO_0000019,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,9552,,
Area under plasma time curve determined in male rat,7830,,CHEMBL620891,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,11911,,
Area under the MAP curve measured over 5 min.,7831,,CHEMBL620892,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,16618,,
Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,7832,,CHEMBL621079,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14387,,
Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,7833,,CHEMBL621080,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14387,,
Area under the concentration vs time curve in dog at 10 mg/kg oral dose,7834,,CHEMBL621081,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12836,,
Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,7835,,CHEMBL621082,100712,BAO_0000218,,,,1,,,Cricetinae,,10026.0,1,Intermediate,N,A,,12836,,
Area under the concentration vs time curve in rat at 10 mg/kg oral dose,7836,,CHEMBL621083,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12836,,
Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,7837,,CHEMBL621084,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14339,,
Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,7838,,CHEMBL621085,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14339,,
Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,7839,,CHEMBL621086,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14339,,
Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),7840,,CHEMBL621087,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,10524,,
Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),7841,,CHEMBL622607,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9994,,
Serum AUC in marmosets (IV dose),7842,,CHEMBL622608,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,11325,,
Area under the curve after intravenous administration at a dose of 10 umol/kg,7843,,CHEMBL624481,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12536,,
Area under the curve after intravenous administration at a dose of 2 umol/kg,7844,,CHEMBL624482,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12536,,
Area under the curve after intravenous administration at a dose of 4 umol/kg,7845,,CHEMBL624483,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12536,,
Area under the curve after intravenous administration at a dose of 40 umol/kg,7846,,CHEMBL624484,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12536,,
Area under the curve after intravenous administration at a dose of 5 umol/kg,7847,,CHEMBL624485,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12536,,
Area under the curve for fumarate salt was evaluated in F344 Rats.,7848,,CHEMBL624486,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15556,,
Area under the curve for the compound was calculated.,7849,,CHEMBL624487,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2809,,
Area under the curve in concentration/ time,7850,,CHEMBL624488,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9511,,
Area under the curve administered intraintestinal in rats.,7851,,CHEMBL624489,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12818,,
Area under the curve administered intravenously in rats.,7852,,CHEMBL625184,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12818,,
Area under the curve during intravenous administration,7853,,CHEMBL625185,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15118,,
Area under the curve during intravenous administration; Not determined,7854,,CHEMBL875954,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15118,,
Area under the curve during systemic administration,7855,,CHEMBL625186,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15118,,
Area under the curve during systemic administration; Not determined,7856,,CHEMBL625187,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15118,,
Area under the curve was calculated for the compound.,7857,,CHEMBL625188,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2632,,
Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,7858,,CHEMBL625189,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,7859,,CHEMBL625190,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,7860,,CHEMBL621733,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,7861,,CHEMBL621734,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,7862,,CHEMBL621735,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11149,,
Clearance of the drug was measured in the plasma of rat; No data,7863,,CHEMBL621736,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17796,,
The pharmacokinetic parameter plasma clearance in vivo in rats,7864,,CHEMBL621737,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5247,,
Plasma clearance at the dose of 2 mg/kg in rat,7865,,CHEMBL621738,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4727,,
CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,7866,,CHEMBL622806,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5654,,
CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,7867,,CHEMBL623519,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5654,,
CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7868,,CHEMBL623520,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17260,,
Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,7869,,CHEMBL623521,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17065,,
Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,7870,,CHEMBL623522,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17671,,
Clearance rate in rat,7871,,CHEMBL623523,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6672,,
Clearance rate in rat,7872,,CHEMBL623690,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6673,,
Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,7873,,CHEMBL623691,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,7874,,CHEMBL623692,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,7875,,CHEMBL623693,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,7876,,CHEMBL623694,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Clearance of compound after iv administration of 20 mg/kg dose in rat,7877,,CHEMBL623695,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4413,,
Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,7878,,CHEMBL623696,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,7879,,CHEMBL623697,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,7880,,CHEMBL623698,22224,BAO_0000218,,,In vivo,1,,1969.0,Macaca mulatta,,9544.0,0,Intermediate,U,A,Plasma,5005,,
Compound was tested for its plasma clearance rate in Sprague Dawley rats,7881,,CHEMBL623699,22224,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,0,Intermediate,U,A,Plasma,5005,,
Mean (%CV) PK parameters for CL(mL/min/kg).,7882,,CHEMBL623700,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15765,,
Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,7883,,CHEMBL623701,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3747,,
Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,7884,,CHEMBL623702,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16366,,
Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,7885,,CHEMBL623703,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4199,,
Plasma clearance in rat was determined,7886,,CHEMBL623704,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17267,,
Plasma clearance in rat after administration of 2 mg/kg iv,7887,,CHEMBL623705,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6535,,
Plasma clearance in rat after administration of 2 mg/kg iv,7888,,CHEMBL623706,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6535,,
Plasma clearance was determined,7889,,CHEMBL623707,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
Plasma clearance in rat,7890,,CHEMBL623708,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5960,,
Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,7891,,CHEMBL623709,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5937,,
Plasma clearance in rat by iv administration,7892,,CHEMBL623710,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5871,,
Plasma clearance in rat by iv administration at a dose of 3 mg/kg,7893,,CHEMBL623711,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5874,,
Plasma clearance in rat p.o.,7894,,CHEMBL623712,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6504,,
Plasma clearance in rats,7895,,CHEMBL623713,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6803,,
Plasma clearance was determined; ND denotes no data,7896,,CHEMBL623714,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
Plasma clearance was determined; ND denotes not determined,7897,,CHEMBL623715,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,7898,,CHEMBL623716,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1916,,
Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,7899,,CHEMBL622980,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5199,,
Plasma administration to rats,7900,,CHEMBL622981,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16367,,
Plasma clearance of the compound in female Sprague-Dawley rats,7901,,CHEMBL622982,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6362,,
Plasma clearance was observed after intravenous administration in rat,7902,,CHEMBL622983,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15662,,
Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,7903,,CHEMBL622984,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6215,,
Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,7904,,CHEMBL622985,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1466,,
plasma clearance was observed after intravenous administration in rat,7905,,CHEMBL623631,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15662,,
In vivo CL/F determined,7906,,CHEMBL623632,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4723,,
Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,7907,,CHEMBL623633,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2792,,
Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,7908,,CHEMBL623634,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2792,,
Compound was tested for the lower blood clearance in rat,7909,,CHEMBL623635,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5213,,
Evaluated for the low clearance in rat (in vivo),7910,,CHEMBL621195,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4687,,
Pharmacokinetic property (CLb)of the compound was determined in rat,7911,,CHEMBL621196,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3371,,
Rapid clearance after intravenous administration in rat was determined,7912,,CHEMBL875287,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4690,,
Clearance measured in rat,7913,,CHEMBL621197,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5702,,
Compound was evaluated for plasma clearance in rat,7914,,CHEMBL621198,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,740,,
Low plasma clearance was calculated in rat,7915,,CHEMBL621199,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4853,,
Pharmacokinetic property (Clp) in rat,7916,,CHEMBL621200,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5789,,
Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,7917,,CHEMBL621201,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4527,,
Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,7918,,CHEMBL621202,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4527,,
Plasma clearance after IV dosing at 0.5 mg/kg in rat,7919,,CHEMBL621203,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Plasma clearance after IV dosing at 1 mg/kg in rat,7920,,CHEMBL621204,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,7921,,CHEMBL621205,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,7922,,CHEMBL621206,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,7923,,CHEMBL621207,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,7924,,CHEMBL621208,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,7925,,CHEMBL621209,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,7926,,CHEMBL876484,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7927,,CHEMBL621210,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,7928,,CHEMBL621211,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,7929,,CHEMBL621212,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA at 15 min,7930,,CHEMBL621213,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA at 1 hr,7931,,CHEMBL621214,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA at 30 min,7932,,CHEMBL621215,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA at 4 hr,7933,,CHEMBL621216,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,7934,,CHEMBL621217,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,7935,,CHEMBL621218,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,7936,,CHEMBL621219,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,7937,,CHEMBL621220,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,7938,,CHEMBL621221,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,7939,,CHEMBL621222,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,7940,,CHEMBL621223,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,7941,,CHEMBL876485,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7942,,CHEMBL621224,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,7943,,CHEMBL621225,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,7944,,CHEMBL621226,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9866,,
Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,7945,,CHEMBL621227,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,7946,,CHEMBL621228,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,7947,,CHEMBL621229,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,7948,,CHEMBL621230,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,7949,,CHEMBL621231,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,7950,,CHEMBL621232,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7951,,CHEMBL621233,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,7952,,CHEMBL621234,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,7953,,CHEMBL621235,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7954,,CHEMBL621236,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,7955,,CHEMBL621237,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,7956,,CHEMBL876486,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9866,,
Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,7957,,CHEMBL622436,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,9866,,
Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,7958,,CHEMBL622437,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,9866,,
Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,7959,,CHEMBL622438,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,9866,,
Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,7960,,CHEMBL622439,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,7961,,CHEMBL622440,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,7962,,CHEMBL622441,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,7963,,CHEMBL622442,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,7964,,CHEMBL622443,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,7965,,CHEMBL622444,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,7966,,CHEMBL622445,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,7967,,CHEMBL622446,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7968,,CHEMBL622447,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,7969,,CHEMBL622448,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,7970,,CHEMBL622449,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,7971,,CHEMBL622450,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,7972,,CHEMBL622451,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of GdDTPA at 15 min,7973,,CHEMBL622452,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of GdDTPA at 1 hr,7974,,CHEMBL622453,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of GdDTPA at 30 min,7975,,CHEMBL622454,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of GdDTPA at 4 hr,7976,,CHEMBL622455,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,7977,,CHEMBL876024,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
T max was determined at 3 mg/kg po dose in rats,7978,,CHEMBL622456,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",7979,,CHEMBL622457,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",7980,,CHEMBL622458,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,7981,,CHEMBL622459,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15022,,
The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,7982,,CHEMBL873343,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15022,,
The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,7983,,CHEMBL622460,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15022,,
Time for maximum plasma concentration determined in rat,7984,,CHEMBL622461,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4576,,
Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,7985,,CHEMBL622462,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6681,,
Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,7986,,CHEMBL622463,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,7987,,CHEMBL622464,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,7988,,CHEMBL622465,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,7989,,CHEMBL622466,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,7990,,CHEMBL622467,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Time of maximum plasma concentration in rat,7991,,CHEMBL622468,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6824,,
"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",7992,,CHEMBL876025,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6685,,
"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",7993,,CHEMBL622469,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6685,,
"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",7994,,CHEMBL622470,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6685,,
Time required to reach maximum concentration (Cmax) after oral administration in rat,7995,,CHEMBL622471,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15662,,
Time required to reach maximum concentration in rat plasma,7996,,CHEMBL622472,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1742,,
Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,7997,,CHEMBL622473,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2774,,
Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,7998,,CHEMBL624282,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5199,,
Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,7999,,CHEMBL624283,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12873,,
Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,8000,,CHEMBL624284,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12873,,
Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,8001,,CHEMBL624285,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1916,,
Time to reach Cmax after oral administration to rats,8002,,CHEMBL624286,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16367,,
Time to reach Cmax when a dose of 1 mg/kg is administered orally,8003,,CHEMBL624287,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16366,,
Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,8004,,CHEMBL624288,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,216,,
Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,8005,,CHEMBL624289,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6410,,
Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,8006,,CHEMBL873344,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6410,,
Tmax after peroral administration (10 mg/kg) was determined in rat,8007,,CHEMBL619623,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6215,,
Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,8008,,CHEMBL621399,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Expert,N,A,,3598,,
Tmax by oral administration at a dose of 100 uM/kg in rat was determined,8009,,CHEMBL621400,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4527,,
"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",8010,,CHEMBL621401,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17670,,
Tmax was determined,8011,,CHEMBL621402,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1465,,
Tmax was determined,8012,,CHEMBL621403,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2552,,
Tmax after oral administration in rat,8013,,CHEMBL621121,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5656,,
Tmax after peroral administration in rats at 2.4 uM/kg,8014,,CHEMBL872525,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17764,,
Tmax in male rat,8015,,CHEMBL621122,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5610,,
Tmax in rat at 10 mg/kg,8016,,CHEMBL621123,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6046,,
Tmax in rat by po administration at a dose of 40 mg/kg,8017,,CHEMBL621124,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5874,,
Tmax in rats,8018,,CHEMBL621125,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17596,,
Tmax was measured in rats after peroral administration at 5 mg/kg,8019,,CHEMBL621126,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17804,,
Tmax value after oral dose at a dose of 10 mg/kg in rats.,8020,,CHEMBL621127,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1908,,
Tmax value after administration of 20 mg/Kg oral dose in rat,8021,,CHEMBL621128,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2959,,
Tmax value at a dose of 10 mg/kg in male SD rats,8022,,CHEMBL618263,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6757,,
Tmax value at a dose of 100 mg/kg in male SD rats,8023,,CHEMBL618264,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6757,,
Tmax value at a dose of 50 mg/kg in male SD rats,8024,,CHEMBL618265,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6757,,
Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,8025,,CHEMBL618266,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4186,,
time required to reach maximum concentration (Cmax) after oral administration in rat,8026,,CHEMBL618267,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15662,,
Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),8027,,CHEMBL618450,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,429,,
Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),8028,,CHEMBL618451,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,429,,
Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,8029,,CHEMBL618452,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5546,,
Amount of urine output was measured in rat at a dose of 1 mg/kg/po,8030,,CHEMBL618453,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,3173,,
Amount of urine output was measured in rat at a dose of 10 mg/kg/po,8031,,CHEMBL618454,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,3173,,
Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,8032,,CHEMBL618455,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,3173,,
Volume of distribution was determined in rat after a 3 mg/kg of iv dose,8033,,CHEMBL618456,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4257,,
Compound distribution in rat tissues was determined,8034,,CHEMBL618457,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6011,,
Volume of distribution was evaluated in rat,8035,,CHEMBL618458,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5472,,
Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,8036,,CHEMBL618459,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,8037,,CHEMBL876733,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,8038,,CHEMBL618460,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,8039,,CHEMBL618461,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined after oral administration (300 uM/Kg),8040,,CHEMBL618462,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15469,,
Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,8041,,CHEMBL618463,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,8042,,CHEMBL618464,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,8043,,CHEMBL618465,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,8044,,CHEMBL618466,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,8045,,CHEMBL618467,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,8046,,CHEMBL618468,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,8047,,CHEMBL618469,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,12935,,
Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,8048,,CHEMBL618470,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,12935,,
Plasma drug AUC in rat (PO dose),8049,,CHEMBL618471,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14813,,
Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,8050,,CHEMBL618472,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15792,,
Area under was determined at a dose of 30 mg/kg,8051,,CHEMBL618473,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,3579,,
Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,8052,,CHEMBL621699,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,12487,,
Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,8053,,CHEMBL621700,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12487,,
Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,8054,,CHEMBL621701,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12487,,
Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,8055,,CHEMBL621702,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,12487,,
Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,8056,,CHEMBL621703,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12487,,
Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,8057,,CHEMBL621704,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12487,,
"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",8058,,CHEMBL624259,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12902,,
"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",8059,,CHEMBL624260,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12902,,
"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",8060,,CHEMBL624430,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12902,,
"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",8061,,CHEMBL624431,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12902,,
"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",8062,,CHEMBL624432,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12902,,
"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",8063,,CHEMBL624433,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12902,,
"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",8064,,CHEMBL624434,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12902,,
"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",8065,,CHEMBL624435,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12902,,
Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,8066,,CHEMBL618570,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12745,,
Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8067,,CHEMBL618571,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12745,,
Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,8068,,CHEMBL618572,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12745,,
Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8069,,CHEMBL618573,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12745,,
Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,8070,,CHEMBL619267,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12745,,
Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8071,,CHEMBL619431,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12745,,
Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,8072,,CHEMBL619432,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12745,,
Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8073,,CHEMBL619433,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12745,,
AUC in mice after oral dose (50 mg/kg),8074,,CHEMBL619434,22224,BAO_0000218,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,13298,,
Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,8075,,CHEMBL619435,50594,BAO_0000218,,,,1,,1977.0,Mus musculus,,10090.0,1,Intermediate,N,A,Serum,12226,,
AUC (0-4 hr) ug/ml/h,8076,,CHEMBL619436,22224,BAO_0000019,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,12634,,
Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,8077,,CHEMBL619437,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14810,,
Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,8078,,CHEMBL619438,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,13889,,
Compound was evaluated for Area under curve in mice,8079,,CHEMBL619439,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,10018,,
Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8080,,CHEMBL619440,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8758,,
Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8081,,CHEMBL619441,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,F,,8758,,
Compound was evaluated for area under curve doses in rat at 50 mg/kg po,8082,,CHEMBL619442,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8758,,
Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,8083,,CHEMBL875156,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2249,,
Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,8084,,CHEMBL619443,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2249,,
Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,8085,,CHEMBL619444,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2249,,
Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,8086,,CHEMBL623464,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2249,,
Compound was evaluated for area under curve when administered through oral route in mouse,8087,,CHEMBL623465,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15115,,
Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,8088,,CHEMBL623466,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,8089,,CHEMBL623467,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Plasma clearance in rat,8090,,CHEMBL623468,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6249,,
Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,8091,,CHEMBL622660,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2463,,
Plasma clearance rate in Sprague-Dawley rats,8092,,CHEMBL622661,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4969,,
CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,8093,,CHEMBL622662,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,17720,,
Pharmacokinetic property (total body clearance) in rat,8094,,CHEMBL622663,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3457,,
Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,8095,,CHEMBL622664,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5983,,
In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,8096,,CHEMBL622665,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6295,,
In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,8097,,CHEMBL622666,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6296,,
Cl in rat i.v. at 2 mg/kg concentration,8098,,CHEMBL621615,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17686,,
Clearance of compound after intravenous administration in rats at 24 uM/kg,8099,,CHEMBL621616,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17764,,
Clearance was determined,8100,,CHEMBL621617,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5503,,
Clearance by intravenous administration of 3.4 mg/kg in rat,8101,,CHEMBL621618,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4368,,
Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,8102,,CHEMBL621619,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6005,,
Clearance rate after i.v. administration in rats,8103,,CHEMBL621620,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5031,,
Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,8104,,CHEMBL621786,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4890,,
Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,8105,,CHEMBL621787,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5182,,
Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,8106,,CHEMBL621788,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5979,,
Clearance (Cl) after oral administration in rat,8107,,CHEMBL621789,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5656,,
Compound clearance in rats was measured after intravenous administration at 3 mg/kg,8108,,CHEMBL621790,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17804,,
Compound was tested for plasma clearance in rat,8109,,CHEMBL621791,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4839,,
In vitro microsome metabolism clearance in rat was determined,8110,,CHEMBL621792,50597,BAO_0000218,,,In vitro,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,Microsomes,
In vitro microsome metabolism clearance in rat was determined; ND denotes no data,8111,,CHEMBL621793,50597,BAO_0000218,,,In vitro,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,Microsomes,
In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,8112,,CHEMBL621794,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo plasma clearance was determined,8113,,CHEMBL621795,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5496,,
Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,8114,,CHEMBL621796,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5739,,
Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,8115,,CHEMBL621797,50597,BAO_0000218,Hepatocyte,401.0,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,5676,,
Pharmacokinetic property (Plasma clearance) was measured in rat,8116,,CHEMBL621798,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4239,,
Pharmacokinetic property (clearance) in rat i.v.,8117,,CHEMBL621799,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5676,,
"Plasma Clearance was evaluated in rats, iv",8118,,CHEMBL621800,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1918,,
Plasma clearance (in vivo) in rats was determined,8119,,CHEMBL621801,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17800,,
Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,8120,,CHEMBL621802,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6056,,
Plasma clearance was determined,8121,,CHEMBL618596,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5496,,
Plasma clearance in rat after peroral administration at 10 mg/kg concentration,8122,,CHEMBL618597,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Plasma clearance in rat after peroral administration at 5 mg/kg concentration,8123,,CHEMBL618598,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Plasma clearance in rats,8124,,CHEMBL618599,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17752,,
Plasma clearance rate determined in rat,8125,,CHEMBL618600,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4576,,
Plasma clearance was determined in rat,8126,,CHEMBL618601,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6011,,
Plasma clearance was determined,8127,,CHEMBL618602,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
Plasma clearance value in rat,8128,,CHEMBL618603,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5948,,
Clearance rate constant using isolated perfused rat liver (IPRL) assay,8129,,CHEMBL618604,50597,BAO_0000218,,,Ex vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,6125,,
Clearance in rat,8130,,CHEMBL618605,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4839,,
Total body clearance in rat i.v. at 2 mg/kg concentration,8131,,CHEMBL618606,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17686,,
Clearance of compound in rats after intravenous administration,8132,,CHEMBL618607,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6571,,
Clearance after iv administration to rats,8133,,CHEMBL618608,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3364,,
Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,8134,,CHEMBL618609,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,8135,,CHEMBL618610,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,8136,,CHEMBL618611,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,8137,,CHEMBL618612,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,8138,,CHEMBL618613,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,8139,,CHEMBL621076,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,8140,,CHEMBL621077,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",8141,,CHEMBL621078,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17670,,
Clearance in rat,8142,,CHEMBL621251,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5970,,
Clearance in rat after oral administration at 10 mg/kg,8143,,CHEMBL621252,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6495,,
Clearance in rat.,8144,,CHEMBL621253,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4590,,
Clearance rate following an oral dose of 20 mg/kg in rats,8145,,CHEMBL621254,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6193,,
Compound was evaluated for the rate of clearance in rat upon intravenous administration.,8146,,CHEMBL621255,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2832,,
Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,8147,,CHEMBL621256,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1052,,
Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,8148,,CHEMBL621257,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,8149,,CHEMBL621258,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,8150,,CHEMBL621259,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,8151,,CHEMBL621260,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,8152,,CHEMBL876494,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,8153,,CHEMBL621261,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,8154,,CHEMBL621262,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,8155,,CHEMBL621263,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,8156,,CHEMBL621264,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9866,,
Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,8157,,CHEMBL621265,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,8158,,CHEMBL621266,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,8159,,CHEMBL621267,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,8160,,CHEMBL621268,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,8161,,CHEMBL621269,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,8162,,CHEMBL621270,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,8163,,CHEMBL621271,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,8164,,CHEMBL621272,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,8165,,CHEMBL621273,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,8166,,CHEMBL621274,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,8167,,CHEMBL876495,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,8168,,CHEMBL621275,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,8169,,CHEMBL621276,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,8170,,CHEMBL621277,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9866,,
Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,8171,,CHEMBL621278,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,9866,,
Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,8172,,CHEMBL621279,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,9866,,
Biodistribution in rat s. intestine in the presence of NCA (No carrier added),8173,,CHEMBL621280,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,9866,,
Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,8174,,CHEMBL621281,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,8175,,CHEMBL621282,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,8176,,CHEMBL621283,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,8177,,CHEMBL621284,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,8178,,CHEMBL621285,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,8179,,CHEMBL621286,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,8180,,CHEMBL623220,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,8181,,CHEMBL623221,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,8182,,CHEMBL876029,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9866,,
Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,8183,,CHEMBL623222,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,9866,,
Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,8184,,CHEMBL623223,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,9866,,
Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,8185,,CHEMBL621445,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,9866,,
Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8186,,CHEMBL621446,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13950,,
Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,8187,,CHEMBL621447,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13950,,
Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,8188,,CHEMBL619681,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13950,,
Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,8189,,CHEMBL619682,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13950,,
Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,8190,,CHEMBL619683,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13950,,
Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8191,,CHEMBL619684,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13950,,
Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,8192,,CHEMBL619685,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13950,,
Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,8193,,CHEMBL619686,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13950,,
Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,8194,,CHEMBL619687,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13950,,
Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,8195,,CHEMBL619688,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13950,,
Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8196,,CHEMBL619689,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13950,,
Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,8197,,CHEMBL619690,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13950,,
Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,8198,,CHEMBL619691,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13950,,
Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,8199,,CHEMBL619692,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6062,,
Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,8200,,CHEMBL619693,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Expert,N,A,,3598,,
Vc value after IV dose at a dose of 5 mg/kg in rats.,8201,,CHEMBL619694,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1908,,
Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,8202,,CHEMBL619695,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17596,,
Compound was evaluated for pharmacokinetic parameter volume of distribution,8203,,CHEMBL619696,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4891,,
Compound was evaluated for volume of distribution in rat,8204,,CHEMBL619697,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,740,,
Steady state volume distribution was determined; steady state(ss),8205,,CHEMBL619698,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16366,,
Steady state volume of distribution after iv administration to rats,8206,,CHEMBL619699,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3364,,
Steady state volume of distribution dosing at 3 mg/kg iv,8207,,CHEMBL619700,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2552,,
The compound was evaluated for volume of distribution in rat,8208,,CHEMBL619701,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,406,,
The compound was tested for volume of distribution in rat,8209,,CHEMBL619702,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12500,,
The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,8210,,CHEMBL620335,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12500,,
Volume distribution (VD) after oral administration in rat,8211,,CHEMBL620336,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5656,,
Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,8212,,CHEMBL620337,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17671,,
Volume distribution in rat,8213,,CHEMBL620520,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1094,,
Volume distribution in rat,8214,,CHEMBL620521,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5833,,
Volume distribution in rat after peroral administration at 10 mg/kg,8215,,CHEMBL875825,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Volume distribution in rat after peroral administration at 5 mg/kg,8216,,CHEMBL620522,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,8217,,CHEMBL620523,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6005,,
Volume of distribution in rat.,8218,,CHEMBL620524,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1696,,
Volume of distribution in rat,8219,,CHEMBL620525,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6672,,
Volume of distribution in rat,8220,,CHEMBL620526,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6673,,
Volume of distribution in rat by iv administration,8221,,CHEMBL620527,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5871,,
Volume of distribution in rats,8222,,CHEMBL620528,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6803,,
Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,8223,,CHEMBL620529,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5199,,
Volume distribution at the dose of 2 mg/kg in rat,8224,,CHEMBL620530,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4727,,
Steady state volume of distribution was determined,8225,,CHEMBL620531,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16367,,
Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,8226,,CHEMBL620532,22224,BAO_0000218,,,In vivo,1,,,Macaca mulatta,,9544.0,0,Intermediate,U,A,,5005,,
Compound was tested for its plasma volume distribution in Sprague Dawley rats,8227,,CHEMBL620533,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Intermediate,U,A,,5005,,
Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,8228,,CHEMBL620534,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Intermediate,U,A,,5005,,
Mean (%CV) PK parameters for Vdss(mL/kg).,8229,,CHEMBL620535,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15765,,
Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,8230,,CHEMBL875826,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,8231,,CHEMBL620536,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,8232,,CHEMBL620537,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5334,,
Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,8233,,CHEMBL618526,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5334,,
Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,8234,,CHEMBL618527,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5739,,
Pharmacokinetic property (Vdss) in rat,8235,,CHEMBL618528,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5789,,
Pharmacokinetic property (vdss) was measured in rat,8236,,CHEMBL618529,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4239,,
Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,8237,,CHEMBL618530,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4709,,
Volume of distribution in rat,8238,,CHEMBL618531,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6642,,
The pharmacokinetic parameter volume of distribution in vivo in rats,8239,,CHEMBL618532,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5247,,
Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,8240,,CHEMBL618533,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,17720,,
Vdss in rat i.v. at 2 mg/kg concentration,8241,,CHEMBL618534,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17686,,
Volume distribution after intravenous administration (1 mg/kg) in rat,8242,,CHEMBL618535,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4689,,
Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,8243,,CHEMBL618536,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5654,,
Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,8244,,CHEMBL618537,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5654,,
Volume distribution at a dose of 10 uM/kg in rat was determined,8245,,CHEMBL618538,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4527,,
Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,8246,,CHEMBL618539,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4521,,
Volume distribution was calculated in rat,8247,,CHEMBL618540,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6057,,
Volume distribution was determined,8248,,CHEMBL618541,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
Volume of distribution after intravenous administration was evaluated in rat,8249,,CHEMBL618542,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2938,,
Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,8250,,CHEMBL622544,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6679,,
"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",8251,,CHEMBL622545,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",8252,,CHEMBL622546,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",8253,,CHEMBL622547,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
Volume of distribution in steady state was determined in rat,8254,,CHEMBL622548,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5145,,
Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,8255,,CHEMBL622549,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6467,,
Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,8256,,CHEMBL622550,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6467,,
Compound was evaluated for area under curve when administered through oral route to mouse,8257,,CHEMBL622551,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15115,,
Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8258,,CHEMBL622552,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8758,,
Compound was evaluated for area under curve doses in rat at 50 mg/kg po,8259,,CHEMBL622553,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8758,,
Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,8260,,CHEMBL622554,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,F,,8267,,
Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,8261,,CHEMBL622555,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8267,,
Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,8262,,CHEMBL622556,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14239,,
Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,8263,,CHEMBL622557,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14239,,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,8264,,CHEMBL622558,50594,BAO_0000218,,,,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,10754,,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,8265,,CHEMBL622559,50594,BAO_0000218,,,,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,10754,,
Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,8266,,CHEMBL622560,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,10754,,
Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,8267,,CHEMBL622561,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14681,,
Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,8268,,CHEMBL622562,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14681,,
Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,8269,,CHEMBL622563,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14681,,
Concentration of compound in Central nervous system,8270,,CHEMBL622564,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13118,,
Concentration of compound in Central nervous system; Not detectable,8271,,CHEMBL622565,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13118,,
"Concentration of diester in the blood, following oral administration in mice",8272,,CHEMBL622566,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13318,,
"Concentration of monoester in the blood, following oral administration in mice",8273,,CHEMBL624515,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13318,,
Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,8274,,CHEMBL624516,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13318,,
Evaluated for Pharmacokinetic property: Area under the curve,8275,,CHEMBL624517,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15692,,
In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,8276,,CHEMBL624518,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,8277,,CHEMBL624519,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,8278,,CHEMBL624520,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,8279,,CHEMBL624521,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,8280,,CHEMBL624522,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,8281,,CHEMBL624523,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",8282,,CHEMBL624409,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",8283,,CHEMBL624410,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",8284,,CHEMBL624411,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",8285,,CHEMBL623531,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",8286,,CHEMBL623532,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",8287,,CHEMBL623533,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",8288,,CHEMBL623534,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,8289,,CHEMBL623535,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,8290,,CHEMBL623536,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,8291,,CHEMBL623537,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,8292,,CHEMBL623538,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,8293,,CHEMBL623539,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,8294,,CHEMBL623540,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",8295,,CHEMBL623541,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",8296,,CHEMBL623542,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",8297,,CHEMBL623543,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",8298,,CHEMBL623544,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",8299,,CHEMBL623545,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",8300,,CHEMBL623546,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,8301,,CHEMBL623547,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5408,,
High i.v. clearance in Dawley rats,8302,,CHEMBL623548,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6827,,
In vitro clearance in rat liver microsomes,8303,,CHEMBL623549,50597,BAO_0000218,,,In vitro,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,17538,Microsomes,
Intrinsic clearance in rat liver microsomes was determined,8304,,CHEMBL623550,50597,BAO_0000218,,,In vitro,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,6331,Microsomes,
Intrinsic clearance in rat hepatocytes was determined,8305,,CHEMBL875276,50597,BAO_0000218,Hepatocyte,401.0,In vitro,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,5948,,
Plasma Clearance was determined,8306,,CHEMBL621872,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4026,,
Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,8307,,CHEMBL621873,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6647,,
Plasma clearance in rat.,8308,,CHEMBL621874,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1696,,
Plasma clearance in rats,8309,,CHEMBL621875,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6597,,
Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,8310,,CHEMBL621876,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,347,,
Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,8311,,CHEMBL621877,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16423,,
Plasma clearance was measured in rat,8312,,CHEMBL621878,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2879,,
Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,8313,,CHEMBL621879,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4883,,
"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",8314,,CHEMBL621880,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5328,,
The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,8315,,CHEMBL621881,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5160,,
Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,8316,,CHEMBL621882,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17582,,
Total clearance at 1 mg/kg was determined in rat,8317,,CHEMBL875283,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17651,,
Total clearance at 10 mg/kg was determined in rat,8318,,CHEMBL621883,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17651,,
Clearance in rat,8319,,CHEMBL621884,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6596,,
Plasma clearance rate determined in rats,8320,,CHEMBL621885,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4796,,
Clearance of compound in rat was evaluated,8321,,CHEMBL621886,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6850,,
Plasma concentration in rats after 7 hr at 30mg/kg oral dose,8322,,CHEMBL621887,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5932,,
Pharmacokinetic property (blood clearance) in rat,8323,,CHEMBL621888,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3371,,
Plasma clearance in rat,8324,,CHEMBL621889,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2083,,
Plasma clearance in rats,8325,,CHEMBL621890,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4942,,
Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,8326,,CHEMBL621891,50597,BAO_0000218,,,In vitro,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,6838,Microsomes,
Clearance in Dawley rat,8327,,CHEMBL621892,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5353,,
Clearance rat,8328,,CHEMBL621893,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),8329,,CHEMBL621894,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Clearance rat; Not determined,8330,,CHEMBL621895,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Clearance rate was determined in rat at a dose of 1 mpk i.v.,8331,,CHEMBL875284,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6444,,
Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,8332,,CHEMBL618699,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6444,,
Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,8333,,CHEMBL618700,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6444,,
Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,8334,,CHEMBL618701,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6211,,
"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",8335,,CHEMBL876600,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12873,,
Clearance of compound in rat after 1 mg/kg i.v. administration,8336,,CHEMBL618702,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6570,,
Compound was evaluated for Hepatic clearance in rat,8337,,CHEMBL618703,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3341,,
In vivo clearance after 5 mg/kg dose,8338,,CHEMBL618704,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4891,,
Compound was tested for plasma clearance in rats,8339,,CHEMBL618705,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1094,,
Hepatic clearance after intravenous administration was evaluated in rat,8340,,CHEMBL618706,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2938,,
Lower clearance in rat (i.v.) at 0.5 mpk,8341,,CHEMBL618707,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17853,,
Pharmacokinetic parameter expressed as plasma clearance in rat,8342,,CHEMBL618708,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6049,,
Pharmacokinetic property (Clp) in rat,8343,,CHEMBL618709,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5789,,
Plasma clearance in Sprague-Dawley rats,8344,,CHEMBL618710,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4514,,
Plasma clearance (Clp) in rat,8345,,CHEMBL618711,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6448,,
Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,8346,,CHEMBL618712,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6062,,
Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,8347,,CHEMBL618713,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5710,,
Plasma clearance after intravenous administration of 1 mg/kg in rat,8348,,CHEMBL618714,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4709,,
Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,8349,,CHEMBL618715,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4521,,
Plasma clearance in rat was determined,8350,,CHEMBL618716,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1742,,
Plasma clearance measured in rat,8351,,CHEMBL876601,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6057,,
Plasma clearance was calculated in rat,8352,,CHEMBL618717,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6057,,
Plasma clearance in rat,8353,,CHEMBL618718,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5145,,
Plasma clearance in rat,8354,,CHEMBL618719,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5833,,
Plasma clearance in rat,8355,,CHEMBL618720,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6453,,
Plasma clearance in rat,8356,,CHEMBL618721,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6640,,
Plasma clearance in rats,8357,,CHEMBL621477,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6305,,
Plasma clearance in rat,8358,,CHEMBL621478,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6642,,
Plasma clearance was evaluated in rat,8359,,CHEMBL621479,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5472,,
Plasma clearance was evaluated in rat; Not tested,8360,,CHEMBL621480,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5472,,
Plasma clearance rate was determined for the compound in rat,8361,,CHEMBL621481,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5144,,
"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",8362,,CHEMBL621482,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",8363,,CHEMBL621483,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",8364,,CHEMBL621484,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,8365,,CHEMBL621485,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13950,,
Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,8366,,CHEMBL621486,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13950,,
Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8367,,CHEMBL621487,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,13950,,
Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,8368,,CHEMBL621488,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,13950,,
Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,8369,,CHEMBL621489,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,13950,,
Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,8370,,CHEMBL621490,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,13950,,
Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,8371,,CHEMBL621491,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,13950,,
Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8372,,CHEMBL621492,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13950,,
Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,8373,,CHEMBL621493,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13950,,
Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,8374,,CHEMBL621494,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13950,,
Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,8375,,CHEMBL621495,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13950,,
Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,8376,,CHEMBL621496,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13950,,
Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8377,,CHEMBL621497,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13950,,
Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,8378,,CHEMBL621498,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13950,,
Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,8379,,CHEMBL621499,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13950,,
Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,8380,,CHEMBL618634,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13950,,
Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,8381,,CHEMBL618635,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13950,,
Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8382,,CHEMBL618636,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13950,,
Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,8383,,CHEMBL619737,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13950,,
Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,8384,,CHEMBL619738,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13950,,
Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,8385,,CHEMBL624329,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13950,,
Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,8386,,CHEMBL624330,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13950,,
Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8387,,CHEMBL624331,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13950,,
Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,8388,,CHEMBL624332,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13950,,
Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,8389,,CHEMBL624333,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13950,,
Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,8390,,CHEMBL624334,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13950,,
Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,8391,,CHEMBL624335,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13950,,
Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8392,,CHEMBL620016,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,13950,,
Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,8393,,CHEMBL620169,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,13950,,
Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,8394,,CHEMBL620170,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,13950,,
Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,8395,,CHEMBL620171,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,13950,,
Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,8396,,CHEMBL620172,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,13950,,
Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8397,,CHEMBL620173,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,13950,,
Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,8398,,CHEMBL620174,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,13950,,
Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,8399,,CHEMBL620175,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,13950,,
Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,8400,,CHEMBL620176,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,13950,,
Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,8401,,CHEMBL620177,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,13950,,
Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,8402,,CHEMBL620178,50597,BAO_0000218,,,,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,13950,,
Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,8403,,CHEMBL620179,50597,BAO_0000218,,,,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,13950,,
Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,8404,,CHEMBL620180,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13950,,
Volume of distribution of compound in rat after 1 mg/kg i.v. administration,8405,,CHEMBL620181,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6570,,
Volume of distribution of compound in rats after intravenous administration,8406,,CHEMBL620182,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6571,,
Volume of distribution in rat,8407,,CHEMBL620183,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6453,,
Volume of distribution was determined in rat at a dose of 1 mpk i.v.,8408,,CHEMBL620184,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6444,,
Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,8409,,CHEMBL620185,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6444,,
Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,8410,,CHEMBL620186,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6444,,
Volume of distribution was determined in Dawley rat,8411,,CHEMBL620187,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5353,,
Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,8412,,CHEMBL620188,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5334,,
Volume of distribution was reported in Sprague-Dawley rat,8413,,CHEMBL620189,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5334,,
Volumes of distribution in rat after peroral administration,8414,,CHEMBL620190,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Volumes of distribution in rat after po administration,8415,,CHEMBL620191,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Volumes of distribution in rat after po administration; Not determined,8416,,CHEMBL620192,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Pharmacokinetic property (Volume) in rat i.v.,8417,,CHEMBL620193,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5676,,
Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,8418,,CHEMBL620194,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6410,,
"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",8419,,CHEMBL876730,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17670,,
Volume distribution in rat after oral administration at 10 mg/kg,8420,,CHEMBL620195,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6495,,
Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,8421,,CHEMBL620196,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5408,,
Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,8422,,CHEMBL620197,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4883,,
Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,8423,,CHEMBL620198,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6647,,
Volume of distribution in rats,8424,,CHEMBL620199,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6495,,
Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,8425,,CHEMBL620200,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,8426,,CHEMBL620201,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,8427,,CHEMBL620202,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,8428,,CHEMBL620203,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,8429,,CHEMBL620204,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,8430,,CHEMBL620205,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
Pharmacokinetic parameter (Vss) in rat,8431,,CHEMBL624664,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5960,,
Pharmacokinetic property (Volume) in rat i.v.,8432,,CHEMBL624665,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5676,,
Pharmacokinetic property (Vss) in rat,8433,,CHEMBL624666,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5948,,
Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,8434,,CHEMBL624667,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5979,,
Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,8435,,CHEMBL624668,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,8436,,CHEMBL624669,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,8437,,CHEMBL624670,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,8438,,CHEMBL624671,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Steady state volume distribution in rat,8439,,CHEMBL624672,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6448,,
"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",8440,,CHEMBL624673,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12873,,
Steady state volume of distribution determined in rat,8441,,CHEMBL624674,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4576,,
Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,8442,,CHEMBL624675,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17582,,
Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,8443,,CHEMBL621728,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1466,,
Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,8444,,CHEMBL621729,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5182,,
Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,8445,,CHEMBL621730,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5182,,
Volume distribution in rat after administration of 2 mg/kg iv,8446,,CHEMBL621731,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6535,,
Volume distribution in rat after administration of 2 mg/kg iv,8447,,CHEMBL621732,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6535,,
Volume in steady state distribution value was determined,8448,,CHEMBL621908,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
Volume in steady state distribution value was determined; ND denotes no data,8449,,CHEMBL875347,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
Volume in steady state distribution value was determined; ND denotes not determined,8450,,CHEMBL621909,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,8451,,CHEMBL621910,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17065,,
Volume of distribution at steady state was evaluated in rats,8452,,CHEMBL621911,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6597,,
Volume of distribution at steady state was observed after intravenous administration in rat,8453,,CHEMBL621912,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15662,,
Volume of distribution in steady state was determined in rat,8454,,CHEMBL621913,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6485,,
Volume of distribution in steady state was determined in rat,8455,,CHEMBL621914,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17655,,
Volume of distribution after i.v. administration,8456,,CHEMBL621915,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6616,,
Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,8457,,CHEMBL621916,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1916,,
"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",8458,,CHEMBL621917,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,16438,,
"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",8459,,CHEMBL621918,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,16438,,
Biodistribution of compound (oxidized form) in spleen tissue,8460,,CHEMBL621919,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,16438,,
"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",8461,,CHEMBL621920,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,16438,,
"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",8462,,CHEMBL621921,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,16438,,
"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8463,,CHEMBL622401,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,16438,,
"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",8464,,CHEMBL875348,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,16438,,
"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",8465,,CHEMBL622402,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,16438,,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,8466,,CHEMBL622403,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,16438,,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8467,,CHEMBL622404,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,16438,,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,8468,,CHEMBL622405,50594,BAO_0000218,,,In vivo,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,16438,,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",8469,,CHEMBL622406,50594,BAO_0000218,,,In vivo,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,16438,,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8470,,CHEMBL622407,50594,BAO_0000218,,,In vivo,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,16438,,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,8471,,CHEMBL622408,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,16438,,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",8472,,CHEMBL622409,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,16438,,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8473,,CHEMBL622410,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,16438,,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,8474,,CHEMBL622411,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,16438,,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",8475,,CHEMBL627864,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,16438,,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8476,,CHEMBL627865,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,16438,,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,8477,,CHEMBL627866,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,16438,,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8478,,CHEMBL627751,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,16438,,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,8479,,CHEMBL627752,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,16438,,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",8480,,CHEMBL627753,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,16438,,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8481,,CHEMBL627754,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,16438,,
Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,8482,,CHEMBL627755,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12467,,
Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),8483,,CHEMBL627756,50594,BAO_0000218,,,In vivo,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,17208,,
Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),8484,,CHEMBL627757,50594,BAO_0000218,,,In vivo,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,17208,,
Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),8485,,CHEMBL627758,50594,BAO_0000218,,,In vivo,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,17208,,
Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),8486,,CHEMBL627759,50594,BAO_0000218,,,In vivo,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,17208,,
Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),8487,,CHEMBL627760,50594,BAO_0000218,,,In vivo,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,17208,,
Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),8488,,CHEMBL627761,50594,BAO_0000218,,,In vivo,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,17208,,
Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),8489,,CHEMBL876811,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,17208,,
Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),8490,,CHEMBL627762,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,17208,,
Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),8491,,CHEMBL627763,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,17208,,
Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),8492,,CHEMBL627764,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,17208,,
Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),8493,,CHEMBL627765,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,17208,,
Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),8494,,CHEMBL627766,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,17208,,
Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),8495,,CHEMBL627767,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,17208,,
Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),8496,,CHEMBL627768,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,17208,,
Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),8497,,CHEMBL628422,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,17208,,
Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),8498,,CHEMBL628423,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,17208,,
Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,8499,,CHEMBL628424,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5089,,
Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,8500,,CHEMBL628425,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5089,,
Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,8501,,CHEMBL628426,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4257,,
Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,8502,,CHEMBL628427,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6679,,
Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,8503,,CHEMBL626938,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5546,,
Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,8504,,CHEMBL626939,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6141,,
Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,8505,,CHEMBL626940,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5334,,
Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,8506,,CHEMBL626941,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5334,,
Plasma clearance was reported in Sprague-Dawley rat,8507,,CHEMBL626942,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5334,,
Plasma clearance after intravenous administration (1 mg/kg) in rat,8508,,CHEMBL876812,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4689,,
Plasma clearance of compound in rats was evaluated,8509,,CHEMBL626943,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6848,,
Plasma clearance of compound in rats was evaluated; ND indicates not determined,8510,,CHEMBL626944,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6848,,
Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,8511,,CHEMBL626945,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6467,,
Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,8512,,CHEMBL626946,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6467,,
Plasma clearance rate in Sprague-Dawley rats,8513,,CHEMBL626856,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4956,,
Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),8514,,CHEMBL626857,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5529,,
The compound was evaluated for plasma clearance in rat,8515,,CHEMBL626858,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,406,,
Total plasma clearance in rat,8516,,CHEMBL627018,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17655,,
Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,8517,,CHEMBL625331,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,3293,,
Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,8518,,CHEMBL625332,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,4075,,
C max was determined at 10 mg/kg po dose in rats,8519,,CHEMBL877590,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
C max was determined at 3 mg/kg po dose in rats,8520,,CHEMBL625333,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Cmax after repeated oral dose of compound at 1 mg/kg in rats,8521,,CHEMBL625334,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17594,,
Cmax after single intravenous bolus of 1 mg/kg in rats,8522,,CHEMBL625335,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17594,,
Cmax of compound at 5 mg/kg after po administration was determined in rat,8523,,CHEMBL625336,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4762,,
Cmax 24 hr after 10 mg/kg oral administration in rats,8524,,CHEMBL625337,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17509,,
Cmax 24 hr after 2 mg/kg oral administration in rats,8525,,CHEMBL625338,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17509,,
Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,8526,,CHEMBL625339,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1466,,
Cmax in rat after administration of 2 mg/kg iv,8527,,CHEMBL625340,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6535,,
Cmax in rat after administration of 2 mg/kg iv,8528,,CHEMBL625341,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6535,,
Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,8529,,CHEMBL622687,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3169,,
Cmax wa determined in rat plasma at 30 mg/kg after po administration,8530,,CHEMBL622688,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6515,,
Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,8531,,CHEMBL622689,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11149,,
Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,8532,,CHEMBL620295,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11149,,
Cmax after 10 mg/kg oral administration in rat,8533,,CHEMBL620296,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17858,,
Cmax after IV dosing at 0.5 mg/kg in rat; no data,8534,,CHEMBL620297,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Cmax after IV dosing at 1 mg/kg in rat; no data,8535,,CHEMBL620298,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Cmax after oral administration at 20 mpk in rats,8536,,CHEMBL620299,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4426,,
Cmax after oral administration at 20 mpk in rats; Not performed.,8537,,CHEMBL620300,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4426,,
Cmax after oral administration at 20 mpk in rats d; Not performed.,8538,,CHEMBL620301,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4426,,
Cmax after oral administration in rat,8539,,CHEMBL620302,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5656,,
Cmax after oral administration at a dose of 2 mg/kg in rat,8540,,CHEMBL620303,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Cmax after oral administration at a dose of 4 mg/kg in rat,8541,,CHEMBL620304,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Cmax in rats after 20 mg/kg oral dose,8542,,CHEMBL620305,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6113,,
Cmax after peroral administration in rats at 2.4 uM/kg,8543,,CHEMBL620306,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17764,,
Cmax at the dose of 2 mg/Kg administered perorally in rats,8544,,CHEMBL620307,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4756,,
Cmax at the dose of 5 mg/Kg administered perorally in rats,8545,,CHEMBL620308,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4756,,
Cmax by administering at 20 mg/kg p.o. in rats,8546,,CHEMBL620309,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6402,,
Cmax in male rat,8547,,CHEMBL620310,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5610,,
Cmax in rat,8548,,CHEMBL620311,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5207,,
Cmax in rat,8549,,CHEMBL620312,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6011,,
Cmax in rat,8550,,CHEMBL620313,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6504,,
Cmax in rat at 10 mg/kg,8551,,CHEMBL620314,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6046,,
Cmax in rat at the dose of 1 mg/kg i.v.,8552,,CHEMBL620315,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6504,,
Cmax in rat by po administration at a dose of 40 mg/kg,8553,,CHEMBL620316,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5874,,
Cmax in rat p.o. at 20 mg/kg concentration,8554,,CHEMBL620317,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17686,,
Cmax in rats,8555,,CHEMBL620318,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5836,,
Cmax in rats,8556,,CHEMBL620319,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17596,,
Cmax was evaluated after 20 uM/kg of peroral administration,8557,,CHEMBL620320,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16423,,
Cmax was measured in rats after peroral administration at 3 mg/kg,8558,,CHEMBL620321,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17804,,
Cmax value after oral dose at a dose of 10 mg/kg in rats.,8559,,CHEMBL620322,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1908,,
Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,8560,,CHEMBL620323,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13950,,
Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,8561,,CHEMBL620324,50597,BAO_0000218,,,,1,,1870.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Frontal cortex,13950,,
Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,8562,,CHEMBL620325,50597,BAO_0000218,,,,1,,1870.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Frontal cortex,13950,,
Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,8563,,CHEMBL620326,50597,BAO_0000218,,,,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,13950,,
Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,8564,,CHEMBL620327,50597,BAO_0000218,,,,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,13950,,
Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,8565,,CHEMBL620328,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13950,,
Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,8566,,CHEMBL620329,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13950,,
Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,8567,,CHEMBL620330,50597,BAO_0000218,,,,1,,1891.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Midbrain,13950,,
Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,8568,,CHEMBL875286,50597,BAO_0000218,,,,1,,1891.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Midbrain,13950,,
Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,8569,,CHEMBL620331,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13950,,
Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,8570,,CHEMBL620332,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13950,,
Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,8571,,CHEMBL620333,50597,BAO_0000218,,,,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,13950,,
Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,8572,,CHEMBL620334,50597,BAO_0000218,,,,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,13950,,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8573,,CHEMBL621015,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16434,,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8574,,CHEMBL621016,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16434,,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8575,,CHEMBL621191,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16434,,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8576,,CHEMBL621192,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16434,,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8577,,CHEMBL621193,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16434,,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8578,,CHEMBL621194,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16434,,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8579,,CHEMBL624204,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16434,,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8580,,CHEMBL624205,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16434,,
Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8581,,CHEMBL624206,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8582,,CHEMBL624207,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8583,,CHEMBL624208,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8584,,CHEMBL624209,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8585,,CHEMBL624210,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8586,,CHEMBL624211,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8587,,CHEMBL624212,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8588,,CHEMBL624213,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8589,,CHEMBL876611,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16434,,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8590,,CHEMBL624214,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16434,,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8591,,CHEMBL624215,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16434,,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8592,,CHEMBL624216,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8593,,CHEMBL624217,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8594,,CHEMBL624218,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8595,,CHEMBL624219,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8596,,CHEMBL624220,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8597,,CHEMBL624221,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,16435,,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8598,,CHEMBL624222,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8599,,CHEMBL624223,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8600,,CHEMBL624224,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8601,,CHEMBL624225,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,8602,,CHEMBL622420,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17764,,
Volume of steady state distribution after i.v. administration in rats,8603,,CHEMBL622421,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5031,,
Vss after intravenous administration (5.0 mg/kg) was determined in rat,8604,,CHEMBL622422,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6215,,
Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,8605,,CHEMBL622423,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17671,,
Vss was determined,8606,,CHEMBL622424,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17752,,
Vss in rat,8607,,CHEMBL622425,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6596,,
Vss was evaluated after 10 uM/kg of intra arterial administration,8608,,CHEMBL876612,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16423,,
volume of distribution at steady state was observed after intravenous administration in rat,8609,,CHEMBL622426,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15662,,
Volume of distribution was measured in rat after an iv dose of 1 mg/kg,8610,,CHEMBL622427,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6062,,
Pharmacokinetic (PK) parameter Vz in rat,8611,,CHEMBL622428,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5874,,
Volume distribution in rats,8612,,CHEMBL622429,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4942,,
Volume of distribution in rat; No data,8613,,CHEMBL622430,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17796,,
Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,8614,,CHEMBL622431,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4890,,
% absorption predicted from in vitro rat ileum transport studies,8615,,CHEMBL622432,50597,BAO_0000218,,,,1,,2116.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Ileum,15765,,
Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,8616,,CHEMBL622433,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,8617,,CHEMBL622434,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,8618,,CHEMBL622435,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),8619,,CHEMBL618748,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,8620,,CHEMBL618749,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,8621,,CHEMBL618750,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,8622,,CHEMBL618751,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,8623,,CHEMBL618752,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13569,,
Oral bioavailability in rat,8624,,CHEMBL618753,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4576,,
Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,8625,,CHEMBL618754,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,750,,
Oral bioavailability in rat,8626,,CHEMBL618755,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,750,,
Oral bioavailability in rat,8627,,CHEMBL618756,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4590,,
Oral bioavailability in rat,8628,,CHEMBL618757,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1716,,
Bioavailability in rat,8629,,CHEMBL618758,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1974,,
Oral bioavailability in rat (dose 30 mg/kg),8630,,CHEMBL621088,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4502,,
Pharmacokinetic property (cLogP) in rat,8631,,CHEMBL621089,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3371,,
Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,8632,,CHEMBL621090,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,F,Blood,9099,,
Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,8633,,CHEMBL621091,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,F,Blood,9099,,
Clearance in rat.,8634,,CHEMBL876731,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4590,,
Compound was evaluated for its clearance when administered intravenously in rat,8635,,CHEMBL621092,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3184,,
Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,8636,,CHEMBL621093,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16456,,
Blood: Brain distribution ratio is determined in rat,8637,,CHEMBL621094,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4199,,
Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,8638,,CHEMBL621095,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4199,,
Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,8639,,CHEMBL621096,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4199,,
"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8640,,CHEMBL621097,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8677,,
Percent dose excreted in 0-48 hours administered ip to male rat,8641,,CHEMBL621098,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,7449,,
Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8642,,CHEMBL621099,50597,BAO_0000218,,,,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,11977,,
Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8643,,CHEMBL621100,50597,BAO_0000218,,,,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,11977,,
Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8644,,CHEMBL621101,50597,BAO_0000218,,,,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,11977,,
Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8645,,CHEMBL621102,50597,BAO_0000218,,,,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,11977,,
Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8646,,CHEMBL876732,50597,BAO_0000218,,,,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,11977,,
Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8647,,CHEMBL621103,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11977,,
Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8648,,CHEMBL621104,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11977,,
Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8649,,CHEMBL621105,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11977,,
Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8650,,CHEMBL621106,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11977,,
Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8651,,CHEMBL621107,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11977,,
Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8652,,CHEMBL621108,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11977,,
Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8653,,CHEMBL621109,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11977,,
Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),8654,,CHEMBL621110,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,17208,,
Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),8655,,CHEMBL621111,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,17208,,
Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),8656,,CHEMBL622541,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,17208,,
Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),8657,,CHEMBL622542,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,17208,,
Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),8658,,CHEMBL622543,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,17208,,
Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),8659,,CHEMBL624412,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,17208,,
Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),8660,,CHEMBL624413,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,17208,,
Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),8661,,CHEMBL624414,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,17208,,
Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),8662,,CHEMBL624415,50594,BAO_0000218,,,In vivo,1,,2048.0,Mus musculus,,10090.0,1,Intermediate,N,A,Lung,17208,,
Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),8663,,CHEMBL624416,50594,BAO_0000218,,,In vivo,1,,2048.0,Mus musculus,,10090.0,1,Intermediate,N,A,Lung,17208,,
Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),8664,,CHEMBL624417,50594,BAO_0000218,,,In vivo,1,,2048.0,Mus musculus,,10090.0,1,Intermediate,N,A,Lung,17208,,
Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),8665,,CHEMBL624418,50594,BAO_0000218,,,In vivo,1,,2048.0,Mus musculus,,10090.0,1,Intermediate,N,A,Lung,17208,,
Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),8666,,CHEMBL624419,50594,BAO_0000218,,,In vivo,1,,2048.0,Mus musculus,,10090.0,1,Intermediate,N,A,Lung,17208,,
Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),8667,,CHEMBL624420,50594,BAO_0000218,,,In vivo,1,,2048.0,Mus musculus,,10090.0,1,Intermediate,N,A,Lung,17208,,
Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),8668,,CHEMBL624421,50594,BAO_0000218,,,In vivo,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,17208,,
Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),8669,,CHEMBL624422,50594,BAO_0000218,,,In vivo,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,17208,,
Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),8670,,CHEMBL624423,50594,BAO_0000218,,,In vivo,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,17208,,
Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),8671,,CHEMBL625123,50594,BAO_0000218,,,In vivo,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,17208,,
Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),8672,,CHEMBL625124,50594,BAO_0000218,,,In vivo,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,17208,,
Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),8673,,CHEMBL625125,50594,BAO_0000218,,,In vivo,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,17208,,
Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),8674,,CHEMBL625126,50594,BAO_0000218,,,In vivo,1,,14.0,Mus musculus,,10090.0,1,Intermediate,N,A,Zone of skin,17208,,
Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),8675,,CHEMBL626947,50594,BAO_0000218,,,In vivo,1,,14.0,Mus musculus,,10090.0,1,Intermediate,N,A,Zone of skin,17208,,
Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),8676,,CHEMBL626948,50594,BAO_0000218,,,In vivo,1,,14.0,Mus musculus,,10090.0,1,Intermediate,N,A,Zone of skin,17208,,
Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),8677,,CHEMBL626949,50594,BAO_0000218,,,In vivo,1,,14.0,Mus musculus,,10090.0,1,Intermediate,N,A,Zone of skin,17208,,
Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),8678,,CHEMBL626950,50594,BAO_0000218,,,In vivo,1,,14.0,Mus musculus,,10090.0,1,Intermediate,N,A,Zone of skin,17208,,
Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),8679,,CHEMBL626951,50594,BAO_0000218,,,In vivo,1,,14.0,Mus musculus,,10090.0,1,Intermediate,N,A,Zone of skin,17208,,
Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),8680,,CHEMBL626952,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,17208,,
Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),8681,,CHEMBL626953,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,17208,,
Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),8682,,CHEMBL626954,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,17208,,
Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),8683,,CHEMBL626955,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,17208,,
Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),8684,,CHEMBL626956,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,17208,,
Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),8685,,CHEMBL626957,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,17208,,
Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),8686,,CHEMBL626958,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,17208,,
Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),8687,,CHEMBL626959,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,17208,,
Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),8688,,CHEMBL626960,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,17208,,
Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),8689,,CHEMBL626961,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,17208,,
Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),8690,,CHEMBL627589,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,17208,,
Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),8691,,CHEMBL627590,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,17208,,
Time taken for EC90 was determined when tested in mouse,8692,,CHEMBL627591,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,3132,,
Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,8693,,CHEMBL627592,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,3132,,
At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),8694,,CHEMBL627593,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,16597,,
Half life in mice,8695,,CHEMBL627594,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,5727,,
Half life period in mouse after 10 mg/Kg dose,8696,,CHEMBL876813,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,5302,,
Half life period in mouse after 10 mg/kg dose,8697,,CHEMBL627595,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,5302,,
Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,8698,,CHEMBL627596,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,6348,,
Cmax value at 5 mg/kg po was determined in rat,8699,,CHEMBL627597,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5964,,
Cmax value evaluated in rat,8700,,CHEMBL627598,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6078,,
Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,8701,,CHEMBL627599,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,5206,,
Cmax value after administration of 20 mg/Kg oral dose in rat,8702,,CHEMBL627600,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2959,,
Cmax value at 1 mg/kg po in rat,8703,,CHEMBL627601,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5964,,
Cmax value at 5 mg/kg po in rat,8704,,CHEMBL627776,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5964,,
Cmax value at a dose of 10 mg/kg in male SD rats,8705,,CHEMBL627777,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6757,,
Cmax value at a dose of 100 mg/kg in male SD rats,8706,,CHEMBL627778,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6757,,
Cmax value at a dose of 50 mg/kg in male SD rats,8707,,CHEMBL627779,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6757,,
Cmax value in rats at 10 mg/kg,8708,,CHEMBL876814,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17617,,
Cmax value was evaluated in rats at a dose of 20 mg/kg,8709,,CHEMBL627780,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1445,,
Cmax value was determined after peroral administration of 20 mg/kg in rat,8710,,CHEMBL627781,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6082,,
Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,8711,,CHEMBL627782,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1446,,
Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,8712,,CHEMBL627783,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5407,,
Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,8713,,CHEMBL627784,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2690,,
Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,8714,,CHEMBL627785,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,8715,,CHEMBL627786,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,8716,,CHEMBL627787,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4891,,
Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,8717,,CHEMBL627788,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2807,,
Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,8718,,CHEMBL626579,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2807,,
Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,8719,,CHEMBL626580,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2807,,
Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,8720,,CHEMBL876815,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3634,,
Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,8721,,CHEMBL626581,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1881,,
Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,8722,,CHEMBL626582,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1881,,
Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,8723,,CHEMBL626583,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,429,,
In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,8724,,CHEMBL626205,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,8725,,CHEMBL626206,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,8726,,CHEMBL626207,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,8727,,CHEMBL623882,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,8728,,CHEMBL623883,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17582,,
Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,8729,,CHEMBL623884,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17582,,
"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",8730,,CHEMBL623885,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,3032,,
In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,8731,,CHEMBL623886,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6295,,
Maximal concentration in rat was determined,8732,,CHEMBL623887,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6619,,
Maximal concentration after i.v. administration,8733,,CHEMBL623888,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6616,,
Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,8734,,CHEMBL623889,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,3249,,
Maximal plasma concentration in rat after oral administration at 50 mg/kg,8735,,CHEMBL623890,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17791,,
Cmax in rat plasma after oral dose (50 mg/Kg),8736,,CHEMBL623891,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17791,,
Maximal plasma concentration was determined.,8737,,CHEMBL623892,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1360,,
Maximal plasma drug concentration was determined,8738,,CHEMBL623893,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2552,,
Maximal concentration in rats after peroral administration,8739,,CHEMBL877616,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6571,,
Maximum concentration in rat after 2 mg/kg peroral administration,8740,,CHEMBL623894,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6570,,
Maximum concentration in rat plasma after 5 mg/kg oral gavage,8741,,CHEMBL623895,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6567,,
Maximum concentration of compound in rat was evaluated.,8742,,CHEMBL623896,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3031,,
Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,8743,,CHEMBL623897,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3436,,
Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,8744,,CHEMBL623898,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3436,,
Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,8745,,CHEMBL623899,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2083,,
Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,8746,,CHEMBL623900,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3436,,
Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,8747,,CHEMBL623901,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4527,,
Maximum concentration was evaluated in rats,8748,,CHEMBL623902,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1974,,
Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,8749,,CHEMBL623903,50597,BAO_0000218,,,In vivo,1,,1359.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebrospinal fluid,3307,,
Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,8750,,CHEMBL623904,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,3307,,
Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,8751,,CHEMBL877617,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1916,,
Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,8752,,CHEMBL623905,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1500,,
Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,8753,,CHEMBL623906,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1500,,
Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,8754,,CHEMBL623907,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4186,,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8755,,CHEMBL623908,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,8756,,CHEMBL623909,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8757,,CHEMBL623910,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8758,,CHEMBL623911,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8759,,CHEMBL623912,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8760,,CHEMBL624616,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8761,,CHEMBL624617,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8762,,CHEMBL624618,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8763,,CHEMBL624619,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8764,,CHEMBL624794,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8765,,CHEMBL624795,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8766,,CHEMBL623921,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8767,,CHEMBL623922,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8768,,CHEMBL623923,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8769,,CHEMBL623924,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8770,,CHEMBL623925,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8771,,CHEMBL623926,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8772,,CHEMBL623927,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8773,,CHEMBL623928,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8774,,CHEMBL623929,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8775,,CHEMBL623930,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8776,,CHEMBL623931,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16434,,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8777,,CHEMBL622165,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16434,,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8778,,CHEMBL621249,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16434,,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8779,,CHEMBL621250,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16434,,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8780,,CHEMBL621448,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16434,,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8781,,CHEMBL621449,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16434,,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8782,,CHEMBL621450,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16434,,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8783,,CHEMBL621451,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16434,,
Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8784,,CHEMBL621452,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8785,,CHEMBL621453,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8786,,CHEMBL621454,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8787,,CHEMBL621455,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8788,,CHEMBL621456,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8789,,CHEMBL625145,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8790,,CHEMBL875847,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8791,,CHEMBL625146,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8792,,CHEMBL625147,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16434,,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8793,,CHEMBL625148,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16434,,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8794,,CHEMBL625149,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16434,,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8795,,CHEMBL625150,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8796,,CHEMBL625151,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8797,,CHEMBL625152,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8798,,CHEMBL625153,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8799,,CHEMBL625154,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8800,,CHEMBL625155,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,16435,,
Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8801,,CHEMBL625156,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11977,,
Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8802,,CHEMBL624354,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11977,,
Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8803,,CHEMBL624355,50597,BAO_0000218,,,,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,11977,,
Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8804,,CHEMBL624356,50597,BAO_0000218,,,,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,11977,,
Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8805,,CHEMBL624357,50597,BAO_0000218,,,,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,11977,,
Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8806,,CHEMBL624358,50597,BAO_0000218,,,,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,11977,,
Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8807,,CHEMBL624359,50597,BAO_0000218,,,,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,11977,,
Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8808,,CHEMBL624360,50597,BAO_0000218,,,,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,11977,,
Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8809,,CHEMBL624361,50597,BAO_0000218,,,,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,11977,,
Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8810,,CHEMBL624362,50597,BAO_0000218,,,,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,11977,,
Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8811,,CHEMBL624363,50597,BAO_0000218,,,,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,11977,,
Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8812,,CHEMBL624364,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11977,,
Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8813,,CHEMBL624365,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11977,,
Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8814,,CHEMBL624366,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11977,,
Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8815,,CHEMBL624367,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11977,,
Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8816,,CHEMBL624368,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11977,,
Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8817,,CHEMBL624369,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11977,,
Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8818,,CHEMBL624370,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11977,,
Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8819,,CHEMBL625069,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11977,,
Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8820,,CHEMBL625070,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11977,,
Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8821,,CHEMBL626051,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11977,,
Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8822,,CHEMBL626052,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11977,,
Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8823,,CHEMBL626053,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11977,,
Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8824,,CHEMBL626054,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11977,,
Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8825,,CHEMBL626055,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11977,,
Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8826,,CHEMBL626056,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11977,,
Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8827,,CHEMBL626057,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11977,,
Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8828,,CHEMBL625193,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11977,,
Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8829,,CHEMBL625194,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11977,,
Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8830,,CHEMBL625195,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11977,,
Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8831,,CHEMBL625196,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11977,,
Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8832,,CHEMBL625197,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11977,,
Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8833,,CHEMBL625198,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11977,,
Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8834,,CHEMBL627929,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11977,,
Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8835,,CHEMBL627074,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11977,,
Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8836,,CHEMBL627075,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11977,,
Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8837,,CHEMBL627076,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11977,,
Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8838,,CHEMBL627077,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11977,,
Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8839,,CHEMBL627078,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11977,,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),8840,,CHEMBL627079,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11977,,
Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,8841,,CHEMBL873824,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,4573,,
Half life in mouse plasma was determined at dose 25 mg/kg,8842,,CHEMBL627080,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,3132,,
Half life was determined,8843,,CHEMBL627081,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17718,,
Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,8844,,CHEMBL627082,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17728,,
Half-life in male mice after 1 mg/kg intravenous dose,8845,,CHEMBL627083,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,5961,,
Half life in mice plasma,8847,,CHEMBL627085,50594,BAO_0000218,,,,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,17731,,
Half life in mouse,8848,,CHEMBL627086,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17592,,
Half life in mouse plasma at dose 25 mg/kg,8849,,CHEMBL627087,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,3132,,
Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,8850,,CHEMBL627088,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17729,,
Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,8851,,CHEMBL627089,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17729,,
Half life when injected perorally in mice at a dose of 50 mg/kg was determined,8852,,CHEMBL627090,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17729,,
Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),8853,,CHEMBL627091,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,3277,,
"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",8854,,CHEMBL627092,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,3760,,
"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",8855,,CHEMBL876785,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,3760,,
Half-life by iv administration in mouse,8856,,CHEMBL627093,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,2862,,
Half-life by oral administration in mouse,8857,,CHEMBL627094,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,2862,,
Half-life in mice,8858,,CHEMBL627095,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,5980,,
Half-life using mouse brain homogenate,8859,,CHEMBL627096,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,6159,,
Half-life was measured in mice,8860,,CHEMBL627097,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,6254,,
Half-life was measured in mouse after an iv dose of 1 mg/kg,8861,,CHEMBL627098,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,6062,,
Half-life period was determined in mouse blood,8862,,CHEMBL627099,50594,BAO_0000218,,,,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,1574,,
"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",8863,,CHEMBL627100,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,56,,
Plasma half life in mouse,8864,,CHEMBL627101,50594,BAO_0000218,,,,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,993,,
Stability of the peptide in the presence of mouse serum,8865,,CHEMBL627102,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,6652,,
Terminal half life of compound was determined in mouse,8866,,CHEMBL627103,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17852,,
Terminal half life was evaluated in mice after intravenous administration,8867,,CHEMBL627104,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,2675,,
Terminal half life was evaluated in mice after oral administration,8868,,CHEMBL627105,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,2675,,
The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,8869,,CHEMBL876786,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,499,,
The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,8870,,CHEMBL873825,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,499,,
The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,8871,,CHEMBL627106,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,499,,
half life period is evaluated by administering intravenously at 25 mg/kg in mice,8872,,CHEMBL626336,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14239,,
"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",8873,,CHEMBL877462,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,5506,,
"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",8874,,CHEMBL626337,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,5506,,
Half life after intraperitoneal administration of 100 mg/kg in mice,8875,,CHEMBL626338,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17734,,
Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,8876,,CHEMBL626339,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17728,,
Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,8877,,CHEMBL626340,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17728,,
Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,8878,,CHEMBL625377,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17728,,
Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,8879,,CHEMBL625378,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17728,,
Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,8880,,CHEMBL625379,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,17728,,
Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),8881,,CHEMBL625380,22224,BAO_0000251,,,,1,,,Sus scrofa,,9823.0,0,Autocuration,U,A,,14294,Microsomes,
Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),8882,,CHEMBL625381,22224,BAO_0000251,,,,1,,,Sus scrofa,,9823.0,0,Autocuration,U,A,,14294,Microsomes,
Stability to porcine renal DHP-I,8883,,CHEMBL625382,22224,BAO_0000019,,,,1,,,Sus scrofa,,9823.0,0,Autocuration,U,A,,6056,,
Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,8884,,CHEMBL873828,22224,BAO_0000218,,,In vivo,1,,,Sus scrofa,,9823.0,0,Autocuration,U,A,,1317,,
Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,8885,,CHEMBL625383,22224,BAO_0000218,,,In vivo,1,,,Sus scrofa,,9823.0,0,Autocuration,U,A,,1317,,
Half-life of the parent prodrug in porcine esterase solution,8886,,CHEMBL625384,22224,BAO_0000019,,,,1,,,Sus scrofa,,9823.0,0,Autocuration,U,A,,5229,,
"First order rate constant, k was determined in in pig liver Esterase",8887,,CHEMBL625385,22224,BAO_0000019,,,,1,,,Sus scrofa,,9823.0,0,Autocuration,U,A,,4231,,
Half life of the in pig liver Esterase,8888,,CHEMBL625386,22224,BAO_0000221,,,,1,,2107.0,Sus scrofa,,9823.0,0,Autocuration,U,A,Liver,4231,,
Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,8889,,CHEMBL623571,22224,BAO_0000221,,,,1,,2107.0,Sus scrofa,,9823.0,0,Autocuration,U,A,Liver,5318,,
Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,8890,,CHEMBL623572,22224,BAO_0000221,,,,1,,2107.0,Sus scrofa,,9823.0,0,Autocuration,U,A,Liver,5318,,
Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,8891,,CHEMBL623573,22224,BAO_0000221,,,,1,,2107.0,Sus scrofa,,9823.0,0,Autocuration,U,A,Liver,5318,,
Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,8892,,CHEMBL623574,22224,BAO_0000221,,,,1,,2107.0,Sus scrofa,,9823.0,0,Autocuration,U,A,Liver,3305,,
Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,8893,,CHEMBL623575,22224,BAO_0000221,,,,1,,2107.0,Sus scrofa,,9823.0,0,Autocuration,U,A,Liver,3305,,
Half-life in the presence of pig liver esterase(PLE) was evaluated.,8894,,CHEMBL623749,22224,BAO_0000221,,,,1,,2107.0,Sus scrofa,,9823.0,0,Autocuration,U,A,Liver,2842,,
Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,8895,,CHEMBL623750,22224,BAO_0000221,,,,1,,2107.0,Sus scrofa,,9823.0,0,Autocuration,U,A,Liver,2842,,
Half-life in vitro in pig liver,8896,,CHEMBL623751,22224,BAO_0000221,,,In vitro,1,,2107.0,Sus scrofa,,9823.0,0,Autocuration,U,A,Liver,889,,
Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,8897,,CHEMBL623752,22224,BAO_0000221,,,,1,,2107.0,Sus scrofa,,9823.0,0,Autocuration,U,A,Liver,1904,,
Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,8898,,CHEMBL623753,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4186,,
Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,8899,,CHEMBL623754,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2774,,
Maximum concentration in rat plasma was determined,8900,,CHEMBL623755,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1742,,
Maximum concentration in rats,8901,,CHEMBL623756,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3169,,
Maximum concentration in rats at 1-2 hours,8902,,CHEMBL623757,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3169,,
Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,8903,,CHEMBL623758,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2081,,
Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,8904,,CHEMBL623759,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,3307,,
Maximum concentration at the dose of 2 mg/kg in rat,8905,,CHEMBL623760,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4727,,
Maximum concentration was evaluated in rats,8906,,CHEMBL623761,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6597,,
Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,8907,,CHEMBL623762,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16365,,
Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,8908,,CHEMBL877594,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16365,,
Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,8909,,CHEMBL623763,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16365,,
Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,8910,,CHEMBL623764,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16365,,
Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,8911,,CHEMBL623765,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16365,,
Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,8912,,CHEMBL623766,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,2591,,
Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,8913,,CHEMBL623767,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,2591,,
Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,8914,,CHEMBL623768,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,2591,,
Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,8915,,CHEMBL623769,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5978,,
Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,8916,,CHEMBL623770,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5978,,
Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,8917,,CHEMBL623771,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5978,,
Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,8918,,CHEMBL623772,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5978,,
Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,8919,,CHEMBL623773,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5978,,
Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,8920,,CHEMBL623774,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5978,,
Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,8921,,CHEMBL623775,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5978,,
Cmax in rat (PO dose),8922,,CHEMBL623776,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14465,,
Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,8923,,CHEMBL622191,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4723,,
Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,8924,,CHEMBL622192,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4723,,
Maximum plasma concentration determined in rat,8925,,CHEMBL622193,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4576,,
Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,8926,,CHEMBL622194,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12873,,
Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,8927,,CHEMBL622195,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12873,,
Maximum plasma concentration in rat,8928,,CHEMBL622196,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6824,,
Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,8929,,CHEMBL622197,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17065,,
Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,8930,,CHEMBL622198,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2932,,
Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,8931,,CHEMBL622199,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2932,,
Maximum plasma concentration of compound was measured in rat,8932,,CHEMBL622200,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2879,,
Maximum plasma concentration after 20 mg/kg oral administration in rat,8933,,CHEMBL622201,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2864,,
Maximum plasma concentration after oral administration to rats,8934,,CHEMBL623990,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16367,,
Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,8935,,CHEMBL623991,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17717,,
"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",8936,,CHEMBL623992,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17717,,
Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,8937,,CHEMBL623993,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17717,,
Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,8938,,CHEMBL623994,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17717,,
Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,8939,,CHEMBL623995,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,F,Plasma,17720,,
Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,8940,,CHEMBL623996,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,F,Plasma,17720,,
Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,8941,,CHEMBL623997,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,F,Plasma,17720,,
Maximum plasma concentration dosed orally in rats,8942,,CHEMBL623998,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4516,,
Maximum plasma concentration dosed orally in rats after 6 hours,8943,,CHEMBL623999,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4516,,
Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,8944,,CHEMBL624000,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4516,,
Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,8945,,CHEMBL624001,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5199,,
Maximum plasma concentration in rat after po administration,8946,,CHEMBL624002,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17538,,
"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",8947,,CHEMBL624003,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6685,,
"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",8948,,CHEMBL624004,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6685,,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8949,,CHEMBL624005,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16434,,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8950,,CHEMBL624006,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16434,,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8951,,CHEMBL624007,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16434,,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8952,,CHEMBL624008,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16434,,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8953,,CHEMBL624009,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16434,,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8954,,CHEMBL874387,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16434,,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8955,,CHEMBL624010,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16434,,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,8956,,CHEMBL624011,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16434,,
Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8957,,CHEMBL624012,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8958,,CHEMBL624013,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8959,,CHEMBL624736,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8960,,CHEMBL624737,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8961,,CHEMBL624738,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16434,,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8962,,CHEMBL624739,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16434,,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8963,,CHEMBL624740,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16434,,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8964,,CHEMBL624896,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8965,,CHEMBL624897,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8966,,CHEMBL624108,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8967,,CHEMBL624109,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8968,,CHEMBL624110,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8969,,CHEMBL624111,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8970,,CHEMBL624112,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8971,,CHEMBL624113,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8972,,CHEMBL619709,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8973,,CHEMBL619710,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,16435,,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8974,,CHEMBL619711,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16434,,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8975,,CHEMBL619712,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16434,,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8976,,CHEMBL619713,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16434,,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8977,,CHEMBL619714,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16434,,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8978,,CHEMBL619715,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16434,,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8979,,CHEMBL619716,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16434,,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8980,,CHEMBL619717,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16434,,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8981,,CHEMBL619718,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16434,,
Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8982,,CHEMBL619719,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8983,,CHEMBL875329,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8984,,CHEMBL619720,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8985,,CHEMBL619721,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8986,,CHEMBL619722,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8987,,CHEMBL619723,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8988,,CHEMBL619724,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8989,,CHEMBL619725,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8990,,CHEMBL619726,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16434,,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8991,,CHEMBL619727,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16434,,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8992,,CHEMBL619728,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16434,,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8993,,CHEMBL619729,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8994,,CHEMBL619730,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11977,,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8995,,CHEMBL619731,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11977,,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8996,,CHEMBL619732,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11977,,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8997,,CHEMBL619733,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11977,,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8998,,CHEMBL619734,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11977,,
Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8999,,CHEMBL619735,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,11977,,
Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9000,,CHEMBL875330,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,11977,,
Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),9001,,CHEMBL628465,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,11977,,
Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),9002,,CHEMBL628466,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,11977,,
Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),9003,,CHEMBL628467,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,11977,,
Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),9004,,CHEMBL628468,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,11977,,
Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9005,,CHEMBL628469,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,11977,,
Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),9006,,CHEMBL628470,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,11977,,
Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),9007,,CHEMBL628471,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,11977,,
Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),9008,,CHEMBL628472,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,11977,,
Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),9009,,CHEMBL625191,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11977,,
Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9010,,CHEMBL625192,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11977,,
Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),9011,,CHEMBL875337,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11977,,
Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),9012,,CHEMBL626341,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11977,,
Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),9013,,CHEMBL626342,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11977,,
Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9014,,CHEMBL621943,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11977,,
Half life in rats,9015,,CHEMBL621944,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3748,,
Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,9016,,CHEMBL621945,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15765,,
Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),9017,,CHEMBL621946,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4871,,
Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,9018,,CHEMBL621947,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4871,,
Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),9019,,CHEMBL621948,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4872,,
Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,9020,,CHEMBL621949,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4872,,
Rate constant (k) of clearance from isolated perfused rat liver (IPRL),9021,,CHEMBL621950,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5413,,
Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,9022,,CHEMBL621951,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5413,,
Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,9023,,CHEMBL621952,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,15272,,
Stability (%) in rat liver microsomes,9024,,CHEMBL621953,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,4689,,
Area under curve was calculated after intravenous administration,9025,,CHEMBL621954,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6057,,
Area under the curve was calculated after iv administration in rat,9026,,CHEMBL621955,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6057,,
Area under the curve was calculated in rat after peroral administration,9027,,CHEMBL621956,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6057,,
Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,9028,,CHEMBL621957,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6211,,
Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,9029,,CHEMBL621958,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5710,,
Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,9030,,CHEMBL621959,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5710,,
Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,9031,,CHEMBL621960,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17853,,
Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,9032,,CHEMBL621961,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17853,,
p value of the compound,9033,,CHEMBL621962,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15765,,
p value of the compound,9034,,CHEMBL876787,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,15765,,
p value of the compound,9035,,CHEMBL621963,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15765,,
pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9036,,CHEMBL622637,50597,BAO_0000218,,,,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,6175,,
pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9037,,CHEMBL622638,50597,BAO_0000218,,,,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,6175,,
pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9038,,CHEMBL626561,50597,BAO_0000218,,,,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,6175,,
Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),9039,,CHEMBL626562,22224,BAO_0000019,,,,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,F,,7991,,
Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),9040,,CHEMBL626563,22224,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,429,,
Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),9041,,CHEMBL626564,22224,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,429,,
Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,9042,,CHEMBL626565,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,6253,,
Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,9043,,CHEMBL626566,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,6253,,
Clearance rate in rabbits,9044,,CHEMBL626567,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,3615,,
Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,9045,,CHEMBL626568,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,4059,,
Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9046,,CHEMBL626569,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,5124,,
Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9047,,CHEMBL626570,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,5124,,
Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9048,,CHEMBL626571,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,5124,,
Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,9049,,CHEMBL626572,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,429,,
Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,9050,,CHEMBL626573,22224,BAO_0000218,,,In vivo,1,,1969.0,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,Plasma,4059,,
Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,9051,,CHEMBL626574,22224,BAO_0000251,,,,1,,2107.0,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,Liver,9659,Microsomes,
Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,9052,,CHEMBL626575,22224,BAO_0000251,,,,1,,2107.0,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,Liver,9659,Microsomes,
Dose at which bioavailability of intravenously administered compound was tested in rabbit,9053,,CHEMBL626576,22224,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,3639,,
Dose at which bioavailability of perorally administered compound was tested in rabbit,9054,,CHEMBL626577,22224,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,3639,,
The compound was tested for its bioavailability in rabbit (by oral dosage).,9055,,CHEMBL626578,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,3639,,
Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9056,,CHEMBL625263,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,5124,,
Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9057,,CHEMBL625264,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,5124,,
Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9058,,CHEMBL625265,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,5124,,
Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),9059,,CHEMBL625266,22224,BAO_0000251,,,,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,14294,Microsomes,
Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),9060,,CHEMBL876796,22224,BAO_0000251,,,,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,14294,Microsomes,
Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,9061,,CHEMBL625267,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,429,,
Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9062,,CHEMBL625268,22224,BAO_0000218,,,In vivo,1,,1969.0,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,Plasma,5124,,
Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9063,,CHEMBL625269,22224,BAO_0000218,,,In vivo,1,,1969.0,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,Plasma,5124,,
Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9064,,CHEMBL624689,22224,BAO_0000218,,,In vivo,1,,1969.0,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,Plasma,5124,,
Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,9065,,CHEMBL624690,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,429,,
Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),9066,,CHEMBL624691,22224,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,Urine,429,,
Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),9067,,CHEMBL624692,22224,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,Urine,429,,
The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,9068,,CHEMBL624693,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,4059,,
Volume of distribution after intravenous administration of 1 mg/kg/h in dog,9069,,CHEMBL624694,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,4137,,
In vitro Biological half-life in crude homogenate of rabbit renal cortex,9070,,CHEMBL877596,22224,BAO_0000221,,,In vitro,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,11672,,
Time within which only 10% of the drug was degraded,9071,,CHEMBL624695,22224,BAO_0000019,,,,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,12886,,
Half life period in rabbit liver homogenate,9072,,CHEMBL624696,22224,BAO_0000221,,,,1,,2107.0,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,Liver,3853,,
Half life value in rabbits,9073,,CHEMBL624697,22224,BAO_0000019,,,,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,3615,,
Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,9074,,CHEMBL624698,22224,BAO_0000218,,,In vivo,1,,178.0,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,Blood,6253,,
Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,9075,,CHEMBL624699,22224,BAO_0000218,,,In vivo,1,,178.0,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,Blood,6253,,
Half-life period in rabbits following intravenous administration at 2 mg/kg,9076,,CHEMBL624700,22224,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,0,Autocuration,U,A,,6077,,
AUC 0-8 hr value in rats at 10 mg/kg,9077,,CHEMBL622903,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17617,,
AUC after administration at 2000 mg/kg/day in rats,9078,,CHEMBL622904,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17594,,
AUC of compound for a 2 mpk po dose of the sodium salt in rats.,9079,,CHEMBL622905,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6149,,
AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,9080,,CHEMBL622906,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17260,,
AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,9081,,CHEMBL622907,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17260,,
AUC in rat after oral administration at 10.5 mg/kg dose,9082,,CHEMBL622908,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6644,,
AUC in rat after oral administration at 11.2 mg/kg dose,9083,,CHEMBL622909,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6644,,
AUC in rat after oral administration at 9.7 mg/kg dose,9084,,CHEMBL622910,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6644,,
AUC in rat brain after oral administration at 10 mg/kg,9085,,CHEMBL622911,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,6495,,
AUC in rat p.o.,9086,,CHEMBL622912,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6504,,
AUC in rat p.o. at 20 mg/kg concentration,9087,,CHEMBL622913,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17686,,
AUC in rat plasma after oral administration at 10 mg/kg,9088,,CHEMBL622914,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6495,,
AUC in rats,9089,,CHEMBL622915,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,216,,
AUC value after IV dose at a dose of 5 mg/kg in rats.,9090,,CHEMBL622916,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1908,,
AUC value after oral dose at a dose of 10 mg/kg in rats.,9091,,CHEMBL622917,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1908,,
"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",9092,,CHEMBL622918,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6685,,
Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,9093,,CHEMBL622919,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,216,,
Maximum plasma concentration was evaluated in rat,9094,,CHEMBL622920,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6049,,
Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,9095,,CHEMBL622921,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2463,,
Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,9096,,CHEMBL622922,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6679,,
Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,9097,,CHEMBL622923,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6681,,
Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,9098,,CHEMBL877604,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4890,,
Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,9099,,CHEMBL622924,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6410,,
Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,9100,,CHEMBL622925,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6410,,
Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,9101,,CHEMBL622926,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16366,,
Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,9102,,CHEMBL623625,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6227,,
Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,9103,,CHEMBL623626,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Expert,N,A,Plasma,3598,,
Maximum plasma drug concentration was determined,9104,,CHEMBL623627,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1465,,
Maximum concentration by intravenous administration of 3.4 mg/kg in rat,9105,,CHEMBL623628,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4368,,
Mean peak plasma concentration was observed after intravenous administration in rat,9106,,CHEMBL623629,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15662,,
Mean peak plasma concentration was observed after oral administration in rat,9107,,CHEMBL623630,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15662,,
Peak concentration (Cmax) at a dose of 10 mg/kg in rats,9108,,CHEMBL623804,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5355,,
Peak concentration (Cmax) at a dose of 20 mg/kg in rats,9109,,CHEMBL623805,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5355,,
Peak oral plasma concentration was determined in rats by oral administration,9110,,CHEMBL623806,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1567,,
Peak plasma concentration (Cmax) was determined,9111,,CHEMBL623807,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4026,,
Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,9112,,CHEMBL623808,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6193,,
Peak plasma concentration (Cmax) in rats,9113,,CHEMBL623809,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4026,,
Peak plasma concentration at 1 mg/kg peroral administration,9114,,CHEMBL623810,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6485,,
Peak plasma concentration in rat,9115,,CHEMBL623811,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17655,,
"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",9116,,CHEMBL623812,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14941,,
Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,9117,,CHEMBL877605,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5394,,
Pharmacokinetic property (Cmax) in rat,9118,,CHEMBL623813,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4408,,
Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,9119,,CHEMBL623814,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5983,,
Cmax in rat after 3mg/kg oral dose,9120,,CHEMBL623815,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4878,,
Clearance in Sprague-Dawley rats after 2mg/kg oral dose,9121,,CHEMBL623816,50597,BAO_0000218,,,In vivo,1,Sprague-Dawley,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5862,,
Cmax in rats after 20 mg/kg oral dose,9122,,CHEMBL623145,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4517,,
Cmax in rat plasma after 30mg/kg oral dose,9123,,CHEMBL623146,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5932,,
Plasma concentration after oral administration of 100 mg/kg to rats,9124,,CHEMBL623147,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5436,,
Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,9125,,CHEMBL623042,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,4910,,
Tested for the Cmax in rat at 10 mg/kg per orally,9126,,CHEMBL623043,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4950,,
"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",9127,,CHEMBL623044,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",9128,,CHEMBL623045,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
Bioavailability as oral Cmax in rats at 30 mins,9129,,CHEMBL623046,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3360,,
Bioavailability as oral Cmax in rats at 6hr,9130,,CHEMBL623226,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3360,,
The maximum concentration of compound was measured at the dose of 100 umol/kg,9131,,CHEMBL623227,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15022,,
The maximum concentration of compound was measured at the dose of 300 umol/kg,9132,,CHEMBL623228,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15022,,
The maximum concentration of compound was measured at the dose of 30 umol/kg,9133,,CHEMBL623229,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15022,,
The maximum plasma levels for the compounds were determined by LC-MS.,9134,,CHEMBL623230,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5160,,
mean peak plasma concentration was observed after intravenous administration in rat,9135,,CHEMBL623231,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15662,,
mean peak plasma concentration was observed after oral administration in rat,9136,,CHEMBL623232,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15662,,
Concentration in the plasma after intravenous administration of 1 mg/kg in rat,9137,,CHEMBL623233,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4709,,
Concentration in plasma (portal) following oral dose in rats at 0.25 hr,9138,,CHEMBL623234,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3535,,
Concentration in plasma (portal) following oral dose in rats at 1 hr,9139,,CHEMBL623235,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3535,,
Concentration in plasma (portal) following oral dose in rats at 2 hr,9140,,CHEMBL623236,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3535,,
Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,9141,,CHEMBL623237,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3535,,
Concentration in plasma (systemic) following oral dose in rats at 1 hr,9142,,CHEMBL623238,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3535,,
Concentration in plasma (systemic) following oral dose in rats at 2 hr,9143,,CHEMBL623239,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3535,,
Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,9144,,CHEMBL623240,22224,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,0,Intermediate,U,A,Plasma,5005,,
"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",9145,,CHEMBL623241,50597,BAO_0000218,,,,1,,1898.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hypothalamus,6326,,
"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",9146,,CHEMBL623242,50597,BAO_0000218,,,,1,,1898.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hypothalamus,6326,,
"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",9147,,CHEMBL874394,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6326,,
"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",9148,,CHEMBL623243,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6326,,
Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9149,,CHEMBL623244,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17411,,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9150,,CHEMBL623245,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9151,,CHEMBL623246,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9152,,CHEMBL623247,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9153,,CHEMBL623248,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9154,,CHEMBL623249,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,16435,,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9155,,CHEMBL625072,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16434,,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9156,,CHEMBL625073,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16434,,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9157,,CHEMBL625074,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16434,,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9158,,CHEMBL625075,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16434,,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,9159,,CHEMBL625076,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16434,,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9160,,CHEMBL625077,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16434,,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9161,,CHEMBL625078,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16434,,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9162,,CHEMBL874395,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16434,,
Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9163,,CHEMBL625079,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9164,,CHEMBL625080,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9165,,CHEMBL625081,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9166,,CHEMBL625082,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9167,,CHEMBL625083,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9168,,CHEMBL625084,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9169,,CHEMBL625085,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9170,,CHEMBL625086,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9171,,CHEMBL625087,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16434,,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9172,,CHEMBL625088,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16434,,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9173,,CHEMBL622205,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16434,,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9174,,CHEMBL622206,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9175,,CHEMBL622207,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9176,,CHEMBL622366,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9177,,CHEMBL622367,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9178,,CHEMBL875331,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9179,,CHEMBL622368,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,16435,,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9180,,CHEMBL622369,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16434,,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9181,,CHEMBL622370,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16434,,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9182,,CHEMBL622371,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16434,,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9183,,CHEMBL622372,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16434,,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9184,,CHEMBL622373,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16434,,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9185,,CHEMBL622374,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16434,,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9186,,CHEMBL622375,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16434,,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,9187,,CHEMBL622376,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16434,,
Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9188,,CHEMBL622377,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9189,,CHEMBL622378,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9190,,CHEMBL622379,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9191,,CHEMBL622380,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9192,,CHEMBL622381,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9193,,CHEMBL622382,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,9194,,CHEMBL622383,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16434,,
pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9195,,CHEMBL875332,50597,BAO_0000218,,,,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,6175,,
pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9196,,CHEMBL622384,50597,BAO_0000218,,,,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,6175,,
pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9197,,CHEMBL622385,50597,BAO_0000218,,,,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,6175,,
pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9198,,CHEMBL622386,50597,BAO_0000218,,,,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,6175,,
The compound was tested for the plasma binding in rat,9199,,CHEMBL622387,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10839,,
"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",9200,,CHEMBL622388,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16459,,
"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",9201,,CHEMBL622389,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16459,,
"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",9202,,CHEMBL622390,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16459,,
Plasma concentration after oral aministration at 1 hr. (10 mg/kg),9203,,CHEMBL622391,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16459,,
Plasma concentration after oral aministration at 2 hr. (10 mg/kg),9204,,CHEMBL622392,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16459,,
Plasma concentration after oral aministration at 4 hr. (10 mg/kg),9205,,CHEMBL622393,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16459,,
Plasma level at 2 hr after administration of the compound,9206,,CHEMBL622394,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3278,,
plasma level at 2 hr after administration of the compound,9207,,CHEMBL622395,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3278,,
Stability in rat serum measured as % recovery at 1 min,9208,,CHEMBL622396,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,4684,,
Stability in rat serum measured as % recovery at 10 min,9209,,CHEMBL624894,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,4684,,
Stability in rat serum measured as % recovery at 10 mins,9210,,CHEMBL624895,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,4684,,
Stability in rat serum measured as % recovery at 2 hr,9211,,CHEMBL624058,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,4684,,
Stability in rat serum measured as % recovery at 3 min,9212,,CHEMBL624059,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,4684,,
Stability in rat serum measured as % recovery at 3 mins,9213,,CHEMBL624060,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,4684,,
Stability in rat serum measured as % recovery at 5 min,9214,,CHEMBL624061,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,4684,,
Stability in rat serum measured as % recovery at 5 mins,9215,,CHEMBL624062,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,4684,,
Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,9216,,CHEMBL624063,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16456,,
Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,9217,,CHEMBL624064,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16456,,
Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,9218,,CHEMBL624065,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,723,,
Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,9219,,CHEMBL624066,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,723,,
Half life tested in mature male rat at a dose of 30 mg/kg,9220,,CHEMBL877490,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5160,,
Half life after intravenous administration of 1 mg/kg in rat,9221,,CHEMBL874442,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4709,,
Half life period after administration (30 mg/kg) in rat,9222,,CHEMBL626890,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5633,,
Half life period in rat after 5 mg/Kg dose,9223,,CHEMBL626891,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5302,,
Half life period in rat after 5 mg/kg dose,9224,,CHEMBL626892,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5302,,
Half life period was determined,9225,,CHEMBL626893,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17791,,
Half life period was evaluated in rat,9226,,CHEMBL626894,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17791,,
Half life period was evaluated in rat; 0.5-1.0,9227,,CHEMBL626895,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17791,,
Half life period was evaluated in rat; 5.9-7.5,9228,,CHEMBL626896,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17791,,
Half-life in rat plasma,9229,,CHEMBL626897,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14512,,
Half-life time in rat was determined,9230,,CHEMBL626898,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6230,,
Terminal half-life after iv administration to rats,9231,,CHEMBL626899,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3364,,
Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,9232,,CHEMBL626900,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6874,,
Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,9233,,CHEMBL626901,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,857,,
Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),9234,,CHEMBL626902,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,858,,
Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),9235,,CHEMBL626903,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,858,,
Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,9236,,CHEMBL874443,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5355,,
Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,9237,,CHEMBL626904,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5355,,
Half life in rats,9238,,CHEMBL626905,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6305,,
Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,9239,,CHEMBL873830,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13501,,
Apparent half-life after single intravenous bolus of 1 mg/kg in rats,9240,,CHEMBL626906,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17594,,
Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,9241,,CHEMBL631076,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4186,,
Biological half-life was measured in plasma of rats,9242,,CHEMBL631077,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2932,,
Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,9243,,CHEMBL631078,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17065,,
Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,9244,,CHEMBL631079,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15765,,
Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,9245,,CHEMBL631080,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2713,,
Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,9246,,CHEMBL631081,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,9247,,CHEMBL631239,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for plasma half life in rat,9248,,CHEMBL631240,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,740,,
AUC value at a dose of 5 mg/kg (p.o.) in rats,9249,,CHEMBL631241,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6597,,
AUC value after administration of 20 mg/Kg oral dose in rat,9250,,CHEMBL631242,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2959,,
AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,9251,,CHEMBL631243,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17594,,
AUC0-96 after administration at 50 mg/kg,9252,,CHEMBL874444,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17596,,
AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,9253,,CHEMBL631244,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17594,,
"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",9254,,CHEMBL631245,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3293,,
Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,9255,,CHEMBL627162,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6757,,
Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,9256,,CHEMBL627163,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6757,,
Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,9257,,CHEMBL627164,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6757,,
Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,9258,,CHEMBL627165,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,5979,,
Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,9259,,CHEMBL627166,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5979,,
Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,9260,,CHEMBL627167,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5979,,
Area under curve (AUC) at a dose of 30 mg/kg in rats,9261,,CHEMBL627822,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4026,,
Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,9262,,CHEMBL627823,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5355,,
Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,9263,,CHEMBL627824,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5355,,
Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,9264,,CHEMBL627825,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5355,,
Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,9265,,CHEMBL627826,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5633,,
Area under curve (Pharmacokinetic property) was determined,9266,,CHEMBL627827,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1716,,
Area under curve (Pharmacokinetic property) of the compound; Not determined,9267,,CHEMBL627828,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1716,,
Area under curve after intravenous administration (1 mg/kg) in rat,9268,,CHEMBL627829,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4689,,
Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,9269,,CHEMBL627830,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4527,,
Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,9270,,CHEMBL627831,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4527,,
Area under curve in male SD rats was observed after oral administration in rat,9271,,CHEMBL627832,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15662,,
Area under curve of compound after iv administration of 20 mg/kg dose in rat,9272,,CHEMBL627833,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4413,,
Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,9273,,CHEMBL627834,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Expert,N,A,,3598,,
Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,9274,,CHEMBL628004,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Expert,N,A,,3598,,
Area under curve at 5 mg/kg po was determined in rat,9275,,CHEMBL628005,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5964,,
Area under curve in Rat at a oral dose of 5 mg/kg,9276,,CHEMBL628006,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4689,,
Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,9277,,CHEMBL628007,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4186,,
Area under curve was determined,9278,,CHEMBL625676,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,9279,,CHEMBL631309,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17858,,
Area under curve after intravenous administration at 3 mg/kg,9280,,CHEMBL631310,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17804,,
Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,9281,,CHEMBL631311,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6106,,
Area under curve at 4 hr in rat,9282,,CHEMBL631312,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5964,,
Area under curve at a dose of 30 mg/kg,9283,,CHEMBL631313,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4026,,
Area under curve at the dose of 2 mg/Kg administered perorally in rats,9284,,CHEMBL631314,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4756,,
Area under curve at the dose of 5 mg/Kg administered perorally in rats,9285,,CHEMBL631315,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4756,,
Area under curve for a 2-mpk po dose in SD rats,9286,,CHEMBL631316,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5862,,
Area under curve in SD rats,9287,,CHEMBL631317,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5862,,
Area under curve in rat after oral administration at 13 mg/kg dose,9288,,CHEMBL874471,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6644,,
Area under curve in rat by po administration at 0-24 hr,9289,,CHEMBL631318,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5871,,
Area under curve in rat plasma,9290,,CHEMBL631319,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5919,,
Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,9291,,CHEMBL631320,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,9292,,CHEMBL631321,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,9293,,CHEMBL631322,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10,,
Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,9294,,CHEMBL631323,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11149,,
Area under curve value in rat at a dose of 5 mg/kg,9295,,CHEMBL631324,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5302,,
Area under curve was determined after oral administration in rats,9296,,CHEMBL631325,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17796,,
Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,9297,,CHEMBL631326,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4890,,
Area under curve was determined after peroral administration in rat,9298,,CHEMBL631327,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6011,,
Area under curve was determined at a dose 30 mpk administered orally.,9299,,CHEMBL631328,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5375,,
Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,9300,,CHEMBL631329,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17764,,
Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,9301,,CHEMBL627217,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4368,,
Area under curve was determined in male rat,9302,,CHEMBL626352,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5610,,
Area under curve was determined in rat after PO administration,9303,,CHEMBL626353,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5833,,
Area under curve was determined in rat after a 3 mg/kg of oral dose,9304,,CHEMBL626354,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4257,,
Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,9305,,CHEMBL626355,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5937,,
Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,9306,,CHEMBL626356,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5932,,
Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,9307,,CHEMBL626357,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5932,,
Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9308,,CHEMBL626358,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17411,,
Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9309,,CHEMBL626359,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17411,,
Peak plasma concentration in rat at a dose of 3 mg/kg,9310,,CHEMBL626360,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17771,,
Plasma concentration at 2 hr in rats was evaluated.,9311,,CHEMBL626361,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1628,,
Plasma concentration at 2 hr in rats was evaluated; Not available,9312,,CHEMBL626362,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1628,,
Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9313,,CHEMBL626363,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17411,,
Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,9314,,CHEMBL626970,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4910,,
Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,9315,,CHEMBL626971,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4910,,
Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,9316,,CHEMBL626972,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4910,,
Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,9317,,CHEMBL626973,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4910,,
Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,9318,,CHEMBL626974,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4910,,
Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,9319,,CHEMBL874592,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4910,,
Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,9320,,CHEMBL626975,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,9321,,CHEMBL626976,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,9322,,CHEMBL626977,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,9323,,CHEMBL626978,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
PK study was carried to determine the relative absorption ranking in rat.,9324,,CHEMBL626979,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16427,,
Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,9325,,CHEMBL626980,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4689,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",9326,,CHEMBL626981,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",9327,,CHEMBL626982,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",9328,,CHEMBL626983,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",9329,,CHEMBL622522,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",9330,,CHEMBL622523,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",9331,,CHEMBL622524,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",9332,,CHEMBL622525,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",9333,,CHEMBL622526,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",9334,,CHEMBL619849,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",9335,,CHEMBL619850,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",9336,,CHEMBL623864,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",9337,,CHEMBL623865,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",9338,,CHEMBL623866,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",9339,,CHEMBL623867,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",9340,,CHEMBL877615,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",9341,,CHEMBL623868,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",9342,,CHEMBL623869,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",9343,,CHEMBL623870,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11450,,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,9344,,CHEMBL623871,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16434,,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9345,,CHEMBL623872,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16434,,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9346,,CHEMBL622129,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9347,,CHEMBL622130,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9348,,CHEMBL622131,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9349,,CHEMBL622132,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9350,,CHEMBL622133,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9351,,CHEMBL622134,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9352,,CHEMBL622135,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9353,,CHEMBL622136,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,16435,,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9354,,CHEMBL622137,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16434,,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9355,,CHEMBL622138,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16434,,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9356,,CHEMBL623017,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16434,,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9357,,CHEMBL623018,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16434,,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9358,,CHEMBL623019,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16434,,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9359,,CHEMBL623020,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16434,,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,9360,,CHEMBL623021,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16434,,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,9361,,CHEMBL623022,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16434,,
Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9362,,CHEMBL623023,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9363,,CHEMBL623024,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9364,,CHEMBL623025,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9365,,CHEMBL620545,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9366,,CHEMBL620546,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9367,,CHEMBL620547,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9368,,CHEMBL620548,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9369,,CHEMBL620549,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9370,,CHEMBL620550,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16434,,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,9371,,CHEMBL620551,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16434,,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9372,,CHEMBL620552,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16434,,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9373,,CHEMBL620553,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9374,,CHEMBL620554,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9375,,CHEMBL875845,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9376,,CHEMBL620555,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9377,,CHEMBL620556,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9378,,CHEMBL620557,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,16435,,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9379,,CHEMBL620558,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9380,,CHEMBL620559,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9381,,CHEMBL622939,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9382,,CHEMBL622940,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9383,,CHEMBL622941,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9384,,CHEMBL622942,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9385,,CHEMBL622943,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9386,,CHEMBL622944,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9387,,CHEMBL622945,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9388,,CHEMBL622946,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Compound was evaluated for terminal half life in rat,9389,,CHEMBL622947,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3341,,
Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,9390,,CHEMBL622948,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,3634,,
Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,9391,,CHEMBL622949,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,3634,,
Compound was tested for its half life in rat,9392,,CHEMBL622950,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4839,,
Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,9393,,CHEMBL622951,22224,BAO_0000218,,,In vivo,1,,1969.0,Macaca mulatta,,9544.0,0,Intermediate,U,A,Plasma,5005,,
Compound was tested for its plasma half life in Sprague Dawley rats,9394,,CHEMBL622952,22224,BAO_0000366,,,,1,,1969.0,Rattus norvegicus,,10116.0,0,Intermediate,U,A,Plasma,5005,,
Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,9395,,CHEMBL622953,22224,BAO_0000366,,,,1,,1969.0,Rattus norvegicus,,10116.0,0,Intermediate,U,A,Plasma,5005,,
Compound was tested for plasma half-life period in rat,9396,,CHEMBL873818,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1094,,
Elimination half life after i.v. administration of compound in rats,9397,,CHEMBL622954,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5031,,
Elimination half-life after IV dosing at 0.5 mg/kg in rat,9398,,CHEMBL622955,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Elimination half-life after IV dosing at 1 mg/kg in rat,9399,,CHEMBL875229,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Elimination half-life after oral administration at a dose of 2 mg/kg in rat,9400,,CHEMBL622956,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Elimination half-life after oral administration at a dose of 4 mg/kg in rat,9401,,CHEMBL622957,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,9402,,CHEMBL622958,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,5408,,
Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,9403,,CHEMBL622959,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5408,,
Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,9404,,CHEMBL622960,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,5408,,
Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,9405,,CHEMBL622961,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5408,,
Evaluated for the half life in rat (in vivo),9406,,CHEMBL622962,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4687,,
Hafl life in rat,9407,,CHEMBL622963,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6640,,
Hafl life rat,9408,,CHEMBL622964,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6640,,
Hafl life rat,9409,,CHEMBL622965,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Hafl life rat; Not determined,9410,,CHEMBL622966,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6640,,
Hafl life rat; Not determined,9411,,CHEMBL622967,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9412,,CHEMBL622968,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,17411,,
Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9413,,CHEMBL622969,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,17411,,
Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9414,,CHEMBL875327,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,17411,,
Half life in rat after 1 mg/kg i.v. administration,9415,,CHEMBL628638,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6570,,
Half life in rat after 2 mg/kg peroral administration,9416,,CHEMBL628639,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6570,,
Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9417,,CHEMBL625840,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17411,,
Half life of 10 mg/kg oral dose determined in rats,9418,,CHEMBL625841,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4722,,
Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,9419,,CHEMBL625842,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,9420,,CHEMBL625843,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,9421,,CHEMBL625844,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,9422,,CHEMBL873822,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,9423,,CHEMBL625845,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,9424,,CHEMBL627059,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,9425,,CHEMBL627060,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,9426,,CHEMBL627061,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Half life of compound at 5 mg/kg after po administration was determined in rat,9427,,CHEMBL627709,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4762,,
Half life of compound determined after intravenous administration to rat,9428,,CHEMBL627710,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5327,,
Half life of compound was determined in rat,9429,,CHEMBL627711,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4847,,
Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,9430,,CHEMBL627712,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17720,,
Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9431,,CHEMBL627713,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4723,,
Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,9432,,CHEMBL627714,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4723,,
Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,9433,,CHEMBL627889,22224,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,0,Intermediate,U,A,,4256,,
Half life determined in rat by intravenous administration,9434,,CHEMBL627890,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Intermediate,U,A,,4256,,
Half life determined in rats after iv administration,9435,,CHEMBL627891,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4722,,
Half life in rat plasma after administration of 2 mg/kg iv,9436,,CHEMBL627892,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6535,,
Half life in rat plasma after administration of 2 mg/kg iv,9437,,CHEMBL627893,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6535,,
Half life in rat plasma was determined,9438,,CHEMBL627894,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1435,,
Half life in rat plasma was determined; NA means not applicable,9439,,CHEMBL627895,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1435,,
Half life in rat was tested,9440,,CHEMBL627896,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5206,,
Half life measured in rat plasma,9441,,CHEMBL627897,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6080,,
Half life recorded in rats,9442,,CHEMBL627898,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4449,,
Half life was calculated,9443,,CHEMBL627899,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6057,,
Half life was calculated in rat,9444,,CHEMBL873823,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6057,,
Half life was determined,9445,,CHEMBL627900,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3747,,
Half life after 10 mg/kg oral administration in rat,9446,,CHEMBL627901,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17858,,
Half life after administering orally a dose of 10 mg/kg to a fasting rat,9447,,CHEMBL627902,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Half life after administering orally a dose of 30 mg/kg,9448,,CHEMBL627903,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,9449,,CHEMBL627904,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5031,,
Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,9450,,CHEMBL627905,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4722,,
Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,9451,,CHEMBL627906,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6078,,
Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,9452,,CHEMBL627907,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6078,,
Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,9453,,CHEMBL876783,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6078,,
Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,9454,,CHEMBL627908,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6078,,
Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,9455,,CHEMBL627909,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17065,,
Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,9456,,CHEMBL627910,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1353,,
Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),9457,,CHEMBL627911,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1353,,
Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),9458,,CHEMBL627912,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1353,,
Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),9459,,CHEMBL627913,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1353,,
Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),9460,,CHEMBL627914,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1353,,
Area under the curve was evaluated after 10 uM/kg of intra arterial administration,9461,,CHEMBL627915,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16423,,
Area under the curve was evaluated after 20 uM/kg of peroral administration,9462,,CHEMBL627916,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16423,,
Area under the curve was measured in rat after an iv dose of 1 mg/kg,9463,,CHEMBL627917,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6062,,
Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,9464,,CHEMBL627918,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6056,,
Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,9465,,CHEMBL627919,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5182,,
Area under the curve was evaluated at an intravenous dose of 3 mg/kg,9466,,CHEMBL627920,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6410,,
Area under the curve was evaluated at an oral dose of 30 mg/kg,9467,,CHEMBL627921,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6410,,
Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9468,,CHEMBL627922,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4723,,
Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,9469,,CHEMBL876784,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4723,,
Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9470,,CHEMBL627923,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4723,,
Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,9471,,CHEMBL626208,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4723,,
Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9472,,CHEMBL626209,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4723,,
Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,9473,,CHEMBL626210,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4723,,
Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,9474,,CHEMBL627994,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2463,,
Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,9475,,CHEMBL627995,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4709,,
Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,9476,,CHEMBL627996,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4075,,
Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,9477,,CHEMBL627997,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5394,,
Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,9478,,CHEMBL627998,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,9479,,CHEMBL628640,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,9480,,CHEMBL628641,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,9481,,CHEMBL628642,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for area under the curve expressed as (h*ug/ml),9482,,CHEMBL628643,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17791,,
Compound was tested for area under curve in rat,9483,,CHEMBL628644,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2591,,
Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,9484,,CHEMBL628645,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6567,,
Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,9485,,CHEMBL628646,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6211,,
Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),9486,,CHEMBL628647,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5529,,
Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,9487,,CHEMBL628648,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5408,,
Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,9488,,CHEMBL625358,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5408,,
Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,9489,,CHEMBL625359,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5408,,
Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,9490,,CHEMBL625360,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5408,,
Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),9491,,CHEMBL625361,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,429,,
Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),9492,,CHEMBL625362,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,429,,
Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),9493,,CHEMBL625363,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,429,,
Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,9494,,CHEMBL625364,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4796,,
In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,9495,,CHEMBL625365,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,9496,,CHEMBL625366,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,9497,,CHEMBL625367,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",9498,,CHEMBL625368,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",9499,,CHEMBL625369,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",9500,,CHEMBL625370,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",9501,,CHEMBL625371,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",9502,,CHEMBL625372,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",9503,,CHEMBL625373,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",9504,,CHEMBL625374,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",9505,,CHEMBL877593,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",9506,,CHEMBL625375,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",9507,,CHEMBL625376,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",9508,,CHEMBL621973,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",9509,,CHEMBL621974,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",9510,,CHEMBL621975,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",9511,,CHEMBL622166,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",9512,,CHEMBL622167,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",9513,,CHEMBL622168,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",9514,,CHEMBL622169,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",9515,,CHEMBL622170,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",9516,,CHEMBL622171,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",9517,,CHEMBL622172,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",9518,,CHEMBL622173,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",9519,,CHEMBL622174,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",9520,,CHEMBL622175,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",9521,,CHEMBL622176,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",9522,,CHEMBL622177,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",9523,,CHEMBL622178,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",9524,,CHEMBL622179,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",9525,,CHEMBL622180,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9526,,CHEMBL622181,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9527,,CHEMBL622182,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9528,,CHEMBL622183,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9529,,CHEMBL622184,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9530,,CHEMBL622185,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9531,,CHEMBL622186,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9532,,CHEMBL622187,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,9533,,CHEMBL625002,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,9534,,CHEMBL622090,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9535,,CHEMBL622091,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9536,,CHEMBL622092,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9537,,CHEMBL622093,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9538,,CHEMBL622094,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9539,,CHEMBL622095,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9540,,CHEMBL622264,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9541,,CHEMBL622265,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16434,,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9542,,CHEMBL622266,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16434,,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9543,,CHEMBL622267,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16434,,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9544,,CHEMBL622268,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16434,,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9545,,CHEMBL622269,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16434,,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9546,,CHEMBL625071,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16434,,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9547,,CHEMBL621621,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16434,,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9548,,CHEMBL621622,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16434,,
Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9549,,CHEMBL621623,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9550,,CHEMBL621624,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9551,,CHEMBL621625,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9552,,CHEMBL621626,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9553,,CHEMBL621627,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9554,,CHEMBL621628,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9555,,CHEMBL875328,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9556,,CHEMBL621629,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9557,,CHEMBL621630,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16434,,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9558,,CHEMBL621631,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16434,,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9559,,CHEMBL621632,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16434,,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9560,,CHEMBL621633,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9561,,CHEMBL621634,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9562,,CHEMBL621635,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9563,,CHEMBL621636,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9564,,CHEMBL621637,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9565,,CHEMBL621638,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,16435,,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9566,,CHEMBL618883,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9567,,CHEMBL618884,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9568,,CHEMBL628627,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9569,,CHEMBL628628,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9570,,CHEMBL628629,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Half life after administering orally a dose of 3 mg/kg,9571,,CHEMBL628630,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Half life after administering orally a dose of 3 mg/kg to a fasting rat,9572,,CHEMBL628631,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Half life after administering intravenously a dose of 1 mg/kg,9573,,CHEMBL628632,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Half life after oral dosing in rats,9574,,CHEMBL628633,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,526,,
Half life after the administered orally a dose of 1 mg/kg to a fasting rat,9575,,CHEMBL628634,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Half life by intravenous administration of 3.4 mg/kg in rat,9576,,CHEMBL627789,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4368,,
Half life in rat,9577,,CHEMBL627790,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3371,,
Half life in rat,9578,,CHEMBL627791,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6448,,
Half life in rat,9579,,CHEMBL627792,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6453,,
Half life in rat after intravenous administration of the compound,9580,,CHEMBL627793,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4353,,
Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,9581,,CHEMBL627794,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4353,,
Half life in rat after po administration of the compound,9582,,CHEMBL627795,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4353,,
Half life in rat after po administration of the compound; ND means Not determined,9583,,CHEMBL627796,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4353,,
Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,9584,,CHEMBL875335,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4353,,
Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,9585,,CHEMBL627797,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4353,,
Half life in rat i.v.,9586,,CHEMBL627798,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5789,,
Half life in rat i.v. at 2 mg/kg concentration,9587,,CHEMBL627799,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17686,,
Half life in rats,9588,,CHEMBL627800,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6495,,
Half life in rats after intravenous administration,9589,,CHEMBL627801,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,484,,
Half life in rats at the dose of 1.0 mpk by i.v. administration,9590,,CHEMBL627802,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6467,,
Half life in rat,9591,,CHEMBL627803,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Expert,N,A,,6642,,
Half life was evaluated after intravenous administration to rats,9592,,CHEMBL873820,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16367,,
Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),9593,,CHEMBL627804,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1369,,
Half life was evaluated in rat,9594,,CHEMBL627805,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5472,,
Half life was evaluated in rat,9595,,CHEMBL627806,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6049,,
Half life was evaluated in rat; Not tested,9596,,CHEMBL627107,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5472,,
Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,9597,,CHEMBL627108,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16366,,
Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,9598,,CHEMBL627109,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11149,,
Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,9599,,CHEMBL627110,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11149,,
Half life was measured in monkey at dose of 10 mg/kg by po administration,9600,,CHEMBL627111,22224,BAO_0000218,,,In vivo,1,,,Primates,,9443.0,0,Intermediate,U,A,,2891,,
Half life was measured in monkey at dose of 10 mg/kg by po administration,9601,,CHEMBL627112,22224,BAO_0000218,,,In vivo,1,,,Primates,,9443.0,0,Intermediate,U,A,,2891,,
Half life was measured in rat at dose of 30 mg/kg by iv administration,9602,,CHEMBL627113,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Intermediate,U,A,,2891,,
Half life was measured in rat at dose of 30 mg/kg by po administration,9603,,CHEMBL627114,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Intermediate,U,A,,2891,,
Half life (t1/2) was determined,9604,,CHEMBL627115,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4026,,
Half life period at a dose of 10 uM/kg in rat was determined,9605,,CHEMBL627116,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4527,,
Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,9606,,CHEMBL627117,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4527,,
Half life period was determined,9607,,CHEMBL627118,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5503,,
Half life period after intravenous administration at 20 mpk in rats,9608,,CHEMBL627119,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4426,,
Half life period after intravenous administration at 20 mpk in rats; Not performed.,9609,,CHEMBL627120,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4426,,
Half life period after intravenous administration in rat,9610,,CHEMBL626922,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6109,,
Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,9611,,CHEMBL626923,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5654,,
Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,9612,,CHEMBL626924,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5654,,
Half life period in 80% rat plasma at 37 degree Centigrade,9613,,CHEMBL626925,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4755,,
Half life period in SD rats,9614,,CHEMBL626926,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5862,,
Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),9615,,CHEMBL626927,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1515,,
Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),9616,,CHEMBL626928,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1515,,
Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9617,,CHEMBL626929,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1515,,
Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9618,,CHEMBL626930,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1515,,
Half life period in rat,9619,,CHEMBL626931,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5960,,
Half life period in rat,9620,,CHEMBL626932,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6103,,
Half life period in rat,9621,,CHEMBL626933,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6317,,
Half life period in rat after oral administration at 10.5 mg/kg dose,9622,,CHEMBL873826,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6644,,
Half life period in rat after oral administration at 11.2 mg/kg dose,9623,,CHEMBL626934,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6644,,
Half life period in rat after oral administration at 13 mg/kg dose,9624,,CHEMBL626935,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6644,,
Half life period in rat after oral administration at 9.7 mg/kg dose,9625,,CHEMBL626936,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6644,,
In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,9626,,CHEMBL626937,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,9627,,CHEMBL625906,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6295,,
In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,9628,,CHEMBL625907,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6296,,
PK study was carried to determine AUC (area under curve) value in rat,9629,,CHEMBL625908,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16427,,
Pharmacokinetic parameter AUC after intravenous administration to rats,9630,,CHEMBL625909,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16367,,
Pharmacokinetic parameter AUC after oral administration to rats,9631,,CHEMBL625910,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16367,,
Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,9632,,CHEMBL625911,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,9633,,CHEMBL625912,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,9634,,CHEMBL626538,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,9635,,CHEMBL876794,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,9636,,CHEMBL626539,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,9637,,CHEMBL626540,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,9638,,CHEMBL626541,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5394,,
Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,9639,,CHEMBL626542,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5394,,
Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,9640,,CHEMBL626543,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,9641,,CHEMBL626544,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,9642,,CHEMBL626545,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,9643,,CHEMBL626546,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Pharmacokinetic parameter area under curve was reported,9644,,CHEMBL626547,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5334,,
Pharmacokinetic property (AUC) in rat,9645,,CHEMBL626548,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4408,,
Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,9646,,CHEMBL626549,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5983,,
Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,9647,,CHEMBL626550,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4397,,
Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,9648,,CHEMBL626551,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4397,,
Pharmacokinetic property was determined,9649,,CHEMBL623777,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5491,,
Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,9650,,CHEMBL623778,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5491,,
Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,9651,,CHEMBL623779,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5491,,
Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,9652,,CHEMBL623780,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4199,,
Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,9653,,CHEMBL622015,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4199,,
Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,9654,,CHEMBL622016,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4199,,
"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",9655,,CHEMBL622017,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5173,,
"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",9656,,CHEMBL622018,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5173,,
"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",9657,,CHEMBL622019,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5173,,
"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",9658,,CHEMBL622020,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5173,,
Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,9659,,CHEMBL622021,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16366,,
Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,9660,,CHEMBL622022,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16366,,
Plasma concentration expressed as area under curve after intravenous administration was determined in rat,9661,,CHEMBL622023,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5327,,
Plasma concentration for the compound was determined in rats at 50 mg/kg dose,9662,,CHEMBL622024,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6681,,
Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),9663,,CHEMBL622693,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12873,,
Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),9664,,CHEMBL622694,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12873,,
"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",9665,,CHEMBL622695,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",9666,,CHEMBL622696,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",9667,,CHEMBL622697,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",9668,,CHEMBL622874,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6619,,
"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",9669,,CHEMBL622875,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6619,,
Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,9670,,CHEMBL622876,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10363,,
Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,9671,,CHEMBL622877,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4796,,
Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,9672,,CHEMBL622878,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4910,,
Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,9673,,CHEMBL622879,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4910,,
Tested for the pharmacokinetic parameter in rat and expressed as area under curve,9674,,CHEMBL877602,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4839,,
"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",9675,,CHEMBL622880,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",9676,,CHEMBL622881,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",9677,,CHEMBL622882,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",9678,,CHEMBL622883,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",9679,,CHEMBL622884,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",9680,,CHEMBL622885,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,11450,,
Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,9681,,CHEMBL622886,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8151,,
Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,9682,,CHEMBL622887,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8151,,
Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,9683,,CHEMBL622888,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8151,,
"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9684,,CHEMBL622889,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8677,,
"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9685,,CHEMBL622890,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8677,,
"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9686,,CHEMBL622891,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8677,,
"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9687,,CHEMBL877603,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8677,,
"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9688,,CHEMBL622892,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8677,,
"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9689,,CHEMBL622893,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8677,,
"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9690,,CHEMBL622894,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8677,,
"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9691,,CHEMBL622895,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8677,,
Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,9692,,CHEMBL622896,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8677,,
"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9693,,CHEMBL622897,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8677,,
"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9694,,CHEMBL622898,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8677,,
"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9695,,CHEMBL622899,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8677,,
"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9696,,CHEMBL622900,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8677,,
"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9697,,CHEMBL624114,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8677,,
"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9698,,CHEMBL624115,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8677,,
"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9699,,CHEMBL624116,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8677,,
"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9700,,CHEMBL624117,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8677,,
"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9701,,CHEMBL624118,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8677,,
"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9702,,CHEMBL624119,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8677,,
"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9703,,CHEMBL624120,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8677,,
"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9704,,CHEMBL624121,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8677,,
"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9705,,CHEMBL624122,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8677,,
"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9706,,CHEMBL624123,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8677,,
"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9707,,CHEMBL624124,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8677,,
"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9708,,CHEMBL624125,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8677,,
"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9709,,CHEMBL624126,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8677,,
"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9710,,CHEMBL624127,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8677,,
"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9711,,CHEMBL624128,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8677,,
"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9712,,CHEMBL624129,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,8677,,
"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9713,,CHEMBL624130,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,8677,,
"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9714,,CHEMBL622340,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,8677,,
"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9715,,CHEMBL622341,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,8677,,
"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9716,,CHEMBL622342,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8677,,
"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9717,,CHEMBL622343,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8677,,
"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9718,,CHEMBL622344,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8677,,
"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9719,,CHEMBL622345,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8677,,
"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9720,,CHEMBL622346,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8677,,
"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9721,,CHEMBL622347,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8677,,
"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9722,,CHEMBL622348,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8677,,
"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9723,,CHEMBL622349,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8677,,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9724,,CHEMBL622350,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9725,,CHEMBL622351,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9726,,CHEMBL622352,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9727,,CHEMBL622353,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9728,,CHEMBL622354,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9729,,CHEMBL622355,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9730,,CHEMBL622356,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9731,,CHEMBL622357,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9732,,CHEMBL622358,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9733,,CHEMBL622359,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9734,,CHEMBL874393,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9735,,CHEMBL622872,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9736,,CHEMBL622873,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9737,,CHEMBL623047,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9738,,CHEMBL623048,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9739,,CHEMBL623049,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9740,,CHEMBL623050,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9741,,CHEMBL623051,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9742,,CHEMBL623052,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9743,,CHEMBL626343,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9744,,CHEMBL626344,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9745,,CHEMBL626345,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9746,,CHEMBL626346,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9747,,CHEMBL626347,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9748,,CHEMBL626348,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9749,,CHEMBL626349,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16434,,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9750,,CHEMBL626350,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,16435,,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9751,,CHEMBL626351,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9752,,CHEMBL627650,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9753,,CHEMBL627651,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,16435,,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9754,,CHEMBL627652,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9755,,CHEMBL627653,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16435,,
Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,9756,,CHEMBL627654,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,9757,,CHEMBL627835,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,9758,,CHEMBL627836,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,9759,,CHEMBL627837,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,9760,,CHEMBL627838,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,9761,,CHEMBL875338,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,9762,,CHEMBL627839,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,9763,,CHEMBL627840,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,9764,,CHEMBL627841,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,9765,,CHEMBL627842,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,9766,,CHEMBL627843,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,9767,,CHEMBL627844,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,9768,,CHEMBL627845,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Half life period in rat by iv administration at a dose of 3 mg/kg,9769,,CHEMBL627846,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5874,,
Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),9770,,CHEMBL627847,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1515,,
Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),9771,,CHEMBL873821,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1515,,
Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9772,,CHEMBL626079,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1515,,
Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9773,,CHEMBL626080,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1515,,
Half life period was evaluated in rat plasma,9774,,CHEMBL626081,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5491,,
Half life period was evaluated in rat plasma; Not tested,9775,,CHEMBL875344,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5491,,
Half life period was evaluated in rats,9776,,CHEMBL626082,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1918,,
"Half life period was evaluated in rats, iv",9777,,CHEMBL626250,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1918,,
Half life period after intravenous administration at 5 mg/kg in rat,9778,,CHEMBL626251,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6113,,
Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,9779,,CHEMBL626252,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5546,,
Half life period was determined in rat after iv administration at a dose of 5 mg/kg,9780,,CHEMBL626253,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5553,,
Half life stability of compound was evaluated in rat plasma,9781,,CHEMBL626254,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4188,,
Half life time after intravenous administration (5.0 mg/kg) was determined in rat,9782,,CHEMBL626255,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6215,,
Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,9783,,CHEMBL626256,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6141,,
Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,9784,,CHEMBL626257,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5182,,
Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,9785,,CHEMBL626258,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5182,,
Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,9786,,CHEMBL626259,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5710,,
Half in rat i.v.,9787,,CHEMBL626260,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5789,,
Half period in rat after intravenous administration,9788,,CHEMBL875345,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6011,,
Half-life after repeated oral dose of compound at 1 mg/kg in rats,9789,,CHEMBL626261,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17594,,
Half-life measured in in vitro Cathepsin B assay in rat liver,9790,,CHEMBL626262,50597,BAO_0000218,,,In vitro,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12357,,
Half-life of compound was determined in rats,9791,,CHEMBL626263,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5210,,
Half-life at 10 mg/kg in rat upon intravenous administration,9792,,CHEMBL625270,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17596,,
Half-life determined in rat,9793,,CHEMBL625271,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6672,,
Half-life determined in rat,9794,,CHEMBL625272,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6673,,
Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,9795,,CHEMBL625273,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,4910,,
"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",9796,,CHEMBL625274,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,3741,,
Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,9797,,CHEMBL625275,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17671,,
Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,9798,,CHEMBL625276,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4910,,
Half-life in rat plasma,9799,,CHEMBL625277,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17537,,
Half-life in rat plasma was determined,9800,,CHEMBL625278,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4965,,
Half-life in rat plasma; Not tested,9801,,CHEMBL625279,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17537,,
Half-life in rat serum,9802,,CHEMBL625280,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,6124,,
Half-life in rat serum; na is not available,9803,,CHEMBL876797,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,6124,,
Half-life was calculated in rat,9804,,CHEMBL625281,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6078,,
Half-life was calculated in rat plasma,9805,,CHEMBL873827,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17668,,
Half-life was determined,9806,,CHEMBL625282,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3185,,
Half-life was determined,9807,,CHEMBL625283,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4883,,
Half-life after administration of 20 mg/Kg oral dose in rat,9808,,CHEMBL625284,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2959,,
Half-life after administration of 3.2 mg/kg intravenously in male rat,9809,,CHEMBL625285,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4029,,
Half-life after intravenous administration in female rat,9810,,CHEMBL625286,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4029,,
Half-life after intravenous administration in male rat,9811,,CHEMBL625287,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4029,,
Half-life after intravenous dose in rat,9812,,CHEMBL625288,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6180,,
Half-life in a rat liver homogenate preparation,9813,,CHEMBL625289,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,1557,,
Half-life in plasma of rat,9814,,CHEMBL625290,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12500,,
Half-life in plasma of rat at dose of 3-10 mgkg,9815,,CHEMBL876798,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12500,,
Half-life in rat,9816,,CHEMBL625291,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5064,,
Half-life in rat,9817,,CHEMBL625292,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5145,,
Half-life in rat,9818,,CHEMBL625293,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5147,,
Half-life in rat,9819,,CHEMBL622832,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5833,,
Half-life in rat,9820,,CHEMBL622833,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6596,,
Half-life in rat,9821,,CHEMBL622834,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17655,,
Half-life in rat after oral administration at 10 mg/kg,9822,,CHEMBL622835,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6495,,
Half-life in rat after po administration at a dose of 10 mg/kg,9823,,CHEMBL622836,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17538,,
Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,9824,,CHEMBL622837,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17538,,
Half-life in rat at 3 mg/kg dose administered intravenously,9825,,CHEMBL622838,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10,,
Half-life in rat brain homogenate,9826,,CHEMBL622839,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,17669,,
Half-life in rat plasma,9827,,CHEMBL622840,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17065,,
Half-life in rats,9828,,CHEMBL622841,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4333,,
Half-life in Dawley rats,9829,,CHEMBL622842,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6827,,
Half-life in vitro in rat plasma,9830,,CHEMBL622843,50597,BAO_0000218,,,In vitro,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,889,,
Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,9831,,CHEMBL622844,50597,BAO_0000218,,,In vitro,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,889,,
"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",9832,,CHEMBL622845,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3747,,
The area under the curve of compound was measured at the dose of 100 umol/kg,9833,,CHEMBL622846,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15022,,
The area under the curve of compound was measured at the dose of 300 umol/kg,9834,,CHEMBL622847,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15022,,
The area under the curve of compound was measured at the dose of 30 umol/kg,9835,,CHEMBL622848,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15022,,
Bioavailability as oral AUC in rats,9836,,CHEMBL622849,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3360,,
The plasma concentration versus time curve (AUC) was determined,9837,,CHEMBL622850,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5334,,
Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9838,,CHEMBL876807,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17411,,
Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9839,,CHEMBL622851,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17411,,
Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9840,,CHEMBL622852,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17411,,
Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,9841,,CHEMBL622853,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6570,,
Total concentration in rat after 2 mg/kg peroral administration in 24 hours,9842,,CHEMBL622854,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6570,,
Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9843,,CHEMBL622855,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17411,,
"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",9844,,CHEMBL622856,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14941,,
"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",9845,,CHEMBL622857,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14941,,
AUC in rat after po administration at a dose of 10 mg/kg,9846,,CHEMBL622858,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17538,,
Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,9847,,CHEMBL622859,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17752,,
Area under curve value 24 hr after 10 mg/kg iv administration in rats,9848,,CHEMBL622860,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17509,,
Area under curve value 24 hr after 10 mg/kg oral administration in rats,9849,,CHEMBL622861,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17509,,
Area under curve value 24 hr after 2 mg/kg iv administration in rats,9850,,CHEMBL622862,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17509,,
Area under curve value 24 hr after 2 mg/kg oral administration in rats,9851,,CHEMBL622863,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17509,,
Area under curve value 6 hr after po administration in rat,9852,,CHEMBL623817,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17509,,
Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,9853,,CHEMBL623818,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",9854,,CHEMBL623819,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,9855,,CHEMBL623820,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,9856,,CHEMBL623821,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
AUC normalized for dose (AUCN) in rat,9857,,CHEMBL623822,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6642,,
Area under curve in rat after p.o. administration,9858,,CHEMBL623823,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6640,,
Area under curve in rat after p.o. administration,9859,,CHEMBL623824,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Area under curve in rat after p.o. administration; Not determined,9860,,CHEMBL623825,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Area under curve in rat after peroral administration,9861,,CHEMBL622070,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Area under curve (carotid artery) value of the compound,9862,,CHEMBL622071,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3603,,
Bioavailability expressed as the area under curve of rat carotid artery,9863,,CHEMBL622072,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3550,,
Area under curve in male SD rats was observed after intravenous administration in rat,9864,,CHEMBL622073,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15662,,
Area under curve of the compound was determined,9865,,CHEMBL622074,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17720,,
Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,9866,,CHEMBL622075,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5407,,
Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,9867,,CHEMBL622076,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17752,,
Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,9868,,CHEMBL622077,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17752,,
Area under curve (portal vein) value of the compound,9869,,CHEMBL622078,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3603,,
Bioavailability expressed as the area under curve of rat portal vein,9870,,CHEMBL622079,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3550,,
Area Under plasma concentration time curve in rat upon peroral administration,9871,,CHEMBL622080,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17655,,
In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,9872,,CHEMBL877612,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17582,,
In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,9873,,CHEMBL622081,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17582,,
Compound was evaluated for oral bioavailability in rats,9874,,CHEMBL622082,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17791,,
Compound was evaluated for oral bioavailability in rats after iv administration,9875,,CHEMBL622083,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17791,,
Compound was evaluated for oral bioavailability in rats; 30-80,9876,,CHEMBL622084,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17791,,
Compound was evaluated for oral bioavailability in rats; 50-60,9877,,CHEMBL622085,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17791,,
Compound was evaluated for oral bioavailability in rats; no data,9878,,CHEMBL622086,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17791,,
Compound was evaluated for oral bioavailability in rats; peptide,9879,,CHEMBL622087,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17791,,
"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",9880,,CHEMBL622088,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,7768,,
"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",9881,,CHEMBL622089,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,7768,,
"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",9882,,CHEMBL623685,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,7768,,
"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",9883,,CHEMBL623686,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,7768,,
"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9884,,CHEMBL623687,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,8677,,
"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9885,,CHEMBL623688,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,8677,,
"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9886,,CHEMBL623689,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,8677,,
"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9887,,CHEMBL622485,50597,BAO_0000218,,,In vivo,1,,945.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Stomach,8677,,
"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9888,,CHEMBL622486,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8677,,
"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9889,,CHEMBL877613,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8677,,
"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9890,,CHEMBL622487,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8677,,
"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9891,,CHEMBL622488,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8677,,
"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9892,,CHEMBL622489,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8677,,
Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,9893,,CHEMBL622490,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,6899,,
Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,9894,,CHEMBL622491,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,6899,,
Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,9895,,CHEMBL622492,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,6899,,
Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,9896,,CHEMBL622493,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,6899,,
Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,9897,,CHEMBL622494,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,6899,,
"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9898,,CHEMBL622495,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8677,,
Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,9899,,CHEMBL622496,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6899,,
Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,9900,,CHEMBL622497,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,6899,,
Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,9901,,CHEMBL622498,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2189,,
Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,9902,,CHEMBL624918,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,2189,,
Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,9903,,CHEMBL624919,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,2189,,
Biodistribution of compound in rat blood after 5 min of administration,9904,,CHEMBL624920,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,10839,,
Biodistribution of compound in rat blood after 5 min of administration.,9905,,CHEMBL624921,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,10839,,
Biodistribution of compound in rat brain after 5 min of administration,9906,,CHEMBL624922,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,10839,,
Biodistribution of compound in rat heart after 5 min of administration,9907,,CHEMBL624923,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,10839,,
Biodistribution of compound in rat heart after 5 min of administration.,9908,,CHEMBL624924,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,10839,,
Biodistribution of compound in rat kidney after 5 min of administration,9909,,CHEMBL624925,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,10839,,
Biodistribution of compound in rat kidney after 5 min of administration.,9910,,CHEMBL624926,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,10839,,
Biodistribution of compound in rat liver after 5 min of administration,9911,,CHEMBL624927,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,10839,,
Biodistribution of compound in rat liver after 5 min of administration.,9912,,CHEMBL874402,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,10839,,
Biodistribution of compound in rat lung after 5 min of administration,9913,,CHEMBL624928,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,10839,,
Biodistribution of compound in rat lung after 5 min of administration.,9914,,CHEMBL624929,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,10839,,
Biodistribution of compound in rat muscle after 5 min of administration,9915,,CHEMBL624930,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10839,,
Biodistribution of compound in rat muscle after 5 min of administration.,9916,,CHEMBL624931,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10839,,
In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9917,,CHEMBL624932,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,4043,,
In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9918,,CHEMBL624933,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,4043,,
In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9919,,CHEMBL624934,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,4043,,
In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9920,,CHEMBL624935,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,4043,,
In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9921,,CHEMBL624936,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4043,,
In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9922,,CHEMBL624937,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4043,,
In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9923,,CHEMBL624938,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,4043,,
In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9924,,CHEMBL624939,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,4043,,
In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9925,,CHEMBL624940,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4043,,
In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9926,,CHEMBL874403,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4043,,
Compound was tested for the duration that the plasma drug concentrations remained above the IC95,9927,,CHEMBL624941,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1446,,
Dose required to lower urine osmolality to 300 mOsm/kg in rat,9928,,CHEMBL624942,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,9971,,
Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,9929,,CHEMBL624943,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,9971,,
% Bioavailability after 1 day of the drug administration in rats,9930,,CHEMBL624944,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5765,,
% Bioavailability after 4 day of the drug administration in rats,9931,,CHEMBL624945,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5765,,
Absolute bioavailability was evaluated in rat,9932,,CHEMBL624946,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4257,,
Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,9933,,CHEMBL624947,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,9934,,CHEMBL624948,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,9935,,CHEMBL624949,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,9936,,CHEMBL622025,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13091,,
Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,9937,,CHEMBL622026,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13091,,
Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,9938,,CHEMBL622027,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13091,,
Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,9939,,CHEMBL622028,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13091,,
Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,9940,,CHEMBL622029,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13091,,
Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,9941,,CHEMBL622208,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13091,,
Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,9942,,CHEMBL622209,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13091,,
Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,9943,,CHEMBL622210,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13091,,
Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,9944,,CHEMBL622211,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,9945,,CHEMBL622212,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,9946,,CHEMBL622213,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,9947,,CHEMBL874404,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,9948,,CHEMBL620452,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13091,,
Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,9949,,CHEMBL620453,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13091,,
Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,9950,,CHEMBL620454,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13091,,
Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,9951,,CHEMBL624067,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13091,,
Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,9952,,CHEMBL624068,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,9953,,CHEMBL624069,50597,BAO_0000218,,,,1,,992.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Female gonad,13091,,
Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,9954,,CHEMBL624070,50597,BAO_0000218,,,,1,,992.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Female gonad,13091,,
Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,9955,,CHEMBL624071,50597,BAO_0000218,,,,1,,992.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Female gonad,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,9956,,CHEMBL624072,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,9957,,CHEMBL624073,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,9958,,CHEMBL624788,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,9959,,CHEMBL624789,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,9960,,CHEMBL624790,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,9961,,CHEMBL624791,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,9962,,CHEMBL624792,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,9963,,CHEMBL624793,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,9964,,CHEMBL877491,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,9965,,CHEMBL624957,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,9966,,CHEMBL624958,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13091,,
Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,9967,,CHEMBL624959,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13091,,
Dissociation constant was determined,9968,,CHEMBL624960,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11977,,
"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",9969,,CHEMBL624961,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14941,,
"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",9970,,CHEMBL624962,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",9971,,CHEMBL624963,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
Observed rate constant in 80% rat plasma at 37 degree Centigrade,9972,,CHEMBL624964,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4755,,
LogP value was evaluated in the in situ rat gut perfusion assay,9973,,CHEMBL624965,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,589,,
In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,9974,,CHEMBL624966,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17582,,
Mean residence time (Pharmacokinetic property) after i.v. administration in rats,9975,,CHEMBL624967,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5031,,
Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,9976,,CHEMBL624968,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17764,,
Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,9977,,CHEMBL624969,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17720,,
Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,9978,,CHEMBL624970,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Expert,N,F,,2862,,
Half-life was evaluated after 10 uM/kg of intra arterial administration,9979,,CHEMBL624971,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16423,,
Half-life was evaluated after 20 uM/kg of peroral administration,9980,,CHEMBL624972,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16423,,
Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,9981,,CHEMBL624973,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6005,,
Half-life was evaluated in plasma of rat,9982,,CHEMBL624974,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2938,,
Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,9983,,CHEMBL624975,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6410,,
Half-life was evaluated in rats at an oral dose of 30 mg/kg,9984,,CHEMBL877492,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6410,,
Half-life was measured in rat after an iv dose of 1 mg/kg,9985,,CHEMBL624976,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6062,,
Half-life period of compound in rats after peroral administration,9986,,CHEMBL624977,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6571,,
Half-life period of compound was measured in rat plasma.,9987,,CHEMBL626848,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,3136,,
Half-life period of compound was measured in rat plasma; ND is not determined,9988,,CHEMBL626849,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,3136,,
Half-life period of compound was measured in rat plasma; not determined,9989,,CHEMBL626850,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,3136,,
Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,9990,,CHEMBL626851,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4521,,
Half-life period in rat by iv administration,9991,,CHEMBL626852,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5871,,
Half-life period in rats following intravenous administration at 2 mg/kg,9992,,CHEMBL626853,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6077,,
Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,9993,,CHEMBL626854,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6679,,
Half-life period was determined for the compound in rat,9994,,CHEMBL627486,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5144,,
"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",9995,,CHEMBL627487,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4498,,
"Half-life period was evaluated in rat, after administering 10 mg/kg orally",9996,,CHEMBL627488,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4498,,
Half-life value after IV dose at a dose of 5 mg/kg in rats.,9997,,CHEMBL627489,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1908,,
Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,9998,,CHEMBL627490,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6211,,
Half-life was determined in rat after intravenous administration (0.5 mg/kg),9999,,CHEMBL873829,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5529,,
Half-life was determined in rat at a dose of 1 mpk i.v.,10000,,CHEMBL627655,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6444,,
Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,10001,,CHEMBL625994,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6444,,
Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,10002,,CHEMBL625995,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6444,,
Half-life in rat,10003,,CHEMBL625996,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5207,,
In vitro half life in rat plasma,10004,,CHEMBL625850,50597,BAO_0000218,,,In vitro,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,530,,
"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",10005,,CHEMBL625851,50597,BAO_0000218,,,In vitro,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1116,,
In vitro half life in rat,10006,,CHEMBL625852,50597,BAO_0000218,,,In vitro,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3219,,
In vivo half life period after intravenous administration in rat,10007,,CHEMBL625853,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6109,,
In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,10008,,CHEMBL625854,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17582,,
In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,10009,,CHEMBL874450,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17582,,
In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10010,,CHEMBL625855,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10011,,CHEMBL625856,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,10012,,CHEMBL625857,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10013,,CHEMBL873831,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
Longer half-life in rat (i.v.) at 0.5 mpk,10014,,CHEMBL625858,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17853,,
Longer half-life in rat (p.o.) at 2.0 mpk,10015,,CHEMBL625859,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17853,,
Pharmacokinetic property (half life) in rat,10016,,CHEMBL625860,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3457,,
Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,10017,,CHEMBL625861,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,10018,,CHEMBL625862,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,10019,,CHEMBL625863,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,10020,,CHEMBL625864,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,10021,,CHEMBL625865,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5739,,
Pharmacokinetic half time was determined intravenously in rats.,10022,,CHEMBL625866,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15765,,
Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,10023,,CHEMBL625867,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6567,,
Plasma half life of hydrolysis of the compound,10024,,CHEMBL625868,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2448,,
Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,10025,,CHEMBL625869,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5423,,
Plasma half life period was calculated in rat,10026,,CHEMBL874451,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4853,,
Plasma half-life in Sprague-Dawley rats,10027,,CHEMBL625870,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4514,,
Plasma half-life in Sprague-Dawley rats; Not determined,10028,,CHEMBL625871,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4514,,
Plasma half-life in rats,10029,,CHEMBL625872,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1500,,
Plasma half-life in rats; <MQL,10030,,CHEMBL625873,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,1500,,
Plasma half-life period (0-8 h) was determined,10031,,CHEMBL625874,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5334,,
Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,10032,,CHEMBL625875,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5334,,
Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,10033,,CHEMBL625876,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5334,,
Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,10034,,CHEMBL631258,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5334,,
Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,10035,,CHEMBL631259,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4956,,
Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,10036,,CHEMBL631260,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4956,,
"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",10037,,CHEMBL631261,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,7768,,
"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",10038,,CHEMBL631262,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,7768,,
"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",10039,,CHEMBL631263,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,7768,,
"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",10040,,CHEMBL631264,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7768,,
"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",10041,,CHEMBL631265,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7768,,
"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",10042,,CHEMBL631266,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7768,,
"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",10043,,CHEMBL631267,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7768,,
"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",10044,,CHEMBL631268,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7768,,
"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",10045,,CHEMBL631269,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7768,,
"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",10046,,CHEMBL631270,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7768,,
"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",10047,,CHEMBL631271,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,7768,,
"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",10048,,CHEMBL631272,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,7768,,
"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",10049,,CHEMBL631273,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,7768,,
"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",10050,,CHEMBL631274,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,7768,,
"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",10051,,CHEMBL631275,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,7768,,
"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",10052,,CHEMBL626984,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,7768,,
"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",10053,,CHEMBL626985,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,7768,,
"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",10054,,CHEMBL626986,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,7768,,
"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",10055,,CHEMBL626987,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,7768,,
"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",10056,,CHEMBL626988,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,7768,,
"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",10057,,CHEMBL626989,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,7768,,
"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",10058,,CHEMBL626990,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,7768,,
"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",10059,,CHEMBL626991,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,7768,,
"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",10060,,CHEMBL626992,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,7768,,
"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",10061,,CHEMBL626993,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,7768,,
"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",10062,,CHEMBL874593,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,7768,,
"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",10063,,CHEMBL626994,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,7768,,
"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",10064,,CHEMBL626995,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,7768,,
"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",10065,,CHEMBL626190,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,7768,,
"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",10066,,CHEMBL626191,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,7768,,
"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",10067,,CHEMBL626364,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,7768,,
"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",10068,,CHEMBL626365,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,7768,,
"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",10069,,CHEMBL626366,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,7768,,
"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",10070,,CHEMBL626367,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,7768,,
"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",10071,,CHEMBL626368,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,7768,,
"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",10072,,CHEMBL626369,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,7768,,
"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",10073,,CHEMBL626370,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,7768,,
"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",10074,,CHEMBL626371,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4498,,
"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",10075,,CHEMBL626372,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4498,,
Bioavailability after a dose of 10 mg/kg p.o.,10076,,CHEMBL626373,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3603,,
Bioavailability after peroral administration (10 mg/kg) was determined in rat,10077,,CHEMBL626374,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6215,,
Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,10078,,CHEMBL626375,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5710,,
Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),10079,,CHEMBL626376,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5710,,
Bioavailability in rat po was determined,10080,,CHEMBL626377,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5676,,
Bioavailability of compound at 10 mg/kg in rat after oral administration,10081,,CHEMBL626378,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17667,,
Bioavailability of compound at 3 mg/kg in rat after i.v. administration,10082,,CHEMBL626379,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17667,,
Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10083,,CHEMBL626380,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6848,,
Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10084,,CHEMBL626381,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6848,,
Bioavailability in rat,10085,,CHEMBL626382,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17267,,
Bioavailability in rat (Sprague-Dawley) (female),10086,,CHEMBL626383,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6362,,
Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,10087,,CHEMBL874652,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17671,,
Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),10088,,CHEMBL626384,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17671,,
Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,10089,,CHEMBL626385,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4333,,
Bioavailability in rat at an oral dose of 2 mg/kg,10090,,CHEMBL626386,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6077,,
Bioavailability in rat,10091,,CHEMBL626387,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3278,,
Bioavailability in rat,10092,,CHEMBL626388,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5964,,
Bioavailability in rat,10093,,CHEMBL626389,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4884,,
Bioavailability in rat,10094,,CHEMBL626390,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4905,,
Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,10095,,CHEMBL626391,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4884,,
Bioavailability in rat,10096,,CHEMBL626392,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6850,,
Oral bioavailability in rat,10097,,CHEMBL626393,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2864,,
Bioavailability was determined in rat,10098,,CHEMBL623026,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5780,,
Bioavailability,10099,,CHEMBL623027,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1465,,
Bioavailability,10100,,CHEMBL623028,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5199,,
Bioavailability in rat after 1 day dosing,10101,,CHEMBL623029,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5765,,
Bioavailability in rat after 4 day dosing,10102,,CHEMBL623030,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5765,,
Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,10103,,CHEMBL623031,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Bioavailability after IV dosing at 1 mg/kg in rat; no data,10104,,CHEMBL623032,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Bioavailability after oral administration at a dose of 2 mg/kg in rat,10105,,CHEMBL623033,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Bioavailability after oral administration at a dose of 4 mg/kg in rat,10106,,CHEMBL623034,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6518,,
Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,10107,,CHEMBL623035,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2083,,
Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,10108,,CHEMBL623036,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17260,,
Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10109,,CHEMBL623037,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4956,,
Bioavailability by intravenous administration of 3.4 mg/kg in rat,10110,,CHEMBL623038,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4368,,
Bioavailability from rat plasma at a single oral dose of 25 mg/kg,10111,,CHEMBL874385,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17752,,
Bioavailability in rat (Fisher) (fasted),10112,,CHEMBL623039,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1446,,
Bioavailability in monkey after po administration of 10 mg/kg dose,10113,,CHEMBL623040,22224,BAO_0000218,,,In vivo,1,,,Primates,,9443.0,0,Intermediate,U,A,,2891,,
Oral bioavailability in monkey (dose 10 mg/kg),10114,,CHEMBL623041,22224,BAO_0000218,,,In vivo,1,,,Primates,,9443.0,0,Intermediate,U,A,,2891,,
Bioavailability in rat,10115,,CHEMBL623741,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6672,,
Bioavailability in rat,10116,,CHEMBL623742,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6673,,
Bioavailability in rat,10117,,CHEMBL623743,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17655,,
Bioavailability in rat,10118,,CHEMBL623744,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17796,,
Bioavailability in rat (dose 2.0 mg/kg p.o.),10119,,CHEMBL623745,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17853,,
Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),10120,,CHEMBL623746,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4521,,
Oral bioavailability in rat (dose 5 mg/kg p.o.),10121,,CHEMBL623747,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4940,,
Bioavailability in rat after po administration of 30 mg/kg dose,10122,,CHEMBL623748,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Intermediate,U,A,,2891,,
Bioavailability in rat after po administration of 30 mg/kg dose,10123,,CHEMBL623916,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Intermediate,U,A,,2891,,
Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,10124,,CHEMBL623917,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4521,,
Bioavailability in rat (dose 2 mg/kg i.v.),10125,,CHEMBL623918,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17686,,
Bioavailability in rat,10126,,CHEMBL874386,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17796,,
Bioavailability in rat; Only traces detected in rat plasma,10127,,CHEMBL623919,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17796,,
Bioavailability in rat,10128,,CHEMBL623920,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5064,,
Bioavailability upon oral administration of compound,10129,,CHEMBL623148,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5147,,
Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),10130,,CHEMBL623149,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1916,,
Bioavailability in rat,10131,,CHEMBL623150,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6049,,
"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",10132,,CHEMBL623151,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1445,,
"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",10133,,CHEMBL623152,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1445,,
Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,10134,,CHEMBL623153,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Expert,N,F,,2862,,
Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,10135,,CHEMBL623154,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Expert,N,F,,2862,,
In vitro and metabolic stability was determined,10136,,CHEMBL623155,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4194,,
In vitro metabolic stability in rat hepatocytes,10137,,CHEMBL623156,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4194,,
In vitro metabolic stability in rat was measured as pmol/min/mg/protein,10138,,CHEMBL623157,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5486,,
Metabolic rate for compound was observed in rat hepatocytes,10139,,CHEMBL623158,50597,BAO_0000218,Hepatocyte,401.0,In vitro,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,17582,,
In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,10140,,CHEMBL623159,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5600,,
Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),10141,,CHEMBL874390,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14294,,
Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),10142,,CHEMBL623160,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14294,,
Metabolism of compound in rat S9 microsomes; Trace,10143,,CHEMBL623161,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14294,,
Metabolism was measured as percent loss at 4 hr in rat hepatocytes,10144,,CHEMBL623162,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17847,,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,10145,,CHEMBL623163,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,10146,,CHEMBL623164,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,10147,,CHEMBL623165,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,10148,,CHEMBL623166,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,10149,,CHEMBL624983,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,10150,,CHEMBL624984,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,10151,,CHEMBL624985,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,10152,,CHEMBL622970,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,10153,,CHEMBL622971,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,10154,,CHEMBL622972,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,10155,,CHEMBL622973,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,10156,,CHEMBL622974,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,10157,,CHEMBL622975,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,10158,,CHEMBL622976,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,10159,,CHEMBL622977,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,10160,,CHEMBL624351,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,10161,,CHEMBL624352,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,10162,,CHEMBL624353,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,10163,,CHEMBL622397,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,10164,,CHEMBL622398,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,10165,,CHEMBL622399,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,10166,,CHEMBL622400,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,10167,,CHEMBL628428,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,10168,,CHEMBL628590,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,10169,,CHEMBL628591,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,10170,,CHEMBL628592,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,10171,,CHEMBL628593,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,10172,,CHEMBL875333,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,10173,,CHEMBL628594,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,10174,,CHEMBL628595,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4969,,
Stability in rat plasma was determined,10175,,CHEMBL628596,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6737,,
Stability in rat plasma was determined; ND= no data,10176,,CHEMBL628597,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,6737,,
Tested for plasma half life period in rat (0-8 hr),10177,,CHEMBL628598,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5089,,
Tested for plasma half life period in rat (0-8 hr); Not determined,10178,,CHEMBL628599,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5089,,
Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,10179,,CHEMBL628600,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1466,,
Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,10180,,CHEMBL628601,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1466,,
Tested for the half life in rat,10181,,CHEMBL628602,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4950,,
Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,10182,,CHEMBL628603,50597,BAO_0000218,,,In vitro,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2412,,
Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,10183,,CHEMBL628604,50597,BAO_0000218,,,In vitro,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2412,,
Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,10184,,CHEMBL628605,50597,BAO_0000218,,,In vitro,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2412,,
Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,10185,,CHEMBL628606,50597,BAO_0000218,,,In vitro,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2412,,
Tested in vitro for the time for half reactivation against rat small intestinal sucrase,10186,,CHEMBL628607,50597,BAO_0000218,,,In vitro,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2412,,
The biological half life the compound was measured at the dose of 100 umol/kg,10187,,CHEMBL628608,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15022,,
The biological half life the compound was measured at the dose of 30 umol/kg,10188,,CHEMBL628609,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15022,,
The compound was evaluated for plasma half life period in rat,10189,,CHEMBL628610,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,406,,
"The half life value in female wistar rat at 100 mg/kg, p.o. dose",10190,,CHEMBL873819,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
"The half life value in male wistar rat at 100 mg/kg, p.o. dose",10191,,CHEMBL628611,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
The pharmacokinetic parameter half-life period in vivo in rats,10192,,CHEMBL628612,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5247,,
"The pharmacokinetic property, Half-life was determined",10193,,CHEMBL628613,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
"The pharmacokinetic property, Half-life in rat in vivo",10194,,CHEMBL628614,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
"The pharmacokinetic property, Half-life was determined; ND denotes no data",10195,,CHEMBL628615,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
"The pharmacokinetic property, Half-life was determined; ND denotes not determined",10196,,CHEMBL628616,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
The plasma half life period in rats,10197,,CHEMBL627924,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,3918,,
The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,10198,,CHEMBL627925,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,2906,,
half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,10199,,CHEMBL627926,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6467,,
t1/2 (apparent elimination)of the compound was determined,10200,,CHEMBL627927,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
t1/2 value in rat,10201,,CHEMBL627928,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3788,,
Half life in rat,10202,,CHEMBL627539,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17796,,
"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",10203,,CHEMBL876790,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12873,,
Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,10204,,CHEMBL858186,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5983,,
Half-life period in fasted rats,10205,,CHEMBL627540,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15765,,
Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,10206,,CHEMBL627541,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,10207,,CHEMBL627715,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,10208,,CHEMBL627716,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,429,,
Maximum time required to achieve Cmax was determined in rat,10209,,CHEMBL627717,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17655,,
Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,10210,,CHEMBL627718,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,10211,,CHEMBL627719,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,10212,,CHEMBL627720,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Time to reach maximum concentration in rat after 2 mg/kg peroral administration,10213,,CHEMBL627721,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6570,,
Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,10214,,CHEMBL627722,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6570,,
Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,10215,,CHEMBL627723,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,10216,,CHEMBL626058,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,10217,,CHEMBL626059,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,10218,,CHEMBL626060,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,10219,,CHEMBL626061,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17720,,
Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,10220,,CHEMBL876791,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4723,,
Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,10221,,CHEMBL626062,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4723,,
Tmax at the dose of 2 mg/Kg administered perorally in rats,10222,,CHEMBL626063,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4756,,
Tmax at the dose of 5 mg/Kg administered perorally in rats,10223,,CHEMBL626064,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4756,,
tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,10224,,CHEMBL626065,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17720,,
tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,10225,,CHEMBL626066,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17720,,
tmax upon peroral administration of 10.0 mg/Kg dose in rat,10226,,CHEMBL626067,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1466,,
Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,10227,,CHEMBL626068,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,7449,,
Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,10228,,CHEMBL626069,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,7449,,
Percent total excretion of 3-methoxyacetaminophen glucuronide,10229,,CHEMBL626070,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,7449,,
Percent total excretion of N-methoxyacetaminophen glucuronide,10230,,CHEMBL626071,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,7449,,
Percent total excretion of N-methoxyacetaminophen sulfate,10231,,CHEMBL626072,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,7449,,
Percent total excretion of acetaminophen,10232,,CHEMBL626073,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,7449,,
"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",10233,,CHEMBL626741,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,7768,,
"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",10234,,CHEMBL626742,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17655,,
Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,10235,,CHEMBL626743,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17735,,
Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,10236,,CHEMBL876792,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5960,,
Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,10237,,CHEMBL626744,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17735,,
Compound was tested for antidiuretic activity in rats,10238,,CHEMBL626745,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7116,,
AUC in rat after 3mg/kg oral dose,10239,,CHEMBL626746,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,4878,,
Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,10240,,CHEMBL626747,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,10241,,CHEMBL626748,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Bioavailability administered orally at a dose of 10 mg/kg to rats,10242,,CHEMBL626749,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16367,,
Oral Bioavailability was determined,10243,,CHEMBL626750,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16366,,
Oral bioavailability in rat,10244,,CHEMBL626751,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4426,,
Oral bioavailability in rat; Not performed.,10245,,CHEMBL626913,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4426,,
Bioavailability,10246,,CHEMBL626914,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
Bioavailability was determined; ND denotes no data,10247,,CHEMBL626915,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5041,,
Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,10248,,CHEMBL626916,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1500,,
Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,10249,,CHEMBL626917,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1500,,
Binding towards rat plasma protein at 10 uM,10250,,CHEMBL626918,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17409,,
Binding towards rat plasma protein at 100 uM,10251,,CHEMBL626919,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17409,,
Bioavailability in rat (dose 20 mg/kg p.o.),10252,,CHEMBL626920,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2959,,
Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,10253,,CHEMBL621976,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13501,,
Bioavailability in rat after 5 mg/kg oral gavage,10254,,CHEMBL877599,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6567,,
Bioavailability in rat,10255,,CHEMBL621977,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6571,,
Bioavailability in rat (dose 1 mg/kg i.v.),10256,,CHEMBL621978,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6715,,
Bioavailability in rat (dose 3 mg/kg p.o.),10257,,CHEMBL621979,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6715,,
Oral bioavailability in rat,10258,,CHEMBL621980,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2932,,
Bioavailability of the compound in rats after administration of 30 mg/kg,10259,,CHEMBL621981,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4171,,
Bioavailability after administration of 10 mg/kg in rats,10260,,CHEMBL621982,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17509,,
Bioavailability after administration of 2 mg/kg in rats,10261,,CHEMBL882953,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17509,,
Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,10262,,CHEMBL621983,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4527,,
Bioavailability in dogs was determined; high,10263,,CHEMBL621984,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4026,,
Bioavailability in monkey after intravenous administration at 1 mpk,10264,,CHEMBL621985,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6659,,
Bioavailability in monkey after peroral administration at 10 mpk,10265,,CHEMBL621986,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6659,,
Bioavailability in rat after intravenous administration at 1 mpk,10266,,CHEMBL621987,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6659,,
Bioavailability in rat after intravenous administration at 2 mpk,10267,,CHEMBL877600,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,6659,,
Bioavailability in rat after peroral administration at 30 mpk,10268,,CHEMBL621988,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6659,,
Bioavailability in rat after peroral administration at at 100 mpk,10269,,CHEMBL621989,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,6659,,
Bioavailability in rats was evaluated,10270,,CHEMBL621990,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6597,,
Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,10271,,CHEMBL621991,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1202,,
Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,10272,,CHEMBL621992,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1202,,
Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,10273,,CHEMBL621993,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1202,,
Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,10274,,CHEMBL621994,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1202,,
Bioavailability in rat,10275,,CHEMBL621995,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5207,,
Bioavailability in rat,10276,,CHEMBL621996,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5970,,
Oral bioavailability in rat (dose 10 mg/kg),10277,,CHEMBL621997,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17538,,
Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,10278,,CHEMBL621998,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17538,,
Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,10279,,CHEMBL621999,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1466,,
Oral bioavailability in rat,10280,,CHEMBL622000,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2879,,
Bioavailability was measured in rat after oral administration; 2-4,10281,,CHEMBL622001,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2879,,
Bioavailability was measured in rat after oral administration; 3-7,10282,,CHEMBL622002,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2879,,
Bioavailability in rat (intraduodenal administration),10283,,CHEMBL622003,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3777,,
Bioavailability in rat (intraduodenal administration),10284,,CHEMBL877601,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3777,,
Oral bioavailability in rat,10285,,CHEMBL624871,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3777,,
Oral bioavailability in rat,10286,,CHEMBL622004,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3777,,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),10287,,CHEMBL882954,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5423,,
Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,10288,,CHEMBL622005,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,10289,,CHEMBL622006,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16365,,
Bioavailability was measured in rat,10290,,CHEMBL622007,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4239,,
Bioavailability was reported,10291,,CHEMBL622008,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5438,,
Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10292,,CHEMBL622009,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5334,,
Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10293,,CHEMBL622010,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5334,,
Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,10294,,CHEMBL622011,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4199,,
Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),10295,,CHEMBL622012,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4199,,
Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),10296,,CHEMBL622013,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4199,,
Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,10297,,CHEMBL622014,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4890,,
Bioavailability was determined at 3 mg/kg po dose in rats,10298,,CHEMBL624749,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2792,,
Oral bioavailability in rat (dose 2 mg/kg),10299,,CHEMBL624750,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5529,,
"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",10300,,CHEMBL624751,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",10301,,CHEMBL624752,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",10302,,CHEMBL624753,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6685,,
Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,10303,,CHEMBL624754,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6005,,
Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,10304,,CHEMBL624755,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6410,,
Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,10305,,CHEMBL624756,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6410,,
Bioavailability in rat,10306,,CHEMBL624757,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6103,,
Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,10307,,CHEMBL624758,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6410,,
Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,10308,,CHEMBL622270,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6410,,
Bioavailability in rat (Sprague-Dawley),10309,,CHEMBL622271,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5353,,
Bioavailability in rat at the dose of 2 mg/kg,10310,,CHEMBL622272,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4727,,
Oral bioavailability in rat,10311,,CHEMBL622273,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17804,,
Bioavailability in rat (cannulated) (dose 2 mg/kg),10312,,CHEMBL622274,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5809,,
Bioavailability value of compound in rats was determined after peroral administration,10313,,CHEMBL622275,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17804,,
Oral bioavailability in rat (dose 20 mg/kg),10314,,CHEMBL622276,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3634,,
Oral bioavailability in rat,10315,,CHEMBL622277,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3341,,
Oral bioavailability in rat (dose 5 mg/kg),10316,,CHEMBL622278,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2690,,
Oral bioavailability in rat,10317,,CHEMBL622279,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3184,,
Oral bioavailability in rat,10318,,CHEMBL622280,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,740,,
Compound was evaluated for oral bioavailability in rats; 15-27 %,10319,,CHEMBL624083,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1806,,
Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,10320,,CHEMBL624084,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4891,,
Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),10321,,CHEMBL624085,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3634,,
Compound was tested for bioavailability in rats,10322,,CHEMBL624086,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,64,,
Bioavailability in rat,10323,,CHEMBL624087,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4839,,
Oral bioavailability in rat,10324,,CHEMBL624088,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1094,,
Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,10325,,CHEMBL624089,22224,BAO_0000218,,,In vivo,1,,,Macaca mulatta,,9544.0,0,Intermediate,U,A,,5005,,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10326,,CHEMBL624090,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Intermediate,U,A,,5005,,
Evaluated for the bioavailability in rat (in vivo),10327,,CHEMBL624091,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4687,,
F value of compound in rats was determined after peroral administration,10328,,CHEMBL624092,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17804,,
In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10329,,CHEMBL624093,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10330,,CHEMBL624094,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,10331,,CHEMBL624095,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10332,,CHEMBL624096,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5974,,
"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",10333,,CHEMBL624097,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1088,,
Maximum fall in carotid flow in rat,10334,,CHEMBL624098,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1742,,
Oral Bioavailability after intravenous administration (1 mg/kg) in rat,10335,,CHEMBL874392,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4689,,
Oral bioavailability in rat (dose 5 mg/kg),10336,,CHEMBL624099,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2463,,
Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,10337,,CHEMBL624100,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5654,,
Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,10338,,CHEMBL624101,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5654,,
Oral bioavailability in rat (male Wistar),10339,,CHEMBL624102,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6874,,
Oral bioavailability after administration (30 mg/kg) in rat; good,10340,,CHEMBL624103,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5633,,
Oral bioavailability at the dose of 2 mg/kg in rat,10341,,CHEMBL624104,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5496,,
Oral bioavailability determined in rats,10342,,CHEMBL624105,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2358,,
Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),10343,,CHEMBL624106,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16456,,
Oral bioavailability in rat (dose single 10 mg/kg),10344,,CHEMBL624107,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5302,,
Oral bioavailability in rat (dose single 10 mg/kg),10345,,CHEMBL623943,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5302,,
Oral bioavailability in rat (dose 5 mg/kg,10346,,CHEMBL623944,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5302,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,10347,,CHEMBL623945,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,10348,,CHEMBL623946,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,10349,,CHEMBL623947,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,10350,,CHEMBL623948,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,10351,,CHEMBL623949,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,10352,,CHEMBL623950,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,10353,,CHEMBL874398,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,10354,,CHEMBL623951,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,10355,,CHEMBL623952,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,10356,,CHEMBL623953,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,10357,,CHEMBL623954,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,10358,,CHEMBL623955,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,10359,,CHEMBL623956,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,10360,,CHEMBL627807,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,10361,,CHEMBL627808,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,10362,,CHEMBL627809,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,10363,,CHEMBL627810,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",10364,,CHEMBL627811,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",10365,,CHEMBL627812,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",10366,,CHEMBL627813,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",10367,,CHEMBL627814,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",10368,,CHEMBL875336,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",10369,,CHEMBL627815,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",10370,,CHEMBL627816,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",10371,,CHEMBL627817,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",10372,,CHEMBL627818,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",10373,,CHEMBL627819,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",10374,,CHEMBL627820,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",10375,,CHEMBL627821,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,10376,,CHEMBL628464,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,10377,,CHEMBL626239,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,10378,,CHEMBL626240,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,10379,,CHEMBL626241,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,10380,,CHEMBL626242,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,10381,,CHEMBL626243,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,10382,,CHEMBL626244,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,10383,,CHEMBL626907,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,10384,,CHEMBL626908,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,10385,,CHEMBL626909,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,10386,,CHEMBL626910,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
Percent total excretion of acetaminophen cysteine conjugate,10387,,CHEMBL875342,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,7449,,
Percent total excretion of acetaminophen glucuronide,10388,,CHEMBL626911,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,7449,,
Percent total excretion of acetaminophen sulfate,10389,,CHEMBL626912,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,7449,,
Percent total excretion of acetaminophen-mercapturic acid,10390,,CHEMBL627065,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,F,,7449,,
Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,10391,,CHEMBL627066,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,3172,,
Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,10392,,CHEMBL627067,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16456,,
Biodistribution of compound in rat muscle after 5 min of administration,10393,,CHEMBL627068,22224,BAO_0000218,,,In vivo,1,,2385.0,ratrat,,8656.0,0,Autocuration,U,A,Muscle tissue,10839,,
Biodistribution of compound in rat muscle after 5 min of administration.,10394,,CHEMBL627069,22224,BAO_0000218,,,In vivo,1,,2385.0,ratrat,,8656.0,0,Autocuration,U,A,Muscle tissue,10839,,
Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10395,,CHEMBL627070,22224,BAO_0000218,,,In vivo,1,,,Ovis aries,,9940.0,0,Autocuration,U,A,,5334,,
Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10396,,CHEMBL627071,22224,BAO_0000218,,,In vivo,1,,,Ovis aries,,9940.0,0,Autocuration,U,A,,5334,,
Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10397,,CHEMBL627072,22224,BAO_0000218,,,In vivo,1,,,Ovis aries,,9940.0,0,Autocuration,U,A,,5334,,
Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10398,,CHEMBL627073,22224,BAO_0000218,,,In vivo,1,,,Ovis aries,,9940.0,0,Autocuration,U,A,,5334,,
Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10399,,CHEMBL625387,22224,BAO_0000218,,,In vivo,1,,,Ovis aries,,9940.0,0,Autocuration,U,A,,5334,,
Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10400,,CHEMBL625388,22224,BAO_0000218,,,In vivo,1,,,Ovis aries,,9940.0,0,Autocuration,U,A,,5334,,
Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10401,,CHEMBL625389,22224,BAO_0000218,,,In vivo,1,,1969.0,Ovis aries,,9940.0,0,Autocuration,U,A,Plasma,5334,,
Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10402,,CHEMBL875343,22224,BAO_0000218,,,In vivo,1,,1969.0,Ovis aries,,9940.0,0,Autocuration,U,A,Plasma,5334,,
Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),10403,,CHEMBL876795,50497,BAO_0000218,,,,1,,,Serpentes,,8570.0,1,Intermediate,N,A,,1735,,
Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,10404,,CHEMBL626552,50497,BAO_0000218,,,,1,,,Serpentes,,8570.0,1,Intermediate,N,A,,1469,,
Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,10405,,CHEMBL626553,50497,BAO_0000218,,,,1,,,Serpentes,,8570.0,1,Intermediate,N,A,,1336,,
The human biological plasma half life of the compound,10406,,CHEMBL626554,22224,BAO_0000366,,,,1,,1969.0,Homo sapiens,,9606.0,0,Autocuration,U,A,Plasma,12403,,
Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,10407,,CHEMBL626555,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8151,,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,10408,,CHEMBL626556,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,10409,,CHEMBL626557,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,10410,,CHEMBL626558,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,10411,,CHEMBL626559,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,10412,,CHEMBL626560,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,10413,,CHEMBL876803,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,10414,,CHEMBL627964,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,10415,,CHEMBL627965,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,10416,,CHEMBL627966,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,10417,,CHEMBL627967,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,10418,,CHEMBL627968,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,10419,,CHEMBL627969,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,10420,,CHEMBL627970,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8004,,
Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,10421,,CHEMBL627971,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8004,,
Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,10422,,CHEMBL627972,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8004,,
Dissociation constant against binding to human cyclophilin A,10423,,CHEMBL856029,180,BAO_0000357,,,,1,,,Homo sapiens,,9606.0,9,Expert,D,B,,15917,,
Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,10424,,CHEMBL627973,11591,BAO_0000019,,,,1,,,Bos taurus,,9913.0,8,Expert,H,B,,12396,,
-Log C was determined by performing the electroshock minimum test,10425,,CHEMBL627974,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7065,,
-Log C was determined by performing the foot shock test,10426,,CHEMBL627975,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7065,,
-Log C was determined by performing the incl screen test,10427,,CHEMBL627976,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7065,,
-Log C was determined by performing the maximum electroshock test,10428,,CHEMBL627977,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7065,,
-Log C was determined by performing the pentylenetetrazole test,10429,,CHEMBL627978,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7065,,
Tested for experimental arotinoid inhibitory dose,10430,,CHEMBL627979,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12415,,
Negative log transformed activity,10431,,CHEMBL876804,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10256,,
"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",10432,,CHEMBL627980,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7991,,
Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,10433,,CHEMBL627981,50512,BAO_0000218,,,,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,14342,,
Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,10434,,CHEMBL627982,50512,BAO_0000218,,,,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,14342,,
Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,10435,,CHEMBL627983,50512,BAO_0000218,,,,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,14342,,
Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,10436,,CHEMBL627984,50512,BAO_0000218,,,,1,,2116.0,Cavia porcellus,,10141.0,1,Intermediate,N,A,Ileum,14342,,
Solubility in water was determined; values expressed as -log,10437,,CHEMBL627985,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6047,,
Ratio of Kcat to that of Km was determined,10438,,CHEMBL627986,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17269,,
Observed first order rate constant,10439,,CHEMBL627987,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10026,,
Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,10440,,CHEMBL627988,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14583,,
Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,10441,,CHEMBL627989,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,10442,,CHEMBL627990,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2661,,
Oral Bioavailability after administration of 10 mg/kg in male rat,10443,,CHEMBL876805,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4029,,
Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),10444,,CHEMBL627991,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17735,,
Oral bioavailability in rat,10445,,CHEMBL627992,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4576,,
Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,10446,,CHEMBL627993,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17582,,
Oral bioavailability at 1 mg/kg was determined in rat,10447,,CHEMBL622817,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17651,,
Oral bioavailability at 10 mg/kg was determined in rat,10448,,CHEMBL622818,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17651,,
"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",10449,,CHEMBL622819,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17670,,
Oral bioavailability in rat,10450,,CHEMBL872267,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5045,,
Oral bioavailability in rat,10451,,CHEMBL622820,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1696,,
Oral bioavailability after intravenous administration in rats at 24 uM/kg,10452,,CHEMBL622821,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17764,,
Oral bioavailability in rat,10453,,CHEMBL622822,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6448,,
Oral bioavailability in rat,10454,,CHEMBL622823,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6596,,
Oral bioavailability in rat,10455,,CHEMBL622824,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17547,,
Oral bioavailability in rat at a dose of 3 mg/kg,10456,,CHEMBL622825,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17771,,
Oral bioavailability in rat after oral administration at 10 mg/kg,10457,,CHEMBL622901,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6495,,
Oral bioavailability in rat,10458,,CHEMBL622902,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4558,,
Oral bioavailability in rat,10459,,CHEMBL621844,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17596,,
Oral bioavailability in Dawley rats,10460,,CHEMBL621845,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6827,,
Oral bioavailability,10461,,CHEMBL621846,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4026,,
Oral bioavailability in rat (dose 30 mg/kg),10462,,CHEMBL621847,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10,,
Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,10463,,CHEMBL877609,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Bioavailability in rat (dose 3 mg/kg i.v.),10464,,CHEMBL621848,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,10465,,CHEMBL621849,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Oral bioavailability in rat (dose 60 mg/kg p.o.),10466,,CHEMBL622030,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Percent oral bioavailability determined in rats,10467,,CHEMBL622031,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4796,,
Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,10468,,CHEMBL622032,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4883,,
The compound was evaluated for bioavailability in rats; 32-51,10469,,CHEMBL622033,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2137,,
Bioavailability in rat (dose 20 mg/kg p.o.),10470,,CHEMBL622034,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2959,,
Oral bioavailability in rat,10471,,CHEMBL622035,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1361,,
Bioavailability percent in rat at the dose of 2 mg/kg,10472,,CHEMBL882966,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4727,,
Bioavailability was evaluated after 20 uM/kg of peroral administration,10473,,CHEMBL622036,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16423,,
Oral bioavailability in rat,10474,,CHEMBL622037,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5206,,
Oral bioavailability in rat,10475,,CHEMBL622038,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6448,,
Bioavailability in rats,10476,,CHEMBL622039,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17723,,
Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,10477,,CHEMBL622040,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,17738,,
Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,10478,,CHEMBL622041,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,17738,,
Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,10479,,CHEMBL622042,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,17738,,
Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,10480,,CHEMBL622043,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,17738,,
Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,10481,,CHEMBL622044,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,17738,,
Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,10482,,CHEMBL622045,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,17738,,
Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,10483,,CHEMBL622046,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,17738,,
Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,10484,,CHEMBL622047,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,17738,,
Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,10485,,CHEMBL877610,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,17738,,
Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,10486,,CHEMBL622048,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,17738,,
Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,10487,,CHEMBL622049,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,17738,,
Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,10488,,CHEMBL622050,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,17738,,
Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,10489,,CHEMBL622051,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,17738,,
Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,10490,,CHEMBL622052,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17738,,
Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,10491,,CHEMBL622053,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17738,,
Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,10492,,CHEMBL622054,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17738,,
Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,10493,,CHEMBL622055,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17738,,
Oral bioavailability in rats was determined; High,10494,,CHEMBL622056,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5237,,
Oral bioavailability in the rat was determined,10495,,CHEMBL622057,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5503,,
Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,10496,,CHEMBL628008,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15765,,
Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),10497,,CHEMBL622058,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15660,,
Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,10498,,CHEMBL622059,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,10499,,CHEMBL622060,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,10500,,CHEMBL622061,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,10501,,CHEMBL622062,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5978,,
Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,10502,,CHEMBL622063,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5656,,
Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,10503,,CHEMBL877611,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Expert,N,A,,3598,,
Oral bioavailability of compound in Sprague Dawley rats,10504,,CHEMBL622064,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4216,,
Oral bioavailability of compound in rat,10505,,CHEMBL622065,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17839,,
Oral bioavailability in rat (dose 2 mg/kg),10506,,CHEMBL622066,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6570,,
Oral bioavailability of compound in rat was determined,10507,,CHEMBL622067,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5334,,
Oral bioavailability of compound in rats,10508,,CHEMBL622068,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6886,,
Oral bioavailability of compound was determined in rats,10509,,CHEMBL622069,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5210,,
Oral bioavailability at a dose of 30 mg/kg in rats,10510,,CHEMBL624796,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4170,,
Oral bioavailability in rat (dose 10 mg/kg),10511,,CHEMBL624797,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6028,,
Oral bioavailability in rat (dose 10 mg/kg),10512,,CHEMBL623053,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6028,,
Oral bioavailability evaluated in rat,10513,,CHEMBL623054,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6078,,
Oral bioavailability in fasted rat,10514,,CHEMBL623055,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6168,,
Oral bioavailability in fed rat,10515,,CHEMBL623056,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6168,,
Oral bioavailability in rat (mature male) (dose 30 mg/kg),10516,,CHEMBL623057,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5160,,
Oral bioavailability in rat,10517,,CHEMBL623058,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6057,,
Oral bioavailability in rat (dose 10 mg/kg p.o.),10518,,CHEMBL623059,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6535,,
Oral bioavailability in rat after administration of 10 mg/kg po,10519,,CHEMBL623060,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6535,,
Oral bioavailability in rat,10520,,CHEMBL623061,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4194,,
Oral bioavailability in rat,10521,,CHEMBL623062,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6230,,
Oral bioavailability in rat,10522,,CHEMBL623063,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6619,,
Oral bioavailability in rat,10523,,CHEMBL623064,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17607,,
Oral bioavailability in ratrs,10524,,CHEMBL623065,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4942,,
Oral bioavailability in rat,10525,,CHEMBL623066,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4942,,
Oral bioavailability in rat,10526,,CHEMBL623067,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6646,,
Oral bioavailability in rats was determined; High,10527,,CHEMBL623068,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5237,,
Oral bioavailability in rat,10528,,CHEMBL623069,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6646,,
Oral bioavailability in rat,10529,,CHEMBL623070,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4449,,
Oral bioavailability was calculated in rat,10530,,CHEMBL623071,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6057,,
Oral bioavailability,10531,,CHEMBL623072,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2552,,
Oral bioavailability,10532,,CHEMBL623073,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5496,,
Oral bioavailability,10533,,CHEMBL623074,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6484,,
Oral bioavailability,10534,,CHEMBL623075,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6485,,
Oral bioavailability after i.v. administration,10535,,CHEMBL623076,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6616,,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10536,,CHEMBL623077,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4969,,
Oral bioavailability in rat (Sprague-Dawley),10537,,CHEMBL623078,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5862,,
Oral bioavailability in Sprague-Dawley rats,10538,,CHEMBL623079,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4514,,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10539,,CHEMBL623080,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4514,,
Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10540,,CHEMBL623081,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4514,,
Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,10541,,CHEMBL623082,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5546,,
Oral bioavailability in fasted rat,10542,,CHEMBL874400,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6168,,
Oral bioavailability in fed rat,10543,,CHEMBL623083,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6168,,
Oral bioavailability in rat,10544,,CHEMBL623084,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3624,,
Oral bioavailability in rat,10545,,CHEMBL623085,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5213,,
Oral bioavailability in rat,10546,,CHEMBL623086,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5496,,
Oral bioavailability in rat,10547,,CHEMBL623087,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5553,,
Oral bioavailability in rat,10548,,CHEMBL623088,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5833,,
Oral bioavailability in rat,10549,,CHEMBL623089,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5836,,
Oral bioavailability in rat,10550,,CHEMBL623090,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5865,,
Oral bioavailability in rat,10551,,CHEMBL623091,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5960,,
Oral bioavailability in rat,10552,,CHEMBL623092,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6249,,
Oral bioavailability in rat,10553,,CHEMBL623093,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6448,,
Oral bioavailability in rat,10554,,CHEMBL874401,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6453,,
Oral bioavailability in rat,10555,,CHEMBL623094,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6640,,
Oral bioavailability in rat,10556,,CHEMBL623095,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17607,,
Oral bioavailability in rat after peroral administration at 10 mg/kg,10557,,CHEMBL623096,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Oral bioavailability in rat after peroral administration at 5 mg/kg,10558,,CHEMBL624913,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5939,,
Oral bioavailability in rat (dose 2.8 mg/kg p.o.),10559,,CHEMBL624914,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6281,,
Oral bioavailability in rat by po administration at a dose of 40 mg/kg,10560,,CHEMBL624915,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5874,,
Oral bioavailability in rat; Not measured,10561,,CHEMBL624916,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5213,,
Oral bioavailability in rat,10562,,CHEMBL624917,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4964,,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,10563,,CHEMBL625157,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11020,,
In vitro metabolic potential in rat liver microsomes,10564,,CHEMBL625158,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,6251,,
"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",10565,,CHEMBL625159,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1568,,
"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",10566,,CHEMBL625160,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3032,,
Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,10567,,CHEMBL625161,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3748,,
Oral bioavailability in rat,10568,,CHEMBL625162,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,401,,
Oral bioavailability in rat,10569,,CHEMBL625163,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6512,,
Oral bioavailability in rats at 10 mg/kg,10570,,CHEMBL625164,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17617,,
Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,10571,,CHEMBL625165,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6679,,
Oral bioavailability in rat,10572,,CHEMBL625166,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6742,,
Tested for effective permeability across the rat intestinal membrane using mass balance analysis,10573,,CHEMBL625167,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,589,,
Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,10574,,CHEMBL625168,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,589,,
Plasma clearance of the compound,10575,,CHEMBL625169,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3185,,
Plasma clearance at 10 mg/kg in rat upon intravenous administration,10576,,CHEMBL626264,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17596,,
Plasma clearance upon intravenous administration of 1 mg/Kg in rats,10577,,CHEMBL626265,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2713,,
The compound was tested for plasma clearance in rat,10578,,CHEMBL626266,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12500,,
The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,10579,,CHEMBL626267,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12500,,
Plasma concentration upon oral administration of 1 mg/Kg in rats,10580,,CHEMBL626268,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2713,,
Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,10581,,CHEMBL626269,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1446,,
Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,10582,,CHEMBL626270,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6227,,
Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,10583,,CHEMBL626271,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4709,,
"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",10584,,CHEMBL626272,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",10585,,CHEMBL626273,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",10586,,CHEMBL875346,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",10587,,CHEMBL626274,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5510,,
Compound was tested for protein binding in rat plasma,10588,,CHEMBL626275,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4514,,
Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,10589,,CHEMBL624646,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2713,,
Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,10590,,CHEMBL624647,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2713,,
In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,10591,,CHEMBL624648,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,5340,,
Area under curve ratio was determined (po/iv) in rat,10592,,CHEMBL624649,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12058,,
Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,10593,,CHEMBL624650,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11195,,
Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,10594,,CHEMBL624651,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11195,,
Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,10595,,CHEMBL624652,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11195,,
Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,10596,,CHEMBL624653,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6495,,
Ratio of AUCbrain to AUCplasma,10597,,CHEMBL624654,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6078,,
Ratio of brain to plasma,10598,,CHEMBL624655,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5656,,
Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,10599,,CHEMBL624656,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4910,,
Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,10600,,CHEMBL624657,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4910,,
Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,10601,,CHEMBL624658,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4910,,
Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,10602,,CHEMBL624659,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10130,,
Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,10603,,CHEMBL624660,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10130,,
Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,10604,,CHEMBL624661,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10130,,
Steady state brain :blood ratio was determined,10605,,CHEMBL624662,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5213,,
Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,10606,,CHEMBL625199,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4910,,
Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,10607,,CHEMBL625200,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4910,,
Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,10608,,CHEMBL625201,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4910,,
Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,10609,,CHEMBL625202,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4910,,
Percentage recovery after 3h incubation with rat hapatocytes was determined,10610,,CHEMBL625203,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2083,,
Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,10611,,CHEMBL625204,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2082,,
Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,10612,,CHEMBL625205,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2082,,
Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,10613,,CHEMBL625206,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6351,,
"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",10614,,CHEMBL625207,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14583,,
Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,10615,,CHEMBL625208,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14583,,
In vivo absorption in Caco-2 cell line monolayers was determined,10616,,CHEMBL625209,50587,BAO_0000218,Caco-2,495.0,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,4608,,
Calculated partition coefficient (clogP),10617,,CHEMBL625210,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13668,,
Area under curve was determine after peroral administration at 10 mpk in Rat,10618,,CHEMBL625211,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5669,,
Area under curve was determine after peroral administration at 10 mpk in Rhesus,10619,,CHEMBL625212,50797,BAO_0000218,,,,1,,,Macaca mulatta,,9544.0,1,Intermediate,N,A,,5669,,
Area under curve was determine after peroral administration at 160 mpk in Rat,10620,,CHEMBL625213,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5669,,
Area under curve was determine after peroral administration at 20 mpk in Rat,10621,,CHEMBL625214,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5669,,
Area under curve was determine after peroral administration at 50 mpk in Rat,10622,,CHEMBL874542,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5669,,
Calculated partition coefficient (clogP) (AlogP),10623,,CHEMBL625215,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6472,,
Activated partial thromboplastin time measured,10624,,CHEMBL625216,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15106,,
Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),10625,,CHEMBL625217,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,15207,,
Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),10626,,CHEMBL625218,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,15207,,
AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,10627,,CHEMBL622864,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,13941,,
AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,10628,,CHEMBL622865,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13941,,
AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,10629,,CHEMBL622866,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13941,,
AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,10630,,CHEMBL622867,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,13941,,
AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,10631,,CHEMBL876808,50512,BAO_0000218,,,,1,,1969.0,Cavia porcellus,,10141.0,1,Intermediate,N,A,Plasma,15240,,
AUC in brain,10632,,CHEMBL627725,22224,BAO_0000019,,,,1,,955.0,,,,0,Autocuration,U,A,Brain,10655,,
AUC in serum,10633,,CHEMBL627726,22224,BAO_0000019,,,,1,,1977.0,,,,0,Autocuration,U,A,Serum,10655,,
AUC was determined,10634,,CHEMBL627727,22224,BAO_0000019,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,6504,,
AUC of the compound.,10635,,CHEMBL627728,22224,BAO_0000019,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,10615,,
AUC value (0-4 hr),10636,,CHEMBL627729,22224,BAO_0000019,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,10353,,
"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",10637,,CHEMBL627730,22224,BAO_0000019,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14907,,
AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,10638,,CHEMBL627731,22224,BAO_0000019,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14907,,
"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",10639,,CHEMBL627732,22224,BAO_0000019,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14907,,
"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",10640,,CHEMBL627733,22224,BAO_0000019,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14907,,
AUC(area under curve) was determined after intravenous administration in rats,10641,,CHEMBL627734,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16359,,
AUC(area under curve) was determined after oral administration in rats,10642,,CHEMBL627735,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16359,,
AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,10643,,CHEMBL627736,50512,BAO_0000218,,,,1,,1969.0,Cavia porcellus,,10141.0,1,Intermediate,N,A,Plasma,15240,,
AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,10644,,CHEMBL876809,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15240,,
Area Under Curve after oral dosing of 100 uM/Kg,10645,,CHEMBL627737,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15469,,
Area Under Curve after oral dosing of 30 uM/Kg,10646,,CHEMBL627738,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15469,,
Area Under Curve was measured by ploting the graph between concentration verses time,10647,,CHEMBL627739,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13520,,
Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,10648,,CHEMBL626143,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,17025,,
Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,10649,,CHEMBL626144,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,17025,,
Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,10650,,CHEMBL626145,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,17025,,
Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,10651,,CHEMBL626146,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17025,,
Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,10652,,CHEMBL626147,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12032,,
Area under curve (AUC) was determined,10653,,CHEMBL626148,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10291,,
Area under curve (AUC) following ip administration at 1 mg/kg,10654,,CHEMBL626149,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,5767,,
Area under curve (AUC) was determined; ND is Not determined,10655,,CHEMBL626150,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,1434,,
Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,10656,,CHEMBL626151,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14925,,
Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,10657,,CHEMBL626152,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14925,,
Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,10658,,CHEMBL626153,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14925,,
Area under curve (AUR) was determined,10659,,CHEMBL626154,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,1434,,
Area under curve at 1 uM/dg administered intravenously,10660,,CHEMBL626155,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11883,,
Area under curve at 10 uM/dg administered perorally,10661,,CHEMBL626156,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11883,,
Area under curve at 2 uM/dg administered intravenously,10662,,CHEMBL626157,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11883,,
Area under curve at 20 uM/dg administered perorally,10663,,CHEMBL626158,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11883,,
Area under curve at a peroral dose of 3 mg/kg in dog,10664,,CHEMBL626159,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15233,,
Area under curve at a peroral dose of 3 mg/kg in rat,10665,,CHEMBL626160,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15233,,
Area under curve at an iv dose of 1 mg/kg in dog,10666,,CHEMBL626161,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15233,,
Area under curve at an iv dose of 1 mg/kg in rat,10667,,CHEMBL626162,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15233,,
Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,10668,,CHEMBL626163,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12978,,
Area under curve gives the effective duration for the angiotensin II antagonist effect.,10669,,CHEMBL626164,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12978,,
Area under curve measured as conc vs time after intravenous administration to mice.,10670,,CHEMBL626165,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,11355,,
Area under curve measured as conc vs time after peroral administration to mice.,10671,,CHEMBL626166,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,11355,,
Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,10672,,CHEMBL626167,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12923,,
Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,10673,,CHEMBL626168,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12923,,
Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,10674,,CHEMBL877463,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12923,,
Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,10675,,CHEMBL626169,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12923,,
Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,10676,,CHEMBL626170,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,17738,,
Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,10677,,CHEMBL626171,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,17738,,
Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,10678,,CHEMBL626172,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,17738,,
Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,10679,,CHEMBL626173,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,17738,,
Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,10680,,CHEMBL626174,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,17738,,
Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,10681,,CHEMBL626175,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,17738,,
Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,10682,,CHEMBL626176,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,17738,,
Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,10683,,CHEMBL626177,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,17738,,
Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,10684,,CHEMBL622499,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,17738,,
Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,10685,,CHEMBL622500,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,17738,,
Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,10686,,CHEMBL622501,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,17738,,
Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,10687,,CHEMBL622502,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,17738,,
Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,10688,,CHEMBL622503,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,17738,,
Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,10689,,CHEMBL877614,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,17738,,
Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,10690,,CHEMBL624839,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,17738,,
Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,10691,,CHEMBL624840,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,17738,,
Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,10692,,CHEMBL624841,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,17738,,
Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,10693,,CHEMBL624842,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,17738,,
Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,10694,,CHEMBL624843,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,17738,,
Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,10695,,CHEMBL624844,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,17738,,
Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,10696,,CHEMBL624845,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,17738,,
Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,10697,,CHEMBL621904,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,17738,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,10698,,CHEMBL621905,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,10699,,CHEMBL874382,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,10700,,CHEMBL621906,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,10701,,CHEMBL621907,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,10702,,CHEMBL622096,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,10703,,CHEMBL622097,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,10704,,CHEMBL622098,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,10705,,CHEMBL622099,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,10706,,CHEMBL622100,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,10707,,CHEMBL622101,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,10708,,CHEMBL622102,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,10709,,CHEMBL622103,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,10710,,CHEMBL622104,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,10711,,CHEMBL622105,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,10712,,CHEMBL622106,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,10713,,CHEMBL622107,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,10714,,CHEMBL622108,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,10715,,CHEMBL622109,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,10716,,CHEMBL622110,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,10717,,CHEMBL622111,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,10718,,CHEMBL874383,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,10719,,CHEMBL622112,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,10720,,CHEMBL622113,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,10721,,CHEMBL622114,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,10722,,CHEMBL622115,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,11195,,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,10723,,CHEMBL622116,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,11195,,
Oral bioavailability in rat,10724,,CHEMBL622117,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6193,,
Oral bioavailability in rat,10725,,CHEMBL622118,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6803,,
Oral bioavailability in rats at 6 mg/kg,10726,,CHEMBL622119,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6647,,
Oral bioavailability in rat (dose 6 mg/kg),10727,,CHEMBL622120,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6647,,
Oral bioavailability in rats at 6 mg/kg dose; Not tested,10728,,CHEMBL622121,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6647,,
Oral bioavailability in rat,10729,,CHEMBL622122,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6640,,
Oral bioavailability in rat,10730,,CHEMBL622123,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Oral bioavailability in rat,10731,,CHEMBL622124,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6641,,
Bioavailability in rat,10732,,CHEMBL622125,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6642,,
Oral bioavailability,10733,,CHEMBL622126,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5472,,
Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10734,,CHEMBL620455,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6141,,
Oral bioavailability in rat,10735,,CHEMBL620456,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4390,,
Oral bioavailability in rat,10736,,CHEMBL620457,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5472,,
Oral bioavailability was evaluated; Not tested,10737,,CHEMBL620458,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5472,,
Oral bioavailability,10738,,CHEMBL620459,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5438,,
Oral bioavailability in rat by oral dosing,10739,,CHEMBL620460,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4883,,
Oral bioavailability in rat (dose 10 mg/kg p.o.),10740,,CHEMBL620461,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1908,,
Oral bioavailability in rat (Sprague-Dawley),10741,,CHEMBL620462,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4853,,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10742,,CHEMBL620463,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4853,,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10743,,CHEMBL620464,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4853,,
Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10744,,CHEMBL620465,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4853,,
Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),10745,,CHEMBL620466,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4853,,
Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,10746,,CHEMBL620467,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4853,,
Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,10747,,CHEMBL620468,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4853,,
Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,10748,,CHEMBL620469,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12873,,
Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,10749,,CHEMBL620470,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12873,,
Oral bioavailability in rat,10750,,CHEMBL620471,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3169,,
Oral bioavailability in rat,10751,,CHEMBL620472,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6305,,
Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,10752,,CHEMBL620473,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4762,,
Oral bioavailability in rat,10753,,CHEMBL620474,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17847,,
Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),10754,,CHEMBL620475,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6211,,
Oral bioavailability in rat,10755,,CHEMBL620476,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6011,,
Oral bioavailability in rat,10756,,CHEMBL620477,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6317,,
Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,10757,,CHEMBL620478,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6644,,
Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,10758,,CHEMBL618768,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6644,,
Oral bioavailability in rat after oral administration at 13 mg/kg dose,10759,,CHEMBL618769,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6644,,
Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,10760,,CHEMBL618770,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6644,,
Oral bioavailability (dose 20 mg/kg p.o.),10761,,CHEMBL618771,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6113,,
Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,10762,,CHEMBL618772,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5937,,
Oral bioavailability in rat at 10 mg/kg of the compound,10763,,CHEMBL618773,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5711,,
Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,10764,,CHEMBL875842,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Bioavailability in rat (dose 3 mg/kg i.v.),10765,,CHEMBL618774,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,10766,,CHEMBL618775,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Oral bioavailability in rat (dose 60 mg/kg p.o.),10767,,CHEMBL618776,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17717,,
Percent bioavailability (F) in rats after iv administration,10768,,CHEMBL618777,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4722,,
Percent bioavailability (F) in rats after oral dose of 10 mg/kg,10769,,CHEMBL618778,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4722,,
Bioavailability in rat (dose 5 uM/kg p.o.),10770,,CHEMBL618779,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4353,,
Oral bioavailability,10771,,CHEMBL618780,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15662,,
Bioavailability in rat (dose 2 mg/kg p.o.),10772,,CHEMBL618781,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4756,,
Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,10773,,CHEMBL618782,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,4756,,
Oral bioavailability in rat (dose 20 mg/kg),10774,,CHEMBL618783,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3436,,
Oral bioavailability in rat,10775,,CHEMBL618784,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17800,,
Percent oral bioavailability evaluated in rat,10776,,CHEMBL618785,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15762,,
Oral bioavailability in rat,10777,,CHEMBL618786,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5089,,
Percent oral bioavailability in rat; Not determined,10778,,CHEMBL618787,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5089,,
Oral bioavailability in rat,10779,,CHEMBL618788,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3185,,
Bioavailability in rat,10780,,CHEMBL618789,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5145,,
Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),10781,,CHEMBL618790,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3457,,
Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),10782,,CHEMBL618791,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3457,,
Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,10783,,CHEMBL875843,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5983,,
Oral bioavailability in rat (dose 20 mg/kg p.o.),10784,,CHEMBL618792,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5739,,
Cmax at a dose of 30 mg/kg in rat,10785,,CHEMBL623395,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,3579,,
Cmax in monkeys at a dose of 1 mg/kg,10786,,CHEMBL623396,22224,BAO_0000218,,,In vivo,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,17788,,
Cmax in rat,10787,,CHEMBL623397,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14956,,
Cmax in rats at a dose of 1 mg/kg,10788,,CHEMBL623398,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17788,,
Cmax was measured in mice after an oral dose of 50 mg/kg.,10789,,CHEMBL623399,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,9750,,
"Cmax value at a dose of 12.7 uM/kg, po",10790,,CHEMBL623400,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12767,,
"Cmax value at a dose of 6.3 uM/kg, iv",10791,,CHEMBL623401,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12767,,
"Cmax value at a dose of 7.1 uM/kg, iv",10792,,CHEMBL623402,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12767,,
Cmax value of compound was determined after 1 hr,10793,,CHEMBL623403,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12703,,
Cmax value of the compound,10794,,CHEMBL623404,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15778,,
Cmax value administered intraintestinal in rats.,10795,,CHEMBL625997,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12818,,
Cmax value administered perorally was determined in rat; Not determined,10796,,CHEMBL625998,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14964,,
Cmax value at the dose of 2.3 mg/kg,10797,,CHEMBL625999,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15808,,
Cmax value at the dose of 5 mg/kg,10798,,CHEMBL626000,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15808,,
Cmax value in the period of 8 hr after dosing. ,10799,,CHEMBL626001,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15778,,
Cmax value at a oral dose of 20 mg/kg; Not tested,10800,,CHEMBL626002,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,3715,,
Cmax value at a oral dose of 20 mg/kg,10801,,CHEMBL626003,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,3715,,
Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,10802,,CHEMBL626004,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,1446,,
Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,10803,,CHEMBL626005,50512,BAO_0000218,,,In vivo,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,15240,,
Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,10804,,CHEMBL626006,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15240,,
Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,10805,,CHEMBL626007,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14810,,
Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,10806,,CHEMBL626008,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,14239,,
Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,10807,,CHEMBL626009,50588,BAO_0000218,,,In vivo,1,,2107.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Liver,12555,,
Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,10808,,CHEMBL626010,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,10754,,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,10809,,CHEMBL626011,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,10754,,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,10810,,CHEMBL626012,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,10754,,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,10811,,CHEMBL626013,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,10754,,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,10812,,CHEMBL626014,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,10754,,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,10813,,CHEMBL877496,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,10754,,
Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,10814,,CHEMBL626015,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,F,,14600,,
Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,10815,,CHEMBL626016,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,F,,14600,,
Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,10816,,CHEMBL626017,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,F,,14600,,
Bioavailability as maximal plasma concentration in dogs,10817,,CHEMBL626018,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,13543,,
Bioavailability as maximal plasma concentration in dogs,10818,,CHEMBL626692,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,13543,,
Bioavailability as maximal plasma concentration in rats,10819,,CHEMBL626693,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13543,,
Bioavailability as maximal plasma concentration in rats,10820,,CHEMBL626694,22224,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,0,Autocuration,U,A,Plasma,13543,,
Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10821,,CHEMBL626695,50588,BAO_0000218,,,In vivo,1,,178.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Blood,14600,,
Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10822,,CHEMBL626696,50588,BAO_0000218,,,In vivo,1,,178.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Blood,14600,,
Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10823,,CHEMBL626697,50588,BAO_0000218,,,In vivo,1,,178.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Blood,14600,,
Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,10824,,CHEMBL626859,50588,BAO_0000218,,,In vivo,1,,178.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Blood,14600,,
Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10825,,CHEMBL626860,50588,BAO_0000218,,,In vivo,1,,178.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Blood,14600,,
Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10826,,CHEMBL626861,50588,BAO_0000218,,,In vivo,1,,178.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Blood,14600,,
Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,10827,,CHEMBL626296,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14681,,
Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,10828,,CHEMBL626297,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15905,,
Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,10829,,CHEMBL626298,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,15905,,
"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",10830,,CHEMBL626299,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13304,,
Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,10831,,CHEMBL626300,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15137,,
Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,10832,,CHEMBL626301,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15137,,
Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,10833,,CHEMBL626962,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15137,,
Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,10834,,CHEMBL626963,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15137,,
Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,10835,,CHEMBL626964,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15137,,
In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,10836,,CHEMBL626965,100710,BAO_0000218,,,In vivo,1,,1969.0,Macaca fascicularis,,9541.0,1,Intermediate,N,A,Plasma,14839,,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10837,,CHEMBL626966,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,14839,,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10838,,CHEMBL626967,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,14839,,
In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,10839,,CHEMBL626968,100710,BAO_0000218,,,In vivo,1,,1969.0,Macaca fascicularis,,9541.0,1,Intermediate,N,A,Plasma,14839,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,10840,,CHEMBL626969,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,10841,,CHEMBL627126,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,10842,,CHEMBL631276,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,10843,,CHEMBL631277,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,10844,,CHEMBL631278,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,10845,,CHEMBL874457,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,10846,,CHEMBL631279,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,10847,,CHEMBL631280,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,10848,,CHEMBL631281,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,10849,,CHEMBL631968,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,10850,,CHEMBL631969,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,10851,,CHEMBL631970,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,10852,,CHEMBL631971,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,10853,,CHEMBL631972,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,10854,,CHEMBL630435,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,10855,,CHEMBL630436,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,10856,,CHEMBL630437,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,10857,,CHEMBL630438,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,10858,,CHEMBL630439,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,10859,,CHEMBL630440,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,10860,,CHEMBL630441,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,10861,,CHEMBL630442,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,10862,,CHEMBL625234,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,10863,,CHEMBL625235,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,10864,,CHEMBL625236,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,10865,,CHEMBL625237,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,10866,,CHEMBL626125,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,10867,,CHEMBL626126,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,10868,,CHEMBL626127,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,10869,,CHEMBL626128,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,10870,,CHEMBL626129,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,10871,,CHEMBL626130,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,10872,,CHEMBL626131,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,10873,,CHEMBL626132,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,10874,,CHEMBL626752,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,10875,,CHEMBL626753,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,10876,,CHEMBL626754,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,10877,,CHEMBL626755,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,10878,,CHEMBL626756,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,10879,,CHEMBL626757,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,10880,,CHEMBL626758,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,10881,,CHEMBL626759,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,10882,,CHEMBL626760,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),10883,,CHEMBL626394,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,10884,,CHEMBL626395,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),10885,,CHEMBL626396,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),10886,,CHEMBL626397,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),10887,,CHEMBL626398,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),10888,,CHEMBL626399,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,10889,,CHEMBL874653,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10890,,CHEMBL626400,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),10891,,CHEMBL626401,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),10892,,CHEMBL626402,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),10893,,CHEMBL626403,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10894,,CHEMBL626404,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,10895,,CHEMBL626405,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10896,,CHEMBL625529,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),10897,,CHEMBL625530,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),10898,,CHEMBL625531,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),10899,,CHEMBL625532,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10900,,CHEMBL625533,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,10901,,CHEMBL875474,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10902,,CHEMBL625534,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),10903,,CHEMBL625535,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),10904,,CHEMBL625536,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),10905,,CHEMBL625537,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10906,,CHEMBL625538,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,10907,,CHEMBL625539,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10908,,CHEMBL625540,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),10909,,CHEMBL625541,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),10910,,CHEMBL625542,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),10911,,CHEMBL625543,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10912,,CHEMBL625544,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,10913,,CHEMBL625545,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),10914,,CHEMBL625546,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,10915,,CHEMBL625547,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),10916,,CHEMBL625548,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),10917,,CHEMBL625549,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),10918,,CHEMBL625550,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),10919,,CHEMBL625551,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),10920,,CHEMBL875475,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),10921,,CHEMBL625552,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),10922,,CHEMBL625553,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),10923,,CHEMBL625554,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),10924,,CHEMBL625555,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),10925,,CHEMBL625556,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,10926,,CHEMBL624986,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),10927,,CHEMBL624987,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),10928,,CHEMBL624988,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,10929,,CHEMBL624989,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,10930,,CHEMBL624990,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,10931,,CHEMBL874391,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,10932,,CHEMBL624991,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,10933,,CHEMBL624992,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,10934,,CHEMBL624993,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,10935,,CHEMBL624994,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,10936,,CHEMBL624995,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,10937,,CHEMBL624996,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,10938,,CHEMBL624997,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,10939,,CHEMBL624998,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,10940,,CHEMBL624999,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,10941,,CHEMBL882955,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,10942,,CHEMBL625000,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,10943,,CHEMBL625001,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,10944,,CHEMBL625089,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,10945,,CHEMBL625090,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,10946,,CHEMBL625091,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,10947,,CHEMBL625092,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,10948,,CHEMBL625093,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,10949,,CHEMBL625094,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,10950,,CHEMBL625095,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Compound was evaluated for its bioavailability in the dogs,10951,,CHEMBL625096,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,2249,,
Compound was evaluated for its bioavailability in the rats,10952,,CHEMBL625097,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2249,,
Compound was evaluated for oral bioavailability,10953,,CHEMBL882956,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,17515,,
Compound was evaluated for percentage of Oral bioavailability in rats,10954,,CHEMBL625098,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14541,,
Bioavailability in guinea pig,10955,,CHEMBL625099,22224,BAO_0000218,,,In vivo,1,,,Cavia porcellus,,10141.0,0,Autocuration,U,A,,12797,,
Compound was evaluated for the oral bioavailability in rat,10956,,CHEMBL625100,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12797,,
Compound was evaluated for the oral bioavailability in dog,10957,,CHEMBL625101,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12797,,
Compound was evaluated for the oral bioavailability in rat,10958,,CHEMBL874396,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12797,,
Bioavailability in dog (dosed i.v.),10959,,CHEMBL625102,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,F,,11727,,
Compound was tested for in vivo bioavailability in dog,10960,,CHEMBL625103,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13249,,
Compound was tested for in vivo bioavailability in hamsters,10961,,CHEMBL625104,100712,BAO_0000218,,,In vivo,1,,,Cricetinae,,10026.0,1,Intermediate,N,A,,13249,,
Compound was tested for in vivo bioavailability in monkey,10962,,CHEMBL625105,22224,BAO_0000218,,,In vivo,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,13249,,
Compound was tested for in vivo bioavailability in rat,10963,,CHEMBL625106,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13249,,
Oral bioavailability in mouse,10964,,CHEMBL625107,22224,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,0,Autocuration,U,A,,9552,,
Compound was tested for percent of oral bioavailability in mice; 56-74,10965,,CHEMBL625108,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,9552,,
Oral bioavailability in mouse (nude) (dose of 25 mg/kg),10966,,CHEMBL625109,22224,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,0,Autocuration,U,A,,14839,,
Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),10967,,CHEMBL625110,22224,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,0,Autocuration,U,A,,14839,,
Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),10968,,CHEMBL625111,22224,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,0,Autocuration,U,A,,14839,,
Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),10969,,CHEMBL625112,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
Oral bioavailability in nude mice,10970,,CHEMBL875334,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
Bioavailability in monkey (i.d. dosing),10971,,CHEMBL628617,22224,BAO_0000218,,,In vivo,1,,,Primates,,9443.0,0,Autocuration,U,A,,11219,,
Bioavailability in rat,10972,,CHEMBL628618,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,9552,,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,10973,,CHEMBL628619,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11732,,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,10974,,CHEMBL628620,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11732,,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",10975,,CHEMBL628621,100710,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",10976,,CHEMBL628622,100710,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",10977,,CHEMBL628623,100710,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14839,,
Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,10978,,CHEMBL628624,100710,BAO_0000218,,,In vivo,1,,1969.0,Macaca fascicularis,,9541.0,1,Intermediate,N,A,Plasma,14839,,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10979,,CHEMBL628625,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,14839,,
Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,10980,,CHEMBL628626,100710,BAO_0000218,,,In vivo,1,,1969.0,Macaca fascicularis,,9541.0,1,Intermediate,N,A,Plasma,14839,,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10981,,CHEMBL627041,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,14839,,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10982,,CHEMBL627042,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,14839,,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10983,,CHEMBL627043,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,14839,,
In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,10984,,CHEMBL627044,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,13932,,
Cmax in mouse plasma,10985,,CHEMBL627045,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,11637,,
Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,10986,,CHEMBL627046,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,11637,,
Maximal plasma concentration in rat,10987,,CHEMBL627047,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13960,,
Maximal plasma level when administered 1 mg/kg perorally (po) in rat,10988,,CHEMBL627048,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15905,,
Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,10989,,CHEMBL627049,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14062,,
Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,10990,,CHEMBL627050,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14062,,
Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,10991,,CHEMBL627051,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14062,,
Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,10992,,CHEMBL627052,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14062,,
Maximum concentration at an peroral dose of 6.2 mg/kg in rat,10993,,CHEMBL627053,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14062,,
Maximum concentration at an peroral dose of 6.3 mg/kg in rat,10994,,CHEMBL627054,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14062,,
Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,10995,,CHEMBL627055,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,10996,,CHEMBL627056,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),10997,,CHEMBL627057,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,10998,,CHEMBL627058,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,10999,,CHEMBL626211,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Maximum Concentration of the compound.,11000,,CHEMBL626212,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,10291,,
Maximum Concentration was measured after iv administration into Beagle dog,11001,,CHEMBL626213,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14599,,
Maximum Concentration was measured after iv administration into Beagle dog.,11002,,CHEMBL626214,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14599,,
Maximum Concentration was measured after po administration into Beagle dog,11003,,CHEMBL626215,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14599,,
Maximum Concentration was measured after po administration into Beagle dog.,11004,,CHEMBL626216,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14599,,
Maximum blood level reached after an dose of 10.6 uM/kg intravenously,11005,,CHEMBL626217,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,12767,,
Maximum blood level reached after an iv dose of 12.2 uM/kg,11006,,CHEMBL626218,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,12767,,
Maximum blood level reached after an oral dose 14.7 uM/kg oral route,11007,,CHEMBL626219,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,12767,,
Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,11008,,CHEMBL626220,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,12767,,
Maximum blood level reached after an oral dose of 5.0 mg/kg,11009,,CHEMBL626221,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,12767,,
Maximum blood level reached at dose of 10.6 uM/kg orally,11010,,CHEMBL626222,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,12767,,
Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,11011,,CHEMBL626223,50512,BAO_0000218,,,In vivo,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,14706,,
Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,11012,,CHEMBL626224,50512,BAO_0000218,,,In vivo,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,14706,,
Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,11013,,CHEMBL626225,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,14793,,
Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,11014,,CHEMBL626226,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,14793,,
Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,11015,,CHEMBL626227,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,14793,,
Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,11016,,CHEMBL626228,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,14793,,
Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,11017,,CHEMBL626229,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,11018,,CHEMBL626921,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,11019,,CHEMBL876793,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,11020,,CHEMBL625309,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14793,,
Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),11021,,CHEMBL625310,50278,BAO_0000218,,,In vivo,1,,,Bacillus subtilis,,1423.0,1,Intermediate,N,A,,10524,,
Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,11022,,CHEMBL625311,22224,BAO_0000218,,,In vivo,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,11871,,
Maximum concentration determined in rats dosed intravenously with 20 mg/kg,11023,,CHEMBL625312,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11871,,
Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,11024,,CHEMBL625313,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,3437,,
Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,11025,,CHEMBL625314,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12038,,
Maximum concentration in male rats after iv administration of 20 mg/kg,11026,,CHEMBL625315,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12038,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,11027,,CHEMBL625316,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,11028,,CHEMBL625317,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,11029,,CHEMBL625318,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,11030,,CHEMBL625319,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,11031,,CHEMBL625320,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,11032,,CHEMBL625321,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,11033,,CHEMBL625322,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,11034,,CHEMBL876801,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,11035,,CHEMBL625323,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,11036,,CHEMBL625324,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,11037,,CHEMBL625325,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,11038,,CHEMBL625326,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,11039,,CHEMBL625327,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,11040,,CHEMBL625328,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,11041,,CHEMBL625329,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,11042,,CHEMBL625330,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,11043,,CHEMBL627774,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,11044,,CHEMBL627775,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,11045,,CHEMBL627949,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,11046,,CHEMBL627950,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,11047,,CHEMBL627951,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,11048,,CHEMBL627952,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,11049,,CHEMBL627953,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,11050,,CHEMBL627954,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,11051,,CHEMBL627955,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,11052,,CHEMBL627956,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,11053,,CHEMBL876802,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,11054,,CHEMBL627957,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,11055,,CHEMBL627958,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,11056,,CHEMBL627959,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,11057,,CHEMBL627960,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,11058,,CHEMBL627961,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,11059,,CHEMBL627962,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8418,,
Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11060,,CHEMBL627963,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9796,,
Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,11061,,CHEMBL624759,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9796,,
Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11062,,CHEMBL624760,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9796,,
Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11063,,CHEMBL624761,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9796,,
Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11064,,CHEMBL877607,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9796,,
Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11065,,CHEMBL624762,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9796,,
Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,11066,,CHEMBL624763,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9796,,
Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11067,,CHEMBL624764,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9796,,
Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11068,,CHEMBL624765,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9796,,
Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11069,,CHEMBL624766,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9796,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),11070,,CHEMBL624767,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,11071,,CHEMBL624768,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),11072,,CHEMBL624769,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),11073,,CHEMBL624770,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),11074,,CHEMBL624771,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),11075,,CHEMBL624772,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,11076,,CHEMBL624773,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),11077,,CHEMBL624774,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),11078,,CHEMBL624775,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),11079,,CHEMBL624776,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),11080,,CHEMBL624777,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),11081,,CHEMBL624778,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,11082,,CHEMBL624779,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),11083,,CHEMBL624780,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),11084,,CHEMBL624781,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),11085,,CHEMBL877608,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),11086,,CHEMBL624782,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),11087,,CHEMBL624783,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,11088,,CHEMBL624784,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),11089,,CHEMBL624785,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),11090,,CHEMBL624786,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),11091,,CHEMBL624787,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),11092,,CHEMBL628676,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,11093,,CHEMBL621842,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),11094,,CHEMBL621843,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),11095,,CHEMBL623873,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),11096,,CHEMBL623874,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),11097,,CHEMBL623875,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),11098,,CHEMBL623876,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,11099,,CHEMBL623877,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),11100,,CHEMBL623878,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,11101,,CHEMBL623879,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),11102,,CHEMBL623880,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),11103,,CHEMBL623881,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),11104,,CHEMBL623957,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),11105,,CHEMBL623958,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),11106,,CHEMBL623959,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),11107,,CHEMBL623960,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),11108,,CHEMBL623961,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),11109,,CHEMBL623962,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),11110,,CHEMBL624676,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),11111,,CHEMBL624677,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,11112,,CHEMBL624678,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),11113,,CHEMBL624679,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),11114,,CHEMBL624680,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,11115,,CHEMBL624849,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11732,,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,11116,,CHEMBL624850,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11732,,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,11117,,CHEMBL874399,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11732,,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,11118,,CHEMBL624851,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11732,,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,11119,,CHEMBL624852,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11732,,
Oral bioavailability in rat (dose 10 mg/kg),11120,,CHEMBL624853,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,13359,,
Oral bioavailability in rat (Sprague-Dawley),11121,,CHEMBL624854,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,16618,,
Oral bioavailability in rat,11122,,CHEMBL624855,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,13960,,
Oral bioavailability in rats was determined in vivo,11123,,CHEMBL624856,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,13917,,
Oral bioavailability in dog,11124,,CHEMBL882957,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,,14266,,
Oral bioavailability of compound in monkey,11125,,CHEMBL624857,22224,BAO_0000218,,,In vivo,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12359,,
Oral bioavailability of compound in rat,11126,,CHEMBL622202,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12359,,
Bioavailability in rat of PMEA prodrug,11127,,CHEMBL622203,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,12359,,
Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,11128,,CHEMBL625522,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12359,,
Serum conc at 3 hours following 25 mg/kg dose,11129,,CHEMBL622868,22224,BAO_0000218,,,In vivo,1,,,Macaca mulatta,,9544.0,0,Autocuration,U,A,,10791,,
Urine conc 0-5 hours following 25 mg/kg dose,11130,,CHEMBL622869,22224,BAO_0000218,,,In vivo,1,,1088.0,Macaca mulatta,,9544.0,0,Autocuration,U,A,Urine,10791,,
Urine conc 0-24 hours following 25 mg/kg dose,11131,,CHEMBL622870,22224,BAO_0000218,,,In vivo,1,,1088.0,Macaca mulatta,,9544.0,0,Autocuration,U,A,Urine,10791,,
Oral bioavailability in African green monkeys; 20-25,11132,,CHEMBL622871,22224,BAO_0000218,,,In vivo,1,,,Chlorocebus aethiops,,9534.0,0,Autocuration,U,A,,138,,
Oral bioavailability in cynomolgus monkey.,11133,,CHEMBL620560,100710,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14521,,
Oral bioavailability in dog,11134,,CHEMBL620561,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,,13953,,
Oral bioavailability in dog at 10 mg/kg oral dose,11135,,CHEMBL620562,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12836,,
Oral bioavailability in hamster at 10 mg/kg oral dose,11136,,CHEMBL620563,100712,BAO_0000218,,,In vivo,1,,,Cricetinae,,10026.0,1,Intermediate,N,A,,12836,,
Oral bioavailability in rat at 10 mg/kg oral dose,11137,,CHEMBL620564,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12836,,
Oral bioavailability in rat,11138,,CHEMBL872265,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,14521,,
Oral bioavailability in rat,11139,,CHEMBL620565,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,13953,,
Oral bioavailability,11140,,CHEMBL620566,22224,BAO_0000218,,,In vivo,1,,,Eutheria,,9347.0,0,Autocuration,U,A,,6799,,
Oral bioavailability was determined; range 49-102%,11141,,CHEMBL620567,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11311,,
Oral bioavailability was determined in dogs,11142,,CHEMBL620568,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,4013,,
Oral bioavailability in rat,11143,,CHEMBL620569,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,4013,,
Oral bioavailability,11144,,CHEMBL620570,22224,BAO_0000218,,,In vivo,1,,,Eutheria,,9347.0,0,Autocuration,U,A,,17591,,
Oral bioavailability was determined; Not orally available,11145,,CHEMBL620571,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,17591,,
Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),11146,,CHEMBL620572,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15011,,
Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),11147,,CHEMBL620573,22224,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,0,Autocuration,U,A,,15011,,
Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,11148,,CHEMBL620574,22224,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,0,Autocuration,U,A,,15011,,
Oral bioavailability in Rhesus monkey,11149,,CHEMBL620575,22224,BAO_0000218,,,In vivo,1,,,Macaca mulatta,,9544.0,0,Autocuration,U,A,,9552,,
Oral bioavailability in dog (female mongrel),11150,,CHEMBL620576,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,,9552,,
Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,11151,,CHEMBL875846,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,3639,,
Oral bioavailability in dog,11152,,CHEMBL620577,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,,13397,,
Percentage Bioavailability was evaluated.,11153,,CHEMBL620578,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,3031,,
Bioavailability in rat administered i.d.,11154,,CHEMBL620579,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,12818,,
Bioavailability,11155,,CHEMBL621248,22224,BAO_0000218,,,In vivo,1,,,Eutheria,,9347.0,0,Autocuration,U,A,,4847,,
Bioavailability in dog (male Beagle) i.v. administration,11156,,CHEMBL625390,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,,12421,,
"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",11157,,CHEMBL625391,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,11966,,
Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),11158,,CHEMBL872266,22224,BAO_0000218,,,In vivo,1,,,Primates,,9443.0,0,Autocuration,U,A,,11218,,
Oral bioavailability in rat (Sprague-Dawley) (male),11159,,CHEMBL625392,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,13129,,
The oral bioavailability was measured on rats after oral administration,11160,,CHEMBL625393,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12350,,
Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,11161,,CHEMBL625394,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2231,,
Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,11162,,CHEMBL625395,50797,BAO_0000218,,,In vivo,1,,,Macaca mulatta,,9544.0,1,Intermediate,N,A,,2231,,
Bioavailability in rat (dose 10 mg/kg i.d.),11163,,CHEMBL625396,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,12187,,
Bioavailability in dog (male Beagle) i.v. administration,11164,,CHEMBL625397,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,,12421,,
Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),11165,,CHEMBL625398,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),11166,,CHEMBL625399,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,13256,,
Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),11167,,CHEMBL626074,50594,BAO_0000218,,,In vivo,1,,2037.0,Mus musculus,,10090.0,1,Intermediate,N,A,Cerebellum,13256,,
Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),11168,,CHEMBL626075,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,11169,,CHEMBL626076,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2231,,
Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,11170,,CHEMBL626077,50797,BAO_0000218,,,In vivo,1,,1969.0,Macaca mulatta,,9544.0,1,Intermediate,N,A,Plasma,2231,,
Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),11171,,CHEMBL626078,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12178,,
Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),11172,,CHEMBL625846,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,12178,,
Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),11173,,CHEMBL625847,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,12178,,
Maximum concentration observed in rats at an oral dose of 50 mg/kg,11174,,CHEMBL625848,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Expert,N,A,,15633,,
Maximum concentration of compound in plasma administered orally to rats,11175,,CHEMBL625849,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14258,,
"Maximum concentration (10 mg/kg, orally) in plasma of dogs",11176,,CHEMBL626023,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14224,,
"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",11177,,CHEMBL626024,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14224,,
"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",11178,,CHEMBL626025,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14224,,
Maximum concentration after 10 mg/kg by oral administration,11179,,CHEMBL626026,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,5566,,
Maximum concentration at a dose of 1.5 mg/kg,11180,,CHEMBL626027,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,16935,,
Maximum concentration at a dose of 2.0 mg/kg,11181,,CHEMBL626028,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,16935,,
Maximum concentration in dog plasma,11182,,CHEMBL626029,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14224,,
Maximum concentration in plasma after administration of 10 umol/kg dose perorally,11183,,CHEMBL626030,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,12536,,
Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,11184,,CHEMBL626031,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,12536,,
Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,11185,,CHEMBL626032,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,12536,,
Maximum concentration in plasma after administration of 40 umol/kg dose perorally,11186,,CHEMBL626033,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,12536,,
Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,11187,,CHEMBL626034,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,12536,,
Maximum concentration in plasma after oral administration in dog (25 mg/kg),11188,,CHEMBL626035,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,9994,,
Maximum concentration in plasma at Tmax,11189,,CHEMBL626036,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,1434,,
Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,11190,,CHEMBL626037,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Expert,N,A,Plasma,12836,,
Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,11191,,CHEMBL626038,100712,BAO_0000218,,,In vivo,1,,1969.0,Cricetinae,,10026.0,1,Intermediate,N,A,Plasma,12836,,
Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,11192,,CHEMBL626039,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12836,,
Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,11193,,CHEMBL626040,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12545,,
Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,11194,,CHEMBL626041,50592,BAO_0000218,,,In vivo,1,,1969.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Plasma,13856,,
Maximum concentration was calculated,11195,,CHEMBL626042,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,3550,,
Maximum concentration was calculated.,11196,,CHEMBL626043,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,2632,,
Maximum concentration at a peroral dose of 10 mg/kg,11197,,CHEMBL626044,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,5566,,
Maximum concentration of the drug at 10 uM/dg administered perorally,11198,,CHEMBL626045,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11883,,
Maximum concentration of the drug at 2 uM/dg administered intravenously,11199,,CHEMBL626046,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11883,,
"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",11200,,CHEMBL626047,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14122,,
"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",11201,,CHEMBL626048,100712,BAO_0000218,,,In vivo,1,,1969.0,Cricetinae,,10026.0,1,Intermediate,N,A,Plasma,14122,,
"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",11202,,CHEMBL626049,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14122,,
Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,11203,,CHEMBL626050,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12542,,
Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,11204,,CHEMBL874541,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,12542,,
Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,11205,,CHEMBL622826,100712,BAO_0000218,,,In vivo,1,,1969.0,Cricetinae,,10026.0,1,Intermediate,N,A,Plasma,12542,,
Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,11206,,CHEMBL622827,100712,BAO_0000218,,,In vivo,1,,1969.0,Cricetinae,,10026.0,1,Intermediate,N,A,Plasma,12542,,
Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,11207,,CHEMBL622828,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12542,,
Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,11208,,CHEMBL622829,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14080,,
Maximum concentration reached following intravenous administration in male rat,11209,,CHEMBL876806,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11911,,
Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,11210,,CHEMBL622830,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13204,,
Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,11211,,CHEMBL622831,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13204,,
Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,11212,,CHEMBL626794,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14346,,
Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,11213,,CHEMBL626795,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,11214,,CHEMBL626796,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,11215,,CHEMBL626797,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14346,,
Maximum drug concentration is determined after oral dosing in rats.,11216,,CHEMBL626798,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14127,,
Maximum observed concentration in oral (5 mg/kg) fasted dogs,11217,,CHEMBL626799,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14339,,
Maximum observed concentration in oral (5 mg/kg) fed dogs,11218,,CHEMBL626800,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14339,,
Maximum plasma concentration,11219,,CHEMBL626801,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,13494,,
Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,11220,,CHEMBL876816,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14925,,
Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,11221,,CHEMBL626802,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14474,,
Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,11222,,CHEMBL626803,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14474,,
Maximum plasma concentration following oral administration of 30 umol/kg,11223,,CHEMBL626804,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,13917,,
Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,11224,,CHEMBL626805,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,9796,,
Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11225,,CHEMBL626309,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,9796,,
Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11226,,CHEMBL626310,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,9796,,
Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11227,,CHEMBL626311,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,9796,,
Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11228,,CHEMBL626312,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,9796,,
Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,11229,,CHEMBL626313,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,9796,,
Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11230,,CHEMBL626314,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,9796,,
Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11231,,CHEMBL626315,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,9796,,
Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11232,,CHEMBL626316,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,9796,,
Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11233,,CHEMBL626317,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,9796,,
Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),11234,,CHEMBL626318,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),11235,,CHEMBL626319,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),11236,,CHEMBL626320,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),11237,,CHEMBL875053,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),11238,,CHEMBL626321,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),11239,,CHEMBL626322,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),11240,,CHEMBL626323,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),11241,,CHEMBL626324,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),11242,,CHEMBL626325,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),11243,,CHEMBL626326,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),11244,,CHEMBL626327,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),11245,,CHEMBL626328,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8363,,
"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",11246,,CHEMBL626329,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8684,,
"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",11247,,CHEMBL626330,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8684,,
"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",11248,,CHEMBL626331,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8684,,
"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",11249,,CHEMBL626332,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8684,,
"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",11250,,CHEMBL626333,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8684,,
"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",11251,,CHEMBL626334,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8684,,
"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",11252,,CHEMBL626335,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8684,,
"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",11253,,CHEMBL624798,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8684,,
"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",11254,,CHEMBL624799,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8684,,
"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",11255,,CHEMBL624800,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8684,,
"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",11256,,CHEMBL624801,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8684,,
"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",11257,,CHEMBL624802,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8684,,
"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",11258,,CHEMBL624803,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8684,,
"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",11259,,CHEMBL624804,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8684,,
"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",11260,,CHEMBL624805,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8684,,
"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",11261,,CHEMBL624806,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,8684,,
"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",11262,,CHEMBL624807,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",11263,,CHEMBL624808,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",11264,,CHEMBL624809,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",11265,,CHEMBL624810,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",11266,,CHEMBL877618,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",11267,,CHEMBL624811,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",11268,,CHEMBL624812,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",11269,,CHEMBL624813,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",11270,,CHEMBL624814,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",11271,,CHEMBL624815,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",11272,,CHEMBL624816,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",11273,,CHEMBL624817,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),11274,,CHEMBL624818,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,11275,,CHEMBL624819,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),11276,,CHEMBL624820,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),11277,,CHEMBL624821,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),11278,,CHEMBL624822,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),11279,,CHEMBL624823,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Observed diffusion coefficient in organic solvent for Escherichia coli,11280,,CHEMBL624824,50212,BAO_0000218,,,,1,,,Escherichia coli,,562.0,1,Intermediate,N,A,,15599,,
"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11281,,CHEMBL624825,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9614,,
"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11282,,CHEMBL624826,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9614,,
"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11283,,CHEMBL876817,50597,BAO_0000218,,,,1,,2081.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cardiac atrium,9614,,
"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11284,,CHEMBL624827,50597,BAO_0000218,,,,1,,2081.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cardiac atrium,9614,,
"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11285,,CHEMBL624828,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9614,,
"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11286,,CHEMBL624829,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9614,,
"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11287,,CHEMBL624830,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9614,,
"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11288,,CHEMBL624831,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9614,,
"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11289,,CHEMBL624832,50597,BAO_0000218,,,,1,,2081.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cardiac atrium,9614,,
"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11290,,CHEMBL624833,50597,BAO_0000218,,,,1,,2081.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cardiac atrium,9614,,
"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11291,,CHEMBL624834,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9614,,
"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11292,,CHEMBL624835,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9614,,
"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11293,,CHEMBL624836,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9614,,
"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11294,,CHEMBL624837,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,9614,,
Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,11295,,CHEMBL624838,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9071,,
Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,11296,,CHEMBL622188,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9071,,
Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,11297,,CHEMBL622189,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9071,,
Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,11298,,CHEMBL622190,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9071,,
Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,11299,,CHEMBL625170,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9071,,
Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,11300,,CHEMBL625171,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9071,,
Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,11301,,CHEMBL625172,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9071,,
Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,11302,,CHEMBL625173,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,9071,,
Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,11303,,CHEMBL625174,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9071,,
Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,11304,,CHEMBL625175,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9071,,
Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,11305,,CHEMBL625176,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9071,,
Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,11306,,CHEMBL625177,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,9071,,
Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,11307,,CHEMBL625178,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,9071,,
Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,11308,,CHEMBL625179,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,9071,,
Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,11309,,CHEMBL625180,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,9071,,
"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",11310,,CHEMBL625181,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,10677,,
Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,11311,,CHEMBL625182,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,9750,,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11312,,CHEMBL625183,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,11313,,CHEMBL875848,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11314,,CHEMBL622260,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,11315,,CHEMBL622261,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11316,,CHEMBL622262,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,11317,,CHEMBL622263,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8319,,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11318,,CHEMBL622418,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8319,,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,11319,,CHEMBL622419,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8319,,
Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),11320,,CHEMBL623388,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),11321,,CHEMBL623389,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,13256,,
Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),11322,,CHEMBL623390,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),11323,,CHEMBL623391,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),11324,,CHEMBL623392,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,13256,,
Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),11325,,CHEMBL623393,50594,BAO_0000218,,,In vivo,1,,2037.0,Mus musculus,,10090.0,1,Intermediate,N,A,Cerebellum,13256,,
Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),11326,,CHEMBL623394,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),11327,,CHEMBL618885,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),11328,,CHEMBL618886,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,13256,,
Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),11329,,CHEMBL618887,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),11330,,CHEMBL619535,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),11331,,CHEMBL619536,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,13256,,
Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),11332,,CHEMBL619537,50594,BAO_0000218,,,In vivo,1,,2037.0,Mus musculus,,10090.0,1,Intermediate,N,A,Cerebellum,13256,,
Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),11333,,CHEMBL619705,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),11334,,CHEMBL619706,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),11335,,CHEMBL619707,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,13256,,
Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),11336,,CHEMBL619708,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),11337,,CHEMBL625219,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),11338,,CHEMBL625220,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,13256,,
Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),11339,,CHEMBL625221,50594,BAO_0000218,,,In vivo,1,,2037.0,Mus musculus,,10090.0,1,Intermediate,N,A,Cerebellum,13256,,
Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),11340,,CHEMBL625222,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),11341,,CHEMBL625223,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),11342,,CHEMBL625224,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,13256,,
Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),11343,,CHEMBL625225,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13256,,
Biodistribution in Rat blood after 24 hours of iv administration,11344,,CHEMBL625226,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8829,,
Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,11345,,CHEMBL625227,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8829,,
Biodistribution in Rat blood after 30 minutes of iv administration,11346,,CHEMBL625228,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8829,,
Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,11347,,CHEMBL875354,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8829,,
Biodistribution in Rat blood after 5 minutes of iv administration,11348,,CHEMBL625229,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8829,,
Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,11349,,CHEMBL625230,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8829,,
Biodistribution in Rat heart after 24 hours of iv administration,11350,,CHEMBL625231,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8829,,
Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,11351,,CHEMBL625900,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8829,,
Biodistribution in Rat heart after 30 minutes of iv administration,11352,,CHEMBL625901,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8829,,
Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,11353,,CHEMBL625902,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8829,,
Biodistribution in Rat heart after 5 minutes of iv administration,11354,,CHEMBL625903,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8829,,
Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,11355,,CHEMBL625904,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8829,,
Biodistribution in Rat liver after 24 hours of iv administration,11356,,CHEMBL625905,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8829,,
Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,11357,,CHEMBL627861,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8829,,
Biodistribution in Rat liver after 30 minutes of iv administration,11358,,CHEMBL627862,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8829,,
Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,11359,,CHEMBL627863,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8829,,
Biodistribution in Rat liver after 30 minutes of iv administration,11360,,CHEMBL627769,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8829,,
Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,11361,,CHEMBL627770,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,13249,,
Cmax in cynomolgus monkey (PO dose),11362,,CHEMBL627771,100710,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,13622,,
Cmax in rat (PO dose),11363,,CHEMBL627772,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13622,,
Cmax in rat (PO dose),11364,,CHEMBL627773,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13622,,
Maximum plasma concentration in rats after an oral dose of 5 mg/kg,11365,,CHEMBL621922,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13494,,
Cmax in rat plasma after oral dose (10 mg/kg),11366,,CHEMBL621923,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12170,,
Cmax in plasma after oral dose (10 mg/kg),11367,,CHEMBL621924,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,12170,,
Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,11368,,CHEMBL621925,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,17025,,
Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,11369,,CHEMBL621926,22224,BAO_0000218,,,In vivo,1,,1969.0,Simiiformes,,314293.0,0,Autocuration,U,A,Plasma,17025,,
Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,11370,,CHEMBL621927,50592,BAO_0000218,,,In vivo,1,,1969.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Plasma,17025,,
Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,11371,,CHEMBL621928,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17025,,
Maximum plasma concentration after p.o. (10 mpk) administration in rats.,11372,,CHEMBL621929,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14187,,
Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,11373,,CHEMBL621930,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,14816,,
Maximum plasma concentration after oral dosing in rat,11374,,CHEMBL621931,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17820,,
Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,11375,,CHEMBL621932,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14380,,
Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,11376,,CHEMBL621933,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14380,,
Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,11377,,CHEMBL621934,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14691,,
Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,11378,,CHEMBL621935,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14691,,
Maximum plasma concentration in rat upon oral administration of 40 mg/kg,11379,,CHEMBL621936,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13375,,
Maximum plasma concentration was determined,11380,,CHEMBL621937,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,6236,,
Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11381,,CHEMBL621938,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14380,,
Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11382,,CHEMBL621939,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14380,,
Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,11383,,CHEMBL621940,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14380,,
Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,11384,,CHEMBL621941,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14380,,
Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,11385,,CHEMBL621942,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14380,,
Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,11386,,CHEMBL626178,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14380,,
Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,11387,,CHEMBL626179,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14380,,
Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,11388,,CHEMBL626180,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14380,,
Plasma Cmax in rat (PO dose),11389,,CHEMBL626181,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13622,,
Maximum serum concentration after po dose of 5.22 mg/kg in rats,11390,,CHEMBL626182,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Maximum serum concentration after po dose of 5.46 mg/kg in rats,11391,,CHEMBL626183,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,11392,,CHEMBL626184,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,11393,,CHEMBL626185,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15372,,
Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,11394,,CHEMBL626186,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14925,,
Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,11395,,CHEMBL877589,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14925,,
Maximum concentration of the drug at 1 uM/dg administered intravenously,11396,,CHEMBL626187,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11883,,
Maximum concentration of the drug at 20 uM/dg administered perorally,11397,,CHEMBL626188,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11883,,
Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,11398,,CHEMBL626189,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13391,,
Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,11399,,CHEMBL626855,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,13391,,
Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,11400,,CHEMBL623781,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,13391,,
Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,11401,,CHEMBL623782,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,13391,,
Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,11402,,CHEMBL623783,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16360,,
Cmax in dog plasma after 1mg/kg oral dose,11403,,CHEMBL623784,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,3673,,
Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,11404,,CHEMBL623785,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14431,,
Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,11405,,CHEMBL623786,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14431,,
Oral maximum concentration in rat,11406,,CHEMBL623787,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14964,,
Oral maximum concentration in rat,11407,,CHEMBL623788,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14964,,
Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,11408,,CHEMBL623789,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,14209,,
Peak concentration in blood after intravenous administration to mice,11409,,CHEMBL623790,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,11355,,
Peak concentration in blood after peroral administration to mice,11410,,CHEMBL623791,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,11355,,
Peak concentration in rat plasma was determined,11411,,CHEMBL623792,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,11966,,
Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,11412,,CHEMBL623793,22224,BAO_0000218,,,In vivo,1,,1969.0,Simiiformes,,314293.0,0,Autocuration,U,A,Plasma,8918,,
Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,11413,,CHEMBL623794,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,8918,,
Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,11414,,CHEMBL623795,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,8918,,
"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",11415,,CHEMBL623796,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",11416,,CHEMBL623797,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",11417,,CHEMBL623798,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",11418,,CHEMBL623799,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",11419,,CHEMBL624490,50597,BAO_0000218,,,,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8684,,
"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",11420,,CHEMBL624491,50597,BAO_0000218,,,,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8684,,
"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",11421,,CHEMBL624492,50597,BAO_0000218,,,,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8684,,
"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",11422,,CHEMBL624493,50597,BAO_0000218,,,,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8684,,
"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",11423,,CHEMBL877595,50597,BAO_0000218,,,,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8684,,
"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",11424,,CHEMBL624494,50597,BAO_0000218,,,,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8684,,
"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",11425,,CHEMBL624495,50597,BAO_0000218,,,,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8684,,
"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",11426,,CHEMBL624681,50597,BAO_0000218,,,,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,8684,,
"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",11427,,CHEMBL624682,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",11428,,CHEMBL624683,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",11429,,CHEMBL624684,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",11430,,CHEMBL624685,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",11431,,CHEMBL624686,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",11432,,CHEMBL624687,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",11433,,CHEMBL624688,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",11434,,CHEMBL627161,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",11435,,CHEMBL622127,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",11436,,CHEMBL622128,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",11437,,CHEMBL874384,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",11438,,CHEMBL624898,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",11439,,CHEMBL624899,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",11440,,CHEMBL624900,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",11441,,CHEMBL624901,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",11442,,CHEMBL624902,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",11443,,CHEMBL624903,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",11444,,CHEMBL624904,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",11445,,CHEMBL624905,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",11446,,CHEMBL624906,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",11447,,CHEMBL624907,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",11448,,CHEMBL624908,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",11449,,CHEMBL624909,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",11450,,CHEMBL624910,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",11451,,CHEMBL624911,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8684,,
"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",11452,,CHEMBL874388,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8684,,
"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",11453,,CHEMBL624912,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8684,,
"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",11454,,CHEMBL622930,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8684,,
"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",11455,,CHEMBL623121,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8684,,
"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",11456,,CHEMBL623122,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8684,,
"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",11457,,CHEMBL623123,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8684,,
"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",11458,,CHEMBL623124,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,8684,,
"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",11459,,CHEMBL623125,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",11460,,CHEMBL623126,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",11461,,CHEMBL623127,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",11462,,CHEMBL623128,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",11463,,CHEMBL623129,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",11464,,CHEMBL623130,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",11465,,CHEMBL623131,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",11466,,CHEMBL623132,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11467,,CHEMBL623133,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8319,,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11468,,CHEMBL623134,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11469,,CHEMBL874389,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,11470,,CHEMBL623135,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11471,,CHEMBL623136,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,11472,,CHEMBL623137,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11473,,CHEMBL623138,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,11474,,CHEMBL623139,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8319,,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11475,,CHEMBL623140,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8319,,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,11476,,CHEMBL623141,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8319,,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11477,,CHEMBL623142,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8319,,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11478,,CHEMBL623143,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,11479,,CHEMBL623144,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,14571,,
The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,11480,,CHEMBL623405,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,14571,,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11481,,CHEMBL624074,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,11482,,CHEMBL624075,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11483,,CHEMBL624076,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,11484,,CHEMBL624077,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11485,,CHEMBL624078,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,11486,,CHEMBL624079,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8319,,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11487,,CHEMBL624261,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8319,,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,11488,,CHEMBL624262,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11489,,CHEMBL624263,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11490,,CHEMBL624264,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11491,,CHEMBL624265,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,11492,,CHEMBL624266,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11493,,CHEMBL624267,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,11494,,CHEMBL624268,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11495,,CHEMBL875227,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,11496,,CHEMBL624269,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8319,,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11497,,CHEMBL624270,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8319,,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,11498,,CHEMBL624271,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11499,,CHEMBL624272,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11500,,CHEMBL624273,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8319,,
Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,11501,,CHEMBL624274,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12064,,
Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,11502,,CHEMBL624275,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12064,,
Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,11503,,CHEMBL624276,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12064,,
Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,11504,,CHEMBL624277,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12038,,
% dose converted to 2-amino-5-chlorophenyl sulfate,11505,,CHEMBL624278,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14314,,
% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),11506,,CHEMBL624279,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14314,,
"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",11507,,CHEMBL624280,50597,BAO_0000218,,,,1,,1988.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Feces,11488,,
"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",11508,,CHEMBL624281,50597,BAO_0000218,,,,1,,1988.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Feces,11488,,
"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",11509,,CHEMBL622933,50597,BAO_0000218,,,,1,,1988.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Feces,11488,,
"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",11510,,CHEMBL622934,50597,BAO_0000218,,,,1,,1988.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Feces,11488,,
Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,11511,,CHEMBL622935,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8829,,
Biodistribution in Rat liver after 5 minutes of iv administration,11512,,CHEMBL622936,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8829,,
Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,11513,,CHEMBL875228,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8829,,
Biodistribution in Rat lung after 24 hours of iv administration,11514,,CHEMBL622937,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8829,,
Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,11515,,CHEMBL622938,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8829,,
Biodistribution in Rat lung after 30 minutes of iv administration,11516,,CHEMBL619736,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8829,,
Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,11517,,CHEMBL625117,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8829,,
Biodistribution in Rat lung after 5 minutes of iv administration,11518,,CHEMBL625118,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8829,,
Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,11519,,CHEMBL625119,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8829,,
"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",11520,,CHEMBL625120,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,14972,,
"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",11521,,CHEMBL625121,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14972,,
"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",11522,,CHEMBL625122,50597,BAO_0000218,,,In vivo,1,,10000006.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thalamus,14972,,
Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,11523,,CHEMBL622204,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,14608,,
Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,11524,,CHEMBL877503,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,14608,,
Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,11525,,CHEMBL627127,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,14608,,
Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,11526,,CHEMBL627128,22224,BAO_0000218,,,In vivo,1,,10000000.0,,,,0,Autocuration,U,A,Hippocampus,14608,,
Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,11527,,CHEMBL627129,22224,BAO_0000218,,,In vivo,1,,10000000.0,,,,0,Autocuration,U,A,Hippocampus,14608,,
Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,11528,,CHEMBL627130,22224,BAO_0000218,,,In vivo,1,,10000000.0,,,,0,Autocuration,U,A,Hippocampus,14608,,
Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,11529,,CHEMBL627131,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,14608,,
Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,11530,,CHEMBL627132,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,14608,,
Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,11531,,CHEMBL627133,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,14608,,
Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,11532,,CHEMBL627134,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,14608,,
Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,11533,,CHEMBL627135,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,14608,,
Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,11534,,CHEMBL627136,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,14608,,
Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,11535,,CHEMBL628435,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14608,,
Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,11536,,CHEMBL628436,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14608,,
Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,11537,,CHEMBL628437,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14608,,
Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,11538,,CHEMBL628438,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,14608,,
Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,11539,,CHEMBL628439,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,14608,,
Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,11540,,CHEMBL628440,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,14608,,
Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,11541,,CHEMBL628441,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,14608,,
Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,11542,,CHEMBL628442,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,14608,,
Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,11543,,CHEMBL628443,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,14608,,
Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,11544,,CHEMBL628444,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,14608,,
Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,11545,,CHEMBL628445,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,14608,,
Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,11546,,CHEMBL877504,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,14608,,
Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,11547,,CHEMBL628446,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,14608,,
Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,11548,,CHEMBL626874,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,14608,,
Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,11549,,CHEMBL626875,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,14608,,
Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,11550,,CHEMBL626876,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,14608,,
Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,11551,,CHEMBL626877,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,14608,,
Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,11552,,CHEMBL626878,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,14608,,
Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,11553,,CHEMBL626879,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,14608,,
Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,11554,,CHEMBL626880,22224,BAO_0000218,,,In vivo,1,,1969.0,Simiiformes,,314293.0,0,Autocuration,U,A,Plasma,8918,,
Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,11555,,CHEMBL626881,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,8918,,
Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,11556,,CHEMBL626882,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,8918,,
Peak plasma concentration was measured in dogs,11557,,CHEMBL626883,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14470,,
Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,11558,,CHEMBL626884,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14393,,
Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,11559,,CHEMBL626885,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14886,,
Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,11560,,CHEMBL626886,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14886,,
Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,11561,,CHEMBL626887,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14886,,
Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,11562,,CHEMBL626888,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14393,,
Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,11563,,CHEMBL626889,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13465,,
Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,11564,,CHEMBL626761,22224,BAO_0000218,,,In vivo,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,13465,,
Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,11565,,CHEMBL626762,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13465,,
Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,11566,,CHEMBL626763,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13465,,
Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,11567,,CHEMBL626764,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13465,,
Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,11568,,CHEMBL626765,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13465,,
Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,11569,,CHEMBL626766,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13465,,
Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,11570,,CHEMBL626767,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13465,,
Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,11571,,CHEMBL626768,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13465,,
Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,11572,,CHEMBL626769,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13465,,
Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,11573,,CHEMBL874463,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13465,,
Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,11574,,CHEMBL626770,22224,BAO_0000218,,,In vivo,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,13465,,
Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,11575,,CHEMBL626771,22224,BAO_0000218,,,In vivo,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,13465,,
Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,11576,,CHEMBL626772,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13465,,
Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,11577,,CHEMBL626773,100710,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14731,,
Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,11578,,CHEMBL626774,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14731,,
Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,11579,,CHEMBL626775,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13376,,
Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,11580,,CHEMBL626776,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13376,,
Maximum concentration (Cmax) in rat when administered orally,11581,,CHEMBL626777,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14443,,
Maximal concentration in monkey plasma after 25 mg/kg oral dose,11582,,CHEMBL626778,22224,BAO_0000218,,,In vivo,1,,1969.0,Simiiformes,,314293.0,0,Autocuration,U,A,Plasma,13465,,
"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",11583,,CHEMBL626779,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,16359,,
"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",11584,,CHEMBL626780,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,16359,,
Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,11585,,CHEMBL626781,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,15618,,
Pharmacokinetic profile Cmax was evaluated in rats,11586,,CHEMBL632164,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14554,,
Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),11587,,CHEMBL632165,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,11537,,
Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),11588,,CHEMBL632166,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,11537,,
Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),11589,,CHEMBL632167,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,11537,,
Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),11590,,CHEMBL632168,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,11537,,
Cmax in rat plasma,11591,,CHEMBL632169,22224,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,0,Autocuration,U,A,Plasma,2021,,
Cmax in dog plasma after 30mg/kg oral dose,11592,,CHEMBL632170,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,5932,,
Cmax in rat plasma after 30mg/kg oral dose,11593,,CHEMBL632171,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5932,,
Plasma level in rats at 30 mg/kg,11594,,CHEMBL632172,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17320,,
Tested for maximum plasma concentration in mice,11595,,CHEMBL632173,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,15831,,
"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",11596,,CHEMBL632174,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
The Cmax values in female wistar rats.,11597,,CHEMBL632175,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14941,,
The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,11598,,CHEMBL632176,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,15343,,
The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,11599,,CHEMBL632177,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15343,,
The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,11600,,CHEMBL632178,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14856,,
The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,11601,,CHEMBL632179,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13129,,
The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,11602,,CHEMBL632180,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13098,,
The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,11603,,CHEMBL632181,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13098,,
The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,11604,,CHEMBL632182,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13098,,
The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,11605,,CHEMBL632183,22224,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,0,Autocuration,U,A,Blood,15478,,
The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,11606,,CHEMBL632184,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15341,,
The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,11607,,CHEMBL874470,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15341,,
"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",11608,,CHEMBL631302,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",11609,,CHEMBL631303,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",11610,,CHEMBL631304,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",11611,,CHEMBL631305,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",11612,,CHEMBL631306,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",11613,,CHEMBL631307,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",11614,,CHEMBL631308,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",11615,,CHEMBL625557,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8684,,
"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",11616,,CHEMBL625558,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8684,,
"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",11617,,CHEMBL625559,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8684,,
"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",11618,,CHEMBL625560,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8684,,
"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",11619,,CHEMBL625561,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8684,,
"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",11620,,CHEMBL625562,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8684,,
"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",11621,,CHEMBL875320,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8684,,
"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",11622,,CHEMBL625563,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8684,,
"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",11623,,CHEMBL625564,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,8684,,
"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",11624,,CHEMBL625565,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8684,,
"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",11625,,CHEMBL625566,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8684,,
"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",11626,,CHEMBL625567,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8684,,
"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",11627,,CHEMBL625568,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8684,,
"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",11628,,CHEMBL628217,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8684,,
"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",11629,,CHEMBL628218,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8684,,
"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",11630,,CHEMBL628219,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8684,,
"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",11631,,CHEMBL628220,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8684,,
Distribution in the blood after 120 min of intravenous administration,11632,,CHEMBL628221,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the blood after 15 min of intravenous administration,11633,,CHEMBL628222,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the blood after 30 min of intravenous administration,11634,,CHEMBL628223,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the blood after 5 min of intravenous administration,11635,,CHEMBL628224,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the blood after 60 min of intravenous administration,11636,,CHEMBL628225,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the blood after 90 min of intravenous administration,11637,,CHEMBL628226,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the bone after 120 min of intravenous administration,11638,,CHEMBL628227,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the bone after 15 min of intravenous administration,11639,,CHEMBL875481,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the bone after 30 min of intravenous administration,11640,,CHEMBL628228,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the bone after 5 min of intravenous administration,11641,,CHEMBL628229,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the bone after 60 min of intravenous administration,11642,,CHEMBL628230,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the bone after 90 min of intravenous administration,11643,,CHEMBL628231,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the heart after 120 min of intravenous administration,11644,,CHEMBL628232,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the heart after 15 min of intravenous administration,11645,,CHEMBL628233,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the heart after 30 min of intravenous administration,11646,,CHEMBL628234,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the heart after 5 min of intravenous administration,11647,,CHEMBL628235,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the heart after 60 min of intravenous administration,11648,,CHEMBL628236,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the heart after 90 min of intravenous administration,11649,,CHEMBL628237,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the kidneys after 120 min of intravenous administration,11650,,CHEMBL628238,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the kidneys after 15 min of intravenous administration,11651,,CHEMBL628239,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the kidneys after 30 min of intravenous administration,11652,,CHEMBL628240,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the kidneys after 5 min of intravenous administration,11653,,CHEMBL628241,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the kidneys after 60 min of intravenous administration,11654,,CHEMBL628242,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the kidneys after 90 min of intravenous administration,11655,,CHEMBL875482,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the liver after 120 min of intravenous administration,11656,,CHEMBL628243,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the liver after 15 min of intravenous administration,11657,,CHEMBL628244,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the liver after 30 min of intravenous administration,11658,,CHEMBL628245,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the liver after 5 min of intravenous administration,11659,,CHEMBL628246,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the liver after 60 min of intravenous administration,11660,,CHEMBL628247,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the liver after 90 min of intravenous administration,11661,,CHEMBL628248,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the lung after 120 min of intravenous administration,11662,,CHEMBL628249,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",11663,,CHEMBL625452,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",11664,,CHEMBL625453,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",11665,,CHEMBL625454,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",11666,,CHEMBL623844,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14839,,
Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,11667,,CHEMBL623845,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12178,,
Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,11668,,CHEMBL623846,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12178,,
Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,11669,,CHEMBL623847,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,12178,,
Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,11670,,CHEMBL623848,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,12186,,
Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,11671,,CHEMBL623849,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,12186,,
Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,11672,,CHEMBL623850,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,12186,,
Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,11673,,CHEMBL623851,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,12186,,
Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,11674,,CHEMBL623852,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12187,,
Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,11675,,CHEMBL624551,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,12187,,
"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",11676,,CHEMBL624552,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,12187,,
Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,11677,,CHEMBL624553,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12187,,
Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,11678,,CHEMBL624554,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12187,,
Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,11679,,CHEMBL624555,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12187,,
"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",11680,,CHEMBL624741,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12187,,
"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",11681,,CHEMBL624742,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14122,,
"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",11682,,CHEMBL624743,100712,BAO_0000218,,,,1,,,Cricetinae,,10026.0,1,Intermediate,N,A,,14122,,
"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",11683,,CHEMBL877606,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14122,,
Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,11684,,CHEMBL624744,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,13391,,
Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,11685,,CHEMBL624745,22224,BAO_0000218,,,,1,,178.0,,,,0,Autocuration,U,A,Blood,13391,,
Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,11686,,CHEMBL624746,22224,BAO_0000218,,,,1,,178.0,,,,0,Autocuration,U,A,Blood,13391,,
Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,11687,,CHEMBL624747,22224,BAO_0000218,,,,1,,178.0,,,,0,Autocuration,U,A,Blood,13391,,
Oral absorption expressed as Area under curve was determined,11688,,CHEMBL624748,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,16360,,
Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,11689,,CHEMBL622504,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,3673,,
"Oral integrated area under the concentration vs time curve, for compound in dog plasma",11690,,CHEMBL622505,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14122,,
"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",11691,,CHEMBL622506,100712,BAO_0000218,,,,1,,,Cricetinae,,10026.0,1,Intermediate,N,A,,14122,,
"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",11692,,CHEMBL622507,100712,BAO_0000218,,,,1,,,Cricetinae,,10026.0,1,Intermediate,N,A,,14122,,
"Oral integrated area under the concentration vs time curve, for compound in rat plasma",11693,,CHEMBL622508,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14122,,
Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,11694,,CHEMBL622509,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13889,,
Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,11695,,CHEMBL622510,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14393,,
Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),11696,,CHEMBL622511,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17279,,
Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,11697,,CHEMBL622512,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14548,,
Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,11698,,CHEMBL622513,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14548,,
Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,11699,,CHEMBL622514,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14548,,
Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,11700,,CHEMBL622515,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14548,,
Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,11701,,CHEMBL622516,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14548,,
Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,11702,,CHEMBL622517,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14548,,
Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,11703,,CHEMBL622518,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14548,,
Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,11704,,CHEMBL622519,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14548,,
Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,11705,,CHEMBL622520,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,14608,,
Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,11706,,CHEMBL622521,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,14608,,
Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,11707,,CHEMBL625113,50594,BAO_0000218,,,In vivo,1,,14.0,Mus musculus,,10090.0,1,Intermediate,N,A,Zone of skin,14608,,
Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,11708,,CHEMBL625114,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,14608,,
Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,11709,,CHEMBL874397,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,14608,,
Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,11710,,CHEMBL625115,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,14608,,
Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,11711,,CHEMBL625116,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,14608,,
Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,11712,,CHEMBL623932,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,14608,,
Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,11713,,CHEMBL623933,50597,BAO_0000218,,,In vivo,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,14608,,
Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,11714,,CHEMBL623934,50597,BAO_0000218,,,In vivo,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,14608,,
Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,11715,,CHEMBL623935,50597,BAO_0000218,,,In vivo,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,14608,,
Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,11716,,CHEMBL623936,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,14608,,
Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,11717,,CHEMBL623937,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,14608,,
Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,11718,,CHEMBL623938,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,14608,,
In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11719,,CHEMBL623939,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11720,,CHEMBL623940,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11721,,CHEMBL623941,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11722,,CHEMBL627216,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11723,,CHEMBL623942,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11724,,CHEMBL618793,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,15383,,
In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11725,,CHEMBL618794,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,15383,,
In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11726,,CHEMBL618795,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,15383,,
In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11727,,CHEMBL618796,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11728,,CHEMBL618797,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,11729,,CHEMBL618798,50594,BAO_0000218,,,,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,15383,,
In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11730,,CHEMBL618799,50594,BAO_0000218,,,,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,15383,,
In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11731,,CHEMBL618800,50594,BAO_0000218,,,,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,15383,,
In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11732,,CHEMBL618801,50594,BAO_0000218,,,,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,15383,,
In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11733,,CHEMBL618802,50594,BAO_0000218,,,,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,15383,,
In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11734,,CHEMBL618803,50594,BAO_0000218,,,,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,15383,,
In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,11735,,CHEMBL618804,50594,BAO_0000218,,,,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,15383,,
In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11736,,CHEMBL618805,50594,BAO_0000218,,,,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,15383,,
In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11737,,CHEMBL618806,50594,BAO_0000218,,,,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,15383,,
In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11738,,CHEMBL618807,50594,BAO_0000218,,,,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,15383,,
In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11739,,CHEMBL618808,50594,BAO_0000218,,,,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,15383,,
In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11740,,CHEMBL618809,50594,BAO_0000218,,,,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,15383,,
In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11741,,CHEMBL618810,50594,BAO_0000218,,,,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,15383,,
In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11742,,CHEMBL618811,50594,BAO_0000218,,,,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,15383,,
In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11743,,CHEMBL875844,50594,BAO_0000218,,,,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,15383,,
In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11744,,CHEMBL618812,50594,BAO_0000218,,,,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,15383,,
In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11745,,CHEMBL618813,50594,BAO_0000218,,,,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,15383,,
In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11746,,CHEMBL618814,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11747,,CHEMBL618815,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11748,,CHEMBL618816,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11749,,CHEMBL618817,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11750,,CHEMBL620544,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,11751,,CHEMBL626230,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15341,,
The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,11752,,CHEMBL626231,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15341,,
The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,11753,,CHEMBL626232,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15341,,
The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,11754,,CHEMBL626233,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14906,,
The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,11755,,CHEMBL626234,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14906,,
The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,11756,,CHEMBL875341,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14906,,
The maximum plasma concentration (100 mg/kg) administered orally in human,11757,,CHEMBL626235,50587,BAO_0000218,,,In vivo,1,,1969.0,Homo sapiens,,9606.0,1,Intermediate,N,A,Plasma,14215,,
The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,11758,,CHEMBL626236,22224,BAO_0000218,,,In vivo,1,,1969.0,Callithrix,,9481.0,0,Autocuration,U,A,Plasma,14215,,
The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,11759,,CHEMBL626237,22224,BAO_0000218,,,In vivo,1,,1969.0,Simiiformes,,314293.0,0,Autocuration,U,A,Plasma,14215,,
The maximum plasma concentration (15 mg/kg) administered intravenously in dog,11760,,CHEMBL626238,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14215,,
The maximum plasma concentration (200 mg/kg) administered orally in human,11761,,CHEMBL622412,50587,BAO_0000218,,,In vivo,1,,1969.0,Homo sapiens,,9606.0,1,Intermediate,N,A,Plasma,14215,,
The maximum plasma concentration (25 mg/kg) administered intravenously in rat,11762,,CHEMBL623114,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14215,,
The maximum plasma concentration (25 mg/kg) administered orally in marmoset,11763,,CHEMBL623115,22224,BAO_0000218,,,In vivo,1,,1969.0,Callithrix,,9481.0,0,Autocuration,U,A,Plasma,14215,,
The maximum plasma concentration (25 mg/kg) administered orally in monkey,11764,,CHEMBL623116,22224,BAO_0000218,,,In vivo,1,,1969.0,Simiiformes,,314293.0,0,Autocuration,U,A,Plasma,14215,,
The maximum plasma concentration (30 mg/kg) administered orally in dog,11765,,CHEMBL623117,22224,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,Plasma,14215,,
The maximum plasma concentration (400 mg/kg) administered orally in human,11766,,CHEMBL623118,50587,BAO_0000218,,,In vivo,1,,1969.0,Homo sapiens,,9606.0,1,Intermediate,N,A,Plasma,14215,,
The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,11767,,CHEMBL623119,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14215,,
The maximum plasma concentration (50 mg/kg) administered orally in rat,11768,,CHEMBL623120,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14215,,
The maximum plasma concentration (800 mg/kg) administered orally in human,11769,,CHEMBL623286,50587,BAO_0000218,,,In vivo,1,,1969.0,Homo sapiens,,9606.0,1,Intermediate,N,A,Plasma,14215,,
The maximum plasma concentration was measured on rats,11770,,CHEMBL623287,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14067,,
The maximum plasma concentration was measured on rats after oral administration,11771,,CHEMBL623288,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12350,,
Plasma drug Cmax in rat (PO dose),11772,,CHEMBL623289,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14813,,
Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,11773,,CHEMBL623290,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12536,,
maximum Plasma concentration in Dog was determined after Peroral administration,11774,,CHEMBL623291,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14169,,
maximum Plasma concentration in Rats was determined after Peroral administration,11775,,CHEMBL623292,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14169,,
maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,11776,,CHEMBL623293,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,15604,,
maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,11777,,CHEMBL623294,22224,BAO_0000218,,,In vivo,1,,1969.0,Simiiformes,,314293.0,0,Autocuration,U,A,Plasma,15604,,
maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,11778,,CHEMBL623295,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15604,,
maximum concentration was measured when administered through oral route in mice,11779,,CHEMBL623296,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14387,,
Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,11780,,CHEMBL875349,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15115,,
Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,11781,,CHEMBL623297,22224,BAO_0000019,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,15115,,
Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,11782,,CHEMBL623298,22224,BAO_0000019,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,15115,,
Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,11783,,CHEMBL623299,22224,BAO_0000019,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,15115,,
Pharmacokinetic parameter was evaluated in rats,11784,,CHEMBL623300,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16359,,
Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,11785,,CHEMBL623301,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12829,,
Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,11786,,CHEMBL623302,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12829,,
Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,11787,,CHEMBL623303,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12829,,
Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,11788,,CHEMBL623304,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12829,,
Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,11789,,CHEMBL623305,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12829,,
Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,11790,,CHEMBL623306,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15137,,
Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,11791,,CHEMBL623307,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15137,,
Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,11792,,CHEMBL623308,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15137,,
Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,11793,,CHEMBL623309,50594,BAO_0000218,,,,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,15137,,
Plasma Concentration after 120 min of oral administration to mice,11794,,CHEMBL623310,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13509,,
Plasma Concentration after 30 min of oral administration to mice,11795,,CHEMBL623311,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13509,,
Plasma Concentration after 60 min of oral administration to mice,11796,,CHEMBL623312,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,13509,,
Plasma Concentration after 60 min of oral administration to mice; Not determined,11797,,CHEMBL875350,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13509,,
Plasma Concentration after 90 min of oral administration to mice,11798,,CHEMBL628635,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13509,,
Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,11799,,CHEMBL628636,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12064,,
Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,11800,,CHEMBL628637,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12064,,
Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,11801,,CHEMBL628058,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12064,,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,11802,,CHEMBL628059,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10677,,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,11803,,CHEMBL628060,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10677,,
Distribution in the lung after 15 min of intravenous administration,11804,,CHEMBL628061,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the lung after 30 min of intravenous administration,11805,,CHEMBL628062,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the lung after 5 min of intravenous administration,11806,,CHEMBL628063,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the lung after 60 min of intravenous administration,11807,,CHEMBL628064,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the lung after 90 min of intravenous administration,11808,,CHEMBL628065,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8926,,
Distribution in the muscle after 120 min of intravenous administration,11809,,CHEMBL628066,22224,BAO_0000019,,,,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,8926,,
Distribution in the muscle after 15 min of intravenous administration,11810,,CHEMBL628067,22224,BAO_0000019,,,,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,8926,,
Distribution in the muscle after 30 min of intravenous administration,11811,,CHEMBL874646,50594,BAO_0000218,,,,1,,2385.0,Mus musculus,,10090.0,1,Intermediate,N,A,Muscle tissue,8926,,
Distribution in the muscle after 5 min of intravenous administration,11812,,CHEMBL628068,22224,BAO_0000019,,,,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,8926,,
Distribution in the muscle after 60 min of intravenous administration,11813,,CHEMBL628069,22224,BAO_0000019,,,,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,8926,,
Distribution in the muscle after 90 min of intravenous administration,11814,,CHEMBL628070,22224,BAO_0000019,,,,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,8926,,
Distribution in the spleen after 120 min of intravenous administration,11815,,CHEMBL628071,22224,BAO_0000019,,,,1,,2106.0,,,,0,Autocuration,U,A,Spleen,8926,,
Distribution in the spleen after 15 min of intravenous administration,11816,,CHEMBL628072,22224,BAO_0000019,,,,1,,2106.0,,,,0,Autocuration,U,A,Spleen,8926,,
Distribution in the spleen after 30 min of intravenous administration,11817,,CHEMBL628073,22224,BAO_0000019,,,,1,,2106.0,,,,0,Autocuration,U,A,Spleen,8926,,
Distribution in the spleen after 5 min of intravenous administration,11818,,CHEMBL628074,22224,BAO_0000019,,,,1,,2106.0,,,,0,Autocuration,U,A,Spleen,8926,,
Distribution in the spleen after 60 min of intravenous administration,11819,,CHEMBL628075,22224,BAO_0000019,,,,1,,2106.0,,,,0,Autocuration,U,A,Spleen,8926,,
Distribution in the spleen after 90 min of intravenous administration,11820,,CHEMBL628076,22224,BAO_0000019,,,,1,,2106.0,,,,0,Autocuration,U,A,Spleen,8926,,
Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,11821,,CHEMBL628077,50597,BAO_0000218,,,,1,,1235.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Adrenal cortex,7570,,
Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,11822,,CHEMBL628078,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,7570,,
Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,11823,,CHEMBL628079,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,7570,,
Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,11824,,CHEMBL628080,50597,BAO_0000218,,,,1,,992.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Female gonad,7570,,
Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,11825,,CHEMBL628081,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,7570,,
Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,11826,,CHEMBL628082,50597,BAO_0000218,,,,1,,1235.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Adrenal cortex,7570,,
Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,11827,,CHEMBL874647,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,7570,,
Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,11828,,CHEMBL626406,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,7570,,
Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,11829,,CHEMBL626407,50597,BAO_0000218,,,,1,,992.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Female gonad,7570,,
Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,11830,,CHEMBL626408,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,7570,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",11831,,CHEMBL626409,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",11832,,CHEMBL626410,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",11833,,CHEMBL626411,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",11834,,CHEMBL626412,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",11835,,CHEMBL626413,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",11836,,CHEMBL626414,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",11837,,CHEMBL626415,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",11838,,CHEMBL626416,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",11839,,CHEMBL627062,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",11840,,CHEMBL627063,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",11841,,CHEMBL627064,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",11842,,CHEMBL627227,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",11843,,CHEMBL627228,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",11844,,CHEMBL627229,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",11845,,CHEMBL625792,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",11846,,CHEMBL625793,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",11847,,CHEMBL625794,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",11848,,CHEMBL625795,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8608,,
Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,11849,,CHEMBL625796,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13792,,
Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,11850,,CHEMBL625797,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13376,,
Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,11851,,CHEMBL625798,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13376,,
Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11852,,CHEMBL875613,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14380,,
Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11853,,CHEMBL625799,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14380,,
Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,11854,,CHEMBL625800,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14380,,
Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,11855,,CHEMBL625801,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14380,,
Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,11856,,CHEMBL625802,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14380,,
Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,11857,,CHEMBL625803,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14380,,
Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,11858,,CHEMBL625804,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14380,,
Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,11859,,CHEMBL622530,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14380,,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,11860,,CHEMBL622531,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),11861,,CHEMBL622532,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),11862,,CHEMBL623176,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),11863,,CHEMBL623177,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),11864,,CHEMBL623178,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,11865,,CHEMBL623179,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),11866,,CHEMBL623180,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),11867,,CHEMBL623181,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),11868,,CHEMBL624131,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),11869,,CHEMBL624132,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),11870,,CHEMBL624133,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,11871,,CHEMBL624846,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),11872,,CHEMBL624847,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),11873,,CHEMBL624848,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),11874,,CHEMBL625012,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),11875,,CHEMBL625013,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,11876,,CHEMBL625014,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),11877,,CHEMBL625015,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),11878,,CHEMBL625016,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,11879,,CHEMBL625017,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),11880,,CHEMBL625018,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),11881,,CHEMBL625019,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),11882,,CHEMBL625020,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,11883,,CHEMBL625021,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,11884,,CHEMBL625022,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14393,,
Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,11885,,CHEMBL625023,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14731,,
Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,11886,,CHEMBL625024,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14731,,
Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,11887,,CHEMBL627626,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14731,,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,11888,,CHEMBL627627,22224,BAO_0000218,,,,1,,955.0,,,,0,Autocuration,U,A,Brain,13758,,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,11889,,CHEMBL627628,22224,BAO_0000218,,,,1,,1977.0,,,,0,Autocuration,U,A,Serum,13758,,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,11890,,CHEMBL627629,22224,BAO_0000218,,,,1,,955.0,,,,0,Autocuration,U,A,Brain,13758,,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,11891,,CHEMBL627630,22224,BAO_0000218,,,,1,,1977.0,,,,0,Autocuration,U,A,Serum,13758,,
Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),11892,,CHEMBL627631,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,16359,,
Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),11893,,CHEMBL629515,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,16359,,
In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11894,,CHEMBL629516,50594,BAO_0000218,,,,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,15383,,
In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11895,,CHEMBL629517,50594,BAO_0000218,,,,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,15383,,
In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11896,,CHEMBL629518,50594,BAO_0000218,,,,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,15383,,
In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11897,,CHEMBL877499,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11898,,CHEMBL629519,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11899,,CHEMBL629520,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11900,,CHEMBL629521,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,15383,,
Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),11901,,CHEMBL629522,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),11902,,CHEMBL629523,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),11903,,CHEMBL629524,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),11904,,CHEMBL629525,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),11905,,CHEMBL629526,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),11906,,CHEMBL629527,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),11907,,CHEMBL629528,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),11908,,CHEMBL629529,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),11909,,CHEMBL629530,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),11910,,CHEMBL629531,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),11911,,CHEMBL628656,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),11912,,CHEMBL628657,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",11913,,CHEMBL628658,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",11914,,CHEMBL628659,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",11915,,CHEMBL877500,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",11916,,CHEMBL628660,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11917,,CHEMBL628661,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",11918,,CHEMBL628662,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",11919,,CHEMBL628663,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",11920,,CHEMBL628664,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",11921,,CHEMBL628665,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13751,,
"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",11922,,CHEMBL628666,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13751,,
"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",11923,,CHEMBL628667,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13751,,
"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11924,,CHEMBL628668,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13751,,
"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",11925,,CHEMBL628669,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13751,,
"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",11926,,CHEMBL628670,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13751,,
"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",11927,,CHEMBL628671,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13751,,
"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",11928,,CHEMBL628672,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,13751,,
"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",11929,,CHEMBL630300,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,13751,,
"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11930,,CHEMBL629787,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,13751,,
"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",11931,,CHEMBL629788,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,13751,,
"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",11932,,CHEMBL629789,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13751,,
"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",11933,,CHEMBL629790,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13751,,
"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",11934,,CHEMBL629791,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13751,,
"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11935,,CHEMBL629792,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13751,,
"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",11936,,CHEMBL629793,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13751,,
"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",11937,,CHEMBL629794,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13751,,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,11938,,CHEMBL874459,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10677,,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,11939,,CHEMBL629795,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10677,,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,11940,,CHEMBL629796,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10677,,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,11941,,CHEMBL629797,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10677,,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,11942,,CHEMBL629798,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10677,,
Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11943,,CHEMBL629799,50597,BAO_0000218,,,In vivo,1,,2369.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Adrenal gland,10911,,
Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11944,,CHEMBL629800,50597,BAO_0000218,,,In vivo,1,,2369.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Adrenal gland,10911,,
Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11945,,CHEMBL629801,50597,BAO_0000218,,,In vivo,1,,2369.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Adrenal gland,10911,,
Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,11946,,CHEMBL629802,50597,BAO_0000218,,,In vivo,1,,2369.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Adrenal gland,10911,,
Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11947,,CHEMBL629803,50597,BAO_0000218,,,In vivo,1,,2369.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Adrenal gland,10911,,
Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11948,,CHEMBL629804,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,10911,,
Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11949,,CHEMBL629805,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,10911,,
Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,11950,,CHEMBL629806,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,10911,,
Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11951,,CHEMBL629807,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,10911,,
Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11952,,CHEMBL629808,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,10911,,
Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11953,,CHEMBL629809,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,10911,,
Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11954,,CHEMBL629810,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,10911,,
Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,11955,,CHEMBL629811,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,10911,,
Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11956,,CHEMBL629812,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,10911,,
Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,11957,,CHEMBL629813,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,10911,,
Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11958,,CHEMBL874460,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,10911,,
Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11959,,CHEMBL629814,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10911,,
Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11960,,CHEMBL629815,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10911,,
Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11961,,CHEMBL629816,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10911,,
Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11962,,CHEMBL629817,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10911,,
Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11963,,CHEMBL626643,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,10911,,
Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11964,,CHEMBL626644,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,10911,,
Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11965,,CHEMBL626806,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,10911,,
Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11966,,CHEMBL626807,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,10911,,
Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11967,,CHEMBL627261,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,10911,,
Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11968,,CHEMBL627262,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,10911,,
Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11969,,CHEMBL627263,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,10911,,
Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11970,,CHEMBL627264,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,10911,,
Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11971,,CHEMBL627265,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,10911,,
Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11972,,CHEMBL627266,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,10911,,
Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11973,,CHEMBL627267,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,10911,,
Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11974,,CHEMBL627268,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,10911,,
Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11975,,CHEMBL627269,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10911,,
Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11976,,CHEMBL627270,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10911,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",11977,,CHEMBL627271,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",11978,,CHEMBL627946,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",11979,,CHEMBL875472,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",11980,,CHEMBL627947,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",11981,,CHEMBL627948,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",11982,,CHEMBL628113,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",11983,,CHEMBL628114,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",11984,,CHEMBL628115,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",11985,,CHEMBL628116,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",11986,,CHEMBL628117,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",11987,,CHEMBL628118,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",11988,,CHEMBL628119,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",11989,,CHEMBL628120,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",11990,,CHEMBL628121,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",11991,,CHEMBL628122,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",11992,,CHEMBL627297,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",11993,,CHEMBL627298,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",11994,,CHEMBL627299,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",11995,,CHEMBL627300,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",11996,,CHEMBL627301,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",11997,,CHEMBL627302,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",11998,,CHEMBL627303,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",11999,,CHEMBL627304,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",12000,,CHEMBL627305,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",12001,,CHEMBL627306,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",12002,,CHEMBL623982,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",12003,,CHEMBL623983,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",12004,,CHEMBL623984,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",12005,,CHEMBL623985,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",12006,,CHEMBL623986,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",12007,,CHEMBL623987,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",12008,,CHEMBL623988,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",12009,,CHEMBL623989,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",12010,,CHEMBL622215,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",12011,,CHEMBL622216,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",12012,,CHEMBL877481,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8608,,
Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),12013,,CHEMBL622217,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,16359,,
Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),12014,,CHEMBL622218,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13701,,
Pharmacokinetic profile AUC was evaluated in rats,12015,,CHEMBL622219,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14554,,
Pharmacokinetic property (Area under curve),12016,,CHEMBL622220,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6241,,
"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",12017,,CHEMBL622221,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,11537,,
"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",12018,,CHEMBL622222,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,11537,,
"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",12019,,CHEMBL622223,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,11537,,
"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",12020,,CHEMBL622224,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,11537,,
Plasma concentration (AUC) was determined,12021,,CHEMBL622225,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13118,,
Plasma concentration (AUC) was determined; Not detectable,12022,,CHEMBL622226,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13118,,
Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),12023,,CHEMBL624154,50512,BAO_0000218,,,,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,9562,,
Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,12024,,CHEMBL624155,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10363,,
Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,12025,,CHEMBL624156,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10363,,
Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,12026,,CHEMBL624157,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10363,,
Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,12027,,CHEMBL624158,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10363,,
Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,12028,,CHEMBL624159,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12504,,
Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,12029,,CHEMBL624160,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12504,,
Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,12030,,CHEMBL624161,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12504,,
Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,12031,,CHEMBL624162,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12504,,
Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,12032,,CHEMBL624163,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13317,,
"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",12033,,CHEMBL624164,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
The AUC(0-infinity) values in female wistar rats.,12034,,CHEMBL624165,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14941,,
"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",12035,,CHEMBL624166,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",12036,,CHEMBL624167,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
The AUC(0-t)values in female wistar rats.,12037,,CHEMBL624168,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14941,,
The Area under the concentration time curve of compound was measured on rats,12038,,CHEMBL624169,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14067,,
The area under curve (100 mg/kg) administered orally in humans,12039,,CHEMBL624170,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,14215,,
The area under curve (12.5 mg/kg) administered intravenously in marmoset,12040,,CHEMBL624171,22224,BAO_0000218,,,,1,,,Callithrix,,9481.0,0,Autocuration,U,A,,14215,,
The area under curve (12.5 mg/kg) administered intravenously in monkey,12041,,CHEMBL624172,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,14215,,
The area under curve (15 mg/kg) administered intravenously in dog,12042,,CHEMBL624173,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14215,,
The area under curve (200 mg/kg) administered orally in humans,12043,,CHEMBL877488,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,14215,,
The area under curve (25 mg/kg) administered intravenously in rat,12044,,CHEMBL624174,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14215,,
The area under curve (25 mg/kg) administered orally in marmoset,12045,,CHEMBL624175,22224,BAO_0000218,,,,1,,,Callithrix,,9481.0,0,Autocuration,U,A,,14215,,
The area under curve (25 mg/kg) administered orally in monkey,12046,,CHEMBL624176,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,14215,,
The area under curve (30 mg/kg) administered orally in dog,12047,,CHEMBL624177,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14215,,
The area under curve (400 mg/kg) administered orally in humans,12048,,CHEMBL624178,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,14215,,
The area under curve (50 mg/kg) administered orally in fasted rat,12049,,CHEMBL624179,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14215,,
The area under curve (50 mg/kg) administered orally in rat,12050,,CHEMBL627689,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14215,,
The area under curve (800 mg/kg) administered orally in humans,12051,,CHEMBL627690,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,14215,,
The compound was evaluated for area under the curve,12052,,CHEMBL627691,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11324,,
The compound was evaluated for area under the curve in marmosets,12053,,CHEMBL627692,22224,BAO_0000019,,,,1,,,Callithrix,,9481.0,0,Autocuration,U,A,,11324,,
The compound was evaluated for area under the curve in marmosets,12054,,CHEMBL627693,22224,BAO_0000019,,,,1,,,Callithrix,,9481.0,0,Autocuration,U,A,,11324,,
The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,12055,,CHEMBL627694,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13875,,
The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,12056,,CHEMBL627695,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13875,,
The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),12057,,CHEMBL627696,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,13875,,
The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,12058,,CHEMBL627697,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13875,,
The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,12059,,CHEMBL627698,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13875,,
The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,12060,,CHEMBL627699,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13875,,
Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,12061,,CHEMBL627700,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13807,,
Total drug exposure is determined after oral dosing in rats.,12062,,CHEMBL627701,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14127,,
Total drug exposure (5 mg/kg) when administered intravenously,12063,,CHEMBL627702,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,15116,,
Total drug exposure (5 mg/kg) when administered orally,12064,,CHEMBL627703,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,15116,,
area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,12065,,CHEMBL626873,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,15604,,
area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,12066,,CHEMBL629583,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15604,,
area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,12067,,CHEMBL629584,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15604,,
area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,12068,,CHEMBL629585,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15604,,
"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",12069,,CHEMBL629586,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13751,,
"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",12070,,CHEMBL629587,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13751,,
"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",12071,,CHEMBL629588,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",12072,,CHEMBL629589,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",12073,,CHEMBL629590,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12074,,CHEMBL629591,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",12075,,CHEMBL629592,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",12076,,CHEMBL629593,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",12077,,CHEMBL629594,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",12078,,CHEMBL629595,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13751,,
"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",12079,,CHEMBL630290,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13751,,
"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",12080,,CHEMBL627137,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13751,,
"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12081,,CHEMBL627138,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13751,,
"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",12082,,CHEMBL627139,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13751,,
"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",12083,,CHEMBL627140,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13751,,
"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",12084,,CHEMBL627141,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13751,,
"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",12085,,CHEMBL627142,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13751,,
"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",12086,,CHEMBL627143,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13751,,
"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",12087,,CHEMBL874449,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13751,,
"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12088,,CHEMBL627144,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13751,,
"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",12089,,CHEMBL627145,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13751,,
"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",12090,,CHEMBL627146,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13751,,
"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",12091,,CHEMBL627147,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13751,,
"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",12092,,CHEMBL627148,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13751,,
"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",12093,,CHEMBL627149,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13751,,
"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",12094,,CHEMBL632160,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13751,,
"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",12095,,CHEMBL632161,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13751,,
"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12096,,CHEMBL632162,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13751,,
"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",12097,,CHEMBL632163,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13751,,
"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",12098,,CHEMBL874469,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13751,,
"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",12099,,CHEMBL627182,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13751,,
"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",12100,,CHEMBL627183,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13751,,
"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",12101,,CHEMBL627184,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13751,,
"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",12102,,CHEMBL627185,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13751,,
"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12103,,CHEMBL627186,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13751,,
"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",12104,,CHEMBL627187,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13751,,
"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",12105,,CHEMBL627188,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13751,,
"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",12106,,CHEMBL627189,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13751,,
"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",12107,,CHEMBL627190,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13751,,
"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",12108,,CHEMBL627191,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13751,,
"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12109,,CHEMBL627192,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13751,,
"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",12110,,CHEMBL627193,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13751,,
Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,12111,,CHEMBL874590,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10911,,
Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12112,,CHEMBL627194,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10911,,
Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12113,,CHEMBL627195,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10911,,
Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12114,,CHEMBL627196,50597,BAO_0000218,,,In vivo,1,,992.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Female gonad,10911,,
Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12115,,CHEMBL627197,50597,BAO_0000218,,,In vivo,1,,992.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Female gonad,10911,,
Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12116,,CHEMBL627198,50597,BAO_0000218,,,In vivo,1,,992.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Female gonad,10911,,
Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,12117,,CHEMBL627199,50597,BAO_0000218,,,In vivo,1,,992.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Female gonad,10911,,
Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12118,,CHEMBL627200,50597,BAO_0000218,,,In vivo,1,,992.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Female gonad,10911,,
Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12119,,CHEMBL627201,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,10911,,
Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12120,,CHEMBL627202,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,10911,,
Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12121,,CHEMBL627203,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,10911,,
Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12122,,CHEMBL627204,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,10911,,
Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12123,,CHEMBL627205,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,10911,,
Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12124,,CHEMBL627206,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,10911,,
Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12125,,CHEMBL627207,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,10911,,
Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12126,,CHEMBL627208,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,10911,,
Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12127,,CHEMBL627209,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,10911,,
Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12128,,CHEMBL627210,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,10911,,
Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12129,,CHEMBL627211,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,10911,,
Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12130,,CHEMBL627212,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,10911,,
Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12131,,CHEMBL627213,50597,BAO_0000218,,,In vivo,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,10911,,
Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12132,,CHEMBL626599,50597,BAO_0000218,,,In vivo,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,10911,,
Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12133,,CHEMBL626600,50597,BAO_0000218,,,In vivo,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,10911,,
Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12134,,CHEMBL626601,50597,BAO_0000218,,,In vivo,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,10911,,
C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,12135,,CHEMBL627484,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8081,,
Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),12136,,CHEMBL627485,100710,BAO_0000218,,,,1,,1969.0,Macaca fascicularis,,9541.0,1,Intermediate,N,A,Plasma,17248,,
Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,12137,,CHEMBL628147,100710,BAO_0000218,,,,1,,1969.0,Macaca fascicularis,,9541.0,1,Intermediate,N,A,Plasma,17248,,
Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,12138,,CHEMBL628148,100710,BAO_0000218,,,,1,,1969.0,Macaca fascicularis,,9541.0,1,Intermediate,N,A,Plasma,17248,,
Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),12139,,CHEMBL628149,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,17248,,
Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,12140,,CHEMBL628150,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,17248,,
Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,12141,,CHEMBL628318,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,17248,,
Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,12142,,CHEMBL628319,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,17248,,
"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",12143,,CHEMBL875609,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15592,,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,12144,,CHEMBL628320,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7040,,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,12145,,CHEMBL628321,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7040,,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,12146,,CHEMBL628322,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7040,,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,12147,,CHEMBL628323,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7040,,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,12148,,CHEMBL628324,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7040,,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,12149,,CHEMBL628325,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7040,,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,12150,,CHEMBL628326,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7040,,
"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",12151,,CHEMBL628327,50588,BAO_0000218,,,,1,,1236.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Adrenal medulla,9614,,
"Concentration of compound in adrenal medulla of dog1, after administering intravenously",12152,,CHEMBL628328,50588,BAO_0000218,,,,1,,1236.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Adrenal medulla,9614,,
"Concentration of compound in blood of dog 1, after administering intravenously",12153,,CHEMBL628329,50588,BAO_0000218,,,,1,,178.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Blood,9614,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",12154,,CHEMBL628330,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",12155,,CHEMBL628331,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",12156,,CHEMBL628332,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",12157,,CHEMBL628333,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",12158,,CHEMBL628334,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",12159,,CHEMBL628335,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",12160,,CHEMBL628336,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",12161,,CHEMBL628337,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",12162,,CHEMBL628338,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",12163,,CHEMBL875610,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",12164,,CHEMBL628339,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",12165,,CHEMBL628340,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",12166,,CHEMBL628341,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",12167,,CHEMBL622214,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",12168,,CHEMBL623167,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",12169,,CHEMBL623168,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",12170,,CHEMBL623169,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",12171,,CHEMBL623170,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",12172,,CHEMBL627224,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",12173,,CHEMBL875634,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",12174,,CHEMBL627225,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",12175,,CHEMBL627226,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",12176,,CHEMBL626083,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",12177,,CHEMBL626084,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",12178,,CHEMBL626085,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",12179,,CHEMBL626086,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",12180,,CHEMBL626087,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",12181,,CHEMBL626088,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",12182,,CHEMBL626089,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",12183,,CHEMBL626090,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",12184,,CHEMBL626091,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",12185,,CHEMBL626092,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",12186,,CHEMBL626093,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",12187,,CHEMBL626094,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",12188,,CHEMBL626095,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",12189,,CHEMBL626096,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8608,,
area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,12190,,CHEMBL626097,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,15604,,
area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,12191,,CHEMBL626098,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15604,,
compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,12192,,CHEMBL626099,22224,BAO_0000218,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,1806,,
compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,12193,,CHEMBL626100,22224,BAO_0000218,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,1806,,
AUC 0-inf in dog,12194,,CHEMBL626101,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,17237,,
AUC 0-inf in guinea pig,12195,,CHEMBL626102,50512,BAO_0000218,,,,1,,1969.0,Cavia porcellus,,10141.0,1,Intermediate,N,A,Plasma,17237,,
AUC 0-t in dog,12196,,CHEMBL626103,50588,BAO_0000218,,,,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,17237,,
AUC 0-t in guinea pig,12197,,CHEMBL628391,50512,BAO_0000218,,,,1,,1969.0,Cavia porcellus,,10141.0,1,Intermediate,N,A,Plasma,17237,,
The compound was tested for brain to plasma partition in rat,12198,,CHEMBL628392,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15194,,
The compound was tested for brain to plasma partition in rat.,12199,,CHEMBL628393,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15194,,
Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,12200,,CHEMBL628394,22224,BAO_0000019,,,,1,,178.0,,,,0,Autocuration,U,A,Blood,8787,,
Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,12201,,CHEMBL628395,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,17025,,
Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,12202,,CHEMBL628396,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,17025,,
Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,12203,,CHEMBL628397,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,17025,,
Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,12204,,CHEMBL628398,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17025,,
Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,12205,,CHEMBL628399,50797,BAO_0000218,,,,1,,,Macaca mulatta,,9544.0,1,Intermediate,N,A,,4236,,
The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,12206,,CHEMBL628400,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15343,,
The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,12207,,CHEMBL874907,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15343,,
Area under curve of the compound was determined,12208,,CHEMBL628401,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17720,,
AUC in monkeys at a dose of 1 mg/kg,12209,,CHEMBL628402,22224,BAO_0000218,,,,1,,1969.0,Simiiformes,,314293.0,0,Autocuration,U,A,Plasma,17788,,
AUC in rats at a dose of 1 mg/kg,12210,,CHEMBL628403,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,17788,,
Compound was evaluated for the overall absorbance loss at pH of 2,12211,,CHEMBL628404,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8778,,
Compound was evaluated for the overall absorbance loss at pH of 4,12212,,CHEMBL628405,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8778,,
Compound was evaluated for the overall absorbance loss at pH of 7,12213,,CHEMBL628406,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8778,,
Compound was evaluated for its absorption in the rats,12214,,CHEMBL628407,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,2249,,
Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,12215,,CHEMBL628408,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8881,,
Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,12216,,CHEMBL629171,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8881,,
Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,12217,,CHEMBL629172,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8881,,
Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,12218,,CHEMBL629173,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8881,,
In vitro percent permeability into rat ileum,12219,,CHEMBL629174,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 10-17,12220,,CHEMBL629175,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 10-18,12221,,CHEMBL629176,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 10-19,12222,,CHEMBL629177,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 12-15,12223,,CHEMBL629178,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 13-19,12224,,CHEMBL631869,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 14-17,12225,,CHEMBL631870,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 15-18,12226,,CHEMBL631871,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 2-5,12227,,CHEMBL631872,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 23-42,12228,,CHEMBL875775,22224,BAO_0000221,,,,1,,2116.0,,,,0,Autocuration,U,A,Ileum,15286,,
In vitro percent permeability into rat ileum; Range is 28-36,12229,,CHEMBL631873,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 29-35,12230,,CHEMBL631874,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 46-66,12231,,CHEMBL631875,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 50-68,12232,,CHEMBL631876,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; Range is 78-81,12233,,CHEMBL631877,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,12234,,CHEMBL631878,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; nd indicates not detected,12235,,CHEMBL631879,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; nt indicates not detected,12236,,CHEMBL631880,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
In vitro percent permeability into rat ileum; nt indicates not tested,12237,,CHEMBL631881,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15286,,
Compound was tested for oral absorption in bile-duct cannulated rats,12238,,CHEMBL631882,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13770,,
Compound was tested for oral absorption in bile-duct cannulated rats.,12239,,CHEMBL630749,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13770,,
Oral absorption using Caco-2 cell monolayers.,12240,,CHEMBL630750,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,5202,,
Percent of the drug absorbed after administration to humans was determined,12241,,CHEMBL630253,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,14920,,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,12242,,CHEMBL630254,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,12243,,CHEMBL630255,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,12244,,CHEMBL630256,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",12245,,CHEMBL875781,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13751,,
"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",12246,,CHEMBL630257,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13751,,
"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",12247,,CHEMBL630258,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13751,,
"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",12248,,CHEMBL630259,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15807,,
"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",12249,,CHEMBL630260,50597,BAO_0000218,,,,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,15807,,
"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",12250,,CHEMBL630261,50597,BAO_0000218,,,,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,15807,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,12251,,CHEMBL630262,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,12252,,CHEMBL630263,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,12253,,CHEMBL630264,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,12254,,CHEMBL630265,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,12255,,CHEMBL630266,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,12256,,CHEMBL630267,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,12257,,CHEMBL630268,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,12258,,CHEMBL630269,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,12259,,CHEMBL630270,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,12260,,CHEMBL630141,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,12261,,CHEMBL630142,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,12262,,CHEMBL630143,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,12263,,CHEMBL630144,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,12264,,CHEMBL630145,50597,BAO_0000218,,,,1,,2367.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Prostate gland,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,12265,,CHEMBL630146,50597,BAO_0000218,,,,1,,2367.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Prostate gland,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,12266,,CHEMBL630147,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,12267,,CHEMBL630148,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,12268,,CHEMBL630149,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,12269,,CHEMBL630150,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,12270,,CHEMBL630151,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,12271,,CHEMBL632031,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,14950,,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,12272,,CHEMBL632032,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,14950,,
Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,12273,,CHEMBL632033,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,12274,,CHEMBL632034,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,12275,,CHEMBL632035,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,14950,,
Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,12276,,CHEMBL632036,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14950,,
Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,12277,,CHEMBL632037,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,14950,,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,12278,,CHEMBL632038,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,12279,,CHEMBL632039,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,12280,,CHEMBL632040,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,12281,,CHEMBL632041,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
"Concentration of compound in blood of dog 2, after administering intravenously",12282,,CHEMBL632042,50588,BAO_0000218,,,,1,,178.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Blood,9614,,
"Concentration of compound in left ventricle of dog 1, after administering intravenously",12283,,CHEMBL632043,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9614,,
"Concentration of compound in left ventricle of dog 2, after administering intravenously",12284,,CHEMBL632044,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9614,,
"Concentration of compound in liver of dog 1, after administering intravenously",12285,,CHEMBL632045,50588,BAO_0000218,,,,1,,2107.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Liver,9614,,
"Concentration of compound in liver of dog 2, after administering intravenously",12286,,CHEMBL632046,50588,BAO_0000218,,,,1,,2107.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Liver,9614,,
"Concentration of compound in lung of dog 1, after administering intravenously",12287,,CHEMBL632047,50588,BAO_0000218,,,,1,,2048.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Lung,9614,,
"Concentration of compound in lung of dog 2, after administering intravenously",12288,,CHEMBL632048,50588,BAO_0000218,,,,1,,2048.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Lung,9614,,
"Concentration of compound in muscle of dog 1, after administering intravenously",12289,,CHEMBL632049,50588,BAO_0000218,,,,1,,2385.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Muscle tissue,9614,,
"Concentration of compound in muscle of dog 2, after administering intravenously",12290,,CHEMBL876418,50588,BAO_0000218,,,,1,,2385.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Muscle tissue,9614,,
"Concentration of compound in spleen of dog 1,after administering intravenously",12291,,CHEMBL632050,50588,BAO_0000218,,,,1,,2106.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Spleen,9614,,
"Concentration of compound in spleen of dog 2, after administering intravenously",12292,,CHEMBL632051,50588,BAO_0000218,,,,1,,2106.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Spleen,9614,,
Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,12293,,CHEMBL632052,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,F,,10353,,
Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,12294,,CHEMBL632053,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,F,,10353,,
Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,12295,,CHEMBL632054,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,10353,,
Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,12296,,CHEMBL632055,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,F,,10353,,
Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,12297,,CHEMBL631181,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,F,,10353,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,12298,,CHEMBL631182,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,12299,,CHEMBL631183,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12300,,CHEMBL631184,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12301,,CHEMBL629774,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12302,,CHEMBL629775,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12303,,CHEMBL876549,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12304,,CHEMBL628172,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,12305,,CHEMBL628173,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,12306,,CHEMBL628174,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,12307,,CHEMBL628175,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,12308,,CHEMBL628176,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,12309,,CHEMBL628177,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12310,,CHEMBL628178,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,12311,,CHEMBL628179,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,12312,,CHEMBL628180,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,12313,,CHEMBL628181,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12314,,CHEMBL628182,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12315,,CHEMBL628183,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,12316,,CHEMBL628184,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12317,,CHEMBL628185,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12318,,CHEMBL875617,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,12319,,CHEMBL628186,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12320,,CHEMBL628187,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,12321,,CHEMBL628188,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,12322,,CHEMBL628189,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,12323,,CHEMBL628190,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,12324,,CHEMBL628191,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,12325,,CHEMBL626513,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",12326,,CHEMBL626514,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",12327,,CHEMBL626515,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",12328,,CHEMBL626516,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",12329,,CHEMBL626517,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",12330,,CHEMBL626518,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",12331,,CHEMBL626519,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",12332,,CHEMBL626520,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",12333,,CHEMBL626521,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",12334,,CHEMBL626522,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",12335,,CHEMBL626523,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",12336,,CHEMBL626524,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",12337,,CHEMBL626688,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",12338,,CHEMBL626689,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",12339,,CHEMBL626690,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",12340,,CHEMBL626691,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",12341,,CHEMBL627319,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",12342,,CHEMBL624052,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",12343,,CHEMBL624053,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8608,,
In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12344,,CHEMBL624054,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8085,,
In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12345,,CHEMBL624055,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8085,,
In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12346,,CHEMBL624056,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8085,,
In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12347,,CHEMBL624057,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8085,,
In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12348,,CHEMBL622281,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8085,,
In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12349,,CHEMBL622282,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8085,,
In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12350,,CHEMBL622283,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8085,,
In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12351,,CHEMBL622284,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8085,,
In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12352,,CHEMBL622285,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8085,,
In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12353,,CHEMBL622286,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,8085,,
Distribution coefficient (D %) between octanol and buffer of pH 7.4,12354,,CHEMBL622287,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,7657,,
Partition coefficient (logD7.4),12355,,CHEMBL622288,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8935,,
"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",12356,,CHEMBL622289,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13792,,
"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",12357,,CHEMBL622290,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,13792,,
Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,12358,,CHEMBL622291,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13792,,
Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,12359,,CHEMBL622292,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,13792,,
"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",12360,,CHEMBL622293,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13792,,
"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",12361,,CHEMBL622294,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,13792,,
Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,12362,,CHEMBL622295,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13792,,
Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,12363,,CHEMBL622296,50597,BAO_0000218,,,,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13792,,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,12364,,CHEMBL874409,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,12365,,CHEMBL622297,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,12366,,CHEMBL622298,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,12367,,CHEMBL622299,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,12368,,CHEMBL622300,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,12369,,CHEMBL622301,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,12370,,CHEMBL622302,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,12371,,CHEMBL622303,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,12372,,CHEMBL622304,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,12373,,CHEMBL622305,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,12374,,CHEMBL622306,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,12375,,CHEMBL626864,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,12376,,CHEMBL626865,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,12377,,CHEMBL626866,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,12378,,CHEMBL626867,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,12379,,CHEMBL626868,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,12380,,CHEMBL626869,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,12381,,CHEMBL626870,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,12382,,CHEMBL626871,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,12383,,CHEMBL626872,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,12384,,CHEMBL632185,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,12385,,CHEMBL632186,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14103,,
Amount of acetic acid produced by the compound,12386,,CHEMBL629310,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12904,,
Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,12387,,CHEMBL629311,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12904,,
Log of (Cbrain/Cblood) in rats,12388,,CHEMBL629312,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9663,,
Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),12389,,CHEMBL629313,22224,BAO_0000221,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),12390,,CHEMBL629314,22224,BAO_0000221,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),12391,,CHEMBL629315,22224,BAO_0000221,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),12392,,CHEMBL629316,22224,BAO_0000219,,,,1,,,,,,0,Autocuration,U,B,,7652,,
Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),12393,,CHEMBL629317,22224,BAO_0000221,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),12394,,CHEMBL629318,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),12395,,CHEMBL877497,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),12396,,CHEMBL629319,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),12397,,CHEMBL629320,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),12398,,CHEMBL629496,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),12399,,CHEMBL629497,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),12400,,CHEMBL629498,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),12401,,CHEMBL629499,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),12402,,CHEMBL629500,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),12403,,CHEMBL629501,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),12404,,CHEMBL629502,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7652,,
Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,12405,,CHEMBL629503,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,F,,8267,,
Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,12406,,CHEMBL629504,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8267,,
Compound was evaluated for the rate of degradation by Carboxypeptidase A.,12407,,CHEMBL629505,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14479,,
Compound was evaluated for total body clearance,12408,,CHEMBL629506,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17515,,
Compound was evaluated for volume of distribution at steady state,12409,,CHEMBL629507,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17515,,
Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,12410,,CHEMBL877498,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8142,,
Percentage of the diamine which is monoprotonated at pH 7.4,12411,,CHEMBL629508,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14849,,
Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,12412,,CHEMBL629509,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7653,,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,12413,,CHEMBL629510,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,12414,,CHEMBL629511,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12415,,CHEMBL629512,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12416,,CHEMBL629513,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,12417,,CHEMBL629514,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12418,,CHEMBL628447,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,12419,,CHEMBL628448,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,12420,,CHEMBL628449,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,12421,,CHEMBL631119,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,12422,,CHEMBL631120,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,12423,,CHEMBL631121,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,12424,,CHEMBL874458,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12425,,CHEMBL631122,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12426,,CHEMBL631123,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12427,,CHEMBL631124,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,12428,,CHEMBL631125,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12429,,CHEMBL631290,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12430,,CHEMBL631291,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12431,,CHEMBL631292,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,12432,,CHEMBL631293,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12433,,CHEMBL631294,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12434,,CHEMBL631295,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,12435,,CHEMBL631296,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12436,,CHEMBL631297,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8631,,
Maximum biodistribution (Bmax) was determined.,12437,,CHEMBL631298,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,10263,,
Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,12438,,CHEMBL631299,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12364,,
Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,12439,,CHEMBL631300,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12364,,
Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,12440,,CHEMBL631301,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12364,,
Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,12441,,CHEMBL630291,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12364,,
Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,12442,,CHEMBL630292,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,12443,,CHEMBL630293,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,12444,,CHEMBL630294,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,12445,,CHEMBL630295,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,12446,,CHEMBL630296,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,12447,,CHEMBL626782,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,12448,,CHEMBL626783,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,12449,,CHEMBL626784,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,12450,,CHEMBL626785,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,12451,,CHEMBL626786,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12452,,CHEMBL626787,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,12453,,CHEMBL626788,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,12454,,CHEMBL625927,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12455,,CHEMBL625928,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,12456,,CHEMBL625929,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,12457,,CHEMBL625930,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",12458,,CHEMBL625931,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,12459,,CHEMBL627230,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12460,,CHEMBL627231,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12461,,CHEMBL627232,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,12462,,CHEMBL627233,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12463,,CHEMBL875470,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12464,,CHEMBL627234,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12465,,CHEMBL627235,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12466,,CHEMBL627236,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12467,,CHEMBL627237,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12468,,CHEMBL627238,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12469,,CHEMBL627239,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12470,,CHEMBL627240,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12471,,CHEMBL627241,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12472,,CHEMBL627242,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,12473,,CHEMBL627243,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12474,,CHEMBL627244,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12475,,CHEMBL627245,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12476,,CHEMBL627246,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12477,,CHEMBL627247,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12478,,CHEMBL627248,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12479,,CHEMBL627249,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12480,,CHEMBL625569,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12481,,CHEMBL625570,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12482,,CHEMBL625571,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,12483,,CHEMBL625572,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12484,,CHEMBL625573,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,12485,,CHEMBL625574,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12486,,CHEMBL626245,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12487,,CHEMBL626246,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12488,,CHEMBL626247,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12489,,CHEMBL626248,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,12490,,CHEMBL626249,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12491,,CHEMBL626420,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,12492,,CHEMBL626421,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,12493,,CHEMBL626422,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12494,,CHEMBL626423,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12495,,CHEMBL626424,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,12496,,CHEMBL626425,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12023,,
Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,12497,,CHEMBL875476,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12023,,
Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,12498,,CHEMBL626426,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,12023,,
Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,12499,,CHEMBL626427,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,10580,,
Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,12500,,CHEMBL626428,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,10580,,
Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,12501,,CHEMBL626429,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,16032,,
Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,12502,,CHEMBL625025,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,16032,,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12503,,CHEMBL625026,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12504,,CHEMBL625027,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12505,,CHEMBL874410,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12506,,CHEMBL625028,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12507,,CHEMBL625029,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12508,,CHEMBL625030,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12509,,CHEMBL625031,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12510,,CHEMBL625032,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12511,,CHEMBL625033,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12512,,CHEMBL625034,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12513,,CHEMBL624872,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12514,,CHEMBL624873,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12515,,CHEMBL624874,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12516,,CHEMBL624875,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12517,,CHEMBL624876,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12518,,CHEMBL624877,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12519,,CHEMBL624878,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12520,,CHEMBL624879,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12521,,CHEMBL624880,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,12522,,CHEMBL624881,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",12523,,CHEMBL624882,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12524,,CHEMBL624883,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12525,,CHEMBL624884,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12526,,CHEMBL624885,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12527,,CHEMBL624886,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12528,,CHEMBL624887,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12529,,CHEMBL624888,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12530,,CHEMBL624889,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12531,,CHEMBL624890,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12532,,CHEMBL621964,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12533,,CHEMBL621965,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12534,,CHEMBL621966,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12535,,CHEMBL621967,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12536,,CHEMBL622164,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),12537,,CHEMBL623097,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7653,,
Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),12538,,CHEMBL623098,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7653,,
Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,12539,,CHEMBL623099,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7653,,
Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,12540,,CHEMBL623100,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7653,,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",12541,,CHEMBL628673,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9104,,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",12542,,CHEMBL628674,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9104,,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",12543,,CHEMBL628675,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9104,,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",12544,,CHEMBL627644,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9104,,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",12545,,CHEMBL627645,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9104,,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",12546,,CHEMBL627646,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9104,,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",12547,,CHEMBL627647,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9104,,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",12548,,CHEMBL627648,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9104,,
Free level in rat plasma,12549,,CHEMBL627649,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12902,,
Level reaching in blood plasma of rat or human was determined,12550,,CHEMBL628313,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6614,,
Log (Cbrain/Cblood) in rats,12551,,CHEMBL628314,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9663,,
Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,12552,,CHEMBL628315,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17658,,
Mean percentage of compound transport through membrane; expressed as membrane transport,12553,,CHEMBL628316,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17658,,
Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,12554,,CHEMBL628317,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14314,,
Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,12555,,CHEMBL628473,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7385,,
"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",12556,,CHEMBL628474,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7385,,
Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,12557,,CHEMBL628475,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7385,,
Net water uptake by a carrier mediated transport (%cm) mechanism,12558,,CHEMBL628476,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,1329,,
Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,12559,,CHEMBL628477,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12187,,
Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,12560,,CHEMBL628478,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,12187,,
"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",12561,,CHEMBL628479,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,12187,,
Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,12562,,CHEMBL628480,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12187,,
"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",12563,,CHEMBL628481,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12187,,
Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,12564,,CHEMBL628482,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12187,,
"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",12565,,CHEMBL628483,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12187,,
"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",12566,,CHEMBL628484,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,9278,,
"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",12567,,CHEMBL628485,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,9278,,
"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",12568,,CHEMBL628486,100710,BAO_0000218,,,,1,,1969.0,Macaca fascicularis,,9541.0,1,Intermediate,N,A,Plasma,9278,,
"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",12569,,CHEMBL628487,50587,BAO_0000218,,,,1,,1969.0,Homo sapiens,,9606.0,1,Intermediate,N,A,Plasma,9278,,
"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",12570,,CHEMBL628488,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,9278,,
"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",12571,,CHEMBL628489,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,9278,,
"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",12572,,CHEMBL628490,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,9278,,
Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,12573,,CHEMBL628491,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,12186,,
Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,12574,,CHEMBL877507,100710,BAO_0000218,,,,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,12186,,
Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,12575,,CHEMBL628492,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,12186,,
% metabolized in monkey S-9 after 2 hours (10 ug/mL),12576,,CHEMBL628493,22224,BAO_0000019,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12041,,
% metabolized in monkey S-9 after 2 hours (1 ug/ml),12577,,CHEMBL628494,22224,BAO_0000019,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12041,,
% metabolized in monkey S-9 after 2 hours (10 ug/ml),12578,,CHEMBL628495,22224,BAO_0000019,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12041,,
Permeability in Caco-2 assay at 10E-6,12579,,CHEMBL628496,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,6737,,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,12580,,CHEMBL628497,22224,BAO_0000218,,,,1,,955.0,,,,0,Autocuration,U,A,Brain,13758,,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,12581,,CHEMBL628498,22224,BAO_0000218,,,,1,,955.0,,,,0,Autocuration,U,A,Brain,13758,,
Plasma protein binding was determined,12582,,CHEMBL628499,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,5676,,
Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,12583,,CHEMBL627656,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,12584,,CHEMBL627657,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,12585,,CHEMBL626808,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,12586,,CHEMBL626809,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,12587,,CHEMBL626810,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,12588,,CHEMBL626811,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,12589,,CHEMBL874465,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,12590,,CHEMBL626812,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,12591,,CHEMBL626813,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,12592,,CHEMBL626814,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,14793,,
Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,12593,,CHEMBL626815,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14000,,
Partition coefficient (logP),12594,,CHEMBL628566,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,5948,,
Calculated partition coefficient (clogP) (CLOGP3 V3.4),12595,,CHEMBL628567,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13824,,
Calculated partition coefficient (clogP),12596,,CHEMBL628568,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,10778,,
C max in dog,12597,,CHEMBL628569,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,17237,,
C max in guinea pig,12598,,CHEMBL628570,50512,BAO_0000218,,,In vivo,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,17237,,
C max value was evaluated,12599,,CHEMBL628571,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,2809,,
Cmax value after oral dose of 0.1 mg//kg,12600,,CHEMBL628572,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11954,,
Cmax value after oral dose of 0.3 mg/kg,12601,,CHEMBL628573,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11954,,
Cmax value after oral dose of 1 mg/kg,12602,,CHEMBL628574,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11954,,
Cmax value after oral dose of 10 mg/kg,12603,,CHEMBL628575,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11954,,
Cmax value after oral dose of 23.4 mg/kg,12604,,CHEMBL628576,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11954,,
Cmax value after oral dose of 3 mg/kg,12605,,CHEMBL628577,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11954,,
Cmax value after oral dose of 3.87 mg/kg,12606,,CHEMBL628578,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11954,,
Cmax value in female Beagle dogs,12607,,CHEMBL874466,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12768,,
Cmax value in male rats,12608,,CHEMBL628579,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12768,,
Cmax value in rat plasma when administered 20 mg/kg perorally,12609,,CHEMBL628580,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,12780,,
Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,12610,,CHEMBL628581,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,15592,,
Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,12611,,CHEMBL628582,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,15592,,
Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,12612,,CHEMBL628583,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,17025,,
Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,12613,,CHEMBL625782,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,17025,,
Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,12614,,CHEMBL625783,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,17025,,
Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,12615,,CHEMBL625784,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17025,,
Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,12616,,CHEMBL625785,50797,BAO_0000218,,,,1,,1969.0,Macaca mulatta,,9544.0,1,Intermediate,N,A,Plasma,4236,,
C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,12617,,CHEMBL625786,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15791,,
C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,12618,,CHEMBL874467,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11149,,
"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",12619,,CHEMBL625787,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15592,,
cytotoxicity against HIV protease enzyme.,12620,,CHEMBL625964,50677,BAO_0000218,,,,1,,,Human immunodeficiency virus,,12721.0,1,Intermediate,N,A,,15778,,
Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,12621,,CHEMBL625965,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12745,,
Apparent clearance in mice after oral administration of 100 mg/kg of dose,12622,,CHEMBL625966,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12745,,
The plasma clearance in dog.,12623,,CHEMBL625967,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,13941,,
The plasma clearance in rat.,12624,,CHEMBL625968,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13941,,
Clearance from plasma in male Sprague-Dawley rats,12625,,CHEMBL625969,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,16449,,
Clearance from plasma in male cynomolgus monkeys,12626,,CHEMBL625970,100710,BAO_0000218,,,In vivo,1,,1969.0,Macaca fascicularis,,9541.0,1,Intermediate,N,A,Plasma,16449,,
"Clearance of compound (5 mg/kg, intravenously), in dog plasma",12627,,CHEMBL625971,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14224,,
Clearance of compound in dog plasma,12628,,CHEMBL625972,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14224,,
Clearance of compound in human plasma,12629,,CHEMBL625973,50587,BAO_0000218,,,In vivo,1,,1969.0,Homo sapiens,,9606.0,1,Intermediate,N,A,Plasma,14224,,
Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,12630,,CHEMBL625974,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14317,,
Clearance of compound when administered intravenously as an individual dose to a single dog.,12631,,CHEMBL625975,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14317,,
"Clearance (10 mg/kg, intravenously) in dog plasma",12632,,CHEMBL625976,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14224,,
Clearance value in dog,12633,,CHEMBL625977,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,17237,,
Clearance value in guinea pig,12634,,CHEMBL625978,50512,BAO_0000218,,,In vivo,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,17237,,
Clearance values in rats after iv administration.,12635,,CHEMBL874468,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14187,,
Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,12636,,CHEMBL625421,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,4806,,
In vivo clearance (5 mg/kg) was determined in rabbits,12637,,CHEMBL625422,50592,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,15025,,
Plasma Clearance rate was determined for the compound in rats,12638,,CHEMBL625423,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13197,,
Plasma Clearance rate was determined for the compound in squirrel monkeys,12639,,CHEMBL625424,22224,BAO_0000218,,,In vivo,1,,,Saimiri,,9520.0,0,Autocuration,U,A,,13197,,
Plasma clearance in rat,12640,,CHEMBL625425,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13960,,
Plasma clearance of the compound,12641,,CHEMBL625426,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,17820,,
Plasma clearance in guinea pigs at 2 mg/kg after iv administration,12642,,CHEMBL625427,50512,BAO_0000218,,,In vivo,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,14706,,
Plasma clearance in guinea pigs at 3 mg/kg after iv administration,12643,,CHEMBL625428,50512,BAO_0000218,,,In vivo,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,14706,,
Plasma clearance was determined,12644,,CHEMBL625429,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,6504,,
Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,12645,,CHEMBL625430,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14925,,
Plasma clearance rate was determined for the compound in rats,12646,,CHEMBL625431,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13197,,
Plasma clearance rate was determined for the compound in squirrel monkeys,12647,,CHEMBL627307,22224,BAO_0000218,,,In vivo,1,,,Saimiri,,9520.0,0,Autocuration,U,A,,13197,,
Slow clearance (CL) was determined,12648,,CHEMBL627308,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,3437,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,12649,,CHEMBL627309,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,12650,,CHEMBL627310,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,12651,,CHEMBL627311,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,12652,,CHEMBL627312,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,12653,,CHEMBL627313,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,12654,,CHEMBL627314,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,12655,,CHEMBL627315,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12656,,CHEMBL627316,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12657,,CHEMBL627317,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12658,,CHEMBL627318,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,12659,,CHEMBL627999,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12660,,CHEMBL628000,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,12661,,CHEMBL628001,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12662,,CHEMBL628002,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,12663,,CHEMBL625610,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12664,,CHEMBL625611,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,12665,,CHEMBL625612,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,12666,,CHEMBL625613,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12667,,CHEMBL875479,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,12668,,CHEMBL625614,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,12669,,CHEMBL625615,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,12670,,CHEMBL626302,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,9196,,
Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12671,,CHEMBL626303,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12672,,CHEMBL627420,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8374,,
Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,12673,,CHEMBL627421,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,12674,,CHEMBL625695,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,12675,,CHEMBL625696,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Distribution of compound in mice brain was measured after 1 hr,12676,,CHEMBL875606,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,10009,,
Distribution of compound in mice brain was measured after 24 hr r,12677,,CHEMBL625697,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,10009,,
Distribution of compound in mice brain was measured after 2 hr,12678,,CHEMBL625698,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,10009,,
Distribution of compound in mice brain was measured after 3 hr,12679,,CHEMBL625699,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,10009,,
Distribution of compound in mice brain was measured after 6 hr,12680,,CHEMBL625700,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,10009,,
Distribution of compound in mice liver was measured after 1 hr,12681,,CHEMBL625701,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,10009,,
Distribution of compound in mice liver was measured after 24 hr; b=Undetected,12682,,CHEMBL625702,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,10009,,
Distribution of compound in mice liver was measured after 2 hr,12683,,CHEMBL625703,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,10009,,
Distribution of compound in mice liver was measured after 3 hr,12684,,CHEMBL625704,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,10009,,
Distribution of compound in mice liver was measured after 6 hr,12685,,CHEMBL625705,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,10009,,
Distribution in dog adrenal medulla 30 min after administration.,12686,,CHEMBL625706,50588,BAO_0000218,,,,1,,1236.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Adrenal medulla,8170,,
Distribution in dog adrenal medulla 72 hours after administration.,12687,,CHEMBL625707,50588,BAO_0000218,,,,1,,1236.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Adrenal medulla,8170,,
Distribution in female dog Ovary 24 hours after administration.,12688,,CHEMBL625708,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog Ovary 72 hours after administration.,12689,,CHEMBL625709,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog adipose 24 hours after administration.,12690,,CHEMBL624180,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog adipose 72 hours after administration.,12691,,CHEMBL624181,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog adrenal cortex 72 hours after administration.,12692,,CHEMBL624182,50588,BAO_0000218,,,,1,,1235.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Adrenal cortex,8170,,
Distribution in female dog adrenal cortex 72 hours after administration.,12693,,CHEMBL624183,50588,BAO_0000218,,,,1,,1235.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Adrenal cortex,8170,,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12694,,CHEMBL624184,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12695,,CHEMBL877489,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12696,,CHEMBL624185,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12697,,CHEMBL624186,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12698,,CHEMBL624187,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12699,,CHEMBL624188,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12700,,CHEMBL624189,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12701,,CHEMBL624190,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12702,,CHEMBL624191,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12703,,CHEMBL624192,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12704,,CHEMBL624193,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12705,,CHEMBL624194,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12706,,CHEMBL624891,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12707,,CHEMBL624892,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12708,,CHEMBL624893,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12709,,CHEMBL627632,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12710,,CHEMBL627633,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12711,,CHEMBL627634,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12712,,CHEMBL627635,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12713,,CHEMBL627636,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12714,,CHEMBL626816,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12715,,CHEMBL626817,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12716,,CHEMBL626818,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12717,,CHEMBL626819,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12718,,CHEMBL626820,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12719,,CHEMBL626821,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12720,,CHEMBL626822,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12721,,CHEMBL626823,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12722,,CHEMBL626824,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12723,,CHEMBL626825,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12724,,CHEMBL626826,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12725,,CHEMBL626827,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12726,,CHEMBL626828,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12727,,CHEMBL626829,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12728,,CHEMBL626830,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12729,,CHEMBL627150,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12730,,CHEMBL627151,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12731,,CHEMBL627152,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12732,,CHEMBL627153,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Rate of acetate production by the compound was determined,12733,,CHEMBL627154,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12904,,
Rate of acetate production by the compound was determined; Not determined,12734,,CHEMBL627155,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12904,,
Rate of hydrolysis of nitrocefin by compound was evaluated in water,12735,,CHEMBL627156,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3730,,
Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,12736,,CHEMBL627157,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3627,,
Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,12737,,CHEMBL627158,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,13799,,
Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,12738,,CHEMBL627159,50592,BAO_0000218,,,,1,,1969.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Plasma,13799,,
Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,12739,,CHEMBL627160,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13799,,
Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,12740,,CHEMBL628540,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13799,,
Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,12741,,CHEMBL628541,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13799,,
Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,12742,,CHEMBL628542,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13799,,
Solubility after at a pH 1.2,12743,,CHEMBL628543,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6629,,
Solubility after at pH 1.2,12744,,CHEMBL628544,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6629,,
Solubility after injection of water,12745,,CHEMBL628545,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6629,,
Statistical significance of IC 50 values; Expressed as R value,12746,,CHEMBL628546,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14000,,
Systemic availability with respect to methyldopa was determined,12747,,CHEMBL874455,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8267,,
Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,12748,,CHEMBL628547,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13799,,
Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,12749,,CHEMBL628548,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,13799,,
"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",12750,,CHEMBL628549,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",12751,,CHEMBL628550,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",12752,,CHEMBL628551,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",12753,,CHEMBL628552,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",12754,,CHEMBL628553,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",12755,,CHEMBL628554,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",12756,,CHEMBL628555,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",12757,,CHEMBL628556,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",12758,,CHEMBL628557,50592,BAO_0000218,,,,1,,2113.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Kidney,7132,,
"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",12759,,CHEMBL628558,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",12760,,CHEMBL628559,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",12761,,CHEMBL628560,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",12762,,CHEMBL874456,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",12763,,CHEMBL628561,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",12764,,CHEMBL628562,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",12765,,CHEMBL628563,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",12766,,CHEMBL628564,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",12767,,CHEMBL628565,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",12768,,CHEMBL631248,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",12769,,CHEMBL631249,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",12770,,CHEMBL627214,50592,BAO_0000218,,,,1,,2113.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Kidney,7132,,
"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",12771,,CHEMBL874591,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",12772,,CHEMBL627215,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,12773,,CHEMBL625471,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,12774,,CHEMBL625472,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,7132,,
Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,12775,,CHEMBL625473,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,7132,,
Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,12776,,CHEMBL625474,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13317,,
The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,12777,,CHEMBL625475,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15341,,
The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,12778,,CHEMBL625476,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15341,,
The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,12779,,CHEMBL625477,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15341,,
The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,12780,,CHEMBL625478,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15341,,
The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,12781,,CHEMBL625479,50597,BAO_0000218,,,In vitro,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,esophageal tunica muscularis mucosae,12801,,
The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,12782,,CHEMBL625480,50597,BAO_0000218,,,In vitro,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,esophageal tunica muscularis mucosae,12801,,
The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,12783,,CHEMBL625481,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14856,,
Total body clearance at an intravenous dose of 5.2 mg/kg in rat,12784,,CHEMBL625482,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14062,,
Total body clearance at an intravenous dose of 5.5 mg/kg in rat,12785,,CHEMBL625483,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14062,,
Total body clearance at an intravenous dose of 6.3 mg/kg in rat,12786,,CHEMBL625484,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14062,,
Total body clearance at an intravenous dose of 6.5 mg/kg in rat,12787,,CHEMBL625485,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14062,,
Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,12788,,CHEMBL625486,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14346,,
Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,12789,,CHEMBL625487,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14346,,
Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,12790,,CHEMBL625488,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14346,,
Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,12791,,CHEMBL625489,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14346,,
Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,12792,,CHEMBL625490,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14346,,
Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,12793,,CHEMBL625491,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14346,,
Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,12794,,CHEMBL625492,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14346,,
plasma clearance in human,12795,,CHEMBL625493,50587,BAO_0000218,,,In vivo,1,,1969.0,Homo sapiens,,9606.0,1,Intermediate,N,A,Plasma,15711,,
Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,12796,,CHEMBL625494,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14886,,
Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,12797,,CHEMBL625495,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14886,,
Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,12798,,CHEMBL625496,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14886,,
1-Octanol/water partition coefficient measured at 7.4,12799,,CHEMBL625497,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,4115,,
Calculated partition coefficient (clogP),12800,,CHEMBL625498,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13733,,
Partition coefficient (logP),12801,,CHEMBL625499,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12102,,
Calculated partition coefficient (clogP),12802,,CHEMBL625500,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,12676,,
Calculated partition coefficient (clogP),12803,,CHEMBL625501,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13733,,
Calculated partition coefficient (clogP),12804,,CHEMBL625502,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13740,,
Calculated partition coefficient (clogP) (relative to BAY K 8644),12805,,CHEMBL625503,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,12766,,
Calculated partition coefficient (clogP),12806,,CHEMBL625504,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,2764,,
Calculated partition coefficient (clogP),12807,,CHEMBL625505,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,12355,,
Calculated partition coefficient of the compound,12808,,CHEMBL625506,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,11314,,
Partition coefficient (logP),12809,,CHEMBL625507,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12706,,
Calculated partition coefficient (clogP),12810,,CHEMBL625508,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,12645,,
Calculated partition coefficient (clogP),12811,,CHEMBL625509,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13668,,
Calculated partition coefficient (clogP),12812,,CHEMBL625510,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,12819,,
Calculated partition coefficient (clogP),12813,,CHEMBL883125,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13668,,
Calculated partition coefficient (clogP),12814,,CHEMBL625511,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13017,,
Partition coefficient of the compound,12815,,CHEMBL874650,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2448,,
Partition coefficient of the compound,12816,,CHEMBL625512,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11526,,
Partition coefficient of compound was determined,12817,,CHEMBL625513,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12426,,
Partition coefficient was determined,12818,,CHEMBL625514,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2448,,
Calculated partition coefficient (clogP),12819,,CHEMBL625515,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,12001,,
partition coefficient of compound was determined,12820,,CHEMBL625516,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,12426,,
The total body administered intravenously in dog,12821,,CHEMBL625517,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13204,,
The total body administered intravenously in rats,12822,,CHEMBL625518,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13204,,
Time taken for the administration to female NIH mice weighing 25-30 g.,12823,,CHEMBL625519,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13889,,
Time taken for the administration,12824,,CHEMBL625520,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13889,,
Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,12825,,CHEMBL874651,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,17025,,
Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,12826,,CHEMBL625521,22224,BAO_0000218,,,In vivo,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,17025,,
Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,12827,,CHEMBL623171,50592,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,17025,,
Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,12828,,CHEMBL623853,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,17025,,
Plasma clearance for the compound was determined.,12829,,CHEMBL623854,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15067,,
CLog P value of the compound,12830,,CHEMBL874405,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,3091,,
Calculated partition coefficient (clogP),12831,,CHEMBL623855,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,15592,,
Calculated partition coefficient (clogP),12832,,CHEMBL623856,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14738,,
ClogP value of the compound; nd ='no data',12833,,CHEMBL623857,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14738,,
ClogP value of the compound; nd ='not determined',12834,,CHEMBL623858,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14738,,
CLog P was determined,12835,,CHEMBL623859,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6076,,
Calculated partition coefficient (clogP),12836,,CHEMBL839829,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,17840,,
CLogP was calculated,12837,,CHEMBL623860,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13589,,
CLogP value was determined,12838,,CHEMBL623861,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17655,,
CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,12839,,CHEMBL623862,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,5867,,
Calculated partition coefficient (clogP),12840,,CHEMBL874406,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,5867,,
Calculated partition coefficient (clogP),12841,,CHEMBL623863,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,10783,,
Calculated partition coefficient (clogP),12842,,CHEMBL624021,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14849,,
Distribution in female dog adrenal medulla 24 hours after administration.,12843,,CHEMBL624022,50588,BAO_0000218,,,,1,,1236.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Adrenal medulla,8170,,
Distribution in female dog adrenal medulla 72 hours after administration.,12844,,CHEMBL624023,50588,BAO_0000218,,,,1,,1236.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Adrenal medulla,8170,,
Distribution in female dog bile 24 hours after administration.,12845,,CHEMBL624024,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog bile 72 hr after administration.,12846,,CHEMBL624025,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog blood 24 hours after administration.,12847,,CHEMBL624026,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog blood 72 hours after administration.,12848,,CHEMBL624027,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog heart 24 hours after administration.,12849,,CHEMBL624028,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog heart 72 hours after administration.,12850,,CHEMBL624029,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog kidney 24 hours after administration.,12851,,CHEMBL624030,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog kidney 72 hours after administration.,12852,,CHEMBL624031,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog large intestine 24 hours after administration.,12853,,CHEMBL624032,50588,BAO_0000218,,,,1,,160.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Intestine,8170,,
Distribution in female dog large intestine 72 hours after administration.,12854,,CHEMBL874407,50588,BAO_0000218,,,,1,,160.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Intestine,8170,,
Distribution in female dog liver 24 hours after administration.,12855,,CHEMBL624033,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog liver 72 hours after administration.,12856,,CHEMBL624034,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog lung 24 hours after administration.,12857,,CHEMBL624035,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog lung 72 hours after administration.,12858,,CHEMBL624036,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog muscle 24 hours after administration.,12859,,CHEMBL624037,50588,BAO_0000218,,,,1,,2385.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Muscle tissue,8170,,
Distribution in female dog muscle 72 hours after administration.,12860,,CHEMBL624038,50588,BAO_0000218,,,,1,,2385.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Muscle tissue,8170,,
Distribution in female dog pancreas 24 hours after administration.,12861,,CHEMBL624039,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog pancreas 72 hours after administration.,12862,,CHEMBL624040,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8170,,
Distribution in female dog small intestine 24 hours after administration.,12863,,CHEMBL624041,50588,BAO_0000218,,,,1,,160.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Intestine,8170,,
Distribution in female dog small intestine 72 hours after administration.,12864,,CHEMBL624042,50588,BAO_0000218,,,,1,,160.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Intestine,8170,,
Distribution in female dog spleen 24 hours after administration.,12865,,CHEMBL624043,50588,BAO_0000218,,,,1,,2106.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Spleen,8170,,
Distribution in female dog spleen 72 hours after administration.,12866,,CHEMBL624044,50588,BAO_0000218,,,,1,,2106.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Spleen,8170,,
Distribution in female dog stomach 24 hours after administration.,12867,,CHEMBL624045,50588,BAO_0000218,,,,1,,945.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Stomach,8170,,
Distribution in female dog stomach 72 hours after administration.,12868,,CHEMBL624046,50588,BAO_0000218,,,,1,,945.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Stomach,8170,,
Distribution in female dog thyroid 24 hours after administration.,12869,,CHEMBL624047,50588,BAO_0000218,,,,1,,2046.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Thyroid gland,8170,,
Distribution in female dog thyroid 72 hours after administration.,12870,,CHEMBL624048,50588,BAO_0000218,,,,1,,2046.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Thyroid gland,8170,,
Distribution in female dog urine 24 hours after administration.,12871,,CHEMBL874408,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8170,,
Distribution in female dog urine 72 hr after administration.,12872,,CHEMBL624049,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8170,,
Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,12873,,CHEMBL624050,22224,BAO_0000218,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14283,,
Plasma concentration at 7 hr after intravenous dosing,12874,,CHEMBL624051,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,5623,,
Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,12875,,CHEMBL623278,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,12876,,CHEMBL623279,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration of 3 mg/kg iv after 1 hr in rats,12877,,CHEMBL623280,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration of 3 mg/kg iv after 2 hr in rats,12878,,CHEMBL623963,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration of 3 mg/kg iv after 4 hr in rats,12879,,CHEMBL623964,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration of 3 mg/kg iv after 6 hr in rats,12880,,CHEMBL623965,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration of 3 mg/kg po after 0.083 hr in rats,12881,,CHEMBL623966,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,12882,,CHEMBL874415,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,12883,,CHEMBL623967,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,12884,,CHEMBL623968,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,12885,,CHEMBL623969,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,12886,,CHEMBL628409,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,12887,,CHEMBL628410,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,12888,,CHEMBL628411,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,12889,,CHEMBL628412,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,12890,,CHEMBL628413,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12553,,
The concentration in plasmat; Not determined,12891,,CHEMBL628414,22224,BAO_0000019,,,,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14548,,
Tissue level at 10 mg/kg/po in wistar rats in blood,12892,,CHEMBL628415,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14393,,
Tissue level at 10 mg/kg/po in wistar rats in brown fat,12893,,CHEMBL628416,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14393,,
Tissue level at 10 mg/kg/po in wistar rats in heart,12894,,CHEMBL628417,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14393,,
Tissue level at 10 mg/kg/po in wistar rats in liver,12895,,CHEMBL874908,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,14393,,
Tissue level at 10 mg/kg/po in wistar rats in plasma,12896,,CHEMBL628418,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14393,,
Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,12897,,CHEMBL628419,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,14393,,
Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,12898,,CHEMBL628420,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14393,,
Water solubility at 37 degree C.,12899,,CHEMBL628421,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,1629,,
Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,12900,,CHEMBL626726,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8194,,
Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,12901,,CHEMBL626727,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8194,,
Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12902,,CHEMBL626728,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12903,,CHEMBL626729,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12904,,CHEMBL626730,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12905,,CHEMBL626731,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12906,,CHEMBL626732,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8594,,
Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12907,,CHEMBL626733,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12908,,CHEMBL626734,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12909,,CHEMBL626735,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12910,,CHEMBL874909,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12911,,CHEMBL626736,50597,BAO_0000218,,,,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,8594,,
Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12912,,CHEMBL626737,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12913,,CHEMBL630999,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12914,,CHEMBL631000,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12915,,CHEMBL631001,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12916,,CHEMBL631002,50597,BAO_0000218,,,,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,8594,,
Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12917,,CHEMBL631003,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12918,,CHEMBL631004,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12919,,CHEMBL631005,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12920,,CHEMBL631006,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12921,,CHEMBL631007,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,8594,,
Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12922,,CHEMBL631008,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12923,,CHEMBL631009,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12924,,CHEMBL631010,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12925,,CHEMBL631011,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12926,,CHEMBL631012,50597,BAO_0000218,,,,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,8594,,
Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12927,,CHEMBL630271,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12928,,CHEMBL630272,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12929,,CHEMBL630273,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12930,,CHEMBL630274,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12931,,CHEMBL630275,50597,BAO_0000218,,,,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,8594,,
Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,12932,,CHEMBL875782,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,12933,,CHEMBL630276,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,12934,,CHEMBL630277,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,12935,,CHEMBL630278,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,12936,,CHEMBL630279,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8594,,
Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,12937,,CHEMBL630280,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8151,,
Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,12938,,CHEMBL630281,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8151,,
Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,12939,,CHEMBL630282,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,7132,,
Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,12940,,CHEMBL630283,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,7132,,
Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),12941,,CHEMBL630284,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,5797,,
Alkylating activity was determined,12942,,CHEMBL630285,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7849,,
Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),12943,,CHEMBL630286,22224,BAO_0000251,,,,1,,,,,,0,Autocuration,U,A,,14220,Microsomes,
"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",12944,,CHEMBL630069,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,8650,,
"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",12945,,CHEMBL630070,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,8650,,
"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",12946,,CHEMBL630071,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,8650,,
"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",12947,,CHEMBL630072,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,8650,,
"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",12948,,CHEMBL875110,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,8650,,
Compound was tested for antidiuretic activity in rats,12949,,CHEMBL630073,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7116,,
Compound was tested for inactivation kinetic values,12950,,CHEMBL630074,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14131,,
Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,12951,,CHEMBL630075,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,7415,,
Dissociation rate calculated from the first-order equation using the t1/2 value,12952,,CHEMBL630076,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13178,,
Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,12953,,CHEMBL630077,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8815,,
Aqueous solubility was measured,12954,,CHEMBL630078,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,1450,,
Aqueous solubility was measured at a pH 4,12955,,CHEMBL630079,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,1450,,
Aqueous solubility (pH 7),12956,,CHEMBL630080,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,1450,,
Aqueous solubility was measured at a pH 9,12957,,CHEMBL630081,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,1450,,
"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",12958,,CHEMBL630082,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12711,,
"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",12959,,CHEMBL630083,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12711,,
"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",12960,,CHEMBL630084,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12711,,
Aqueous solubility of the compound,12961,,CHEMBL629198,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,15032,,
Aqueous solubility at 37 degree Celsius at pH 7.38,12962,,CHEMBL629199,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,9964,,
Aqueous solubility in pH 7.4 phosphate buffer,12963,,CHEMBL629200,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14962,,
Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,12964,,CHEMBL629201,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12487,,
Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,12965,,CHEMBL629202,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12487,,
Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,12966,,CHEMBL875111,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,10026,,
Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,12967,,CHEMBL629203,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,10026,,
The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,12968,,CHEMBL629204,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,10026,,
The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,12969,,CHEMBL629205,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,10026,,
The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,12970,,CHEMBL629206,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,10026,,
The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,12971,,CHEMBL631185,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10026,,
Compound was evaluated for the average bile flow rat in rats,12972,,CHEMBL631186,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7415,,
"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",12973,,CHEMBL631187,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,17025,,
"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",12974,,CHEMBL631188,50592,BAO_0000218,,,,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,17025,,
Average half life period was determined,12975,,CHEMBL876419,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10184,,
Average half life period was determined,12976,,CHEMBL631189,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10184,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,12977,,CHEMBL631190,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,12978,,CHEMBL631191,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,12979,,CHEMBL631192,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,12980,,CHEMBL632400,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,12981,,CHEMBL630564,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,12982,,CHEMBL630565,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,12983,,CHEMBL630566,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,12984,,CHEMBL631229,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,12985,,CHEMBL631230,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Calculated partition coefficient (clogP),12986,,CHEMBL876428,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6030,,
Calculated partition coefficient (clogP),12987,,CHEMBL631231,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6147,,
Calculated partition coefficient (clogP) (MacLogP),12988,,CHEMBL631232,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14556,,
Hydrophilicity was determined,12989,,CHEMBL631233,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,768,,
Calculated partition coefficient (clogP),12990,,CHEMBL631234,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14452,,
Increased absorption was determined,12991,,CHEMBL883126,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,5237,,
Lipophilicity value was evaluated,12992,,CHEMBL631235,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14378,,
Log P value of the compound.,12993,,CHEMBL631236,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14418,,
Partition coefficient of compound was determined,12994,,CHEMBL631237,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,5249,,
Calculated partition coefficient (clogP),12995,,CHEMBL631238,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14621,,
Calculated partition coefficient (clogP),12996,,CHEMBL876429,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,12542,,
Partition coefficient was measured by medchem software; Not calculated,12997,,CHEMBL631414,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12542,,
Partition coefficient was measured by octanol-water using standard shake-flask method,12998,,CHEMBL631415,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,12542,,
Calculated partition coefficient (clogP),12999,,CHEMBL631416,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,15462,,
Partition coefficient (logP),13000,,CHEMBL631417,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14884,,
Calculated partition coefficient (clogP),13001,,CHEMBL631418,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,16526,,
The Octanol/Water partition coefficient CLogP,13002,,CHEMBL631419,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13693,,
The pharmacokinetic parameter C Log p was reported,13003,,CHEMBL631420,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13693,,
Calculated partition coefficient (clogP),13004,,CHEMBL631421,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13779,,
Calculated partition coefficient (clogP),13005,,CHEMBL631422,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14772,,
Calculated partition coefficient (clogP),13006,,CHEMBL631423,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14393,,
Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,13007,,CHEMBL876430,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,13008,,CHEMBL631424,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
Compound was administered intravenously in dog to evaluate plasma clearance values,13009,,CHEMBL631425,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,13744,,
Compound was administered intravenously in monkey to evaluate plasma clearance values,13010,,CHEMBL631426,22224,BAO_0000218,,,In vivo,1,,1969.0,Simiiformes,,314293.0,0,Autocuration,U,A,Plasma,13744,,
Compound was administered intravenously in mouse to evaluate plasma clearance values,13011,,CHEMBL631427,50594,BAO_0000218,,,In vivo,1,,1969.0,Mus musculus,,10090.0,1,Intermediate,N,A,Plasma,13744,,
Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,13012,,CHEMBL631428,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,13207,,
Intrinsic clearance in Rhesus liver microsome,13013,,CHEMBL631429,50797,BAO_0000218,,,In vitro,1,,2107.0,Macaca mulatta,,9544.0,1,Intermediate,N,A,Liver,5669,Microsomes,
Intrinsic clearance in dog liver microsome,13014,,CHEMBL631430,50588,BAO_0000218,,,In vitro,1,,2107.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Liver,5669,Microsomes,
Intrinsic clearance in rat liver microsome,13015,,CHEMBL631431,50597,BAO_0000218,,,In vitro,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,5669,Microsomes,
Low plasma clearance was calculated in rhesus monkey,13016,,CHEMBL631432,50797,BAO_0000218,,,In vivo,1,,1969.0,Macaca mulatta,,9544.0,1,Intermediate,N,A,Plasma,4853,,
Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,13017,,CHEMBL631433,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,16452,,
Plasma clearance after intravenous dose of 0.3 mg/kg,13018,,CHEMBL631434,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11954,,
Plasma clearance after intravenous dose of 1 mg/kg,13019,,CHEMBL631435,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11954,,
Plasma clearance after intravenous dose of 3 mg/kg,13020,,CHEMBL631436,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11954,,
Plasma clearance after intravenous dose of 3.87 mg/kg,13021,,CHEMBL631437,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,11954,,
Plasma clearance after peroral administration at 10 mpk in Rat,13022,,CHEMBL631438,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5669,,
Plasma clearance after peroral administration at 10 mpk in Rhesus,13023,,CHEMBL876431,50797,BAO_0000218,,,In vivo,1,,,Macaca mulatta,,9544.0,1,Intermediate,N,A,,5669,,
Plasma clearance after peroral administration at 10 mpk in dog,13024,,CHEMBL631439,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,5669,,
Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,13025,,CHEMBL631440,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13662,,
Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),13026,,CHEMBL631441,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8272,,
Critical Micellar concentration was determined,13027,,CHEMBL631442,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13410,,
Critical Micellar concentration of the compound. was determined,13028,,CHEMBL626525,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13410,,
Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,13029,,CHEMBL627168,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12628,,
Critical micellar concentration was measured in water by the dye solubilization method,13030,,CHEMBL875618,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9675,,
Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,13031,,CHEMBL626612,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,B,,12628,,
CMR value (relative to BAY K 8644),13032,,CHEMBL626613,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12766,,
Carbamoylating activity was determined,13033,,CHEMBL626614,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7849,,
Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,13034,,CHEMBL626615,22224,BAO_0000218,,,,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12187,,
Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,13035,,CHEMBL626616,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2040,,
Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,13036,,CHEMBL626617,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2040,,
Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,13037,,CHEMBL626618,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,14180,,
Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,13038,,CHEMBL626619,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14180,,
"Clearance rate at 0.46 mg/kg, iv, in dogs",13039,,CHEMBL626620,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14474,,
"Clearance rate at 5.5 mg/kg, iv, in rat",13040,,CHEMBL626621,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14474,,
Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,13041,,CHEMBL626622,100710,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14548,,
Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,13042,,CHEMBL626623,100710,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14548,,
Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,13043,,CHEMBL626624,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,14548,,
Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,13044,,CHEMBL626625,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14548,,
Clearance rate constant using isolated perfused rat liver (IPRL) assay,13045,,CHEMBL626626,50597,BAO_0000218,,,Ex vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,6125,,
Tested for the total clearance of the compound,13046,,CHEMBL626627,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,6874,,
The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,13047,,CHEMBL626628,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15343,,
Total body clearance was determined,13048,,CHEMBL626629,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,6236,,
Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,13049,,CHEMBL626630,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,13050,,CHEMBL626631,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,13051,,CHEMBL626632,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8194,,
Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,13052,,CHEMBL626633,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8194,,
Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,13053,,CHEMBL626634,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8194,,
Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,13054,,CHEMBL626635,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8194,,
Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,13055,,CHEMBL626636,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8194,,
Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,13056,,CHEMBL626637,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8194,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),13057,,CHEMBL626638,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,13058,,CHEMBL626639,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,13059,,CHEMBL626640,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,13060,,CHEMBL626641,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,13061,,CHEMBL627272,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,13062,,CHEMBL627273,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),13063,,CHEMBL627441,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),13064,,CHEMBL628355,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),13065,,CHEMBL628356,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),13066,,CHEMBL628357,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),13067,,CHEMBL628358,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),13068,,CHEMBL622307,50339,BAO_0000218,,,,1,,,Pneumocystis carinii,,4754.0,1,Intermediate,N,A,,13273,,
Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,13069,,CHEMBL622527,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13118,,
Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,13070,,CHEMBL622528,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13118,,
Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,13071,,CHEMBL622529,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13118,,
Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,13072,,CHEMBL622992,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13118,,
Conversion rate by hydrolysis of compound in plasma after 6 hr. ,13073,,CHEMBL622993,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13118,,
Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,13074,,CHEMBL622994,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13118,,
"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",13075,,CHEMBL622995,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10633,,
"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",13076,,CHEMBL622996,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10633,,
"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",13077,,CHEMBL622997,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10633,,
"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",13078,,CHEMBL622998,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10633,,
Cp max following ip administration at 1 mg/kg,13079,,CHEMBL622999,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,5767,,
Maximum concentration in plasma was reported at 0.5 hour,13080,,CHEMBL623000,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,3302,,
Maximum concentration in plasma was reported at 2 hour,13081,,CHEMBL623001,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,3302,,
Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,13082,,CHEMBL623002,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12467,,
Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),13083,,CHEMBL623003,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,11778,,
Steady state concentration was evaluated,13084,,CHEMBL623004,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,4321,,
Partition coefficient (logP),13085,,CHEMBL623005,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14884,,
Partition coefficient (logD7.4),13086,,CHEMBL623006,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15234,,
Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,13087,,CHEMBL623007,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,13088,,CHEMBL623008,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,13089,,CHEMBL876654,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,13090,,CHEMBL623009,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,13091,,CHEMBL623010,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,13092,,CHEMBL623011,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,13093,,CHEMBL623012,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,14198,,
Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,13094,,CHEMBL623013,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8151,,
Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,13095,,CHEMBL623014,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8151,,
Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,13096,,CHEMBL623015,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,8151,,
Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,13097,,CHEMBL623016,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,8151,,
Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,13098,,CHEMBL624858,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,8151,,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,13099,,CHEMBL624859,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8151,,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,13100,,CHEMBL624860,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8151,,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,13101,,CHEMBL624861,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8151,,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,13102,,CHEMBL624862,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8151,,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,13103,,CHEMBL624863,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8151,,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,13104,,CHEMBL876655,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8151,,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,13105,,CHEMBL624864,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,13106,,CHEMBL624865,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,13107,,CHEMBL624866,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,13108,,CHEMBL624867,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Expert,N,F,,6996,,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,13109,,CHEMBL624868,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,13110,,CHEMBL628450,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,13111,,CHEMBL628451,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,13112,,CHEMBL628452,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,13113,,CHEMBL628453,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,13114,,CHEMBL628454,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,13115,,CHEMBL628455,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,13116,,CHEMBL628456,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,13117,,CHEMBL628457,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,13118,,CHEMBL877505,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,13119,,CHEMBL628458,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,13120,,CHEMBL628459,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,13121,,CHEMBL628460,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,13122,,CHEMBL628461,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",13123,,CHEMBL628462,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,B,,6996,,
Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13124,,CHEMBL628463,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",13125,,CHEMBL625666,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Expert,N,F,,6996,,
Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13126,,CHEMBL625667,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,B,,6996,,
Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13127,,CHEMBL625668,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Expert,N,A,,6996,,
Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13128,,CHEMBL625669,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,13129,,CHEMBL625670,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7114,,
Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,13130,,CHEMBL625671,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7114,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,13131,,CHEMBL625672,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,13132,,CHEMBL625673,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,13133,,CHEMBL625674,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,13134,,CHEMBL625675,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,13135,,CHEMBL627637,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,13136,,CHEMBL627638,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,13137,,CHEMBL627639,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,13138,,CHEMBL627640,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,13139,,CHEMBL627641,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,13140,,CHEMBL627642,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,13141,,CHEMBL877506,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,13142,,CHEMBL627275,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8613,,
"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",13143,,CHEMBL627643,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,11219,,
"Average area under curve value dosed at 10 mg/kg, id in ferrets.",13144,,CHEMBL631246,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,11219,,
"Average area under curve value dosed at 10 mg/kg, id in ferrets.",13145,,CHEMBL631247,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,11219,,
Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,13146,,CHEMBL629532,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,11219,,
Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,13147,,CHEMBL629533,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,11219,,
Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,13148,,CHEMBL629534,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,11219,,
Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,13149,,CHEMBL629535,50506,BAO_0000218,,,,1,,,Mustela putorius furo,,9669.0,1,Intermediate,N,A,,11219,,
Pharmacokinetic parameter :drug bound to plasma was reported,13150,,CHEMBL625932,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14837,,
compound was evaluated for drug bound in plasma,13151,,CHEMBL625933,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14837,,
The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,13152,,CHEMBL625934,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15343,,
Bioavailability,13153,,CHEMBL625935,22224,BAO_0000218,,,,1,,,Eutheria,,9347.0,0,Autocuration,U,A,,13761,,
Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,13154,,CHEMBL625936,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14810,,
Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,13155,,CHEMBL625937,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14810,,
Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,13156,,CHEMBL625938,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13249,,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,13157,,CHEMBL625939,50597,BAO_0000218,,,,1,,1970.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bile,9267,,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,13158,,CHEMBL625940,50597,BAO_0000218,,,,1,,1970.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bile,9267,,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,13159,,CHEMBL874464,50597,BAO_0000218,,,,1,,1970.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bile,9267,,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,13160,,CHEMBL625941,50597,BAO_0000218,,,,1,,1970.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bile,9267,,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,13161,,CHEMBL625942,50597,BAO_0000218,,,,1,,1970.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bile,9267,,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,13162,,CHEMBL625943,50597,BAO_0000218,,,,1,,1970.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bile,9267,,
In vitro protein binding in human serum at 5 ug/ml,13163,,CHEMBL625944,50587,BAO_0000218,,,,1,,1977.0,Homo sapiens,,9606.0,1,Intermediate,N,A,Serum,15549,,
Serum protein binding ability was measured,13164,,CHEMBL625945,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10929,,
The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),13165,,CHEMBL625946,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15444,,
Oral bioavailability in dog,13166,,CHEMBL625947,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,,12860,,
% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,13167,,CHEMBL625948,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12170,,
Absolute oral bioavailability at an iv dose of 14 mg/kg,13168,,CHEMBL625949,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
Absolute oral bioavailability at an iv dose of 15.2 mg/kg,13169,,CHEMBL625950,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
Oral bioavailability (dose 15 mg/kg i.v.),13170,,CHEMBL625951,22224,BAO_0000218,,,In vivo,1,,,Eutheria,,9347.0,0,Autocuration,U,A,,15173,,
Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,13171,,CHEMBL625952,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,13172,,CHEMBL625953,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,13173,,CHEMBL625954,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,13174,,CHEMBL882959,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,13175,,CHEMBL625955,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,11767,,
Bioavailability in ferret,13176,,CHEMBL625956,22224,BAO_0000218,,,In vivo,1,,,Mustela putorius furo,,9669.0,0,Autocuration,U,A,,11219,,
Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,13177,,CHEMBL625957,100710,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,12186,,
Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,13178,,CHEMBL625958,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,13179,,CHEMBL625959,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,13180,,CHEMBL626642,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,13181,,CHEMBL631330,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,13182,,CHEMBL631331,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,13183,,CHEMBL631332,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,13184,,CHEMBL631333,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,13185,,CHEMBL632018,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,13186,,CHEMBL632019,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,13187,,CHEMBL632020,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,13188,,CHEMBL632021,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,13189,,CHEMBL632022,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,13190,,CHEMBL632023,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,13191,,CHEMBL632024,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,13192,,CHEMBL874472,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,13193,,CHEMBL632025,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,13194,,CHEMBL632026,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,13195,,CHEMBL632027,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,13196,,CHEMBL632028,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,13197,,CHEMBL626430,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,13198,,CHEMBL626431,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,13199,,CHEMBL626432,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,13200,,CHEMBL626433,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,13201,,CHEMBL626434,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,13202,,CHEMBL627280,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,13203,,CHEMBL627281,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,13204,,CHEMBL627282,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Total body clearance was measured at given dose,13205,,CHEMBL627283,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7199,,
Total body clearance was measured at given dose.,13206,,CHEMBL627284,22224,BAO_0000218,,,,1,,,,,,0,Autocuration,U,A,,7199,,
Metabolic clearance from the body in rat,13207,,CHEMBL627285,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7095,,
Renal clearance from the body,13208,,CHEMBL627286,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,7095,,
Renal clearance from the body in rat,13209,,CHEMBL875477,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7095,,
Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,13210,,CHEMBL627287,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12528,,
Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,13211,,CHEMBL627288,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12528,,
Total clearance from the body in rat,13212,,CHEMBL627289,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7095,,
Clearance into cortex from rat plasma or PBS,13213,,CHEMBL627290,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14223,,
Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,13214,,CHEMBL627291,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13569,,
Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,13215,,CHEMBL627292,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13569,,
Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,13216,,CHEMBL627293,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13569,,
Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,13217,,CHEMBL627294,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13569,,
Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,13218,,CHEMBL875478,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13569,,
Clearance was determined,13219,,CHEMBL627295,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13979,,
Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,13220,,CHEMBL627296,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14315,,
Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,13221,,CHEMBL626119,50592,BAO_0000218,,,In vivo,1,,,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,,14315,,
Clearance was measured in rat after administration of compound 20 mg/kg intravenously,13222,,CHEMBL626120,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14315,,
Clearance in rat after iv dose (100 ug/kg),13223,,CHEMBL626121,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12174,,
Clearance in guinea pig,13224,,CHEMBL626122,22224,BAO_0000218,,,In vivo,1,,,Cavia porcellus,,10141.0,0,Autocuration,U,A,,12797,,
Compound was evaluated for clearance in rat,13225,,CHEMBL626123,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12797,,
Compound was evaluated for the clearance in dog,13226,,CHEMBL623456,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12797,,
Compound was evaluated for the clearance in rat,13227,,CHEMBL623457,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12797,,
Compound was tested in vivo for clearance after iv administration in the rat,13228,,CHEMBL623458,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11500,,
IV clearance determined at an iv dose of 14 mg/kg,13229,,CHEMBL623459,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
IV clearance determined at an iv dose of 15.2 mg/kg,13230,,CHEMBL875484,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
IV clearance determined at an iv dose of 15 mg/kg,13231,,CHEMBL623460,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
IV clearance determined at an peroral dose of 30 mg/kg.,13232,,CHEMBL623461,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
IV clearance determined at an peroral dose of 30.2 mg/kg.,13233,,CHEMBL623462,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
IV clearance determined at an peroral dose of 30.3 mg/kg.,13234,,CHEMBL627386,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,13235,,CHEMBL627387,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,13236,,CHEMBL627388,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,13237,,CHEMBL627389,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,13238,,CHEMBL627390,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,13239,,CHEMBL627391,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,13240,,CHEMBL627392,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,13241,,CHEMBL627393,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,14198,,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,13242,,CHEMBL627394,50597,BAO_0000218,,,In vivo,1,,3126.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Trachea,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,13243,,CHEMBL627395,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,13244,,CHEMBL875485,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,13245,,CHEMBL627396,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,13246,,CHEMBL627397,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,13247,,CHEMBL627398,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,13248,,CHEMBL627399,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,13249,,CHEMBL627400,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,13250,,CHEMBL627401,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,13251,,CHEMBL627402,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,13252,,CHEMBL627403,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,13253,,CHEMBL627404,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,13254,,CHEMBL623101,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,13255,,CHEMBL877480,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,14198,,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,13256,,CHEMBL623102,50597,BAO_0000218,,,In vivo,1,,3126.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Trachea,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,13257,,CHEMBL623103,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,13258,,CHEMBL623104,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,13259,,CHEMBL623105,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,13260,,CHEMBL623106,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,13261,,CHEMBL623107,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,13262,,CHEMBL623108,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,13263,,CHEMBL623109,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,13264,,CHEMBL623110,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,13265,,CHEMBL623111,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,13266,,CHEMBL625060,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,13267,,CHEMBL625061,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,13268,,CHEMBL625062,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,13269,,CHEMBL625063,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,13270,,CHEMBL625064,50597,BAO_0000218,,,In vivo,1,,3126.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Trachea,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,13271,,CHEMBL625065,50597,BAO_0000218,,,In vivo,1,,10000001.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Bone,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,13272,,CHEMBL625066,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,13273,,CHEMBL625067,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,13274,,CHEMBL625068,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,13275,,CHEMBL622159,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,13276,,CHEMBL622160,50597,BAO_0000218,,,In vivo,1,,160.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Intestine,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,13277,,CHEMBL622161,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,13278,,CHEMBL622162,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,13279,,CHEMBL622163,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,13280,,CHEMBL622313,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,13281,,CHEMBL622314,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,13282,,CHEMBL622315,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,14198,,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,13283,,CHEMBL622316,50597,BAO_0000218,,,In vivo,1,,3126.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Trachea,14198,,
Normal diffusion coefficient in water for Escherichia coli,13284,,CHEMBL877486,50212,BAO_0000218,,,,1,,,Escherichia coli,,562.0,1,Intermediate,N,A,,15599,,
Average max percent decrease in RVR (renal vascular resistance) was determined,13285,,CHEMBL622317,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8204,,
Average max percent decrease in RVR (renal vascular resistance) was determined.,13286,,CHEMBL622318,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8204,,
In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,13287,,CHEMBL622319,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6154,,
In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,13288,,CHEMBL622320,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6154,,
In vitro stability to pepsin promoting hydrolysis after 64h incubation time,13289,,CHEMBL622321,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6154,,
In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,13290,,CHEMBL622322,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6154,,
Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,13291,,CHEMBL622323,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7114,,
Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,13292,,CHEMBL622324,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7114,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",13293,,CHEMBL622325,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",13294,,CHEMBL622326,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",13295,,CHEMBL877487,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",13296,,CHEMBL622327,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",13297,,CHEMBL622328,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",13298,,CHEMBL622329,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",13299,,CHEMBL622330,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",13300,,CHEMBL622331,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",13301,,CHEMBL622332,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",13302,,CHEMBL622333,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",13303,,CHEMBL627658,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",13304,,CHEMBL630428,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",13305,,CHEMBL630429,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",13306,,CHEMBL630430,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",13307,,CHEMBL630431,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",13308,,CHEMBL630432,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",13309,,CHEMBL630433,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",13310,,CHEMBL630434,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",13311,,CHEMBL629372,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",13312,,CHEMBL629553,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",13313,,CHEMBL629554,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",13314,,CHEMBL874447,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",13315,,CHEMBL629555,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",13316,,CHEMBL629556,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",13317,,CHEMBL629557,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",13318,,CHEMBL629558,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",13319,,CHEMBL629559,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",13320,,CHEMBL629560,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",13321,,CHEMBL629561,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",13322,,CHEMBL629562,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",13323,,CHEMBL629563,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",13324,,CHEMBL629564,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",13325,,CHEMBL629565,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",13326,,CHEMBL629566,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",13327,,CHEMBL629567,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",13328,,CHEMBL629568,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",13329,,CHEMBL629569,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",13330,,CHEMBL629570,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",13331,,CHEMBL629571,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,13332,,CHEMBL629572,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,12170,,
% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,13333,,CHEMBL629573,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,12170,,
Bioavailability (dose 20 mg/kg),13334,,CHEMBL629574,22224,BAO_0000218,,,In vivo,1,,,Eutheria,,9347.0,0,Autocuration,U,A,,4985,,
Bioavailability in dog,13335,,CHEMBL629575,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,,15145,,
Bioavailability in rat (Sprague-Dawley) (male),13336,,CHEMBL874448,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,14080,,
Bioavailability in monkey (dose 10 mg/kg i.d.),13337,,CHEMBL629576,22224,BAO_0000218,,,In vivo,1,,,Primates,,9443.0,0,Autocuration,U,A,,11219,,
Bioavailability in rat,13338,,CHEMBL629577,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,15145,,
Bioavailability in rat,13339,,CHEMBL629578,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,15145,,
Bioavailability in dog (dose 3.0 mg/kg p.o.),13340,,CHEMBL629579,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,,1202,,
Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,13341,,CHEMBL882958,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,,1202,,
Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,13342,,CHEMBL629580,50505,BAO_0000218,,,In vivo,1,,,Pan troglodytes,,9598.0,1,Intermediate,N,A,,1202,,
Bioavailability,13343,,CHEMBL629581,22224,BAO_0000218,,,In vivo,1,,,Eutheria,,9347.0,0,Autocuration,U,A,,4026,,
Bioavailability in squirrel monkey,13344,,CHEMBL629582,22224,BAO_0000218,,,In vivo,1,,,Saimiri,,9520.0,0,Autocuration,U,A,,1492,,
Bioavailability was evaluated in dog,13345,,CHEMBL628522,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,12793,,
Bioavailability was evaluated in hamster,13346,,CHEMBL625432,100712,BAO_0000218,,,In vivo,1,,,Cricetinae,,10026.0,1,Intermediate,N,A,,12793,,
Bioavailability in rat,13347,,CHEMBL625433,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,12793,,
Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,13348,,CHEMBL625434,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,13349,,CHEMBL625435,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,14793,,
Bioavailability in rat (dose 10 mg/kg p.o.),13350,,CHEMBL625436,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,14793,,
Bioavailability was measured in cynomolgus monkeys.,13351,,CHEMBL874588,100710,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,14731,,
Bioavailability was measured in nude mice.,13352,,CHEMBL625437,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14731,,
Bioavailability in ferret (dose 10 mg/kg i.d.),13353,,CHEMBL625438,22224,BAO_0000218,,,In vivo,1,,,Mustela putorius furo,,9669.0,0,Autocuration,U,A,,12187,,
Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),13354,,CHEMBL625439,22224,BAO_0000218,,,In vivo,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12187,,
"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",13355,,CHEMBL625440,22224,BAO_0000218,,,In vivo,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12187,,
Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),13356,,CHEMBL625441,22224,BAO_0000218,,,In vivo,1,,,Simiiformes,,314293.0,0,Autocuration,U,A,,12187,,
Bioavailability in rat (dose 10 mg/kg i.d.),13357,,CHEMBL625442,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,12187,,
"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",13358,,CHEMBL625443,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12187,,
Bioavailability was determined; extremely poor,13359,,CHEMBL625444,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,17431,,
% bioavailability in mice after oral administration of prodrug,13360,,CHEMBL625445,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13318,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,13361,,CHEMBL625446,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,13362,,CHEMBL882960,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,13363,,CHEMBL625447,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,13364,,CHEMBL625448,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,13365,,CHEMBL625449,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),13366,,CHEMBL874589,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,13367,,CHEMBL625450,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,13368,,CHEMBL625451,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,13369,,CHEMBL626584,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,13370,,CHEMBL626585,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,13371,,CHEMBL626586,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,13372,,CHEMBL626587,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,13373,,CHEMBL626588,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,13374,,CHEMBL626589,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,13375,,CHEMBL626590,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,13376,,CHEMBL626591,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,13377,,CHEMBL627181,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,13378,,CHEMBL628083,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
IV clearance determined at an peroral dose of 15 mg/kg.,13379,,CHEMBL628084,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,15173,,
Mouse oral clearance was measured against Hymenolepiasis nana.,13380,,CHEMBL628085,50064,BAO_0000218,,,In vivo,1,,,Hymenolepis nana,,102285.0,1,Expert,N,F,,7732,,
Mouse oral clearance was measured against Nematospiroides dubius,13381,,CHEMBL628086,50545,BAO_0000218,,,In vivo,1,,,Heligmosomoides polygyrus,,6339.0,1,Expert,N,F,,7732,,
Mouse oral clearance was measured against N. dubius; NT is Not Tested,13382,,CHEMBL628087,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,F,,7732,,
Mouse oral clearance was measured against N. nana; NT is Not Tested,13383,,CHEMBL628088,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,7732,,
Mouse oral clearance was measured against N. nana; NT is Not Tested,13384,,CHEMBL628089,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,B,,7732,,
Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,13385,,CHEMBL628090,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,8328,,
Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,13386,,CHEMBL628091,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,8328,,
Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,13387,,CHEMBL628092,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,8328,,
Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,13388,,CHEMBL628093,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,8328,,
Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,13389,,CHEMBL875607,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,8328,,
Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,13390,,CHEMBL625710,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,8328,,
Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,13391,,CHEMBL625711,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,8328,,
Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,13392,,CHEMBL625712,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,8328,,
Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,13393,,CHEMBL625713,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,8328,,
Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,13394,,CHEMBL625714,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,13376,,
Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,13395,,CHEMBL625715,50797,BAO_0000218,,,In vivo,1,,,Macaca mulatta,,9544.0,1,Intermediate,N,A,,13477,,
Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,13396,,CHEMBL625716,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,13397,,CHEMBL625717,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13477,,
Plasma clearance was determined for the compound in rats,13398,,CHEMBL625718,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13313,,
Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,13399,,CHEMBL625719,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12504,,
Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,13400,,CHEMBL625720,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12504,,
Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,13401,,CHEMBL625721,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12504,,
Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,13402,,CHEMBL625722,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12504,,
The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,13403,,CHEMBL625723,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13129,,
Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,13404,,CHEMBL625724,50545,BAO_0000218,,,In vivo,1,,,Heligmosomoides polygyrus,,6339.0,1,Intermediate,N,A,,7732,,
Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,13405,,CHEMBL625725,50545,BAO_0000218,,,In vivo,1,,,Heligmosomoides polygyrus,,6339.0,1,Intermediate,N,A,,7732,,
Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,13406,,CHEMBL625726,50545,BAO_0000218,,,In vivo,1,,,Heligmosomoides polygyrus,,6339.0,1,Intermediate,N,A,,7732,,
Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,13407,,CHEMBL875608,50545,BAO_0000218,,,In vivo,1,,,Heligmosomoides polygyrus,,6339.0,1,Intermediate,N,A,,7732,,
Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,13408,,CHEMBL625727,50545,BAO_0000218,,,In vivo,1,,,Heligmosomoides polygyrus,,6339.0,1,Intermediate,N,A,,7732,,
Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,13409,,CHEMBL625728,22224,BAO_0000218,,,In vivo,1,,1088.0,Rattus norvegicus,,10116.0,0,Autocuration,U,A,Urine,9278,,
Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,13410,,CHEMBL625729,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,9278,,
Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,13411,,CHEMBL625730,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,9278,,
Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,13412,,CHEMBL625731,22224,BAO_0000218,,,In vivo,1,,1088.0,Rattus norvegicus,,10116.0,0,Autocuration,U,A,Urine,9278,,
Urinary clearance was determined in rat at 25 mg/kg os dosage,13413,,CHEMBL626417,22224,BAO_0000218,,,In vivo,1,,1088.0,Rattus norvegicus,,10116.0,0,Autocuration,U,A,Urine,9278,,
Urinary clearance was determined at 100 mg/kg oral dosage in human,13414,,CHEMBL626418,50587,BAO_0000218,,,In vivo,1,,1088.0,Homo sapiens,,9606.0,1,Intermediate,N,A,Urine,9278,,
Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,13415,,CHEMBL626419,50588,BAO_0000218,,,In vivo,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,9278,,
Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,13416,,CHEMBL626592,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,5932,,
Plasma concentration in rats after 7 hr at 30mg/kg oral dose,13417,,CHEMBL626593,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,5932,,
Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,13418,,CHEMBL626594,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5182,,
Clearance rate in dogs,13419,,CHEMBL625035,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,10499,,
Compound was measured for intrinsic clearance,13420,,CHEMBL625036,22224,BAO_0000019,,,In vitro,1,,,,,,0,Autocuration,U,A,,6051,,
Calculated partition coefficient (clogP),13421,,CHEMBL625037,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,17508,,
Calculated partition coefficient (clogP),13422,,CHEMBL625038,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6228,,
Calculated partition coefficient (clogP),13423,,CHEMBL625039,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6231,,
Calculated partition coefficient (clogP),13424,,CHEMBL625040,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,17740,,
Calculated partition coefficient (clogP),13425,,CHEMBL625041,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6495,,
Calculated partition coefficient (clogP),13426,,CHEMBL625042,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,2171,,
Partition coefficient of the compound,13427,,CHEMBL874411,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3255,,
Permeability,13428,,CHEMBL625043,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6821,,
Calculated partition coefficient (clogP),13429,,CHEMBL625044,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,2685,,
Partition coefficient (logD),13430,,CHEMBL625045,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17584,,
Calculated partition coefficient (clogP) (CLOGP3 V3.4),13431,,CHEMBL625046,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13824,,
Calculated partition coefficient (clogP) (CLOGP3 V3.4),13432,,CHEMBL625047,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13824,,
Calculated partition coefficient (clogP),13433,,CHEMBL625048,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,16479,,
Calculated partition coefficient (clogP),13434,,CHEMBL625049,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,11997,,
Calculated logarithm of partition coefficient (P) was determined,13435,,CHEMBL625050,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,2988,,
Calculated partition coefficient (clogP),13436,,CHEMBL625051,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,931,,
Calculated partition coefficient (clogP),13437,,CHEMBL874412,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,4381,,
Calculated partition coefficient (clogP),13438,,CHEMBL625052,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,4397,,
Calculated partition coefficient (clogP),13439,,CHEMBL625053,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,5889,,
In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,13440,,CHEMBL623250,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6154,,
In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,13441,,CHEMBL623251,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6154,,
In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,13442,,CHEMBL623252,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6154,,
In vitro stability to trypsin promoting hydrolysis after 64h incubation time,13443,,CHEMBL623253,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6154,,
In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,13444,,CHEMBL623254,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6154,,
In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,13445,,CHEMBL623255,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6154,,
Percent degradation of compound at a pH of 1 over a 18 hr period,13446,,CHEMBL626831,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6887,,
Percent degradation of compound at pH of 1 over an 18 hr period,13447,,CHEMBL877494,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6887,,
Delta Logarithm of Partition Coefficient value was determined.,13448,,CHEMBL626832,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14116,,
Delta logPoct-cyc,13449,,CHEMBL626833,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11137,,
Lipophilicity estimated on reversed phase TLC,13450,,CHEMBL626834,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,7230,,
Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,13451,,CHEMBL626835,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15741,,
Delta logPoct-cyc,13452,,CHEMBL626836,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9663,,
Change in logarithm of partition coefficient of the compound,13453,,CHEMBL626837,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,9663,,
Delta logD (pH 6.5),13454,,CHEMBL626838,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13807,,
"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",13455,,CHEMBL626839,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13807,,
Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,13456,,CHEMBL626840,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17425,,
Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),13457,,CHEMBL626841,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12143,,
Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,13458,,CHEMBL626842,22224,BAO_0000219,,,,1,,,,,,0,Autocuration,U,A,,12608,,
Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,13459,,CHEMBL626843,22224,BAO_0000219,,,,1,,,,,,0,Autocuration,U,A,,12608,,
Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,13460,,CHEMBL626844,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8649,,
Amount of deuterium retained was reported after normal workup in rats,13461,,CHEMBL877495,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8649,,
Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,13462,,CHEMBL626845,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8649,,
Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,13463,,CHEMBL626846,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8649,,
Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,13464,,CHEMBL626847,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8649,,
Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,13465,,CHEMBL628677,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8649,,
Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,13466,,CHEMBL628678,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8649,,
Compound was subjected to electrochemical oxidation,13467,,CHEMBL628679,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9659,,
Compound was subjected to photochemical oxidation,13468,,CHEMBL628680,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9659,,
Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,13469,,CHEMBL628681,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9659,,
Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,13470,,CHEMBL628682,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9659,,
Oxidation of compound by methemoglobin in presence of hydroperoxide,13471,,CHEMBL628683,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9659,,
Percent diffusion through fuzzy rat skin after 48 h of incubation,13472,,CHEMBL628684,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9607,,
Dissociation constant (pKa),13473,,CHEMBL877501,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,7057,,
Dissociation constant value of the compound; ND means not determined.,13474,,CHEMBL628685,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,7057,,
% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,13475,,CHEMBL628686,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,7911,,
% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13476,,CHEMBL628687,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,7911,,
% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,13477,,CHEMBL628688,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7911,,
% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13478,,CHEMBL628689,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7911,,
% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,13479,,CHEMBL628690,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,7911,,
% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,13480,,CHEMBL629363,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,7911,,
% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,13481,,CHEMBL629364,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,7911,,
% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13482,,CHEMBL629365,50597,BAO_0000218,,,,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,7911,,
% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,13483,,CHEMBL629366,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7911,,
% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,13484,,CHEMBL629367,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,7911,,
% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13485,,CHEMBL629368,50597,BAO_0000218,,,,1,,1988.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Feces,7911,,
% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,13486,,CHEMBL877502,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,7911,,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,13487,,CHEMBL629369,50594,BAO_0000218,,,,1,,2037.0,Mus musculus,,10090.0,1,Intermediate,N,A,Cerebellum,13792,,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,13488,,CHEMBL629370,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,13792,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",13489,,CHEMBL629371,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",13490,,CHEMBL626276,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",13491,,CHEMBL626277,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",13492,,CHEMBL631250,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",13493,,CHEMBL631251,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",13494,,CHEMBL631252,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",13495,,CHEMBL631253,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",13496,,CHEMBL631254,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",13497,,CHEMBL631255,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",13498,,CHEMBL631256,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",13499,,CHEMBL631257,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",13500,,CHEMBL628009,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",13501,,CHEMBL628010,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",13502,,CHEMBL628011,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",13503,,CHEMBL628012,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",13504,,CHEMBL628013,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",13505,,CHEMBL628014,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",13506,,CHEMBL628015,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",13507,,CHEMBL628016,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",13508,,CHEMBL874461,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",13509,,CHEMBL628017,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",13510,,CHEMBL628018,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",13511,,CHEMBL628019,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",13512,,CHEMBL628020,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",13513,,CHEMBL628021,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",13514,,CHEMBL628022,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",13515,,CHEMBL628023,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",13516,,CHEMBL628024,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",13517,,CHEMBL628025,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",13518,,CHEMBL628026,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",13519,,CHEMBL628027,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",13520,,CHEMBL628028,22224,BAO_0000218,,,,1,,1088.0,Simiiformes,,314293.0,0,Autocuration,U,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",13521,,CHEMBL628029,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",13522,,CHEMBL628030,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",13523,,CHEMBL628031,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",13524,,CHEMBL628032,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",13525,,CHEMBL628033,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",13526,,CHEMBL628034,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",13527,,CHEMBL628035,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",13528,,CHEMBL628036,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",13529,,CHEMBL874462,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,13530,,CHEMBL628037,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,13531,,CHEMBL628123,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,13532,,CHEMBL628124,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,13533,,CHEMBL628125,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,13534,,CHEMBL628126,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),13535,,CHEMBL628127,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,13536,,CHEMBL628128,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,13537,,CHEMBL628129,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,13538,,CHEMBL628130,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,13539,,CHEMBL628131,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,13540,,CHEMBL628132,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,13541,,CHEMBL628133,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,13542,,CHEMBL628134,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,13543,,CHEMBL628135,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,13544,,CHEMBL628136,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,13545,,CHEMBL628137,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,13546,,CHEMBL628138,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,13547,,CHEMBL628139,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,13548,,CHEMBL628140,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,13549,,CHEMBL628141,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,13550,,CHEMBL628142,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,13551,,CHEMBL628143,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,13552,,CHEMBL628144,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,13553,,CHEMBL628145,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,13554,,CHEMBL628146,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,13555,,CHEMBL625355,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,13556,,CHEMBL625356,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,13557,,CHEMBL625357,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,13558,,CHEMBL625527,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),13559,,CHEMBL875473,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,13560,,CHEMBL625528,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,13561,,CHEMBL626304,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,9025,,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,13562,,CHEMBL624138,50588,BAO_0000218,,,In vivo,1,,1637.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Artery,9025,,
Calculated partition coefficient (clogP),13563,,CHEMBL624139,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6448,,
Calculated partition coefficient (clogP),13564,,CHEMBL624140,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,17221,,
Calculated partition coefficient (clogP),13565,,CHEMBL624141,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6545,,
Calculated partition coefficient (clogP),13566,,CHEMBL624142,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,577,,
Calculated partition coefficient (clogP),13567,,CHEMBL624143,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6285,,
Calculated partition coefficient (clogP),13568,,CHEMBL624144,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6500,,
Calculated partition coefficient (clogP),13569,,CHEMBL624145,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6716,,
Calculated partition coefficient (clogP),13570,,CHEMBL624146,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13658,,
Calculated partition coefficient (clogP),13571,,CHEMBL624147,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6549,,
Calculated partition coefficient (clogP) (MacLogP),13572,,CHEMBL883123,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14685,,
Partition coefficient (logP),13573,,CHEMBL624148,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6893,,
Kinetic parameter was determined,13574,,CHEMBL874416,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3687,,
Calculated partition coefficient (clogP),13575,,CHEMBL624149,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,4207,,
Calculated partition coefficient (clogP),13576,,CHEMBL624150,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,4626,,
Lipophilicity was determined,13577,,CHEMBL624151,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,1021,,
Lipophilicity was determined,13578,,CHEMBL624152,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,3777,,
Lipophilicity was determined,13579,,CHEMBL622139,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,17533,,
Calculated partition coefficient (clogP),13580,,CHEMBL622140,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6524,,
Lipophilicity was determined,13581,,CHEMBL622141,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,17533,,
Lipophilicity in octanol-water,13582,,CHEMBL622142,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6480,,
Calculated partition coefficient (clogP),13583,,CHEMBL622143,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,17606,,
Octanol-water partition coefficient was determined,13584,,CHEMBL622144,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6863,,
Partition coefficient (logP),13585,,CHEMBL877473,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,1356,,
Calculated partition coefficient (clogP),13586,,CHEMBL622145,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,3326,,
Partition coefficient was determined; ND means not determined,13587,,CHEMBL622146,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,1356,,
Calculated partition coefficient (clogP),13588,,CHEMBL622147,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,12984,,
Partition coefficient of the compound,13589,,CHEMBL622148,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17363,,
Permeability was determined,13590,,CHEMBL883124,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,6827,,
The compound was evaluated for the partition coefficient,13591,,CHEMBL622149,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,261,,
Partition coefficient (logP),13592,,CHEMBL622150,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2685,,
The lipophilicity was reported,13593,,CHEMBL622151,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,414,,
logarithm of the octanol-water partition coefficient for the compound,13594,,CHEMBL622152,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,15769,,
Clogp value was determined,13595,,CHEMBL622153,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17248,,
Clp at a dose of 1.5 mg/kg,13596,,CHEMBL877474,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,16935,,
Clp at a dose of 2.0 mg/kg,13597,,CHEMBL622154,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,16935,,
"Clp, plasma clearance at a dose of 10 mg/kg",13598,,CHEMBL622155,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14832,,
"Clp, plasma clearance at a dose of 50 mg/kg",13599,,CHEMBL622156,22224,BAO_0000218,,,In vivo,1,,1969.0,,,,0,Autocuration,U,A,Plasma,14832,,
Compound was tested for plasma clearance in rat,13600,,CHEMBL622157,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2399,,
Compound was tested for plasma clearance in rat; Not determined,13601,,CHEMBL622158,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,2399,,
Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,13602,,CHEMBL622807,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6227,,
Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,13603,,CHEMBL622808,50797,BAO_0000218,,,In vivo,1,,,Macaca mulatta,,9544.0,1,Intermediate,N,A,,6227,,
Plasma clearance by iv administration at a dose 0.003 ug/mL,13604,,CHEMBL622809,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,5623,,
Plasma clearance determined,13605,,CHEMBL622810,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,4854,,
Plasma clearance after iv administration at 3 mg/kg in hamster,13606,,CHEMBL876653,100712,BAO_0000218,,,In vivo,1,,,Cricetinae,,10026.0,1,Intermediate,N,A,,4493,,
Plasma clearance after iv administration at 4 mg/kg in hamster,13607,,CHEMBL622811,100712,BAO_0000218,,,In vivo,1,,,Cricetinae,,10026.0,1,Intermediate,N,A,,4493,,
Rate of clearance in rat was determined,13608,,CHEMBL622986,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14956,,
Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,13609,,CHEMBL622987,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15372,,
Total plasma clearance after iv dose of 5.10 mg/kg in rats,13610,,CHEMBL622988,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15372,,
Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,13611,,CHEMBL622989,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15372,,
Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,13612,,CHEMBL622990,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15372,,
plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,13613,,CHEMBL622991,22224,BAO_0000218,,,In vivo,1,,1969.0,Simiiformes,,314293.0,0,Autocuration,U,A,Plasma,15604,,
plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,13614,,CHEMBL622227,50597,BAO_0000218,,,In vivo,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15604,,
plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,13615,,CHEMBL622228,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,15604,,
Clpl value in rat,13616,,CHEMBL622229,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14964,,
Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,13617,,CHEMBL622230,50512,BAO_0000218,,,In vivo,1,,,Cavia porcellus,,10141.0,1,Intermediate,N,A,,15240,,
Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,13618,,CHEMBL622231,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16449,,
Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,13619,,CHEMBL622232,100710,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,1,Intermediate,N,A,,16449,,
Cmax in minutes at a iv dose of 1.0(pmol/g/h).,13620,,CHEMBL622233,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12902,,
Cmax in minutes at a iv dose of 2.0(pmol/g/h).,13621,,CHEMBL622234,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12902,,
Cmax in minutes at a iv dose of 4.0(pmol/g/h).,13622,,CHEMBL622235,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12902,,
Cmax in minutes at a iv dose of 5.0(pmol/g/h).,13623,,CHEMBL622236,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12902,,
Cmax in minutes at a iv dose of 54.0(pmol/g/h).,13624,,CHEMBL622237,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12902,,
Cmax in minutes at a po dose of 10.0(pmol/g/h).,13625,,CHEMBL877482,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12902,,
Cmax in minutes at a po dose of 20.0(pmol/g/h).,13626,,CHEMBL622238,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12902,,
Cmax in minutes at a po dose of 40.0(pmol/g/h).,13627,,CHEMBL622239,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,12902,,
Cmax was calculated as maximum concentration reached in the blood,13628,,CHEMBL622240,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,11149,,
Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,13629,,CHEMBL622241,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,11149,,
Cmax was determine after peroral administration at 10 mpk in Rat,13630,,CHEMBL631013,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5669,,
Cmax was determine after peroral administration at 10 mpk in Rhesus,13631,,CHEMBL631014,50797,BAO_0000218,,,In vivo,1,,,Macaca mulatta,,9544.0,1,Intermediate,N,A,,5669,,
Cmax was determine after peroral administration at 10 mpk in dog,13632,,CHEMBL631015,50588,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,5669,,
Cmax was determine after peroral administration at 160 mpk in Rat,13633,,CHEMBL631016,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5669,,
Cmax was determine after peroral administration at 20 mpk in Rat,13634,,CHEMBL631017,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5669,,
Cmax was determine after peroral administration at 50 mpk in Rat,13635,,CHEMBL631018,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,5669,,
Cmax was determined,13636,,CHEMBL631019,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,4236,,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,13637,,CHEMBL875761,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,13792,,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,13638,,CHEMBL631020,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,13792,,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,13639,,CHEMBL631669,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,13792,,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,13640,,CHEMBL631670,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,13792,,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,13641,,CHEMBL631671,50594,BAO_0000218,,,,1,,2435.0,Mus musculus,,10090.0,1,Intermediate,N,A,Striatum,13792,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,13642,,CHEMBL631672,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,13643,,CHEMBL631673,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,13644,,CHEMBL631856,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,13645,,CHEMBL631857,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,13646,,CHEMBL631858,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,13647,,CHEMBL631859,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,13648,,CHEMBL631860,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,13649,,CHEMBL631861,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,13650,,CHEMBL631862,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,13651,,CHEMBL631863,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,13652,,CHEMBL631864,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,13653,,CHEMBL631865,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,13654,,CHEMBL631866,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,13655,,CHEMBL629360,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,13656,,CHEMBL629361,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,13657,,CHEMBL629362,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,13658,,CHEMBL630740,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,13659,,CHEMBL630741,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,13660,,CHEMBL630742,50597,BAO_0000218,,,,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,13661,,CHEMBL630743,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,13662,,CHEMBL630744,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,13663,,CHEMBL630745,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,13664,,CHEMBL630746,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,13665,,CHEMBL630747,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,13666,,CHEMBL630748,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,13667,,CHEMBL632056,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,13668,,CHEMBL632057,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,13669,,CHEMBL632058,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,13670,,CHEMBL632059,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,13671,,CHEMBL632060,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,13672,,CHEMBL632061,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,13673,,CHEMBL629207,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,13674,,CHEMBL629208,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,13675,,CHEMBL629209,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,13676,,CHEMBL629210,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,13677,,CHEMBL629211,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,13678,,CHEMBL629212,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,13679,,CHEMBL629213,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8418,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",13680,,CHEMBL629214,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",13681,,CHEMBL629215,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",13682,,CHEMBL635154,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,8133,,
Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),13683,,CHEMBL629216,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,13684,,CHEMBL629217,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),13685,,CHEMBL629218,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),13686,,CHEMBL629219,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),13687,,CHEMBL629220,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),13688,,CHEMBL629221,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),13689,,CHEMBL631127,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,13690,,CHEMBL631128,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),13691,,CHEMBL631129,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),13692,,CHEMBL631130,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),13693,,CHEMBL631131,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),13694,,CHEMBL631132,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),13695,,CHEMBL631133,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,13696,,CHEMBL631134,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),13697,,CHEMBL875120,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),13698,,CHEMBL631135,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),13699,,CHEMBL631136,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),13700,,CHEMBL631137,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),13701,,CHEMBL631138,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,13702,,CHEMBL631139,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),13703,,CHEMBL631140,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),13704,,CHEMBL631141,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),13705,,CHEMBL631142,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),13706,,CHEMBL631143,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),13707,,CHEMBL631144,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,13708,,CHEMBL631145,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),13709,,CHEMBL631146,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,13710,,CHEMBL631147,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),13711,,CHEMBL631148,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),13712,,CHEMBL631149,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),13713,,CHEMBL631150,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),13714,,CHEMBL631151,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),13715,,CHEMBL631152,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),13716,,CHEMBL631443,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),13717,,CHEMBL631444,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),13718,,CHEMBL631445,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),13719,,CHEMBL631446,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),13720,,CHEMBL631447,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),13721,,CHEMBL631448,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,13722,,CHEMBL631449,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),13723,,CHEMBL631450,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),13724,,CHEMBL629724,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,6996,,
"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13725,,CHEMBL629725,50594,BAO_0000218,,,In vivo,1,,14.0,Mus musculus,,10090.0,1,Intermediate,N,A,Zone of skin,9716,,
"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13726,,CHEMBL629726,50594,BAO_0000218,,,In vivo,1,,14.0,Mus musculus,,10090.0,1,Intermediate,N,A,Zone of skin,9716,,
"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13727,,CHEMBL629727,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,9716,,
"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13728,,CHEMBL630404,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,9716,,
"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13729,,CHEMBL630405,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,9716,,
"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13730,,CHEMBL630406,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,9716,,
"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13731,,CHEMBL630407,50594,BAO_0000218,,,In vivo,1,,945.0,Mus musculus,,10090.0,1,Intermediate,N,A,Stomach,9716,,
"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13732,,CHEMBL630573,50594,BAO_0000218,,,In vivo,1,,945.0,Mus musculus,,10090.0,1,Intermediate,N,A,Stomach,9716,,
"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13733,,CHEMBL630574,50594,BAO_0000218,,,In vivo,1,,945.0,Mus musculus,,10090.0,1,Intermediate,N,A,Stomach,9716,,
"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13734,,CHEMBL630575,50594,BAO_0000218,,,In vivo,1,,945.0,Mus musculus,,10090.0,1,Intermediate,N,A,Stomach,9716,,
"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13735,,CHEMBL630576,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,9716,,
"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13736,,CHEMBL630577,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,9716,,
"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13737,,CHEMBL630578,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,9716,,
"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13738,,CHEMBL630579,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,9716,,
Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),13739,,CHEMBL630580,50594,BAO_0000218,,,,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,12192,,
Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,13740,,CHEMBL630581,50594,BAO_0000218,,,,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,12192,,
Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),13741,,CHEMBL630582,50594,BAO_0000218,,,,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,12192,,
Percent of injected 238-Plutonium(IV) in mice liver at 24 h,13742,,CHEMBL630583,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12192,,
Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),13743,,CHEMBL630584,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12192,,
Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,13744,,CHEMBL630585,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12192,,
Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),13745,,CHEMBL630586,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12192,,
Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,13746,,CHEMBL630587,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12192,,
Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),13747,,CHEMBL630588,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12192,,
Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,13748,,CHEMBL630589,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12192,,
Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),13749,,CHEMBL630590,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,12192,,
Removal of 238-Plutonium(IV) in feces at 24 h,13750,,CHEMBL630591,22224,BAO_0000019,,,,1,,1988.0,,,,0,Autocuration,U,A,Feces,12192,,
Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),13751,,CHEMBL630592,22224,BAO_0000019,,,,1,,1988.0,,,,0,Autocuration,U,A,Feces,12192,,
Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,13752,,CHEMBL630593,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12192,,
Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),13753,,CHEMBL630594,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12192,,
Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),13754,,CHEMBL630595,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,12192,,
Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),13755,,CHEMBL630596,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,12192,,
Removal of 238-Plutonium(IV) in urine after 0-24 h,13756,,CHEMBL630597,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,12192,,
Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),13757,,CHEMBL630598,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,12192,,
Removal of 238-Plutonium(IV) in urine after 0-4 h,13758,,CHEMBL630599,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,12192,,
Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),13759,,CHEMBL630600,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,12192,,
Removal of 238-Plutonium(IV) in urine after 4-24 h,13760,,CHEMBL630601,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,12192,,
Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),13761,,CHEMBL630602,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,12192,,
Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),13762,,CHEMBL630603,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,12192,,
Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),13763,,CHEMBL630604,22224,BAO_0000019,,,,1,,1088.0,,,,0,Autocuration,U,A,Urine,12192,,
Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13764,,CHEMBL624869,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13765,,CHEMBL624870,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13766,,CHEMBL623189,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13767,,CHEMBL623190,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13768,,CHEMBL623191,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13769,,CHEMBL623192,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13770,,CHEMBL623193,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13771,,CHEMBL623194,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13772,,CHEMBL623195,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13773,,CHEMBL623196,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,13774,,CHEMBL623197,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11836,,
Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,13775,,CHEMBL623198,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11836,,
Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,13776,,CHEMBL623199,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11836,,
Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,13777,,CHEMBL623200,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11836,,
Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,13778,,CHEMBL623201,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11836,,
Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,13779,,CHEMBL623202,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11836,,
Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,13780,,CHEMBL623203,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11836,,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,13781,,CHEMBL623204,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11836,,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,13782,,CHEMBL623205,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11836,,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,13783,,CHEMBL623206,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11836,,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,13784,,CHEMBL623207,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11836,,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,13785,,CHEMBL623208,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11836,,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,13786,,CHEMBL623209,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11836,,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,13787,,CHEMBL623210,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,11836,,
Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,13788,,CHEMBL623211,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11836,,
Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,13789,,CHEMBL623212,50597,BAO_0000218,,,,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,11836,,
Tested in vitro for intrinsic activity relative to quinpirole,13790,,CHEMBL623213,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12640,,
"Relative ion enhancement, determined in pulsed ultrafiltration",13791,,CHEMBL623214,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14218,,
% ionization at the pH 7.4 at 37 degree Centigrade,13792,,CHEMBL623215,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11296,,
Percentage ionization was measured,13793,,CHEMBL623216,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10929,,
Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,13794,,CHEMBL623217,50591,BAO_0000218,,,,1,,,Bos taurus,,9913.0,1,Intermediate,N,A,,13841,,
Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,13795,,CHEMBL623218,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10431,,
Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,13796,,CHEMBL623913,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10431,,
Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,13797,,CHEMBL623914,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10431,,
Compound was evaluated for the partition coefficient in octanol/water,13798,,CHEMBL623915,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8826,,
Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),13799,,CHEMBL624080,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8826,,
Equilibrium constant measured by the pulse radiolysis at pH 7,13800,,CHEMBL624081,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9884,,
In vitro hydrolytic rate constant determined in human blood,13801,,CHEMBL624082,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,9827,,
In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,13802,,CHEMBL625054,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,10009,,
In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,13803,,CHEMBL877485,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10009,,
In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,13804,,CHEMBL625055,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,10009,,
In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,13805,,CHEMBL625056,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,10009,,
In vitro oxidation of compound in presence of human plasma,13806,,CHEMBL625057,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,10009,,
In vitro oxidation of compound in presence of hydrogen peroxide,13807,,CHEMBL625058,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10009,,
In vitro oxidation of compound in presence of mouse brain homogenate,13808,,CHEMBL625059,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,10009,,
In vitro oxidation of compound in presence of mouse liver homogenate,13809,,CHEMBL629536,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,10009,,
Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,13810,,CHEMBL629537,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,13811,,CHEMBL629538,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,13812,,CHEMBL629539,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,13813,,CHEMBL874445,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,13814,,CHEMBL629540,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,13815,,CHEMBL629541,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,13816,,CHEMBL629542,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,13817,,CHEMBL630243,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,13818,,CHEMBL630244,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,13819,,CHEMBL630245,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,13820,,CHEMBL630246,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,13821,,CHEMBL630247,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,13822,,CHEMBL630248,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Biodistribution in rat blood at 240 minutes after dose administration.,13823,,CHEMBL630249,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13100,,
Biodistribution in rat blood at 30 minutes after dose administration.,13824,,CHEMBL630250,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13100,,
Biodistribution in rat blood at 360 minutes after dose administration.,13825,,CHEMBL630251,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13100,,
Biodistribution in rat blood at 3 hr after dose administration.,13826,,CHEMBL630252,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13100,,
Biodistribution in rat blood at 60 minutes after dose administration.,13827,,CHEMBL630408,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13100,,
Biodistribution in rat cerebellum at 120 minutes after dose administration.,13828,,CHEMBL630409,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,13100,,
Biodistribution in rat cerebellum at 1440 minutes after dose administration.,13829,,CHEMBL874446,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,13100,,
Biodistribution in rat cerebellum at 15 minutes after dose administration.,13830,,CHEMBL630410,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,13100,,
Biodistribution in rat cerebellum at 240 minutes after dose administration.,13831,,CHEMBL630411,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,13100,,
Biodistribution in rat cerebellum at 30 minutes after dose administration.,13832,,CHEMBL630412,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,13100,,
Biodistribution in rat cerebellum at 360 minutes after dose administration.,13833,,CHEMBL630413,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,13100,,
Biodistribution in rat cerebellum at 3 hr after dose administration.,13834,,CHEMBL630414,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,13100,,
Biodistribution in rat cerebellum at 60 minutes after dose administration.,13835,,CHEMBL630415,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,13100,,
Biodistribution in rat cortex at 120 minutes after dose administration.,13836,,CHEMBL630416,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat cortex at 1440 minutes after dose administration.,13837,,CHEMBL630417,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat cortex at 15 minutes after dose administration.,13838,,CHEMBL630418,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat cortex at 240 minutes after dose administration.,13839,,CHEMBL630419,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat cortex at 30 minutes after dose administration.,13840,,CHEMBL630420,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat cortex at 360 minutes after dose administration.,13841,,CHEMBL630421,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat cortex at 3 hr after dose administration.,13842,,CHEMBL630422,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat cortex at 60 minutes after dose administration.,13843,,CHEMBL630423,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat heart at 120 minutes after dose administration.,13844,,CHEMBL630424,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13100,,
Biodistribution in rat heart at 15 minutes after dose administration.,13845,,CHEMBL630425,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13100,,
Biodistribution in rat heart at 240 minutes after dose administration.,13846,,CHEMBL629462,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13100,,
Biodistribution in rat heart at 30 minutes after dose administration.,13847,,CHEMBL630426,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13100,,
Biodistribution in rat heart at 360 minutes after dose administration.,13848,,CHEMBL630427,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13100,,
Biodistribution in rat heart at 3 hr after dose administration.,13849,,CHEMBL625877,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13100,,
Biodistribution in rat heart at 60 minutes after dose administration.,13850,,CHEMBL625878,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13100,,
Biodistribution in rat hippocampus at 1440 minutes after dose administration.,13851,,CHEMBL625879,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,13100,,
Biodistribution in rat hippocampus at 240 minutes after dose administration.,13852,,CHEMBL625880,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,13100,,
Biodistribution in rat hippocampus at 30 minutes after dose administration.,13853,,CHEMBL625881,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,13100,,
Biodistribution in rat hippocampus at 360 minutes after dose administration.,13854,,CHEMBL625882,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,13100,,
Biodistribution in rat hippocampus at 15 minutes after dose administration.,13855,,CHEMBL625883,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,13100,,
Biodistribution in rat kidney at 120 minutes after dose administration.,13856,,CHEMBL625884,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13100,,
Biodistribution in rat kidney at 1440 minutes after dose administration.,13857,,CHEMBL625885,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13100,,
Biodistribution in rat kidney at 15 minutes after dose administration.,13858,,CHEMBL628649,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13100,,
Biodistribution in rat kidney at 240 minutes after dose administration.,13859,,CHEMBL628650,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13100,,
Biodistribution in rat kidney at 30 minutes after dose administration.,13860,,CHEMBL628651,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13100,,
Biodistribution in rat kidney at 360 minutes after dose administration.,13861,,CHEMBL628652,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13100,,
Biodistribution in rat kidney at 60 minutes after dose administration.,13862,,CHEMBL628653,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13100,,
Biodistribution in rat liver at 120 minutes after dose administration.,13863,,CHEMBL628654,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13100,,
Biodistribution in rat liver at 1440 minutes after dose administration.,13864,,CHEMBL628655,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13100,,
Biodistribution in rat liver at 15 minutes after dose administration.,13865,,CHEMBL625238,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13100,,
Biodistribution in rat liver at 240 minutes after dose administration.,13866,,CHEMBL625239,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13100,,
Biodistribution in rat liver at 30 minutes after dose administration.,13867,,CHEMBL625240,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13100,,
Biodistribution in rat liver at 360 minutes after dose administration.,13868,,CHEMBL625241,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13100,,
Biodistribution in rat liver at 60 minutes after dose administration.,13869,,CHEMBL625242,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13100,,
Biodistribution in rat lung at 120 minutes after dose administration.,13870,,CHEMBL874587,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13100,,
Biodistribution in rat lung at 1440 minutes after dose administration.,13871,,CHEMBL625405,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13100,,
Biodistribution in rat lung at 15 minutes after dose administration.,13872,,CHEMBL625406,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13100,,
Biodistribution in rat lung at 240 minutes after dose administration.,13873,,CHEMBL625407,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13100,,
Biodistribution in rat lung at 30 minutes after dose administration.,13874,,CHEMBL625408,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13100,,
Biodistribution in rat lung at 360 minutes after dose administration.,13875,,CHEMBL625409,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13100,,
Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,13876,,CHEMBL625410,50597,BAO_0000218,,,,1,,1515.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thoracic aorta,12361,,
Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,13877,,CHEMBL625411,50597,BAO_0000218,,,,1,,1515.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thoracic aorta,12361,,
Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,13878,,CHEMBL625412,50597,BAO_0000218,,,,1,,1515.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thoracic aorta,12361,,
Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,13879,,CHEMBL625413,50597,BAO_0000218,,,,1,,1515.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thoracic aorta,12361,,
Percent of maximal contractile response to compound in rat thoracic aorta strips v,13880,,CHEMBL625414,50597,BAO_0000218,,,,1,,1515.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thoracic aorta,12361,,
Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,13881,,CHEMBL625415,50597,BAO_0000218,,,,1,,1515.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thoracic aorta,12361,,
Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,13882,,CHEMBL625416,50597,BAO_0000218,,,,1,,1515.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thoracic aorta,12361,,
% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,13883,,CHEMBL625417,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12712,,
Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,13884,,CHEMBL625418,50597,BAO_0000218,,,,1,,1988.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Feces,7415,,
Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,13885,,CHEMBL625419,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,7415,,
Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,13886,,CHEMBL625420,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7415,,
Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,13887,,CHEMBL626996,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7415,,
"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",13888,,CHEMBL626997,50597,BAO_0000218,,,,1,,1988.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Feces,7415,,
"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",13889,,CHEMBL626998,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,7415,,
"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",13890,,CHEMBL626999,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7415,,
faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,13891,,CHEMBL627000,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8050,,
fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,13892,,CHEMBL627001,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8050,,
fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,13893,,CHEMBL627002,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8050,,
fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,13894,,CHEMBL627003,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8050,,
urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,13895,,CHEMBL627004,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,13896,,CHEMBL627005,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,13897,,CHEMBL874594,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,13898,,CHEMBL627006,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,13899,,CHEMBL627007,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,13900,,CHEMBL627884,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,13901,,CHEMBL627885,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,13902,,CHEMBL627886,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,13903,,CHEMBL627887,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,13904,,CHEMBL627888,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,13905,,CHEMBL628057,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,13906,,CHEMBL627405,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,8050,,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,13907,,CHEMBL627406,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,13908,,CHEMBL627407,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,13909,,CHEMBL627408,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,13910,,CHEMBL627409,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,13911,,CHEMBL875486,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,13912,,CHEMBL627410,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,13913,,CHEMBL627411,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,13914,,CHEMBL627412,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,13915,,CHEMBL627413,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,13916,,CHEMBL627414,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,13917,,CHEMBL627415,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,13918,,CHEMBL627416,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,13919,,CHEMBL627417,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,13920,,CHEMBL627418,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,13921,,CHEMBL627419,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,13922,,CHEMBL627320,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,13923,,CHEMBL627321,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13924,,CHEMBL627322,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13925,,CHEMBL627323,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13926,,CHEMBL627491,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13927,,CHEMBL627492,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13928,,CHEMBL627493,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13929,,CHEMBL627494,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13930,,CHEMBL627495,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13931,,CHEMBL627496,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13932,,CHEMBL627497,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13933,,CHEMBL627498,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13934,,CHEMBL627499,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13935,,CHEMBL627500,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13936,,CHEMBL627501,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13937,,CHEMBL625616,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13938,,CHEMBL625617,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13939,,CHEMBL625618,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13940,,CHEMBL625619,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13941,,CHEMBL625620,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13942,,CHEMBL625621,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13943,,CHEMBL625622,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13944,,CHEMBL625788,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13945,,CHEMBL625789,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13946,,CHEMBL625790,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13947,,CHEMBL625791,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13948,,CHEMBL622334,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13949,,CHEMBL622335,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,12017,,
Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13950,,CHEMBL622336,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,12017,,
Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13951,,CHEMBL622337,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,12017,,
Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13952,,CHEMBL622338,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,12017,,
Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13953,,CHEMBL622339,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,12017,,
Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13954,,CHEMBL624153,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13955,,CHEMBL628430,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13956,,CHEMBL628431,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13957,,CHEMBL628432,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13958,,CHEMBL628433,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13959,,CHEMBL628434,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13960,,CHEMBL626789,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",13961,,CHEMBL626790,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13962,,CHEMBL626791,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13963,,CHEMBL626792,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13964,,CHEMBL626793,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,13965,,CHEMBL627436,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,13966,,CHEMBL627437,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,13967,,CHEMBL627438,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,13968,,CHEMBL627439,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,13969,,CHEMBL627440,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,13970,,CHEMBL627602,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,13971,,CHEMBL627603,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,13972,,CHEMBL627604,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,13973,,CHEMBL627605,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,13974,,CHEMBL627606,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,13975,,CHEMBL627607,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,13976,,CHEMBL627608,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,13977,,CHEMBL627609,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,13978,,CHEMBL627610,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,13979,,CHEMBL627611,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,13980,,CHEMBL627612,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Octanol:water partition coefficient is evaluated,13981,,CHEMBL627613,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8362,,
Partition coefficient in 1-octanol/water system,13982,,CHEMBL627614,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8257,,
Partition coefficient in 1-octanol/water system measured using radio active compounds,13983,,CHEMBL627615,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8257,,
Partition coefficient in octanol/water system was determined,13984,,CHEMBL627616,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,9468,,
Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,13985,,CHEMBL627617,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,9468,,
Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,13986,,CHEMBL627618,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10568,,
"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",13987,,CHEMBL627619,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10568,,
Pseudo-first-order rate constant of the compound,13988,,CHEMBL627620,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15359,,
Pseudo-first-order rate constant with 1-min time point,13989,,CHEMBL627621,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15359,,
Pseudo-first-order rate constant without 1-min time point,13990,,CHEMBL627622,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15359,,
Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,13991,,CHEMBL627623,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10431,,
Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,13992,,CHEMBL627624,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10431,,
Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,13993,,CHEMBL627625,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10431,,
Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,13994,,CHEMBL628523,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15704,,
The alkaline hydrolysis second order rate constant(K OH) of the compound,13995,,CHEMBL628524,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15287,,
The efflux rate constant of the compound,13996,,CHEMBL628525,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7516,,
The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,13997,,CHEMBL625732,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12973,,
The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,13998,,CHEMBL625733,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12973,,
The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,13999,,CHEMBL625734,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,F,,12973,,
The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,14000,,CHEMBL625913,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12973,,
Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,14001,,CHEMBL625914,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8696,,
Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,14002,,CHEMBL625915,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15052,,
Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,14003,,CHEMBL625916,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15052,,
Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),14004,,CHEMBL625917,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10503,,
"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",14005,,CHEMBL625918,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",14006,,CHEMBL625919,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",14007,,CHEMBL625920,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",14008,,CHEMBL874453,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",14009,,CHEMBL625921,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,14010,,CHEMBL625922,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10503,,
"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",14011,,CHEMBL625923,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",14012,,CHEMBL625924,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",14013,,CHEMBL625925,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",14014,,CHEMBL625926,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
Biodistribution in rat lung at 60 minutes after dose administration.,14015,,CHEMBL627704,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13100,,
Biodistribution in rat pons/medulla at 120 minutes after dose administration.,14016,,CHEMBL627705,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat pons/medulla at 15 minutes after dose administration.,14017,,CHEMBL627706,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat pons/medulla at 240 minutes after dose administration.,14018,,CHEMBL627707,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat pons/medulla at 30 minutes after dose administration.,14019,,CHEMBL627708,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat pons/medulla at 360 minutes after dose administration.,14020,,CHEMBL628361,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat pons/medulla at 60 minutes after dose administration.,14021,,CHEMBL628362,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13100,,
Biodistribution in rat striatum at 120 minutes after dose administration.,14022,,CHEMBL628363,50597,BAO_0000218,,,In vivo,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,13100,,
Biodistribution in rat striatum at 1440 minutes after dose administration.,14023,,CHEMBL628364,50597,BAO_0000218,,,In vivo,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,13100,,
Biodistribution in rat striatum at 15 minutes after dose administration.,14024,,CHEMBL628365,50597,BAO_0000218,,,In vivo,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,13100,,
Biodistribution in rat striatum at 240 minutes after dose administration.,14025,,CHEMBL874454,50597,BAO_0000218,,,In vivo,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,13100,,
Biodistribution in rat striatum at 30 minutes after dose administration.,14026,,CHEMBL628531,50597,BAO_0000218,,,In vivo,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,13100,,
Biodistribution in rat striatum at 360 minutes after dose administration.,14027,,CHEMBL628532,50597,BAO_0000218,,,In vivo,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,13100,,
Biodistribution in rat striatum at 3 hr after dose administration.,14028,,CHEMBL628533,50597,BAO_0000218,,,In vivo,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,13100,,
Biodistribution in rat striatum at 60 minutes after dose administration.,14029,,CHEMBL628534,50597,BAO_0000218,,,In vivo,1,,2435.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Striatum,13100,,
Biodistribution in rat thyroid at 120 minutes after dose administration.,14030,,CHEMBL628535,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,13100,,
Biodistribution in rat thyroid at 1440 minutes after dose administration.,14031,,CHEMBL628536,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,13100,,
Biodistribution in rat thyroid at 15 minutes after dose administration.,14032,,CHEMBL628537,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,13100,,
Biodistribution in rat thyroid at 240 minutes after dose administration.,14033,,CHEMBL628538,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,13100,,
Biodistribution in rat thyroid at 30 minutes after dose administration.,14034,,CHEMBL628539,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,13100,,
Biodistribution in rat thyroid at 360 minutes after dose administration.,14035,,CHEMBL630297,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,13100,,
Biodistribution in rat thyroid at 60 minutes after dose administration.,14036,,CHEMBL630298,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,13100,,
Biodistribution in rest of brain of rat 120 minutes after dose administration.,14037,,CHEMBL630299,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13100,,
Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,14038,,CHEMBL628094,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13100,,
Biodistribution in rest of brain of rat at 15 minutes after dose administration.,14039,,CHEMBL628095,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13100,,
Biodistribution in rest of brain of rat at 240 minutes after dose administration.,14040,,CHEMBL874648,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13100,,
Biodistribution in rest of brain of rat at 30 minutes after dose administration.,14041,,CHEMBL628096,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13100,,
Biodistribution in rest of brain of rat at 360 minutes after dose administration.,14042,,CHEMBL628097,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13100,,
Biodistribution in rest of brain of rat at 60 minutes after dose administration.,14043,,CHEMBL628098,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13100,,
"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",14044,,CHEMBL628099,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13331,,
"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",14045,,CHEMBL628100,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13331,,
Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),14046,,CHEMBL628101,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13331,,
"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",14047,,CHEMBL628102,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13331,,
"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",14048,,CHEMBL628103,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13331,,
"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",14049,,CHEMBL628104,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13331,,
"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",14050,,CHEMBL628105,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13331,,
"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",14051,,CHEMBL628106,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13331,,
Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,14052,,CHEMBL628107,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,10086,,
Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,14053,,CHEMBL628108,22224,BAO_0000218,,,,1,,1088.0,,,,0,Autocuration,U,F,Urine,10086,,
Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,14054,,CHEMBL628109,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,10086,,
Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,14055,,CHEMBL625299,22224,BAO_0000218,,,,1,,1088.0,,,,0,Autocuration,U,F,Urine,10086,,
Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,14056,,CHEMBL625300,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,10086,,
Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,14057,,CHEMBL625301,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,10086,,
Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,14058,,CHEMBL625302,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,10086,,
Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,14059,,CHEMBL874649,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,10086,,
In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,14060,,CHEMBL625303,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13248,,
In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,14061,,CHEMBL625463,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13248,,
In vitro metabolism in human liver microsomes,14062,,CHEMBL625464,50587,BAO_0000218,,,,1,,2107.0,Homo sapiens,,9606.0,1,Intermediate,N,A,Liver,14527,,
Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,14063,,CHEMBL625465,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,3008,,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,14064,,CHEMBL625466,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,14065,,CHEMBL625467,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,14066,,CHEMBL625468,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,14067,,CHEMBL625469,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,14068,,CHEMBL625470,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,14069,,CHEMBL632418,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,14070,,CHEMBL627250,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,14071,,CHEMBL627251,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,14072,,CHEMBL627252,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,14073,,CHEMBL627253,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,14074,,CHEMBL627254,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,14075,,CHEMBL875471,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,14076,,CHEMBL627255,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,14077,,CHEMBL627256,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,14078,,CHEMBL627257,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,14079,,CHEMBL627258,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,14080,,CHEMBL627259,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,14081,,CHEMBL627260,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,14082,,CHEMBL623256,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,14083,,CHEMBL874413,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,14084,,CHEMBL623257,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,14085,,CHEMBL623258,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,14086,,CHEMBL623259,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,14087,,CHEMBL623260,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,14088,,CHEMBL623261,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,14089,,CHEMBL623262,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,14090,,CHEMBL623263,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,14091,,CHEMBL623264,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,14092,,CHEMBL623265,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,14093,,CHEMBL623266,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,14094,,CHEMBL623267,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,14095,,CHEMBL623268,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,14096,,CHEMBL623269,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,14097,,CHEMBL623270,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,14098,,CHEMBL623271,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,14099,,CHEMBL623272,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,14100,,CHEMBL623273,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,14101,,CHEMBL623274,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,14102,,CHEMBL874414,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,14103,,CHEMBL623275,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,14104,,CHEMBL629150,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,14105,,CHEMBL623276,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,14106,,CHEMBL623277,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,14107,,CHEMBL623112,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,14108,,CHEMBL623113,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,14109,,CHEMBL623800,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,14110,,CHEMBL623801,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",14111,,CHEMBL623802,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14112,,CHEMBL623803,50597,BAO_0000218,,,In vivo,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,12017,,
Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14113,,CHEMBL623970,50597,BAO_0000218,,,In vivo,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,12017,,
Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14114,,CHEMBL623971,50597,BAO_0000218,,,In vivo,1,,995.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Uterus,12017,,
Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),14115,,CHEMBL623972,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,14045,,
Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),14116,,CHEMBL623973,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,14045,,
Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),14117,,CHEMBL623974,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,14045,,
Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),14118,,CHEMBL623975,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,14045,,
Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),14119,,CHEMBL623976,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,14045,,
Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),14120,,CHEMBL623977,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,14045,,
Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),14121,,CHEMBL623978,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,14045,,
Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),14122,,CHEMBL623979,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,14045,,
Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),14123,,CHEMBL623980,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14045,,
Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),14124,,CHEMBL623981,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14045,,
Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),14125,,CHEMBL626278,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14045,,
Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),14126,,CHEMBL626279,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14045,,
Biodistribution in mice bladder plus excreted urine was determined,14127,,CHEMBL626280,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14045,,
"Percentage biodistribution in mouse blood, 10 minutes post injection",14128,,CHEMBL626281,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14045,,
"Percentage biodistribution in mouse blood, 30 minutes post injection",14129,,CHEMBL626282,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14045,,
"Percentage biodistribution in mouse blood, 5 minutes post injection",14130,,CHEMBL626283,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14045,,
"Percentage biodistribution in mouse blood, 60 minutes post injection",14131,,CHEMBL626284,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14045,,
"Percentage biodistribution in mouse brain, 10 minutes post injection",14132,,CHEMBL626285,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,14045,,
"Percentage biodistribution in mouse brain, 30 minutes post injection",14133,,CHEMBL626286,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,14045,,
"Percentage biodistribution in mouse brain, 5 minutes post injection",14134,,CHEMBL626287,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,14045,,
"Percentage biodistribution in mouse brain, 60 minutes post injection",14135,,CHEMBL626288,50594,BAO_0000218,,,,1,,955.0,Mus musculus,,10090.0,1,Intermediate,N,A,Brain,14045,,
"Percentage biodistribution in mouse heart, 10 minutes post injection",14136,,CHEMBL626289,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14045,,
"Percentage biodistribution in mouse heart, 30 minutes post injection",14137,,CHEMBL626290,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14045,,
"Percentage biodistribution in mouse heart, 5 minutes post injection",14138,,CHEMBL626291,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14045,,
"Percentage biodistribution in mouse heart, 60 minutes post injection",14139,,CHEMBL839888,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14045,,
"Percentage biodistribution in mouse intestine, 10 minutes post injection",14140,,CHEMBL626292,50594,BAO_0000218,,,,1,,160.0,Mus musculus,,10090.0,1,Intermediate,N,A,Intestine,14045,,
"Percentage biodistribution in mouse intestine, 30 minutes post injection",14141,,CHEMBL626293,50594,BAO_0000218,,,,1,,160.0,Mus musculus,,10090.0,1,Intermediate,N,A,Intestine,14045,,
"Percentage biodistribution in mouse intestine, 5 minutes post injection",14142,,CHEMBL626294,50594,BAO_0000218,,,,1,,160.0,Mus musculus,,10090.0,1,Intermediate,N,A,Intestine,14045,,
"Percentage biodistribution in mouse intestine, 60 minutes post injection",14143,,CHEMBL626295,50594,BAO_0000218,,,,1,,160.0,Mus musculus,,10090.0,1,Intermediate,N,A,Intestine,14045,,
"Percentage biodistribution in mouse liver, 10 minutes post injection",14144,,CHEMBL627659,50594,BAO_0000218,,,,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,14045,,
"Percentage biodistribution in mouse liver, 30 minutes of post injection",14145,,CHEMBL627660,50594,BAO_0000218,,,,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,14045,,
"Percentage biodistribution in mouse liver, 5 minutes post injection",14146,,CHEMBL627661,50594,BAO_0000218,,,,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,14045,,
Biodistribution in mice liver at 60 minutes of post injection,14147,,CHEMBL627662,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,14045,,
Biodistribution in mice lungs at 10 min of post injection,14148,,CHEMBL627663,50594,BAO_0000218,,,In vivo,1,,2048.0,Mus musculus,,10090.0,1,Intermediate,N,A,Lung,14045,,
"Percentage biodistribution in mouse lung, 30 minutes post injection",14149,,CHEMBL627664,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14045,,
"Percentage biodistribution in mousee lung, 5 minutes post injection",14150,,CHEMBL627665,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14045,,
Biodistribution in mice lungs at 60 min of post injection,14151,,CHEMBL627666,50594,BAO_0000218,,,In vivo,1,,2048.0,Mus musculus,,10090.0,1,Intermediate,N,A,Lung,14045,,
Percentage biodistribution in mouse spleen,14152,,CHEMBL627667,50594,BAO_0000218,,,,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,14045,,
Percentage biodistribution in mouse stomach,14153,,CHEMBL627668,50594,BAO_0000218,,,,1,,945.0,Mus musculus,,10090.0,1,Intermediate,N,A,Stomach,14045,,
Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,14154,,CHEMBL627669,50594,BAO_0000218,,,,1,,1088.0,Mus musculus,,10090.0,1,Intermediate,N,A,Urine,11745,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,14155,,CHEMBL627670,22224,BAO_0000218,,,In vivo,1,,1255.0,,,,0,Autocuration,U,A,Urinary bladder,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,14156,,CHEMBL627671,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,14157,,CHEMBL627672,22224,BAO_0000218,,,In vivo,1,,1474.0,,,,0,Autocuration,U,A,Bone element,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,14158,,CHEMBL627673,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,14159,,CHEMBL627674,22224,BAO_0000218,,,In vivo,1,,2113.0,,,,0,Autocuration,U,A,Kidney,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,14160,,CHEMBL627675,22224,BAO_0000218,,,In vivo,1,,2107.0,,,,0,Autocuration,U,A,Liver,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,14161,,CHEMBL627676,22224,BAO_0000218,,,In vivo,1,,2048.0,,,,0,Autocuration,U,A,Lung,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,14162,,CHEMBL627677,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",14163,,CHEMBL627678,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
Affinity for protein binding expressed as association constant in fresh rat serum,14164,,CHEMBL627679,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,7095,,
Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,14165,,CHEMBL627680,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12185,,
Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,14166,,CHEMBL627681,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12185,,
Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,14167,,CHEMBL627682,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12185,,
Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,14168,,CHEMBL627683,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12185,,
The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,14169,,CHEMBL627684,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12686,,
"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",14170,,CHEMBL874441,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12686,,
The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,14171,,CHEMBL627685,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12686,,
"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",14172,,CHEMBL627686,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12686,,
Apparent rate constant Koff for inactivation of dTMP synthase.,14173,,CHEMBL627687,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8057,,
The irreversible inhibitor activity by second order rate equation.,14174,,CHEMBL627688,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15778,,
Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,14175,,CHEMBL628038,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12375,,
Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,14176,,CHEMBL628039,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12375,,
Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,14177,,CHEMBL628040,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12375,,
Dissociation rate calculated from the first-order equation using t1/2 value,14178,,CHEMBL628041,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13588,,
The compound was tested for Binding constant against DNA,14179,,CHEMBL630226,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15039,,
First order rate constant for cyclization of the compound,14180,,CHEMBL628042,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9500,,
First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,14181,,CHEMBL625232,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10014,,
First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,14182,,CHEMBL625233,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10014,,
Hydrolysis rate constant was determined,14183,,CHEMBL625979,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,568,,
Observed first order rate constant,14184,,CHEMBL625980,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10026,,
Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,14185,,CHEMBL625981,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10281,,
Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,14186,,CHEMBL625982,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10281,,
Second-order rate constant for attack on PNPA at 25 degree Centigrade,14187,,CHEMBL625983,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9680,,
Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14188,,CHEMBL625984,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14189,,CHEMBL625985,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14190,,CHEMBL625986,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14191,,CHEMBL625987,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14192,,CHEMBL625988,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,14193,,CHEMBL625989,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,14194,,CHEMBL625990,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14195,,CHEMBL625991,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14196,,CHEMBL625992,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14197,,CHEMBL625993,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14198,,CHEMBL631973,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14199,,CHEMBL632143,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14200,,CHEMBL632144,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14201,,CHEMBL632145,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14202,,CHEMBL632146,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,14203,,CHEMBL632147,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,14204,,CHEMBL632148,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14205,,CHEMBL632149,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14206,,CHEMBL632150,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14207,,CHEMBL632151,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,14208,,CHEMBL632152,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,3008,,
Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,14209,,CHEMBL632153,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,4509,,
Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,14210,,CHEMBL632154,50587,BAO_0000218,,,,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,4509,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,14211,,CHEMBL632155,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,14212,,CHEMBL632156,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,14213,,CHEMBL632157,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,14214,,CHEMBL632158,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,14215,,CHEMBL632159,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,14216,,CHEMBL626305,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,14217,,CHEMBL626306,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,14218,,CHEMBL626307,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,14219,,CHEMBL626308,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,14220,,CHEMBL626479,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,14221,,CHEMBL626480,50602,BAO_0000218,,,,1,,,Human herpesvirus 1,,10298.0,1,Intermediate,N,A,,8613,,
Calculated partition coefficient (clogP) (MlogP),14222,,CHEMBL626481,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,6021,,
Equipotent potent ratio relative to carbachol (nicotinic activity),14223,,CHEMBL626482,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9348,,
"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",14224,,CHEMBL626483,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15592,,
"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",14225,,CHEMBL626484,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,15592,,
Solubility at pH 7.4 in micro g/mL;NA denotes available,14226,,CHEMBL626485,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,15592,,
Solubility at pH 7.4 in micro g/mL;NA denotes not available,14227,,CHEMBL626486,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,15592,,
Solubility at pH 7.4 in ug/mL;NA denotes not available,14228,,CHEMBL626487,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,15592,,
Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,14229,,CHEMBL626488,50588,BAO_0000218,,,In vivo,1,,1969.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Plasma,15592,,
Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,14230,,CHEMBL626489,50597,BAO_0000218,,,,1,,1977.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Serum,7095,,
Area under the MAP curve measured over 5 min; ND means Not determined,14231,,CHEMBL626490,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,16618,,
Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,14232,,CHEMBL626491,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,16835,,
The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,14233,,CHEMBL626492,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,15284,,
Half-life was measured in the presence of NADPH at 20 uM; No inhibition,14234,,CHEMBL626493,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15750,,
Half life after oral administration to Sprague-Dawley rats; NT is Not tested,14235,,CHEMBL626494,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16618,,
Half life after oral tested,14236,,CHEMBL626495,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,16618,,
Half life was determined in plasma of rat; NT indicates not tested,14237,,CHEMBL626496,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15812,,
Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,14238,,CHEMBL626497,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,16618,,
Oral bioavailability after oral tested,14239,,CHEMBL626498,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,16618,,
The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),14240,,CHEMBL626499,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13098,,
The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),14241,,CHEMBL626500,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13098,,
half life was determined in plasma of rat; NT indicates not tested,14242,,CHEMBL626501,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15812,,
half life was determined in plasma of rat; NT means not tested,14243,,CHEMBL626502,50597,BAO_0000218,,,,1,,1969.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Plasma,15812,,
Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,14244,,CHEMBL626503,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); inactive,14245,,CHEMBL626504,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,14246,,CHEMBL626505,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,14247,,CHEMBL626506,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,14248,,CHEMBL626507,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,14249,,CHEMBL626508,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,14250,,CHEMBL626509,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,14251,,CHEMBL875480,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,14252,,CHEMBL626510,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,14253,,CHEMBL626511,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,14254,,CHEMBL626512,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,14255,,CHEMBL628208,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,14256,,CHEMBL628209,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,14257,,CHEMBL628210,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,14258,,CHEMBL628211,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,14259,,CHEMBL628212,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,14260,,CHEMBL628213,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,14261,,CHEMBL628214,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,14262,,CHEMBL628215,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,14263,,CHEMBL628216,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,14264,,CHEMBL626595,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,14265,,CHEMBL626596,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,14266,,CHEMBL626597,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,14267,,CHEMBL626598,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,14268,,CHEMBL622242,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,14269,,CHEMBL622243,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,14270,,CHEMBL622244,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,14271,,CHEMBL622245,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,14272,,CHEMBL622246,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,14273,,CHEMBL622247,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,14274,,CHEMBL622248,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,14275,,CHEMBL877483,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,14276,,CHEMBL622249,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,14277,,CHEMBL622250,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,14278,,CHEMBL622251,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,14279,,CHEMBL622252,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,14280,,CHEMBL622253,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,14281,,CHEMBL622254,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,14282,,CHEMBL622255,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,14283,,CHEMBL622256,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,14284,,CHEMBL622257,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,14285,,CHEMBL622258,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,14286,,CHEMBL622259,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,14287,,CHEMBL622927,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,14288,,CHEMBL622928,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,14289,,CHEMBL622929,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,14290,,CHEMBL623182,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,14291,,CHEMBL623183,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,14292,,CHEMBL623184,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,14293,,CHEMBL623185,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,14294,,CHEMBL877484,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,14295,,CHEMBL627274,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,14296,,CHEMBL623186,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,14297,,CHEMBL623187,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,14298,,CHEMBL623188,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,14299,,CHEMBL628055,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,14300,,CHEMBL628056,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,14301,,CHEMBL628200,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,14302,,CHEMBL628201,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,14303,,CHEMBL628202,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,14304,,CHEMBL628203,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,14305,,CHEMBL628204,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,14306,,CHEMBL628205,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,14307,,CHEMBL628206,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),14308,,CHEMBL628207,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,14309,,CHEMBL627220,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,14310,,CHEMBL627221,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),14311,,CHEMBL627222,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,14312,,CHEMBL627223,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,14313,,CHEMBL632062,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,14314,,CHEMBL632063,22224,BAO_0000218,,,In vivo,1,,2106.0,,,,0,Autocuration,U,A,Spleen,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,14315,,CHEMBL632064,22224,BAO_0000218,,,In vivo,1,,1255.0,,,,0,Autocuration,U,A,Urinary bladder,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,14316,,CHEMBL632065,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,14317,,CHEMBL632066,22224,BAO_0000218,,,In vivo,1,,1474.0,,,,0,Autocuration,U,A,Bone element,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,14318,,CHEMBL632067,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,14319,,CHEMBL629188,22224,BAO_0000218,,,In vivo,1,,2113.0,,,,0,Autocuration,U,A,Kidney,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,14320,,CHEMBL629189,22224,BAO_0000218,,,In vivo,1,,2107.0,,,,0,Autocuration,U,A,Liver,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,14321,,CHEMBL629190,22224,BAO_0000218,,,In vivo,1,,2048.0,,,,0,Autocuration,U,A,Lung,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,14322,,CHEMBL629191,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),14323,,CHEMBL629192,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,14324,,CHEMBL629193,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),14325,,CHEMBL629194,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,14326,,CHEMBL629195,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,14327,,CHEMBL629373,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,14328,,CHEMBL629374,22224,BAO_0000218,,,In vivo,1,,2106.0,,,,0,Autocuration,U,A,Spleen,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,14329,,CHEMBL629375,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,14330,,CHEMBL629376,22224,BAO_0000218,,,In vivo,1,,1255.0,,,,0,Autocuration,U,A,Urinary bladder,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,14331,,CHEMBL629377,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,14332,,CHEMBL629378,22224,BAO_0000218,,,In vivo,1,,1474.0,,,,0,Autocuration,U,A,Bone element,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,14333,,CHEMBL629379,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,14334,,CHEMBL629151,22224,BAO_0000218,,,In vivo,1,,2113.0,,,,0,Autocuration,U,A,Kidney,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,14335,,CHEMBL629152,22224,BAO_0000218,,,In vivo,1,,2107.0,,,,0,Autocuration,U,A,Liver,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,14336,,CHEMBL629153,22224,BAO_0000218,,,In vivo,1,,2048.0,,,,0,Autocuration,U,A,Lung,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,14337,,CHEMBL629154,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),14338,,CHEMBL629155,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,14339,,CHEMBL629156,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,14340,,CHEMBL629157,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),14341,,CHEMBL629158,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,14342,,CHEMBL629159,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,14343,,CHEMBL629160,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,14344,,CHEMBL629161,22224,BAO_0000218,,,In vivo,1,,2106.0,,,,0,Autocuration,U,A,Spleen,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,14345,,CHEMBL629162,22224,BAO_0000218,,,In vivo,1,,1255.0,,,,0,Autocuration,U,A,Urinary bladder,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,14346,,CHEMBL629163,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,14347,,CHEMBL629164,22224,BAO_0000218,,,In vivo,1,,1474.0,,,,0,Autocuration,U,A,Bone element,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,14348,,CHEMBL629165,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,14349,,CHEMBL629166,22224,BAO_0000218,,,In vivo,1,,2107.0,,,,0,Autocuration,U,A,Liver,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,14350,,CHEMBL629167,22224,BAO_0000218,,,In vivo,1,,2048.0,,,,0,Autocuration,U,A,Lung,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,14351,,CHEMBL629168,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,14352,,CHEMBL629169,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2193,,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,14353,,CHEMBL629170,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2193,,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,14354,,CHEMBL631153,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2193,,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,14355,,CHEMBL875121,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2193,,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,14356,,CHEMBL631154,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2193,,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,14357,,CHEMBL631155,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2193,,
Hydrolysis rate constant was determined,14358,,CHEMBL631156,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,568,,
"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",14359,,CHEMBL631157,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9680,,
"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",14360,,CHEMBL631158,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9680,,
"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",14361,,CHEMBL631159,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9680,,
Observed second order rate constant,14362,,CHEMBL631160,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10026,,
Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,14363,,CHEMBL631161,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10281,,
Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,14364,,CHEMBL631162,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10014,,
Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,14365,,CHEMBL630313,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10014,,
"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",14366,,CHEMBL630314,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9680,,
"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",14367,,CHEMBL630315,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9680,,
Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14368,,CHEMBL630316,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14369,,CHEMBL630986,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14370,,CHEMBL630987,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,14371,,CHEMBL630988,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14372,,CHEMBL630989,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,14373,,CHEMBL630990,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,14374,,CHEMBL630991,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14375,,CHEMBL630992,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14376,,CHEMBL630993,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14377,,CHEMBL630994,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13028,,
Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,14378,,CHEMBL630995,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,10014,,
Association constant for compound at 31 degree C was determined,14379,,CHEMBL629252,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9962,,
Calculated antagonist equilibrium dissociation constant of the compound,14380,,CHEMBL629253,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12029,,
Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,14381,,CHEMBL629944,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12029,,
Dissociation constants vs LTE4 on guinea pig trachea,14382,,CHEMBL629945,50512,BAO_0000218,,,,1,,3126.0,Cavia porcellus,,10141.0,1,Intermediate,N,A,Trachea,10583,,
"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",14383,,CHEMBL629946,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,568,,
"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",14384,,CHEMBL629947,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,568,,
"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",14385,,CHEMBL629948,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,568,,
"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",14386,,CHEMBL856024,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,568,,
Affinity constant KD value was derived from TMP,14387,,CHEMBL629949,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7493,,
Apparent dissociation (binding) rate constant was evaluated,14388,,CHEMBL629950,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8371,,
Dissociation constant (KD) of the compound,14389,,CHEMBL630127,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13114,,
Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,14390,,CHEMBL630128,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,15515,,
Dissociation constant from ESR titration experiments,14391,,CHEMBL630129,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,522,,
Dissociation constant was evaluated which is similar to Ki (inhibitory constant),14392,,CHEMBL630130,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,,,13888,,
Dissociation constant was evaluated.,14393,,CHEMBL875234,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,2616,,
Dissociation constant was reported,14394,,CHEMBL630131,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,3798,,
Dissociation constant was determined in rat pituitary cells.,14395,,CHEMBL630132,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,8731,,
Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,14396,,CHEMBL630133,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11892,,
Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,14397,,CHEMBL630134,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11892,,
Equilibrium dissociation constant of the compound,14398,,CHEMBL630135,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2582,,
Equilibrium dissociation constant was determined,14399,,CHEMBL630136,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11892,,
Kinetic constant KD was evaluated,14400,,CHEMBL630137,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13396,,
Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,14401,,CHEMBL630138,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,603,,
Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,14402,,CHEMBL630139,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15673,,
Rate constant for hydrolysis in aqueous acetone.,14403,,CHEMBL630140,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10368,,
Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,14404,,CHEMBL875235,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14228,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,14405,,CHEMBL876439,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,14406,,CHEMBL630605,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,14407,,CHEMBL630606,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,14408,,CHEMBL630607,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,14409,,CHEMBL630608,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,14410,,CHEMBL630609,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,14411,,CHEMBL630610,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,14412,,CHEMBL630611,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,14413,,CHEMBL629552,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,14414,,CHEMBL629733,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,14415,,CHEMBL629734,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,14416,,CHEMBL629735,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,14417,,CHEMBL629736,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,14418,,CHEMBL629737,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,14419,,CHEMBL629738,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,14420,,CHEMBL629739,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,14421,,CHEMBL629740,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,14422,,CHEMBL629741,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,14423,,CHEMBL629742,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,14424,,CHEMBL629743,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,14425,,CHEMBL629744,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,14426,,CHEMBL629745,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,14427,,CHEMBL629746,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,14428,,CHEMBL629747,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,14429,,CHEMBL629748,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,14430,,CHEMBL629749,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,14431,,CHEMBL629750,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,14432,,CHEMBL629751,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,14433,,CHEMBL629752,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,14434,,CHEMBL629753,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,14435,,CHEMBL629754,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,14436,,CHEMBL629755,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,14437,,CHEMBL629756,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,14438,,CHEMBL629757,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,14439,,CHEMBL629758,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,14440,,CHEMBL629759,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,14441,,CHEMBL629760,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,14442,,CHEMBL876443,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11510,,
Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,14443,,CHEMBL629761,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,14444,,CHEMBL629762,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14445,,CHEMBL629763,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,14446,,CHEMBL629764,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,14447,,CHEMBL629765,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,14448,,CHEMBL629766,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14449,,CHEMBL629767,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,14450,,CHEMBL629768,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,14451,,CHEMBL629769,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,14452,,CHEMBL629770,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,14453,,CHEMBL629771,50588,BAO_0000218,,,,1,,,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14454,,CHEMBL629772,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14455,,CHEMBL629773,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,14456,,CHEMBL625455,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,14457,,CHEMBL625456,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8310,,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,14458,,CHEMBL625457,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,8310,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,14459,,CHEMBL625458,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,14460,,CHEMBL625459,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,14461,,CHEMBL875483,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,14462,,CHEMBL634779,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,14463,,CHEMBL625460,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,14464,,CHEMBL626117,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,14465,,CHEMBL626118,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,14466,,CHEMBL628342,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,14467,,CHEMBL628343,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,14468,,CHEMBL628344,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,14469,,CHEMBL628345,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,14470,,CHEMBL628346,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,14471,,CHEMBL628347,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,14472,,CHEMBL628348,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,14473,,CHEMBL628349,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,14474,,CHEMBL875611,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,14475,,CHEMBL628350,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,14476,,CHEMBL628351,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,14477,,CHEMBL628352,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,14478,,CHEMBL628353,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,14479,,CHEMBL628354,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,14480,,CHEMBL626667,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,14481,,CHEMBL626668,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,14482,,CHEMBL626669,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,14483,,CHEMBL626670,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,14484,,CHEMBL626671,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,14485,,CHEMBL626672,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,14486,,CHEMBL626673,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,14487,,CHEMBL626674,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,14488,,CHEMBL626675,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,14489,,CHEMBL626676,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,14490,,CHEMBL626677,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,14491,,CHEMBL626678,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,14492,,CHEMBL626679,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,14493,,CHEMBL875612,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,14494,,CHEMBL626680,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,14495,,CHEMBL626681,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,14496,,CHEMBL626682,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,14497,,CHEMBL626683,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,14498,,CHEMBL626684,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,14499,,CHEMBL626685,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,14500,,CHEMBL626686,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,14501,,CHEMBL626687,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,14502,,CHEMBL624978,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,14503,,CHEMBL624979,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,14504,,CHEMBL624980,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,14505,,CHEMBL624981,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,14506,,CHEMBL624982,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),14507,,CHEMBL627564,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),14508,,CHEMBL627565,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,14509,,CHEMBL627566,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,14510,,CHEMBL627567,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,14511,,CHEMBL627568,22224,BAO_0000218,,,In vivo,1,,2106.0,,,,0,Autocuration,U,A,Spleen,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,14512,,CHEMBL627569,22224,BAO_0000218,,,In vivo,1,,2113.0,,,,0,Autocuration,U,A,Kidney,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,14513,,CHEMBL627570,22224,BAO_0000218,,,In vivo,1,,1255.0,,,,0,Autocuration,U,A,Urinary bladder,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,14514,,CHEMBL627571,22224,BAO_0000218,,,In vivo,1,,178.0,,,,0,Autocuration,U,A,Blood,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,14515,,CHEMBL627572,22224,BAO_0000218,,,In vivo,1,,1474.0,,,,0,Autocuration,U,A,Bone element,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,14516,,CHEMBL627573,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,14517,,CHEMBL627574,22224,BAO_0000218,,,In vivo,1,,2113.0,,,,0,Autocuration,U,A,Kidney,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,14518,,CHEMBL627575,22224,BAO_0000218,,,In vivo,1,,2107.0,,,,0,Autocuration,U,A,Liver,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,14519,,CHEMBL627576,22224,BAO_0000218,,,In vivo,1,,2048.0,,,,0,Autocuration,U,A,Lung,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,14520,,CHEMBL627577,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),14521,,CHEMBL627578,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,14522,,CHEMBL627579,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,14523,,CHEMBL627580,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),14524,,CHEMBL627581,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,14525,,CHEMBL627582,22224,BAO_0000218,,,In vivo,1,,,,,,0,Autocuration,U,A,,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,14526,,CHEMBL627583,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,14527,,CHEMBL627584,22224,BAO_0000218,,,In vivo,1,,2106.0,,,,0,Autocuration,U,A,Spleen,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,14528,,CHEMBL627585,22224,BAO_0000218,,,In vivo,1,,2367.0,,,,0,Autocuration,U,A,Prostate gland,13257,,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,14529,,CHEMBL627586,22224,BAO_0000218,,,In vivo,1,,2385.0,,,,0,Autocuration,U,A,Muscle tissue,13257,,
Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,14530,,CHEMBL627587,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15413,,
Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,14531,,CHEMBL627588,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15413,,
Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,14532,,CHEMBL628250,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15413,,
Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,14533,,CHEMBL628251,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15413,,
Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,14534,,CHEMBL628252,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,15413,,
Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,14535,,CHEMBL628253,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,15413,,
Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,14536,,CHEMBL628254,50597,BAO_0000218,,,In vivo,1,,1898.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hypothalamus,15413,,
Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,14537,,CHEMBL877493,50597,BAO_0000218,,,In vivo,1,,1898.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hypothalamus,15413,,
Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,14538,,CHEMBL628255,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15413,,
Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,14539,,CHEMBL628256,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15413,,
Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,14540,,CHEMBL628257,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,15413,,
Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,14541,,CHEMBL628258,50597,BAO_0000218,,,In vivo,1,,1898.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hypothalamus,15413,,
Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,14542,,CHEMBL628259,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15413,,
Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,14543,,CHEMBL628429,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15413,,
Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,14544,,CHEMBL626862,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,15413,,
Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,14545,,CHEMBL626863,50597,BAO_0000218,,,In vivo,1,,1898.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hypothalamus,15413,,
Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,14546,,CHEMBL625886,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,15413,,
Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,14547,,CHEMBL625887,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,15413,,
Biodistribution of the [11C]-radiolabeled compound in rat cortex,14548,,CHEMBL625888,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15413,,
Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,14549,,CHEMBL625889,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15413,,
Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,14550,,CHEMBL625890,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,15413,,
Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,14551,,CHEMBL625891,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,15413,,
Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,14552,,CHEMBL625892,50597,BAO_0000218,,,In vivo,1,,1898.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hypothalamus,15413,,
Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,14553,,CHEMBL625893,50597,BAO_0000218,,,In vivo,1,,1898.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hypothalamus,15413,,
Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,14554,,CHEMBL625894,50597,BAO_0000218,,,In vivo,1,,2037.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Cerebellum,15413,,
Biodistribution of the [18F]-radiolabeled compound in rat cortex,14555,,CHEMBL625895,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15413,,
Reaction rate parameter value for phosphate with transfer with respect to ATP,14556,,CHEMBL625896,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12404,,
"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",14557,,CHEMBL625897,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,568,,
"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",14558,,CHEMBL625898,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,568,,
"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",14559,,CHEMBL625899,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,568,,
Reaction rate parameter value for phosphate with transfer with respect to ATP,14560,,CHEMBL626124,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12404,,
Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,14561,,CHEMBL628500,50212,BAO_0000218,,,,1,,,Escherichia coli,,562.0,1,Intermediate,N,A,,7624,,
"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",14562,,CHEMBL857856,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7624,,
"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",14563,,CHEMBL628501,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7624,,
"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",14564,,CHEMBL628502,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,4643,,
Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,14565,,CHEMBL628503,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11532,,
Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,14566,,CHEMBL628504,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11018,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",14567,,CHEMBL628505,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",14568,,CHEMBL874452,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",14569,,CHEMBL628506,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",14570,,CHEMBL628507,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",14571,,CHEMBL628508,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
Michaelis constant (KM) was evaluated,14572,,CHEMBL628509,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8949,,
Reaction rate parameter value for phosphate with transfer with respect to ATP,14573,,CHEMBL628510,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12404,,
Substrate concentration for half maximal velocity was reported for rat hexokinase I,14574,,CHEMBL628511,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,B,,7625,,
Substrate concentration for half maximal velocity was reported for rat hexokinase II,14575,,CHEMBL628512,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,B,,7625,,
Substrate concentration for half maximal velocity was reported for rat hexokinase III,14576,,CHEMBL628513,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,B,,7625,,
Substrate concentration for half maximal velocity was reported for yeast hexokinase,14577,,CHEMBL628514,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,B,,7625,,
Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,14578,,CHEMBL628515,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,12908,,
Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,14579,,CHEMBL628516,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10368,,
Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),14580,,CHEMBL628517,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13108,,
its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),14581,,CHEMBL628518,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13108,,
Acid dissociation constant evaluated towards Hematin mu-oxo dimer,14582,,CHEMBL628519,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15217,,
Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,14583,,CHEMBL628520,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15217,,
Binding constant was determined,14584,,CHEMBL628521,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10933,,
Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,14585,,CHEMBL630443,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2363,,
Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,14586,,CHEMBL630444,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2363,,
Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,14587,,CHEMBL857732,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,14588,,CHEMBL630445,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14915,,
Catalytic rate constant of the compound,14589,,CHEMBL630446,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8847,,
inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,14590,,CHEMBL630447,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,B,,15357,,
Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),14591,,CHEMBL630448,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2869,,
Catalytic rate constant against phospholipase A2 was determined,14592,,CHEMBL630449,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3484,,
"Compound was evaluated for catalytic constant, Kcat",14593,,CHEMBL630450,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,1373,,
Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,14594,,CHEMBL630451,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8142,,
Kcat calculated from 0.693/T1/2,14595,,CHEMBL630452,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14131,,
Kcat was determined,14596,,CHEMBL630453,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17269,,
Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,14597,,CHEMBL630454,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3485,,
Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,14598,,CHEMBL630455,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3485,,
Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,14599,,CHEMBL631487,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3485,,
Kcat value was determined,14600,,CHEMBL631488,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,5962,,
Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,14601,,CHEMBL876440,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3133,,
Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,14602,,CHEMBL631489,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3133,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",14603,,CHEMBL857742,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",14604,,CHEMBL631490,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",14605,,CHEMBL631491,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",14606,,CHEMBL631492,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",14607,,CHEMBL631493,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
Kinetic parameter for rate of conversion to PABA was determined,14608,,CHEMBL631494,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,4892,,
Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,14609,,CHEMBL631495,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3133,,
"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",14610,,CHEMBL631496,50597,BAO_0000218,,,,1,,1988.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Feces,11488,,
"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",14611,,CHEMBL631497,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,11488,,
"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",14612,,CHEMBL631498,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,11488,,
"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",14613,,CHEMBL629776,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,11488,,
"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",14614,,CHEMBL629777,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,11488,,
"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",14615,,CHEMBL629778,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,11488,,
Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,14616,,CHEMBL630456,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,14617,,CHEMBL630457,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,14618,,CHEMBL630458,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,14619,,CHEMBL630459,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,14620,,CHEMBL630460,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,14621,,CHEMBL876550,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,14622,,CHEMBL630461,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,14623,,CHEMBL630462,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,14624,,CHEMBL630463,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,14625,,CHEMBL630464,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,14626,,CHEMBL630465,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,14627,,CHEMBL630466,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,14628,,CHEMBL630467,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intravenous administration at 2-3 hours in rats,14629,,CHEMBL630633,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intravenous administration at 3-4 hours in rats,14630,,CHEMBL630634,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intravenous administration at 4-6 hours in rats,14631,,CHEMBL630635,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intravenous administration at 6-8 hours in rats,14632,,CHEMBL630636,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
Cumulative dose excreted after intravenous administration at 8-24 hours in rats,14633,,CHEMBL630637,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,11488,,
"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",14634,,CHEMBL630638,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",14635,,CHEMBL630639,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",14636,,CHEMBL630640,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",14637,,CHEMBL876551,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",14638,,CHEMBL630641,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",14639,,CHEMBL630642,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",14640,,CHEMBL630643,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",14641,,CHEMBL630644,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",14642,,CHEMBL630645,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",14643,,CHEMBL625599,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",14644,,CHEMBL625600,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",14645,,CHEMBL625601,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",14646,,CHEMBL625602,50592,BAO_0000218,,,,1,,1988.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Feces,7132,,
"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",14647,,CHEMBL627470,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",14648,,CHEMBL627471,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",14649,,CHEMBL627472,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",14650,,CHEMBL627473,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",14651,,CHEMBL627474,50592,BAO_0000218,,,,1,,1088.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Urine,7132,,
Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14652,,CHEMBL627475,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13925,,
Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14653,,CHEMBL627476,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,13925,,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,14654,,CHEMBL627477,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,14655,,CHEMBL627478,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,14656,,CHEMBL627479,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,14657,,CHEMBL627480,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,14658,,CHEMBL627481,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,14659,,CHEMBL627482,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,14660,,CHEMBL627483,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,14661,,CHEMBL875636,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,14662,,CHEMBL625764,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,14663,,CHEMBL625765,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,14664,,CHEMBL625766,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,14665,,CHEMBL625767,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,14666,,CHEMBL625768,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,14667,,CHEMBL625769,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,14668,,CHEMBL625770,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,14669,,CHEMBL625771,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,14670,,CHEMBL625772,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,14671,,CHEMBL625773,50588,BAO_0000218,,,,1,,1088.0,Canis lupus familiaris,,9615.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,14672,,CHEMBL625774,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,14673,,CHEMBL625775,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,14674,,CHEMBL625776,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,14675,,CHEMBL625777,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,14676,,CHEMBL625778,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,14677,,CHEMBL625779,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,14678,,CHEMBL625780,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,14679,,CHEMBL625781,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,14680,,CHEMBL875637,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,14681,,CHEMBL626473,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,14682,,CHEMBL626474,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,14683,,CHEMBL626475,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,14684,,CHEMBL626476,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,14685,,CHEMBL634397,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,14686,,CHEMBL626477,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,14687,,CHEMBL631069,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,14688,,CHEMBL631070,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,14689,,CHEMBL631071,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,14690,,CHEMBL631072,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,14691,,CHEMBL631073,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,14692,,CHEMBL631074,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,14693,,CHEMBL631075,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,14694,,CHEMBL631725,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,14695,,CHEMBL631726,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,14696,,CHEMBL631727,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,14697,,CHEMBL631728,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,14698,,CHEMBL631729,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,14699,,CHEMBL631730,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,14700,,CHEMBL631731,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,14701,,CHEMBL631910,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,14702,,CHEMBL631911,50597,BAO_0000218,,,In vivo,1,,10000000.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hippocampus,15413,,
Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,14703,,CHEMBL631912,50597,BAO_0000218,,,In vivo,1,,1898.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hypothalamus,15413,,
Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,14704,,CHEMBL631913,50597,BAO_0000218,,,In vivo,1,,1898.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Hypothalamus,15413,,
Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14705,,CHEMBL631914,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14706,,CHEMBL631915,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14707,,CHEMBL875778,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14708,,CHEMBL631916,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14709,,CHEMBL631917,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14710,,CHEMBL631918,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14711,,CHEMBL631919,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14712,,CHEMBL631920,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14713,,CHEMBL631921,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14714,,CHEMBL631922,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14715,,CHEMBL631923,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,12017,,
Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14716,,CHEMBL631924,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14717,,CHEMBL630234,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14718,,CHEMBL630235,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14719,,CHEMBL630236,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14720,,CHEMBL630237,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14721,,CHEMBL630238,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14722,,CHEMBL630239,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14723,,CHEMBL630303,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14724,,CHEMBL630304,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14725,,CHEMBL630305,50597,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,12017,,
Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14726,,CHEMBL630306,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14727,,CHEMBL630307,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14728,,CHEMBL630308,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14729,,CHEMBL630309,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14730,,CHEMBL629309,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14731,,CHEMBL629993,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14732,,CHEMBL629994,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14733,,CHEMBL629995,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14734,,CHEMBL631993,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14735,,CHEMBL631994,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14736,,CHEMBL631995,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,12017,,
Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14737,,CHEMBL631996,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14738,,CHEMBL631997,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14739,,CHEMBL631998,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14740,,CHEMBL631999,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14741,,CHEMBL632000,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14742,,CHEMBL632001,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14743,,CHEMBL874424,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14744,,CHEMBL632002,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14745,,CHEMBL632003,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,14746,,CHEMBL632004,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3133,,
Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,14747,,CHEMBL632005,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2742,,
Compound was tested for amidase rate in the presence of N62C screen enzyme,14748,,CHEMBL632006,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2742,,
Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,14749,,CHEMBL632007,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2742,,
Compound was tested for amidase rate in the presence of S166C screen enzyme,14750,,CHEMBL632008,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2742,,
Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,14751,,CHEMBL632009,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2742,,
Compound was tested for esterase rate in the presence of N62C screen enzyme,14752,,CHEMBL632010,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2742,,
Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,14753,,CHEMBL857750,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2742,,
Compound was tested for esterase rate in the presence of S166C screen enzyme,14754,,CHEMBL632011,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2742,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14755,,CHEMBL632012,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14756,,CHEMBL632013,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",14757,,CHEMBL632014,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14758,,CHEMBL629622,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14759,,CHEMBL629623,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",14760,,CHEMBL629624,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
Ratio of Kcat to that of Km was determined,14761,,CHEMBL629625,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17269,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",14762,,CHEMBL629626,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",14763,,CHEMBL629627,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2276,,
"Compound was evaluated for constant, Kd",14764,,CHEMBL629628,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,15917,,
Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,14765,,CHEMBL629629,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10933,,
Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,14766,,CHEMBL629630,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10933,,
Dissociation Constant of compound determined,14767,,CHEMBL856030,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14293,,
Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,14768,,CHEMBL629631,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,B,,6698,,
Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,14769,,CHEMBL629632,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,B,,6698,,
Dissociation constant of compound with Fructose was determined,14770,,CHEMBL629633,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,4318,,
Dissociation constant of compound with Fructose was determined; Not determined,14771,,CHEMBL629634,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,4318,,
Dissociation constant of compound with Lactulose was determined,14772,,CHEMBL629635,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,4318,,
Dissociation constant of compound with Lactulose was determined; Not determined,14773,,CHEMBL629636,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,4318,,
Dissociation constant of the Compound,14774,,CHEMBL629637,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14959,,
Dissociation constant by non-linear regression analysis,14775,,CHEMBL629638,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,5913,,
Dissociation constant was determined,14776,,CHEMBL629639,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,14218,,
Dissociation constant of the compound; value ranges from 0.81-1.2 nM,14777,,CHEMBL629640,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,10689,,
Dissociation constant was determined,14778,,CHEMBL629641,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,13925,,
Dissociation constant was determined,14779,,CHEMBL631344,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,16359,,
Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,14780,,CHEMBL631345,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10944,,
The dissociation constant determined by fluorescence displacement assay,14781,,CHEMBL631346,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11080,,
kd value surface plasmon resonance (SPR) method,14782,,CHEMBL631524,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,17805,,
Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,14783,,CHEMBL631525,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,10944,,
First dissociation constant of the binding of compound to V30M TTR,14784,,CHEMBL631526,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,F,,16645,,
Second dissociation constant of the binding of compound to V30M TTR,14785,,CHEMBL631527,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,F,,16645,,
"Compound was evaluated for equilibrium constant, Ke",14786,,CHEMBL631528,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7793,,
Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,14787,,CHEMBL631529,22224,BAO_0000019,,,,1,,1898.0,,,,0,Autocuration,U,A,Hypothalamus,12199,,
Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,14788,,CHEMBL631530,22224,BAO_0000019,,,,1,,1898.0,,,,0,Autocuration,U,A,Hypothalamus,12199,,
Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,14789,,CHEMBL631531,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9680,,
Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,14790,,CHEMBL631532,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9680,,
Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,14791,,CHEMBL631533,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,9680,,
In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14792,,CHEMBL876552,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13758,,
In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,14793,,CHEMBL631534,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13758,,
In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14794,,CHEMBL631535,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13758,,
In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14795,,CHEMBL631536,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13758,,
In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,14796,,CHEMBL631537,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13758,,
In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,14797,,CHEMBL631538,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13758,,
In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,14798,,CHEMBL631539,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13758,,
In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14799,,CHEMBL631540,50594,BAO_0000218,,,,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,13758,,
Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14800,,CHEMBL625637,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14393,,
Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14801,,CHEMBL625638,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14393,,
"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",14802,,CHEMBL625639,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,15078,,
Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14803,,CHEMBL625640,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13925,,
Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14804,,CHEMBL625641,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,13925,,
Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14805,,CHEMBL625642,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13925,,
Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14806,,CHEMBL625643,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,13925,,
Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14807,,CHEMBL625644,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13925,,
Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14808,,CHEMBL625645,50597,BAO_0000218,,,In vivo,1,,2113.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Kidney,13925,,
Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14809,,CHEMBL625646,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13925,,
Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14810,,CHEMBL625647,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,13925,,
Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14811,,CHEMBL625648,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13925,,
Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,14812,,CHEMBL625649,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,13925,,
Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14813,,CHEMBL625650,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13925,,
Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14814,,CHEMBL625651,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,13925,,
Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14815,,CHEMBL625652,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,13925,,
Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14816,,CHEMBL625653,50597,BAO_0000218,,,In vivo,1,,14.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Zone of skin,13925,,
Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14817,,CHEMBL625654,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,13925,,
Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14818,,CHEMBL625655,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,13925,,
Biodistribution of Compound in rat blood after 15 minutes of administration,14819,,CHEMBL625656,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9712,,
Biodistribution of Compound in rat blood after 2 minutes of administration,14820,,CHEMBL625657,50597,BAO_0000218,,,In vivo,1,,178.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Blood,9712,,
Biodistribution of Compound in rat brain after 15 minutes of administration,14821,,CHEMBL625658,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,9712,,
Biodistribution of Compound in rat brain after 2 minutes of administration,14822,,CHEMBL625659,50597,BAO_0000218,,,In vivo,1,,955.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Brain,9712,,
Biodistribution of Compound in rat heart after 15 minutes of administration,14823,,CHEMBL625660,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9712,,
Biodistribution of Compound in rat heart after 2 minutes of administration,14824,,CHEMBL625661,50597,BAO_0000218,,,In vivo,1,,948.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Heart,9712,,
Biodistribution of Compound in rat liver after 15 minutes of administration,14825,,CHEMBL625662,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9712,,
Biodistribution of Compound in rat liver after 2 minutes of administration,14826,,CHEMBL625663,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,9712,,
Biodistribution of Compound in rat lung after 15 minutes of administration,14827,,CHEMBL875621,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,9712,,
Biodistribution of Compound in rat lung after 2 minutes of administration,14828,,CHEMBL628382,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,9712,,
Biodistribution of Compound in rat muscle after 15 minutes of administration,14829,,CHEMBL628383,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9712,,
Biodistribution of Compound in rat muscle after 2 minutes of administration,14830,,CHEMBL628384,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,9712,,
Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,14831,,CHEMBL628385,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13925,,
Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,14832,,CHEMBL875753,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13925,,
Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,14833,,CHEMBL628386,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,13925,,
Organ distribution in rat blood 2 minutes after intravenous injection,14834,,CHEMBL628387,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat blood 2 hr after intravenous injection,14835,,CHEMBL628388,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat blood 30 minutes after intravenous injection,14836,,CHEMBL628389,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat blood 30 min after intravenous injection,14837,,CHEMBL632756,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat brain 2 minutes after intravenous injection,14838,,CHEMBL628390,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat brain 2 hr after intravenous injection,14839,,CHEMBL631811,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat brain 30 minutes after intravenous injection,14840,,CHEMBL631812,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat heart 2 minutes after intravenous injection,14841,,CHEMBL631813,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat heart 2 hr after intravenous injection,14842,,CHEMBL631814,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat heart 30 minutes after intravenous injection,14843,,CHEMBL631815,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat kidney 2 minutes after intravenous injection,14844,,CHEMBL631816,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat kidney 2 hr after intravenous injection,14845,,CHEMBL875758,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat kidney 30 minutes after intravenous injection,14846,,CHEMBL631817,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat liver 2 minutes after intravenous injection,14847,,CHEMBL631818,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,6941,,
Organ distribution in rat liver 2 hr after intravenous injection,14848,,CHEMBL631819,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,6941,,
Organ distribution in rat liver 30 minutes after intravenous injection,14849,,CHEMBL631820,50597,BAO_0000218,,,,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,6941,,
Organ distribution in rat lung 2 minutes after intravenous injection,14850,,CHEMBL631821,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat lung 2 hr after intravenous injection,14851,,CHEMBL631822,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat lung 30 minutes after intravenous injection,14852,,CHEMBL631823,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,6941,,
Organ distribution in rat muscle 2 minutes after intravenous injection,14853,,CHEMBL631824,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,6941,,
Organ distribution in rat muscle 2 hr after intravenous injection,14854,,CHEMBL631825,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,6941,,
Organ distribution in rat muscle 30 minutes after intravenous injection,14855,,CHEMBL631826,50597,BAO_0000218,,,,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,6941,,
Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),14856,,CHEMBL631827,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),14857,,CHEMBL631828,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),14858,,CHEMBL631829,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,14859,,CHEMBL875759,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,14860,,CHEMBL631830,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,14861,,CHEMBL631831,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,14862,,CHEMBL631832,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,14863,,CHEMBL631833,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,14864,,CHEMBL631834,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,14865,,CHEMBL631835,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,14866,,CHEMBL631836,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,14867,,CHEMBL631837,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,14868,,CHEMBL631838,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,14869,,CHEMBL631839,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,14870,,CHEMBL631840,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,14871,,CHEMBL631841,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,14872,,CHEMBL631842,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,14873,,CHEMBL631843,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,14874,,CHEMBL631844,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,14875,,CHEMBL631845,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,14876,,CHEMBL631846,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,14877,,CHEMBL875760,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,14878,,CHEMBL632199,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,14879,,CHEMBL631847,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,14880,,CHEMBL631848,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,14881,,CHEMBL628707,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,14882,,CHEMBL628708,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,14883,,CHEMBL628709,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,14884,,CHEMBL628710,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,14885,,CHEMBL628711,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,14886,,CHEMBL628712,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,14887,,CHEMBL628713,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,14888,,CHEMBL628714,50597,BAO_0000218,,,,1,,1088.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Urine,12582,,
"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",14889,,CHEMBL628715,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,7415,,
Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,14890,,CHEMBL629179,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7313,,
Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,14891,,CHEMBL629180,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7313,,
Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,14892,,CHEMBL875108,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7313,,
Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,14893,,CHEMBL629181,22224,BAO_0000019,,,,1,,1235.0,,,,0,Autocuration,U,A,Adrenal cortex,7570,,
Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,14894,,CHEMBL629182,22224,BAO_0000019,,,,1,,1235.0,,,,0,Autocuration,U,A,Adrenal cortex,7570,,
Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,14895,,CHEMBL629183,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7570,,
Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,14896,,CHEMBL629184,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7570,,
Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,14897,,CHEMBL629185,22224,BAO_0000019,,,,1,,1235.0,,,,0,Autocuration,U,A,Adrenal cortex,7570,,
Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,14898,,CHEMBL629186,22224,BAO_0000019,,,,1,,1235.0,,,,0,Autocuration,U,A,Adrenal cortex,7570,,
Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,14899,,CHEMBL629187,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7570,,
Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,14900,,CHEMBL629887,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7570,,
Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,14901,,CHEMBL629888,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7570,,
Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,14902,,CHEMBL629889,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7570,,
Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,14903,,CHEMBL629890,22224,BAO_0000019,,,,1,,1235.0,,,,0,Autocuration,U,A,Adrenal cortex,7570,,
Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,14904,,CHEMBL629891,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7570,,
Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,14905,,CHEMBL629892,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7570,,
Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,14906,,CHEMBL629893,22224,BAO_0000019,,,,1,,1235.0,,,,0,Autocuration,U,A,Adrenal cortex,7570,,
Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,14907,,CHEMBL629894,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7570,,
Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,14908,,CHEMBL629895,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,7570,,
"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",14909,,CHEMBL875109,22224,BAO_0000218,,,In vivo,1,,,Canis lupus familiaris,,9615.0,0,Autocuration,U,A,,14122,,
Absolute bioavailability in male cynomolgus monkeys,14910,,CHEMBL629896,22224,BAO_0000218,,,In vivo,1,,,Macaca fascicularis,,9541.0,0,Autocuration,U,A,,16449,,
Absolute bioavailability in maleSprague-Dawley rats,14911,,CHEMBL629897,22224,BAO_0000218,,,In vivo,1,,,Rattus norvegicus,,10116.0,0,Autocuration,U,A,,16449,,
Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14912,,CHEMBL629898,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14913,,CHEMBL630057,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14914,,CHEMBL630058,50597,BAO_0000218,,,In vivo,1,,2107.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Liver,12017,,
Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14915,,CHEMBL630059,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14916,,CHEMBL630060,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14917,,CHEMBL630061,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14918,,CHEMBL630062,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14919,,CHEMBL630063,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14920,,CHEMBL630064,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14921,,CHEMBL630065,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14922,,CHEMBL630066,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14923,,CHEMBL630067,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14924,,CHEMBL630068,50597,BAO_0000218,,,In vivo,1,,2048.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Lung,12017,,
Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14925,,CHEMBL631113,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14926,,CHEMBL631114,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14927,,CHEMBL631115,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14928,,CHEMBL631116,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14929,,CHEMBL630528,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14930,,CHEMBL630529,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14931,,CHEMBL630530,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14932,,CHEMBL630531,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14933,,CHEMBL630532,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14934,,CHEMBL630533,50597,BAO_0000218,,,In vivo,1,,2385.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Muscle tissue,12017,,
Biodistribution in normal mice blood after 120 hr,14935,,CHEMBL630534,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,15045,,
Biodistribution in normal mice blood after 24 hr,14936,,CHEMBL630535,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,15045,,
Biodistribution in normal mice blood after 4 hr,14937,,CHEMBL630536,50594,BAO_0000218,,,In vivo,1,,178.0,Mus musculus,,10090.0,1,Intermediate,N,A,Blood,15045,,
Biodistribution in normal mice bone after 120 hr,14938,,CHEMBL630537,50594,BAO_0000218,,,In vivo,1,,10000001.0,Mus musculus,,10090.0,1,Intermediate,N,A,Bone,15045,,
Biodistribution in normal mice bone after 24 hr,14939,,CHEMBL630538,50594,BAO_0000218,,,In vivo,1,,10000001.0,Mus musculus,,10090.0,1,Intermediate,N,A,Bone,15045,,
Biodistribution in normal mice bone after 4 hr,14940,,CHEMBL630539,50594,BAO_0000218,,,In vivo,1,,10000001.0,Mus musculus,,10090.0,1,Intermediate,N,A,Bone,15045,,
Biodistribution in normal mice heart after 120 hr,14941,,CHEMBL630540,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,15045,,
Biodistribution in normal mice heart after 24 hr,14942,,CHEMBL630541,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,15045,,
Biodistribution in normal mice heart after 4 hr,14943,,CHEMBL630542,50594,BAO_0000218,,,In vivo,1,,948.0,Mus musculus,,10090.0,1,Intermediate,N,A,Heart,15045,,
Biodistribution in normal mice kidney after 120 hr,14944,,CHEMBL630543,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,15045,,
Biodistribution in normal mice kidney after 24 hr,14945,,CHEMBL630544,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,15045,,
Biodistribution in normal mice kidney after 4 hr,14946,,CHEMBL630545,50594,BAO_0000218,,,In vivo,1,,2113.0,Mus musculus,,10090.0,1,Intermediate,N,A,Kidney,15045,,
Biodistribution in normal mice liver after 120 hr,14947,,CHEMBL630546,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,15045,,
Biodistribution in normal mice liver after 24 hr,14948,,CHEMBL630547,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,15045,,
Biodistribution in normal mice liver after 4 hr,14949,,CHEMBL630548,50594,BAO_0000218,,,In vivo,1,,2107.0,Mus musculus,,10090.0,1,Intermediate,N,A,Liver,15045,,
Biodistribution in normal mice spleen after 120 hr,14950,,CHEMBL630549,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,15045,,
Biodistribution in normal mice spleen after 24 hr,14951,,CHEMBL630550,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,15045,,
Biodistribution in normal mice spleen after 4 hr,14952,,CHEMBL876426,50594,BAO_0000218,,,In vivo,1,,2106.0,Mus musculus,,10090.0,1,Intermediate,N,A,Spleen,15045,,
Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14953,,CHEMBL630551,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14954,,CHEMBL630552,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14955,,CHEMBL630553,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14956,,CHEMBL630554,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14957,,CHEMBL630555,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14958,,CHEMBL630556,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14959,,CHEMBL630557,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14960,,CHEMBL630558,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14961,,CHEMBL630559,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14962,,CHEMBL630560,50597,BAO_0000218,,,In vivo,1,,2106.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Spleen,12017,,
Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14963,,CHEMBL876427,50597,BAO_0000218,,,In vivo,1,,2046.0,Rattus norvegicus,,10116.0,1,Intermediate,N,A,Thyroid gland,12017,,
The Kel values in female wistar rats.,14964,,CHEMBL630561,50597,BAO_0000218,,,,1,,,Rattus norvegicus,,10116.0,1,Intermediate,N,A,,14941,,
The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,14965,,CHEMBL630562,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,4646,,
Hydrolysis rate constant of the compound,14966,,CHEMBL630563,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8847,,
Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,14967,,CHEMBL629673,22229,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,11778,,
"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",14968,,CHEMBL629674,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2363,,
"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",14969,,CHEMBL629675,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2363,,
"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",14970,,CHEMBL629676,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2363,,
"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",14971,,CHEMBL629677,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2363,,
Apparent inactivation rate constant was evaluated,14972,,CHEMBL629678,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8371,,
Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,14973,,CHEMBL629679,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14883,,
Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,14974,,CHEMBL629680,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,14883,,
Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,14975,,CHEMBL629681,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,4643,,
Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,14976,,CHEMBL629682,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,3519,,
DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,14977,,CHEMBL629683,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,10600,,
Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,14978,,CHEMBL629684,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,F,,8501,,
Dissociation constant was determined,14979,,CHEMBL629685,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,8505,,
Dissociation constant was determined,14980,,CHEMBL629686,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,9778,,
Dissociation constant at pH 7.4,14981,,CHEMBL872932,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,9778,,
Dissociation constant in presence of 1 mM dithiothreitol,14982,,CHEMBL629687,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,9778,,
Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,14983,,CHEMBL872931,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13007,,
Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,14984,,CHEMBL628151,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13007,,
Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,14985,,CHEMBL628152,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13007,,
Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,14986,,CHEMBL628153,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,13007,,
Kinetic constant for aromatization of androstenedione,14987,,CHEMBL628154,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11482,,
Kinetic constant for aromatization of testosterone,14988,,CHEMBL628155,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11482,,
Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,14989,,CHEMBL628156,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,2303,,
Local inhibition constant was determined,14990,,CHEMBL628157,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11964,,
Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,14991,,CHEMBL857533,50347,BAO_0000218,,,,1,,,Saccharomyces cerevisiae,,4932.0,1,Intermediate,N,A,,3140,,
Dissociation constant value of the compound,14992,,CHEMBL628158,22224,BAO_0000100,,,,1,,,,,,0,Autocuration,U,P,,10650,,
In vitro permeability through cornea without epithelium,14993,,CHEMBL628159,22224,BAO_0000019,,,,1,,964.0,,,,0,Autocuration,U,A,Cornea,4667,,
In vitro permeability through intact cornea,14994,,CHEMBL875616,22224,BAO_0000019,,,,1,,964.0,,,,0,Autocuration,U,A,Cornea,4667,,
Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,14995,,CHEMBL628160,50592,BAO_0000218,,,,1,,964.0,Oryctolagus cuniculus,,9986.0,1,Intermediate,N,A,Cornea,9199,,
Rate of enzyme inactivation for the compound was determined,14996,,CHEMBL628161,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,11966,,
In vitro permeability through cornea without epithelium,14997,,CHEMBL628162,22224,BAO_0000019,,,,1,,964.0,,,,0,Autocuration,U,A,Cornea,4667,,
In vitro permeability through intact cornea,14998,,CHEMBL628163,22224,BAO_0000019,,,,1,,964.0,,,,0,Autocuration,U,A,Cornea,4667,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",14999,,CHEMBL628164,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",15000,,CHEMBL628165,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",15001,,CHEMBL628166,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",15002,,CHEMBL628167,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",15003,,CHEMBL628168,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",15004,,CHEMBL628169,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",15005,,CHEMBL628170,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",15006,,CHEMBL628171,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",15007,,CHEMBL627434,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",15008,,CHEMBL627435,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",15009,,CHEMBL628110,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",15010,,CHEMBL628111,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",15011,,CHEMBL628112,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",15012,,CHEMBL628260,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",15013,,CHEMBL628261,22224,BAO_0000019,,,,1,,,,,,0,Autocuration,U,A,,8354,,
Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),15014,,CHEMBL628262,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,15015,,CHEMBL628263,50587,BAO_0000218,,,In vivo,1,,,Homo sapiens,,9606.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),15016,,CHEMBL628264,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),15017,,CHEMBL628265,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),15018,,CHEMBL628266,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),15019,,CHEMBL628267,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,15020,,CHEMBL628268,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),15021,,CHEMBL628269,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),15022,,CHEMBL628270,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),15023,,CHEMBL628271,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),15024,,CHEMBL628272,50594,BAO_0000218,,,In vivo,1,,,Mus musculus,,10090.0,1,Intermediate,N,A,,14439,,
